{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "cyp3a4 inhibitors: ketoconazole, an inhibitor of the drug metabolizing enzyme cyp3a4, significantly increased plasma concentrations of tolterodine when coadministered to subjects who were poor metabolizers (see clinical pharmacology, variability in metabolism and drug-drug interactions).", "output": "Let's think step by step.\nThe drug entities in this text are:\nketoconazole, tolterodine\nSo the corresponding drug entities and relations triplets are:\nketoconazole, mechanism, tolterodine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "for patients receiving ketoconazole or other potent cyp3a4 inhibitors such as other azole antifungals (eg, itraconazole, miconazole) or macrolide antibiotics (eg, erythromycin, clarithromycin) or cyclosporine or vinblastine, the recommended dose of detrol la is 2 mg daily.", "output": "Let's think step by step.\nThe drug entities in this text are:\nketoconazole, azole antifungals, itraconazole, miconazole, macrolide antibiotics, erythromycin, clarithromycin, cyclosporine, vinblastine, detrol la\nSo the corresponding drug entities and relations triplets are:\nketoconazole, false, azole antifungals\nketoconazole, false, itraconazole\nketoconazole, false, miconazole\nketoconazole, false, macrolide antibiotics\nketoconazole, false, erythromycin\nketoconazole, false, clarithromycin\nketoconazole, false, cyclosporine\nketoconazole, false, vinblastine\nketoconazole, advise, detrol la\nazole antifungals, false, itraconazole\nazole antifungals, false, miconazole\nazole antifungals, false, macrolide antibiotics\nazole antifungals, false, erythromycin\nazole antifungals, false, clarithromycin\nazole antifungals, false, cyclosporine\nazole antifungals, false, vinblastine\nazole antifungals, advise, detrol la\nitraconazole, false, miconazole\nitraconazole, false, macrolide antibiotics\nitraconazole, false, erythromycin\nitraconazole, false, clarithromycin\nitraconazole, false, cyclosporine\nitraconazole, false, vinblastine\nitraconazole, advise, detrol la\nmiconazole, false, macrolide antibiotics\nmiconazole, false, erythromycin\nmiconazole, false, clarithromycin\nmiconazole, false, cyclosporine\nmiconazole, false, vinblastine\nmiconazole, advise, detrol la\nmacrolide antibiotics, false, erythromycin\nmacrolide antibiotics, false, clarithromycin\nmacrolide antibiotics, false, cyclosporine\nmacrolide antibiotics, false, vinblastine\nmacrolide antibiotics, advise, detrol la\nerythromycin, false, clarithromycin\nerythromycin, false, cyclosporine\nerythromycin, false, vinblastine\nerythromycin, advise, detrol la\nclarithromycin, false, cyclosporine\nclarithromycin, false, vinblastine\nclarithromycin, advise, detrol la\ncyclosporine, false, vinblastine\ncyclosporine, advise, detrol la\nvinblastine, advise, detrol la END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "potential for invega    to affect other drugs paliperidone is not expected to cause clinically important pharmacokinetic interactions with drugs that are metabolized by cytochrome p450 isozymes.", "output": "Let's think step by step.\nThe drug entities in this text are:\ninvega, paliperidone\nSo the corresponding drug entities and relations triplets are:\ninvega, false, paliperidone END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "given the primary cns effects of paliperidone, invega    should be used with caution in combination with other centrally acting drugs and alcohol.", "output": "Let's think step by step.\nThe drug entities in this text are:\npaliperidone, invega, centrally acting drugs, alcohol\nSo the corresponding drug entities and relations triplets are:\npaliperidone, false, invega\npaliperidone, advise, centrally acting drugs\npaliperidone, advise, alcohol\ninvega, advise, centrally acting drugs\ninvega, advise, alcohol\ncentrally acting drugs, false, alcohol END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "paliperidone may antagonize the effect of levodopa and other dopamine agonists.", "output": "Let's think step by step.\nThe drug entities in this text are:\npaliperidone, levodopa, dopamine agonists\nSo the corresponding drug entities and relations triplets are:\npaliperidone, effect, levodopa\npaliperidone, effect, dopamine agonists\nlevodopa, false, dopamine agonists END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "potential for other drugs to affect invega    paliperidone is not a substrate of cyp1a2, cyp2a6, cyp2c9, and cyp2c19, so that an interaction with inhibitors or inducers of these isozymes is unlikely.", "output": "Let's think step by step.\nThe drug entities in this text are:\ninvega, paliperidone\nSo the corresponding drug entities and relations triplets are:\ninvega, false, paliperidone END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the concomitant use of oxybutynin with other anticholinergic drugs or with other agents which produce dry mouth, constipation, somnolence (drowsiness), and/or other anticholinergic-like effects may increase the frequency and/or severity of such effects.", "output": "Let's think step by step.\nThe drug entities in this text are:\noxybutynin, anticholinergic drugs\nSo the corresponding drug entities and relations triplets are:\noxybutynin, effect, anticholinergic drugs END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "mean oxybutynin chloride plasma concentrations were approximately 2 fold higher when ditropan xl was administered with ketoconazole, a potent cyp3a4 inhibitor.", "output": "Let's think step by step.\nThe drug entities in this text are:\noxybutynin chloride, ditropan xl, ketoconazole\nSo the corresponding drug entities and relations triplets are:\noxybutynin chloride, false, ditropan xl\noxybutynin chloride, false, ketoconazole\nditropan xl, mechanism, ketoconazole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "other inhibitors of the cytochrome p450 3a4 enzyme system, such as antimycotic agents (e.g., itraconazole and miconazole) or macrolide antibiotics (e.g., erythromycin and clarithromycin), may alter oxybutynin mean pharmacokinetic parameters (i.e., cmax and auc).", "output": "Let's think step by step.\nThe drug entities in this text are:\nantimycotic agents, itraconazole, miconazole, macrolide antibiotics, erythromycin, clarithromycin, oxybutynin\nSo the corresponding drug entities and relations triplets are:\nantimycotic agents, false, itraconazole\nantimycotic agents, false, miconazole\nantimycotic agents, false, macrolide antibiotics\nantimycotic agents, false, erythromycin\nantimycotic agents, false, clarithromycin\nantimycotic agents, mechanism, oxybutynin\nitraconazole, false, miconazole\nitraconazole, false, macrolide antibiotics\nitraconazole, false, erythromycin\nitraconazole, false, clarithromycin\nitraconazole, mechanism, oxybutynin\nmiconazole, false, macrolide antibiotics\nmiconazole, false, erythromycin\nmiconazole, false, clarithromycin\nmiconazole, mechanism, oxybutynin\nmacrolide antibiotics, false, erythromycin\nmacrolide antibiotics, false, clarithromycin\nmacrolide antibiotics, mechanism, oxybutynin\nerythromycin, false, clarithromycin\nerythromycin, mechanism, oxybutynin\nclarithromycin, mechanism, oxybutynin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "concurrent ingestion of antacid (20 ml of antacid containing aluminum hydroxide, magnesium hydroxide, and simethicone) did not significantly affect the exposure of oxybutynin or desethyloxybutynin.", "output": "Let's think step by step.\nThe drug entities in this text are:\nantacid, antacid, aluminum hydroxide, magnesium hydroxide, simethicone, oxybutynin, desethyloxybutynin\nSo the corresponding drug entities and relations triplets are:\nantacid, false, aluminum hydroxide\nantacid, false, magnesium hydroxide\nantacid, false, simethicone\nantacid, false, oxybutynin\nantacid, false, desethyloxybutynin\nantacid, false, aluminum hydroxide\nantacid, false, magnesium hydroxide\nantacid, false, simethicone\nantacid, false, oxybutynin\nantacid, false, desethyloxybutynin\naluminum hydroxide, false, magnesium hydroxide\naluminum hydroxide, false, simethicone\naluminum hydroxide, false, oxybutynin\naluminum hydroxide, false, desethyloxybutynin\nmagnesium hydroxide, false, simethicone\nmagnesium hydroxide, false, oxybutynin\nmagnesium hydroxide, false, desethyloxybutynin\nsimethicone, false, oxybutynin\nsimethicone, false, desethyloxybutynin\noxybutynin, false, desethyloxybutynin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "mitotane has been reported to accelerate the metabolism of warfarin by the mechanism of hepatic microsomal enzyme induction, leading to an increase in dosage requirements for warfarin.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmitotane, warfarin, warfarin\nSo the corresponding drug entities and relations triplets are:\nmitotane, mechanism, warfarin\nmitotane, false, warfarin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "therefore, physicians should closely monitor patients for a change in anticoagulant dosage requirements when administering mitotane to patients on coumarin-type anticoagulants.", "output": "Let's think step by step.\nThe drug entities in this text are:\nanticoagulant, mitotane, coumarin-type anticoagulants\nSo the corresponding drug entities and relations triplets are:\nanticoagulant, false, mitotane\nanticoagulant, false, coumarin-type anticoagulants\nmitotane, advise, coumarin-type anticoagulants END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "concomitant administration of vancomycin and anesthetic agents has been associated with erythema and histamine-like flushing and anaphylactoid reactions.", "output": "Let's think step by step.\nThe drug entities in this text are:\nvancomycin, anesthetic agents\nSo the corresponding drug entities and relations triplets are:\nvancomycin, effect, anesthetic agents END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "concurrent and/or sequential systemic or topical use of other potentially neurotoxic and/or nephrotoxic drugs, such as amphotericin b, aminoglycosides, bacitracin, polymyxin b, colistin, viomycin, or cisplatin, when indicated, requires careful monitoring.", "output": "Let's think step by step.\nThe drug entities in this text are:\namphotericin b, aminoglycosides, bacitracin, polymyxin b, colistin, viomycin, cisplatin\nSo the corresponding drug entities and relations triplets are:\namphotericin b, false, aminoglycosides\namphotericin b, false, bacitracin\namphotericin b, false, polymyxin b\namphotericin b, false, colistin\namphotericin b, false, viomycin\namphotericin b, false, cisplatin\naminoglycosides, false, bacitracin\naminoglycosides, false, polymyxin b\naminoglycosides, false, colistin\naminoglycosides, false, viomycin\naminoglycosides, false, cisplatin\nbacitracin, false, polymyxin b\nbacitracin, false, colistin\nbacitracin, false, viomycin\nbacitracin, false, cisplatin\npolymyxin b, false, colistin\npolymyxin b, false, viomycin\npolymyxin b, false, cisplatin\ncolistin, false, viomycin\ncolistin, false, cisplatin\nviomycin, false, cisplatin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "coadministration of tritec with clarithromycin resulted in increased plasma ranitidine concentrations (57%), increased plasma bismuth trough concentrations (48%), and increased 14- hydroxy- clarithromycin plasma concentrations (31%).", "output": "Let's think step by step.\nThe drug entities in this text are:\ntritec, clarithromycin, ranitidine, 14- hydroxy- clarithromycin\nSo the corresponding drug entities and relations triplets are:\ntritec, mechanism, clarithromycin\ntritec, false, ranitidine\ntritec, false, 14- hydroxy- clarithromycin\nclarithromycin, false, ranitidine\nclarithromycin, false, 14- hydroxy- clarithromycin\nranitidine, false, 14- hydroxy- clarithromycin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "coadministration with aspirin results in a slight decrease in the rate of salicylate absorption that is clinically unimportant.", "output": "Let's think step by step.\nThe drug entities in this text are:\naspirin, salicylate\nSo the corresponding drug entities and relations triplets are:\naspirin, false, salicylate END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "coadministration with a high dose of antacid (170 meq) results in a 28% decrease in plasma concentrations of ranitidine and may decrease plasma concentrations of bismuth from tritec.", "output": "Let's think step by step.\nThe drug entities in this text are:\nantacid, ranitidine, tritec\nSo the corresponding drug entities and relations triplets are:\nantacid, mechanism, ranitidine\nantacid, mechanism, tritec\nranitidine, false, tritec END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "for information on drug interactions associated with ranitidine, refer to the zantac     package insert.", "output": "Let's think step by step.\nThe drug entities in this text are:\nranitidine, zantac\nSo the corresponding drug entities and relations triplets are:\nranitidine, false, zantac END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "these include sympathomimetic bronchodilators, methylxanthines, and oral and inhaled steroids.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsympathomimetic bronchodilators, methylxanthines, steroids\nSo the corresponding drug entities and relations triplets are:\nsympathomimetic bronchodilators, false, methylxanthines\nsympathomimetic bronchodilators, false, steroids\nmethylxanthines, false, steroids END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "however, the co   administration of spiriva with other anticholinergic   containing drugs (e.g., ipratropium) has not been studied and is therefore not recommended.", "output": "Let's think step by step.\nThe drug entities in this text are:\nspiriva, anticholinergic, ipratropium\nSo the corresponding drug entities and relations triplets are:\nspiriva, advise, anticholinergic\nspiriva, advise, ipratropium\nanticholinergic, false, ipratropium END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "prothrombin time or other suitable anticoagulation test should be monitored if tigecycline is administered with warfarin.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntigecycline, warfarin\nSo the corresponding drug entities and relations triplets are:\ntigecycline, advise, warfarin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "concurrent use of antibacterial drugs with oral contraceptives may render oral contraceptives less effective.", "output": "Let's think step by step.\nThe drug entities in this text are:\nantibacterial drugs, contraceptives, contraceptives\nSo the corresponding drug entities and relations triplets are:\nantibacterial drugs, effect, contraceptives\nantibacterial drugs, false, contraceptives END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "triprolidine may enhance the sedative effects of central nervous system depressants including alcohol, barbiturates, hypnotics, narcotic analgesics, sedatives, and tranquillisers.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntriprolidine, central nervous system depressants, alcohol, barbiturates, hypnotics, narcotic analgesics, sedatives, tranquillisers\nSo the corresponding drug entities and relations triplets are:\ntriprolidine, effect, central nervous system depressants\ntriprolidine, effect, alcohol\ntriprolidine, effect, barbiturates\ntriprolidine, effect, hypnotics\ntriprolidine, effect, narcotic analgesics\ntriprolidine, effect, sedatives\ntriprolidine, effect, tranquillisers\ncentral nervous system depressants, false, alcohol\ncentral nervous system depressants, false, barbiturates\ncentral nervous system depressants, false, hypnotics\ncentral nervous system depressants, false, narcotic analgesics\ncentral nervous system depressants, false, sedatives\ncentral nervous system depressants, false, tranquillisers\nalcohol, false, barbiturates\nalcohol, false, hypnotics\nalcohol, false, narcotic analgesics\nalcohol, false, sedatives\nalcohol, false, tranquillisers\nbarbiturates, false, hypnotics\nbarbiturates, false, narcotic analgesics\nbarbiturates, false, sedatives\nbarbiturates, false, tranquillisers\nhypnotics, false, narcotic analgesics\nhypnotics, false, sedatives\nhypnotics, false, tranquillisers\nnarcotic analgesics, false, sedatives\nnarcotic analgesics, false, tranquillisers\nsedatives, false, tranquillisers END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the effects of anticholinergic drugs, such as atropine and tricyclic antidepressants may be enhanced by the concomitant administration of triprolidine.", "output": "Let's think step by step.\nThe drug entities in this text are:\nanticholinergic drugs, atropine, tricyclic antidepressants, triprolidine\nSo the corresponding drug entities and relations triplets are:\nanticholinergic drugs, false, atropine\nanticholinergic drugs, false, tricyclic antidepressants\nanticholinergic drugs, effect, triprolidine\natropine, false, tricyclic antidepressants\natropine, effect, triprolidine\ntricyclic antidepressants, effect, triprolidine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "cyp 3a4 inhibitors (e.g. macrolide antibiotics and protease inhibitors) there have been rare reports of serious adverse events in connection with the coadministration of certain ergot alkaloid drugs (e.g. dihydroergotamine and ergotamine) and potent cyp 3a4 inhibitors, resulting in vasospasm leading to cerebral ischemia and/or ischemia of the extremities.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmacrolide antibiotics, protease inhibitors, ergot alkaloid drugs, dihydroergotamine, ergotamine\nSo the corresponding drug entities and relations triplets are:\nmacrolide antibiotics, false, protease inhibitors\nmacrolide antibiotics, false, ergot alkaloid drugs\nmacrolide antibiotics, false, dihydroergotamine\nmacrolide antibiotics, false, ergotamine\nprotease inhibitors, false, ergot alkaloid drugs\nprotease inhibitors, false, dihydroergotamine\nprotease inhibitors, false, ergotamine\nergot alkaloid drugs, false, dihydroergotamine\nergot alkaloid drugs, false, ergotamine\ndihydroergotamine, false, ergotamine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "examples of some of the more potent cyp 3a4 inhibitors include macrolide antibiotics (e.g., erythromycin, troleandomycin, clarithromycin), hiv protease or reverse transcriptase inhibitors (e.g., ritonavir, indinavir, nelfinavir, delavirdine) or azole antifungals (e.g., ketoconazole, itraconazole, voriconazole).", "output": "Let's think step by step.\nThe drug entities in this text are:\nmacrolide antibiotics, erythromycin, troleandomycin, clarithromycin, hiv protease inhibitors, reverse transcriptase inhibitors, ritonavir, indinavir, nelfinavir, delavirdine, azole antifungals, ketoconazole, itraconazole, voriconazole\nSo the corresponding drug entities and relations triplets are:\nmacrolide antibiotics, false, erythromycin\nmacrolide antibiotics, false, troleandomycin\nmacrolide antibiotics, false, clarithromycin\nmacrolide antibiotics, false, hiv protease inhibitors\nmacrolide antibiotics, false, reverse transcriptase inhibitors\nmacrolide antibiotics, false, ritonavir\nmacrolide antibiotics, false, indinavir\nmacrolide antibiotics, false, nelfinavir\nmacrolide antibiotics, false, delavirdine\nmacrolide antibiotics, false, azole antifungals\nmacrolide antibiotics, false, ketoconazole\nmacrolide antibiotics, false, itraconazole\nmacrolide antibiotics, false, voriconazole\nerythromycin, false, troleandomycin\nerythromycin, false, clarithromycin\nerythromycin, false, hiv protease inhibitors\nerythromycin, false, reverse transcriptase inhibitors\nerythromycin, false, ritonavir\nerythromycin, false, indinavir\nerythromycin, false, nelfinavir\nerythromycin, false, delavirdine\nerythromycin, false, azole antifungals\nerythromycin, false, ketoconazole\nerythromycin, false, itraconazole\nerythromycin, false, voriconazole\ntroleandomycin, false, clarithromycin\ntroleandomycin, false, hiv protease inhibitors\ntroleandomycin, false, reverse transcriptase inhibitors\ntroleandomycin, false, ritonavir\ntroleandomycin, false, indinavir\ntroleandomycin, false, nelfinavir\ntroleandomycin, false, delavirdine\ntroleandomycin, false, azole antifungals\ntroleandomycin, false, ketoconazole\ntroleandomycin, false, itraconazole\ntroleandomycin, false, voriconazole\nclarithromycin, false, hiv protease inhibitors\nclarithromycin, false, reverse transcriptase inhibitors\nclarithromycin, false, ritonavir\nclarithromycin, false, indinavir\nclarithromycin, false, nelfinavir\nclarithromycin, false, delavirdine\nclarithromycin, false, azole antifungals\nclarithromycin, false, ketoconazole\nclarithromycin, false, itraconazole\nclarithromycin, false, voriconazole\nhiv protease inhibitors, false, reverse transcriptase inhibitors\nhiv protease inhibitors, false, ritonavir\nhiv protease inhibitors, false, indinavir\nhiv protease inhibitors, false, nelfinavir\nhiv protease inhibitors, false, delavirdine\nhiv protease inhibitors, false, azole antifungals\nhiv protease inhibitors, false, ketoconazole\nhiv protease inhibitors, false, itraconazole\nhiv protease inhibitors, false, voriconazole\nreverse transcriptase inhibitors, false, ritonavir\nreverse transcriptase inhibitors, false, indinavir\nreverse transcriptase inhibitors, false, nelfinavir\nreverse transcriptase inhibitors, false, delavirdine\nreverse transcriptase inhibitors, false, azole antifungals\nreverse transcriptase inhibitors, false, ketoconazole\nreverse transcriptase inhibitors, false, itraconazole\nreverse transcriptase inhibitors, false, voriconazole\nritonavir, false, indinavir\nritonavir, false, nelfinavir\nritonavir, false, delavirdine\nritonavir, false, azole antifungals\nritonavir, false, ketoconazole\nritonavir, false, itraconazole\nritonavir, false, voriconazole\nindinavir, false, nelfinavir\nindinavir, false, delavirdine\nindinavir, false, azole antifungals\nindinavir, false, ketoconazole\nindinavir, false, itraconazole\nindinavir, false, voriconazole\nnelfinavir, false, delavirdine\nnelfinavir, false, azole antifungals\nnelfinavir, false, ketoconazole\nnelfinavir, false, itraconazole\nnelfinavir, false, voriconazole\ndelavirdine, false, azole antifungals\ndelavirdine, false, ketoconazole\ndelavirdine, false, itraconazole\ndelavirdine, false, voriconazole\nazole antifungals, false, ketoconazole\nazole antifungals, false, itraconazole\nazole antifungals, false, voriconazole\nketoconazole, false, itraconazole\nketoconazole, false, voriconazole\nitraconazole, false, voriconazole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "less potent inhibitors include saquinavir, nefazodone, fluconazole, grapefruit juice, fluoxetine, fluvoxamine, zileuton, and clotrimazole.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsaquinavir, nefazodone, fluconazole, fluoxetine, fluvoxamine, zileuton, clotrimazole\nSo the corresponding drug entities and relations triplets are:\nsaquinavir, false, nefazodone\nsaquinavir, false, fluconazole\nsaquinavir, false, fluoxetine\nsaquinavir, false, fluvoxamine\nsaquinavir, false, zileuton\nsaquinavir, false, clotrimazole\nnefazodone, false, fluconazole\nnefazodone, false, fluoxetine\nnefazodone, false, fluvoxamine\nnefazodone, false, zileuton\nnefazodone, false, clotrimazole\nfluconazole, false, fluoxetine\nfluconazole, false, fluvoxamine\nfluconazole, false, zileuton\nfluconazole, false, clotrimazole\nfluoxetine, false, fluvoxamine\nfluoxetine, false, zileuton\nfluoxetine, false, clotrimazole\nfluvoxamine, false, zileuton\nfluvoxamine, false, clotrimazole\nzileuton, false, clotrimazole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "caution should be exercised when methergine    (methylergonovine maleate) is used concurrently with other vasoconstrictors or ergot alkaloids.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmethergine, methylergonovine maleate, vasoconstrictors, ergot alkaloids\nSo the corresponding drug entities and relations triplets are:\nmethergine, false, methylergonovine maleate\nmethergine, advise, vasoconstrictors\nmethergine, advise, ergot alkaloids\nmethylergonovine maleate, advise, vasoconstrictors\nmethylergonovine maleate, false, ergot alkaloids\nvasoconstrictors, false, ergot alkaloids END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "agents that might be coadministered with trimetrexate in aids patients for other indications that could elicit this activity include erythromycin, rifampin, rifabutin, ketoconazole, and fluconazole.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntrimetrexate, erythromycin, rifampin, rifabutin, ketoconazole, fluconazole\nSo the corresponding drug entities and relations triplets are:\ntrimetrexate, effect, erythromycin\ntrimetrexate, effect, rifampin\ntrimetrexate, effect, rifabutin\ntrimetrexate, effect, ketoconazole\ntrimetrexate, effect, fluconazole\nerythromycin, false, rifampin\nerythromycin, false, rifabutin\nerythromycin, false, ketoconazole\nerythromycin, false, fluconazole\nrifampin, false, rifabutin\nrifampin, false, ketoconazole\nrifampin, false, fluconazole\nrifabutin, false, ketoconazole\nrifabutin, false, fluconazole\nketoconazole, false, fluconazole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in vitro perfusion of isolated rat liver has shown that cimetidine caused a significant reduction in trimetrexate metabolism and that acetaminophen altered the relative concentration of trimetrexate metabolites possibly by competing for sulfate metabolites.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncimetidine, trimetrexate, acetaminophen\nSo the corresponding drug entities and relations triplets are:\ncimetidine, mechanism, trimetrexate\ncimetidine, false, acetaminophen\ntrimetrexate, false, acetaminophen END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "based on an in vitro rat liver model, nitrogen substituted imidazole drugs (clotrimazole, ketoconazole, miconazole) were potent, non-competitive inhibitors of trimetrexate metabolism.", "output": "Let's think step by step.\nThe drug entities in this text are:\nimidazole drugs, clotrimazole, ketoconazole, miconazole, trimetrexate\nSo the corresponding drug entities and relations triplets are:\nimidazole drugs, false, clotrimazole\nimidazole drugs, false, ketoconazole\nimidazole drugs, false, miconazole\nimidazole drugs, mechanism, trimetrexate\nclotrimazole, false, ketoconazole\nclotrimazole, false, miconazole\nclotrimazole, mechanism, trimetrexate\nketoconazole, false, miconazole\nketoconazole, mechanism, trimetrexate\nmiconazole, mechanism, trimetrexate END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "aggrastat has been studied on a background of aspirin and heparin.", "output": "Let's think step by step.\nThe drug entities in this text are:\naggrastat, aspirin, heparin\nSo the corresponding drug entities and relations triplets are:\naggrastat, false, aspirin\naggrastat, false, heparin\naspirin, false, heparin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the use of aggrastat, in combination with heparin and aspirin, has been associated with an increase in bleeding compared to heparin and aspirin alone (see", "output": "Let's think step by step.\nThe drug entities in this text are:\naggrastat, heparin, aspirin, heparin, aspirin\nSo the corresponding drug entities and relations triplets are:\naggrastat, effect, heparin\naggrastat, effect, aspirin\naggrastat, false, heparin\naggrastat, false, aspirin\nheparin, false, aspirin\nheparin, false, aspirin\naspirin, false, heparin\nheparin, false, aspirin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "however, in patients with paget's disease prior diphosphonate use appears to reduce the anti-resorptive response to calcitonin (salmon) nasal spray.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndiphosphonate, calcitonin (salmon)\nSo the corresponding drug entities and relations triplets are:\ndiphosphonate, effect, calcitonin (salmon) END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "to minimize cns depression and possible potentiation, barbiturates, antihistamines, narcotics, hypotensive agents or phenothiazines should be used with caution.", "output": "Let's think step by step.\nThe drug entities in this text are:\nbarbiturates, antihistamines, narcotics, hypotensive agents, phenothiazines\nSo the corresponding drug entities and relations triplets are:\nbarbiturates, false, antihistamines\nbarbiturates, false, narcotics\nbarbiturates, false, hypotensive agents\nbarbiturates, false, phenothiazines\nantihistamines, false, narcotics\nantihistamines, false, hypotensive agents\nantihistamines, false, phenothiazines\nnarcotics, false, hypotensive agents\nnarcotics, false, phenothiazines\nhypotensive agents, false, phenothiazines END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "because matulane exhibits some monoamine oxidase inhibitory activity, sympathomimetic drugs, tricyclic antidepressant drugs (e.g., amitriptyline hcl, imipramine hcl) and other drugs and foods with known high tyramine content, such as wine, yogurt, ripe cheese and bananas, should be avoided.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmatulane, sympathomimetic drugs, tricyclic antidepressant, amitriptyline hcl, imipramine hcl, tyramine\nSo the corresponding drug entities and relations triplets are:\nmatulane, advise, sympathomimetic drugs\nmatulane, advise, tricyclic antidepressant\nmatulane, advise, amitriptyline hcl\nmatulane, advise, imipramine hcl\nmatulane, advise, tyramine\nsympathomimetic drugs, false, tricyclic antidepressant\nsympathomimetic drugs, false, amitriptyline hcl\nsympathomimetic drugs, false, imipramine hcl\nsympathomimetic drugs, false, tyramine\ntricyclic antidepressant, false, amitriptyline hcl\ntricyclic antidepressant, false, imipramine hcl\ntricyclic antidepressant, false, tyramine\namitriptyline hcl, false, imipramine hcl\namitriptyline hcl, false, tyramine\nimipramine hcl, false, tyramine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "no cross-resistance with other chemotherapeutic agents, radiotherapy or steroids has been demonstrated.", "output": "Let's think step by step.\nThe drug entities in this text are:\nchemotherapeutic agents, steroids\nSo the corresponding drug entities and relations triplets are:\nchemotherapeutic agents, false, steroids END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "patients receiving lithium and neulasta should have more frequent monitoring of neutrophil counts.", "output": "Let's think step by step.\nThe drug entities in this text are:\nlithium, neulasta\nSo the corresponding drug entities and relations triplets are:\nlithium, advise, neulasta END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "a total of 11 clinical drug-drug interaction studies were conducted in healthy volunteers to evaluate the potential for interaction between mycamine and mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, sirolimus, nifedipine, fluconazole, ritonavir, and rifampin.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmycamine, mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, sirolimus, nifedipine, fluconazole, ritonavir, rifampin\nSo the corresponding drug entities and relations triplets are:\nmycamine, false, mycophenolate mofetil\nmycamine, false, cyclosporine\nmycamine, false, tacrolimus\nmycamine, false, prednisolone\nmycamine, false, sirolimus\nmycamine, false, nifedipine\nmycamine, false, fluconazole\nmycamine, false, ritonavir\nmycamine, false, rifampin\nmycophenolate mofetil, false, cyclosporine\nmycophenolate mofetil, false, tacrolimus\nmycophenolate mofetil, false, prednisolone\nmycophenolate mofetil, false, sirolimus\nmycophenolate mofetil, false, nifedipine\nmycophenolate mofetil, false, fluconazole\nmycophenolate mofetil, false, ritonavir\nmycophenolate mofetil, false, rifampin\ncyclosporine, false, tacrolimus\ncyclosporine, false, prednisolone\ncyclosporine, false, sirolimus\ncyclosporine, false, nifedipine\ncyclosporine, false, fluconazole\ncyclosporine, false, ritonavir\ncyclosporine, false, rifampin\ntacrolimus, false, prednisolone\ntacrolimus, false, sirolimus\ntacrolimus, false, nifedipine\ntacrolimus, false, fluconazole\ntacrolimus, false, ritonavir\ntacrolimus, false, rifampin\nprednisolone, false, sirolimus\nprednisolone, false, nifedipine\nprednisolone, false, fluconazole\nprednisolone, false, ritonavir\nprednisolone, false, rifampin\nsirolimus, false, nifedipine\nsirolimus, false, fluconazole\nsirolimus, false, ritonavir\nsirolimus, false, rifampin\nnifedipine, false, fluconazole\nnifedipine, false, ritonavir\nnifedipine, false, rifampin\nfluconazole, false, ritonavir\nfluconazole, false, rifampin\nritonavir, false, rifampin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "there was no effect of a single dose or multiple doses of mycamine on mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, and fluconazole pharmacokinetics.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmycamine, mycophenolate mofetil, cyclosporine, tacrolimus, prednisolone, fluconazole\nSo the corresponding drug entities and relations triplets are:\nmycamine, false, mycophenolate mofetil\nmycamine, false, cyclosporine\nmycamine, false, tacrolimus\nmycamine, false, prednisolone\nmycamine, false, fluconazole\nmycophenolate mofetil, false, cyclosporine\nmycophenolate mofetil, false, tacrolimus\nmycophenolate mofetil, false, prednisolone\nmycophenolate mofetil, false, fluconazole\ncyclosporine, false, tacrolimus\ncyclosporine, false, prednisolone\ncyclosporine, false, fluconazole\ntacrolimus, false, prednisolone\ntacrolimus, false, fluconazole\nprednisolone, false, fluconazole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "sirolimus auc was increased by 21% with no effect on cmax in the presence of steady-state mycamine compared with sirolimus alone.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsirolimus, mycamine, sirolimus\nSo the corresponding drug entities and relations triplets are:\nsirolimus, mechanism, mycamine\nmycamine, false, sirolimus END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "nifedipine auc and cmax were increased by 18% and 42%, respectively, in the presence of steady-state mycamine compared with nifedipine alone.", "output": "Let's think step by step.\nThe drug entities in this text are:\nnifedipine, mycamine, nifedipine\nSo the corresponding drug entities and relations triplets are:\nnifedipine, mechanism, mycamine\nmycamine, false, nifedipine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "patients receiving sirolimus or nifedipine in combination with mycamine should be monitored for sirolimus or nifedipine toxicity and sirolimus or nifedipine dosage should be reduced if necessary.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsirolimus, nifedipine, mycamine, sirolimus, nifedipine, sirolimus, nifedipine\nSo the corresponding drug entities and relations triplets are:\nsirolimus, false, nifedipine\nsirolimus, advise, mycamine\nsirolimus, false, nifedipine\nsirolimus, false, nifedipine\nnifedipine, advise, mycamine\nnifedipine, false, sirolimus\nnifedipine, false, sirolimus\nmycamine, false, sirolimus\nmycamine, false, nifedipine\nmycamine, false, sirolimus\nmycamine, false, nifedipine\nsirolimus, false, nifedipine\nsirolimus, false, nifedipine\nnifedipine, false, sirolimus\nsirolimus, false, nifedipine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "dosages of concomitantly administered opioids should be reduced by approximately half, because levomepromazine amplifies the therapeutic actions and side-effects of opioids.", "output": "Let's think step by step.\nThe drug entities in this text are:\nopioids, levomepromazine, opioids\nSo the corresponding drug entities and relations triplets are:\nopioids, effect, levomepromazine\nlevomepromazine, effect, opioids END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "combination with tramadol (ultram) is associated with increased risk of seizures.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntramadol, ultram\nSo the corresponding drug entities and relations triplets are:\ntramadol, false, ultram END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "additive sedative effects and confusional states may emerge if levomepromazine is given with benzodiazepines or barbiturates.", "output": "Let's think step by step.\nThe drug entities in this text are:\nlevomepromazine, benzodiazepines, barbiturates\nSo the corresponding drug entities and relations triplets are:\nlevomepromazine, effect, benzodiazepines\nlevomepromazine, effect, barbiturates\nbenzodiazepines, false, barbiturates END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "exert particular caution in combining levomepromazine with other anticholinergic drugs (tricyclic antidepressants and antiparkinsonian-agents): particularly the elderly may develop delirium, high fever, severe obstipation, even ileus and glaucoma.", "output": "Let's think step by step.\nThe drug entities in this text are:\nlevomepromazine, anticholinergic drugs, tricyclic antidepressants, antiparkinsonian-agents\nSo the corresponding drug entities and relations triplets are:\nlevomepromazine, advise, anticholinergic drugs\nlevomepromazine, advise, tricyclic antidepressants\nlevomepromazine, advise, antiparkinsonian-agents\nanticholinergic drugs, false, tricyclic antidepressants\nanticholinergic drugs, false, antiparkinsonian-agents\ntricyclic antidepressants, false, antiparkinsonian-agents END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "caffeine and/or stimulantes of the ephedrine/amphetamine type may counteract the specific actions of levomepromazine.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncaffeine, ephedrine, amphetamine, levomepromazine\nSo the corresponding drug entities and relations triplets are:\ncaffeine, false, ephedrine\ncaffeine, false, amphetamine\ncaffeine, effect, levomepromazine\nephedrine, false, amphetamine\nephedrine, effect, levomepromazine\namphetamine, effect, levomepromazine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "although mivacron (a mixture of three stereoisomers) has been administered safely following succinylcholine-facilitated tracheal intubation, the interaction between mivacron and succinylcholine has not been systematically studied.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmivacron, mivacron, succinylcholine\nSo the corresponding drug entities and relations triplets are:\nmivacron, false, succinylcholine\nmivacron, false, succinylcholine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "prior administration of succinylcholine can potentiate the neuromuscular blocking effects of nondepolarizing agents.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsuccinylcholine, nondepolarizing agents\nSo the corresponding drug entities and relations triplets are:\nsuccinylcholine, effect, nondepolarizing agents END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "evidence of spontaneous recovery from succinylcholine should be observed before the administration of mivacron.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsuccinylcholine, mivacron\nSo the corresponding drug entities and relations triplets are:\nsuccinylcholine, advise, mivacron END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the use of mivacron before succinylcholine to attenuate some of the side effects of succinylcholine has not been studied.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmivacron, succinylcholine, succinylcholine\nSo the corresponding drug entities and relations triplets are:\nmivacron, false, succinylcholine\nmivacron, false, succinylcholine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "there are no clinical data on the use of mivacron with other nondepolarizing neuromuscular blocking agents.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmivacron, nondepolarizing neuromuscular blocking agents\nSo the corresponding drug entities and relations triplets are:\nmivacron, false, nondepolarizing neuromuscular blocking agents END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "isoflurane and enflurane (administered with nitrous oxide/oxygen to achieve 1.25 m.c.", "output": "Let's think step by step.\nThe drug entities in this text are:\nisoflurane, enflurane, nitrous oxide, oxygen\nSo the corresponding drug entities and relations triplets are:\nisoflurane, false, enflurane\nisoflurane, false, nitrous oxide\nisoflurane, false, oxygen\nenflurane, false, nitrous oxide\nenflurane, false, oxygen\nnitrous oxide, false, oxygen END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "a greater potentiation of the neuromuscular blocking effects of mivacron may be expected with higher concentrations of enflurane or isoflurane.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmivacron, enflurane, isoflurane\nSo the corresponding drug entities and relations triplets are:\nmivacron, false, enflurane\nmivacron, false, isoflurane\nenflurane, false, isoflurane END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as mivacron include certain antibiotics (e.g., aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, and sodium colistimethate), magnesium salts, lithium, local anesthetics, procainamide, and quinidine.", "output": "Let's think step by step.\nThe drug entities in this text are:\nnondepolarizing agents, mivacron, antibiotics, aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, sodium colistimethate, magnesium, lithium, anesthetics, procainamide, quinidine\nSo the corresponding drug entities and relations triplets are:\nnondepolarizing agents, false, mivacron\nnondepolarizing agents, int, antibiotics\nnondepolarizing agents, int, aminoglycosides\nnondepolarizing agents, int, tetracyclines\nnondepolarizing agents, int, bacitracin\nnondepolarizing agents, int, polymyxins\nnondepolarizing agents, int, lincomycin\nnondepolarizing agents, int, clindamycin\nnondepolarizing agents, int, colistin\nnondepolarizing agents, int, sodium colistimethate\nnondepolarizing agents, int, magnesium\nnondepolarizing agents, int, lithium\nnondepolarizing agents, int, anesthetics\nnondepolarizing agents, int, procainamide\nnondepolarizing agents, int, quinidine\nmivacron, int, antibiotics\nmivacron, int, aminoglycosides\nmivacron, int, tetracyclines\nmivacron, int, bacitracin\nmivacron, int, polymyxins\nmivacron, int, lincomycin\nmivacron, int, clindamycin\nmivacron, int, colistin\nmivacron, int, sodium colistimethate\nmivacron, int, magnesium\nmivacron, int, lithium\nmivacron, int, anesthetics\nmivacron, int, procainamide\nmivacron, int, quinidine\nantibiotics, false, aminoglycosides\nantibiotics, false, tetracyclines\nantibiotics, false, bacitracin\nantibiotics, false, polymyxins\nantibiotics, false, lincomycin\nantibiotics, false, clindamycin\nantibiotics, false, colistin\nantibiotics, false, sodium colistimethate\nantibiotics, false, magnesium\nantibiotics, false, lithium\nantibiotics, false, anesthetics\nantibiotics, false, procainamide\nantibiotics, false, quinidine\naminoglycosides, false, tetracyclines\naminoglycosides, false, bacitracin\naminoglycosides, false, polymyxins\naminoglycosides, false, lincomycin\naminoglycosides, false, clindamycin\naminoglycosides, false, colistin\naminoglycosides, false, sodium colistimethate\naminoglycosides, false, magnesium\naminoglycosides, false, lithium\naminoglycosides, false, anesthetics\naminoglycosides, false, procainamide\naminoglycosides, false, quinidine\ntetracyclines, false, bacitracin\ntetracyclines, false, polymyxins\ntetracyclines, false, lincomycin\ntetracyclines, false, clindamycin\ntetracyclines, false, colistin\ntetracyclines, false, sodium colistimethate\ntetracyclines, false, magnesium\ntetracyclines, false, lithium\ntetracyclines, false, anesthetics\ntetracyclines, false, procainamide\ntetracyclines, false, quinidine\nbacitracin, false, polymyxins\nbacitracin, false, lincomycin\nbacitracin, false, clindamycin\nbacitracin, false, colistin\nbacitracin, false, sodium colistimethate\nbacitracin, false, magnesium\nbacitracin, false, lithium\nbacitracin, false, anesthetics\nbacitracin, false, procainamide\nbacitracin, false, quinidine\npolymyxins, false, lincomycin\npolymyxins, false, clindamycin\npolymyxins, false, colistin\npolymyxins, false, sodium colistimethate\npolymyxins, false, magnesium\npolymyxins, false, lithium\npolymyxins, false, anesthetics\npolymyxins, false, procainamide\npolymyxins, false, quinidine\nlincomycin, false, clindamycin\nlincomycin, false, colistin\nlincomycin, false, sodium colistimethate\nlincomycin, false, magnesium\nlincomycin, false, lithium\nlincomycin, false, anesthetics\nlincomycin, false, procainamide\nlincomycin, false, quinidine\nclindamycin, false, colistin\nclindamycin, false, sodium colistimethate\nclindamycin, false, magnesium\nclindamycin, false, lithium\nclindamycin, false, anesthetics\nclindamycin, false, procainamide\nclindamycin, false, quinidine\ncolistin, false, sodium colistimethate\ncolistin, false, magnesium\ncolistin, false, lithium\ncolistin, false, anesthetics\ncolistin, false, procainamide\ncolistin, false, quinidine\nsodium colistimethate, false, magnesium\nsodium colistimethate, false, lithium\nsodium colistimethate, false, anesthetics\nsodium colistimethate, false, procainamide\nsodium colistimethate, false, quinidine\nmagnesium, false, lithium\nmagnesium, false, anesthetics\nmagnesium, false, procainamide\nmagnesium, false, quinidine\nlithium, false, anesthetics\nlithium, false, procainamide\nlithium, false, quinidine\nanesthetics, false, procainamide\nanesthetics, false, quinidine\nprocainamide, false, quinidine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the neuromuscular blocking effect of mivacron may be enhanced by drugs that reduce plasma cholinesterase activity (e.g., chronically administered oral contraceptives, glucocorticoids, or certain monoamine oxidase inhibitors) or by drugs that irreversibly inhibit plasma cholinesterase . resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmivacron, contraceptives, glucocorticoids, monoamine oxidase inhibitors, neuromuscular blocking agents, phenytoin, carbamazepine\nSo the corresponding drug entities and relations triplets are:\nmivacron, effect, contraceptives\nmivacron, effect, glucocorticoids\nmivacron, effect, monoamine oxidase inhibitors\nmivacron, false, neuromuscular blocking agents\nmivacron, false, phenytoin\nmivacron, false, carbamazepine\ncontraceptives, false, glucocorticoids\ncontraceptives, false, monoamine oxidase inhibitors\ncontraceptives, false, neuromuscular blocking agents\ncontraceptives, false, phenytoin\ncontraceptives, false, carbamazepine\nglucocorticoids, false, monoamine oxidase inhibitors\nglucocorticoids, false, neuromuscular blocking agents\nglucocorticoids, false, phenytoin\nglucocorticoids, false, carbamazepine\nmonoamine oxidase inhibitors, false, neuromuscular blocking agents\nmonoamine oxidase inhibitors, false, phenytoin\nmonoamine oxidase inhibitors, false, carbamazepine\nneuromuscular blocking agents, effect, phenytoin\nneuromuscular blocking agents, effect, carbamazepine\nphenytoin, false, carbamazepine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "while the effects of chronic phenytoin or carbamazepine therapy on the action of mivacron are unknown, slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher.", "output": "Let's think step by step.\nThe drug entities in this text are:\nphenytoin, carbamazepine, mivacron\nSo the corresponding drug entities and relations triplets are:\nphenytoin, false, carbamazepine\nphenytoin, effect, mivacron\ncarbamazepine, effect, mivacron END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "some drug interactions are:  - birth control pills - corticosteroids - medicines for angina or high blood pressure - medicines for pain - medicines to control seizures such as phenytoin or carbamazepine - certain antibiotics given by injection - cisplatin - edrophonium - neostigmine - polymyxin b or bacitracin - local anesthetics such as procaine - general anesthetics - succinylcholine or other muscle relaxants", "output": "Let's think step by step.\nThe drug entities in this text are:\ncorticosteroids, phenytoin, carbamazepine, antibiotics, cisplatin, edrophonium, neostigmine, polymyxin b, bacitracin, anesthetics, procaine, anesthetics, succinylcholine, muscle relaxants\nSo the corresponding drug entities and relations triplets are:\ncorticosteroids, false, phenytoin\ncorticosteroids, false, carbamazepine\ncorticosteroids, false, antibiotics\ncorticosteroids, false, cisplatin\ncorticosteroids, false, edrophonium\ncorticosteroids, false, neostigmine\ncorticosteroids, false, polymyxin b\ncorticosteroids, false, bacitracin\ncorticosteroids, false, anesthetics\ncorticosteroids, false, procaine\ncorticosteroids, false, anesthetics\ncorticosteroids, false, succinylcholine\ncorticosteroids, false, muscle relaxants\nphenytoin, false, carbamazepine\nphenytoin, false, antibiotics\nphenytoin, false, cisplatin\nphenytoin, false, edrophonium\nphenytoin, false, neostigmine\nphenytoin, false, polymyxin b\nphenytoin, false, bacitracin\nphenytoin, false, anesthetics\nphenytoin, false, procaine\nphenytoin, false, anesthetics\nphenytoin, false, succinylcholine\nphenytoin, false, muscle relaxants\ncarbamazepine, false, antibiotics\ncarbamazepine, false, cisplatin\ncarbamazepine, false, edrophonium\ncarbamazepine, false, neostigmine\ncarbamazepine, false, polymyxin b\ncarbamazepine, false, bacitracin\ncarbamazepine, false, anesthetics\ncarbamazepine, false, procaine\ncarbamazepine, false, anesthetics\ncarbamazepine, false, succinylcholine\ncarbamazepine, false, muscle relaxants\nantibiotics, false, cisplatin\nantibiotics, false, edrophonium\nantibiotics, false, neostigmine\nantibiotics, false, polymyxin b\nantibiotics, false, bacitracin\nantibiotics, false, anesthetics\nantibiotics, false, procaine\nantibiotics, false, anesthetics\nantibiotics, false, succinylcholine\nantibiotics, false, muscle relaxants\ncisplatin, false, edrophonium\ncisplatin, false, neostigmine\ncisplatin, false, polymyxin b\ncisplatin, false, bacitracin\ncisplatin, false, anesthetics\ncisplatin, false, procaine\ncisplatin, false, anesthetics\ncisplatin, false, succinylcholine\ncisplatin, false, muscle relaxants\nedrophonium, false, neostigmine\nedrophonium, false, polymyxin b\nedrophonium, false, bacitracin\nedrophonium, false, anesthetics\nedrophonium, false, procaine\nedrophonium, false, anesthetics\nedrophonium, false, succinylcholine\nedrophonium, false, muscle relaxants\nneostigmine, false, polymyxin b\nneostigmine, false, bacitracin\nneostigmine, false, anesthetics\nneostigmine, false, procaine\nneostigmine, false, anesthetics\nneostigmine, false, succinylcholine\nneostigmine, false, muscle relaxants\npolymyxin b, false, bacitracin\npolymyxin b, false, anesthetics\npolymyxin b, false, procaine\npolymyxin b, false, anesthetics\npolymyxin b, false, succinylcholine\npolymyxin b, false, muscle relaxants\nbacitracin, false, anesthetics\nbacitracin, false, procaine\nbacitracin, false, anesthetics\nbacitracin, false, succinylcholine\nbacitracin, false, muscle relaxants\nanesthetics, false, procaine\nanesthetics, false, succinylcholine\nanesthetics, false, muscle relaxants\nprocaine, false, anesthetics\nprocaine, false, succinylcholine\nprocaine, false, muscle relaxants\nanesthetics, false, succinylcholine\nanesthetics, false, muscle relaxants\nsuccinylcholine, false, muscle relaxants END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "do not exceed a 5 mg daily dose of vesicare when administered with therapeutic doses of ketoconazole or other potent cyp3a4 inhibitors.", "output": "Let's think step by step.\nThe drug entities in this text are:\nvesicare, ketoconazole\nSo the corresponding drug entities and relations triplets are:\nvesicare, advise, ketoconazole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "patients with congenital or acquired qt prolongation in a study of the effect of solifenacin on the qt interval in 76 healthy women, the qt prolonging effect appeared less with solifenacin 10 mg than with 30 mg (three times the maximum recommended dose), and the effect of solifenacin 30 mg did not appear as large as that of the positive control moxifloxacin at its therapeutic dose.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsolifenacin, solifenacin, solifenacin, moxifloxacin\nSo the corresponding drug entities and relations triplets are:\nsolifenacin, false, moxifloxacin\nsolifenacin, false, moxifloxacin\nsolifenacin, false, moxifloxacin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "interaction with guanethidine: although minoxidil does not itself cause orthostatic hypotension, its administration to patients already receiving guanethidine can result in profound orthostatic effects.", "output": "Let's think step by step.\nThe drug entities in this text are:\nguanethidine, minoxidil, guanethidine\nSo the corresponding drug entities and relations triplets are:\nguanethidine, false, minoxidil\nminoxidil, effect, guanethidine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "if at all possible guanethidine should be discontinued well before minoxidil is begun.", "output": "Let's think step by step.\nThe drug entities in this text are:\nguanethidine, minoxidil\nSo the corresponding drug entities and relations triplets are:\nguanethidine, advise, minoxidil END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "while co-administration of zavesca    appeared to increase the clearance of cerezyme by 70%, these results are not conclusive because of the small number of subjects studied and because patients took variable doses of cerezyme.", "output": "Let's think step by step.\nThe drug entities in this text are:\nzavesca, cerezyme, cerezyme\nSo the corresponding drug entities and relations triplets are:\nzavesca, mechanism, cerezyme\nzavesca, false, cerezyme END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "combination therapy with cerezyme    (imiglucerase) and zavesca    is not indicated.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncerezyme, imiglucerase, zavesca\nSo the corresponding drug entities and relations triplets are:\ncerezyme, false, imiglucerase\ncerezyme, advise, zavesca\nimiglucerase, advise, zavesca END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "aminoglutethimide administered concomitantly with depo-subq provera 104 may significantly decrease the serum concentrations of mpa.", "output": "Let's think step by step.\nThe drug entities in this text are:\naminoglutethimide, depo-subq provera 104, mpa\nSo the corresponding drug entities and relations triplets are:\naminoglutethimide, mechanism, depo-subq provera 104\naminoglutethimide, false, mpa\ndepo-subq provera 104, false, mpa END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "hypokalemia may develop during concomitant use of steroids or acth.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsteroids, acth\nSo the corresponding drug entities and relations triplets are:\nsteroids, false, acth END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "thiazides may decrease arterial responsiveness to norepinephrine.", "output": "Let's think step by step.\nThe drug entities in this text are:\nthiazides, norepinephrine\nSo the corresponding drug entities and relations triplets are:\nthiazides, effect, norepinephrine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "thiazide drugs may increase the responsiveness of tubocurarine.", "output": "Let's think step by step.\nThe drug entities in this text are:\nthiazide drugs, tubocurarine\nSo the corresponding drug entities and relations triplets are:\nthiazide drugs, effect, tubocurarine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "lithium renal clearance is reduced by thiazides, increasing the risk of lithium toxicity.", "output": "Let's think step by step.\nThe drug entities in this text are:\nlithium, thiazides, lithium\nSo the corresponding drug entities and relations triplets are:\nlithium, mechanism, thiazides\nthiazides, false, lithium END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "thiazides may add to or potentiate the action of other antihypertensive drugs.", "output": "Let's think step by step.\nThe drug entities in this text are:\nthiazides, antihypertensive drugs\nSo the corresponding drug entities and relations triplets are:\nthiazides, effect, antihypertensive drugs END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "potentiation occurs with ganglionic or peripheral adrenergic blocking drugs.", "output": "Let's think step by step.\nThe drug entities in this text are:\nganglionic adrenergic blocking drugs, peripheral adrenergic blocking drugs\nSo the corresponding drug entities and relations triplets are:\nganglionic adrenergic blocking drugs, false, peripheral adrenergic blocking drugs END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "diuretics: patients on diuretics, and especially those started recently, may occasionally experience an excessive reduction of blood pressure after initiation of aceon    tablets therapy.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndiuretics, diuretics, aceon\nSo the corresponding drug entities and relations triplets are:\ndiuretics, false, aceon\ndiuretics, effect, aceon END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the possibility of hypotensive effects can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with perindopril.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndiuretic, perindopril\nSo the corresponding drug entities and relations triplets are:\ndiuretic, effect, perindopril END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "if diuretics cannot be interrupted, close medical supervision should be provided with the first dose of aceon    tablets, for at least two hours and until blood pressure has stabilized for another hour.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndiuretics, aceon\nSo the corresponding drug entities and relations triplets are:\ndiuretics, advise, aceon END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the rate and extent of perindopril absorption and elimination are not affected by concomitant diuretics.", "output": "Let's think step by step.\nThe drug entities in this text are:\nperindopril, diuretics\nSo the corresponding drug entities and relations triplets are:\nperindopril, false, diuretics END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the bioavailability of perindoprilat was reduced by diuretics, however, and this was associated with a decrease in plasma ace inhibition.", "output": "Let's think step by step.\nThe drug entities in this text are:\nperindoprilat, diuretics\nSo the corresponding drug entities and relations triplets are:\nperindoprilat, false, diuretics END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "potassium supplements and potassium-sparing diuretics: aceon    tablets may increase serum potassium because of its potential to decrease aldosterone production.", "output": "Let's think step by step.\nThe drug entities in this text are:\npotassium, potassium-sparing diuretics, aceon\nSo the corresponding drug entities and relations triplets are:\npotassium, false, potassium-sparing diuretics\npotassium, false, aceon\npotassium-sparing diuretics, false, aceon END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "use of potassium-sparing diuretics (spironolactone, amiloride, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, cyclosporine and others) can increase the risk of hyperkalemia.", "output": "Let's think step by step.\nThe drug entities in this text are:\npotassium-sparing diuretics, spironolactone, amiloride, triamterene, potassium, indomethacin, heparin, cyclosporine\nSo the corresponding drug entities and relations triplets are:\npotassium-sparing diuretics, false, spironolactone\npotassium-sparing diuretics, false, amiloride\npotassium-sparing diuretics, false, triamterene\npotassium-sparing diuretics, false, potassium\npotassium-sparing diuretics, false, indomethacin\npotassium-sparing diuretics, false, heparin\npotassium-sparing diuretics, false, cyclosporine\nspironolactone, false, amiloride\nspironolactone, false, triamterene\nspironolactone, false, potassium\nspironolactone, false, indomethacin\nspironolactone, false, heparin\nspironolactone, false, cyclosporine\namiloride, false, triamterene\namiloride, false, potassium\namiloride, false, indomethacin\namiloride, false, heparin\namiloride, false, cyclosporine\ntriamterene, false, potassium\ntriamterene, false, indomethacin\ntriamterene, false, heparin\ntriamterene, false, cyclosporine\npotassium, false, indomethacin\npotassium, false, heparin\npotassium, false, cyclosporine\nindomethacin, false, heparin\nindomethacin, false, cyclosporine\nheparin, false, cyclosporine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "use of a diuretic may further increase the risk of lithium toxicity.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndiuretic, lithium\nSo the corresponding drug entities and relations triplets are:\ndiuretic, false, lithium END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "digoxin: a controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with aceon    tablets, but an effect of digoxin on the plasma concentration of perindopril/perindoprilat has not been excluded.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndigoxin, digoxin, aceon, digoxin, perindopril, perindoprilat\nSo the corresponding drug entities and relations triplets are:\ndigoxin, false, aceon\ndigoxin, false, perindopril\ndigoxin, false, perindoprilat\ndigoxin, false, aceon\ndigoxin, false, perindopril\ndigoxin, false, perindoprilat\naceon, false, digoxin\naceon, false, perindopril\naceon, false, perindoprilat\ndigoxin, mechanism, perindopril\ndigoxin, mechanism, perindoprilat\nperindopril, false, perindoprilat END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "gentamicin: animal data have suggested the possibility of interaction between perindopril and gentamicin.", "output": "Let's think step by step.\nThe drug entities in this text are:\ngentamicin, perindopril, gentamicin\nSo the corresponding drug entities and relations triplets are:\ngentamicin, false, perindopril\nperindopril, int, gentamicin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "food interaction: oral administration of aceon    tablets with food does not significantly lower the rate or extent of perindopril absorption relative to the fasted state.", "output": "Let's think step by step.\nThe drug entities in this text are:\naceon, perindopril\nSo the corresponding drug entities and relations triplets are:\naceon, false, perindopril END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "however, the extent of biotransformation of perindopril to the active metabolite, perindoprilat, is reduced approximately 43%, resulting in a reduction in the plasma ace inhibition curve of approximately 20%, probably clinically insignificant.", "output": "Let's think step by step.\nThe drug entities in this text are:\nperindopril, perindoprilat\nSo the corresponding drug entities and relations triplets are:\nperindopril, false, perindoprilat END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "concurrent use of alcohol and other cns depression-producing drugs may increase the cns depressant effects of methyprylon or these other medications.", "output": "Let's think step by step.\nThe drug entities in this text are:\nalcohol, cns depression-producing drugs, methyprylon\nSo the corresponding drug entities and relations triplets are:\nalcohol, false, cns depression-producing drugs\nalcohol, effect, methyprylon\ncns depression-producing drugs, effect, methyprylon END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "administration of valproic acid decreases oral clearance of temozolomide by about 5%.", "output": "Let's think step by step.\nThe drug entities in this text are:\nvalproic acid, temozolomide\nSo the corresponding drug entities and relations triplets are:\nvalproic acid, mechanism, temozolomide END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in a study in which 34 different drugs were tested, therapeutically relevant concentrations of tolbutamide, sodium salicylate and sulfamethizole displaced protein-bound teniposide in fresh human serum to a small but significant extent.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntolbutamide, sodium salicylate, sulfamethizole, teniposide\nSo the corresponding drug entities and relations triplets are:\ntolbutamide, false, sodium salicylate\ntolbutamide, false, sulfamethizole\ntolbutamide, mechanism, teniposide\nsodium salicylate, false, sulfamethizole\nsodium salicylate, mechanism, teniposide\nsulfamethizole, mechanism, teniposide END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "therefore, caution should be used in administering vumon (teniposide injection) to patients receiving these other agents.", "output": "Let's think step by step.\nThe drug entities in this text are:\nvumon, teniposide\nSo the corresponding drug entities and relations triplets are:\nvumon, false, teniposide END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "there was no change in the plasma kinetics of teniposide when coadministered with methotrexate.", "output": "Let's think step by step.\nThe drug entities in this text are:\nteniposide, methotrexate\nSo the corresponding drug entities and relations triplets are:\nteniposide, false, methotrexate END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "an increase in intracellular levels of methotrexate was observed in vitro in the presence of teniposide.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmethotrexate, teniposide\nSo the corresponding drug entities and relations triplets are:\nmethotrexate, mechanism, teniposide END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "anticoagulants (oral): the activity of oral anticoagulants may be potentiated by anti-vitamin-k activity attributed to methimazole.", "output": "Let's think step by step.\nThe drug entities in this text are:\nanticoagulants, anticoagulants, methimazole\nSo the corresponding drug entities and relations triplets are:\nanticoagulants, false, methimazole\nanticoagulants, effect, methimazole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "digitalis glycosides: serum digitalis levels may be increased when hyperthyroid patients on a stable digitalis glycoside regimen become euthyroid;", "output": "Let's think step by step.\nThe drug entities in this text are:\ndigitalis glycosides, digitalis glycoside\nSo the corresponding drug entities and relations triplets are:\ndigitalis glycosides, false, digitalis glycoside END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the interaction of cylert (pemoline) with other drugs has not been studied in humans.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncylert, pemoline\nSo the corresponding drug entities and relations triplets are:\ncylert, false, pemoline END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "decreased seizure threshold has been reported in patients receiving cylert concomitantly with antiepileptic medications.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncylert, antiepileptic medications\nSo the corresponding drug entities and relations triplets are:\ncylert, effect, antiepileptic medications END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "diuretics: furosemide and probably other loop diuretics given concomitantly with metolazone can cause unusually large or prolonged losses of fluid and electrolytes.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndiuretics, furosemide, loop diuretics, metolazone\nSo the corresponding drug entities and relations triplets are:\ndiuretics, false, furosemide\ndiuretics, false, loop diuretics\ndiuretics, false, metolazone\nfurosemide, false, loop diuretics\nfurosemide, effect, metolazone\nloop diuretics, effect, metolazone END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "other antihypertensives: when mykrox tablets are used with other antihypertensive drugs, care must be taken, especially during initial therapy.", "output": "Let's think step by step.\nThe drug entities in this text are:\nantihypertensives, mykrox, antihypertensive drugs\nSo the corresponding drug entities and relations triplets are:\nantihypertensives, false, mykrox\nantihypertensives, false, antihypertensive drugs\nmykrox, advise, antihypertensive drugs END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "alcohol, barbiturates, and narcotics: the hypotensive effects of these drugs may be potentiated by the volume contraction that may be associated with metolazone therapy.", "output": "Let's think step by step.\nThe drug entities in this text are:\nalcohol, barbiturates, narcotics, metolazone\nSo the corresponding drug entities and relations triplets are:\nalcohol, false, barbiturates\nalcohol, false, narcotics\nalcohol, false, metolazone\nbarbiturates, false, narcotics\nbarbiturates, false, metolazone\nnarcotics, false, metolazone END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "digitalis glycosides: diuretic-induced hypokalemia can increase the sensitivity of the myocardium to digitalis.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndigitalis glycosides, diuretic, digitalis\nSo the corresponding drug entities and relations triplets are:\ndigitalis glycosides, false, diuretic\ndigitalis glycosides, false, digitalis\ndiuretic, effect, digitalis END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "corticosteroids or acth: may increase the risk of hypokalemia and increase salt and water retention.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncorticosteroids, acth\nSo the corresponding drug entities and relations triplets are:\ncorticosteroids, false, acth END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "curariform drugs: diuretic-induced hypokalemia may enhance neuromuscular blocking effects of curariform drugs (such as tubocurarine) the most serious effect would be respiratory depression which could proceed to apnea.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncurariform drugs, diuretic, curariform drugs, tubocurarine\nSo the corresponding drug entities and relations triplets are:\ncurariform drugs, false, diuretic\ncurariform drugs, false, tubocurarine\ndiuretic, effect, curariform drugs\ndiuretic, effect, tubocurarine\ncurariform drugs, false, tubocurarine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "salicylates and other non-steroidal anti-inflammatory drugs: may decrease the antihypertensive effects of mykrox tablets.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsalicylates, non-steroidal anti-inflammatory drugs, mykrox\nSo the corresponding drug entities and relations triplets are:\nsalicylates, false, non-steroidal anti-inflammatory drugs\nsalicylates, effect, mykrox\nnon-steroidal anti-inflammatory drugs, effect, mykrox END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "sympathomimetics: metolazone may decrease arterial responsiveness to norepinephrine, but this diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsympathomimetics, metolazone, norepinephrine\nSo the corresponding drug entities and relations triplets are:\nsympathomimetics, false, metolazone\nsympathomimetics, false, norepinephrine\nmetolazone, effect, norepinephrine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "methenamine: efficacy may be decreased due to urinary alkalizing effect of metolazone.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmethenamine, metolazone\nSo the corresponding drug entities and relations triplets are:\nmethenamine, effect, metolazone END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "anticoagulants: metolazone, as well as other thiazide-like diuretics, may affect the hypoprothrombinemic response to anticoagulants;", "output": "Let's think step by step.\nThe drug entities in this text are:\nanticoagulants, metolazone, thiazide-like diuretics, anticoagulants\nSo the corresponding drug entities and relations triplets are:\nanticoagulants, false, metolazone\nanticoagulants, false, thiazide-like diuretics\nmetolazone, false, thiazide-like diuretics\nmetolazone, effect, anticoagulants\nthiazide-like diuretics, false, anticoagulants END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the following agents may increase certain actions or side effects of anticholinergic drugs: amantadine, antiarrhythmic agents of class i (e.g., quinidine), antihistamines, antipsychotic agents (e.g., phenothiazines), benzodiazepines, mao inhibitors, narcotic analgesics (e.g., meperidine), nitrates and nitrites, sympathomimetic agents, tricyclic antidepressants, and other drugs having anticholinergic activity.", "output": "Let's think step by step.\nThe drug entities in this text are:\nanticholinergic drugs, amantadine, antiarrhythmic agents of class i, quinidine, antihistamines, antipsychotic agents, phenothiazines, benzodiazepines, mao inhibitors, narcotic analgesics, meperidine, nitrates, nitrites, sympathomimetic agents, tricyclic antidepressants\nSo the corresponding drug entities and relations triplets are:\nanticholinergic drugs, effect, amantadine\nanticholinergic drugs, effect, antiarrhythmic agents of class i\nanticholinergic drugs, effect, quinidine\nanticholinergic drugs, effect, antihistamines\nanticholinergic drugs, effect, antipsychotic agents\nanticholinergic drugs, effect, phenothiazines\nanticholinergic drugs, effect, benzodiazepines\nanticholinergic drugs, effect, mao inhibitors\nanticholinergic drugs, effect, narcotic analgesics\nanticholinergic drugs, effect, meperidine\nanticholinergic drugs, effect, nitrates\nanticholinergic drugs, effect, nitrites\nanticholinergic drugs, effect, sympathomimetic agents\nanticholinergic drugs, effect, tricyclic antidepressants\namantadine, false, antiarrhythmic agents of class i\namantadine, false, quinidine\namantadine, false, antihistamines\namantadine, false, antipsychotic agents\namantadine, false, phenothiazines\namantadine, false, benzodiazepines\namantadine, false, mao inhibitors\namantadine, false, narcotic analgesics\namantadine, false, meperidine\namantadine, false, nitrates\namantadine, false, nitrites\namantadine, false, sympathomimetic agents\namantadine, false, tricyclic antidepressants\nantiarrhythmic agents of class i, false, quinidine\nantiarrhythmic agents of class i, false, antihistamines\nantiarrhythmic agents of class i, false, antipsychotic agents\nantiarrhythmic agents of class i, false, phenothiazines\nantiarrhythmic agents of class i, false, benzodiazepines\nantiarrhythmic agents of class i, false, mao inhibitors\nantiarrhythmic agents of class i, false, narcotic analgesics\nantiarrhythmic agents of class i, false, meperidine\nantiarrhythmic agents of class i, false, nitrates\nantiarrhythmic agents of class i, false, nitrites\nantiarrhythmic agents of class i, false, sympathomimetic agents\nantiarrhythmic agents of class i, false, tricyclic antidepressants\nquinidine, false, antihistamines\nquinidine, false, antipsychotic agents\nquinidine, false, phenothiazines\nquinidine, false, benzodiazepines\nquinidine, false, mao inhibitors\nquinidine, false, narcotic analgesics\nquinidine, false, meperidine\nquinidine, false, nitrates\nquinidine, false, nitrites\nquinidine, false, sympathomimetic agents\nquinidine, false, tricyclic antidepressants\nantihistamines, false, antipsychotic agents\nantihistamines, false, phenothiazines\nantihistamines, false, benzodiazepines\nantihistamines, false, mao inhibitors\nantihistamines, false, narcotic analgesics\nantihistamines, false, meperidine\nantihistamines, false, nitrates\nantihistamines, false, nitrites\nantihistamines, false, sympathomimetic agents\nantihistamines, false, tricyclic antidepressants\nantipsychotic agents, false, phenothiazines\nantipsychotic agents, false, benzodiazepines\nantipsychotic agents, false, mao inhibitors\nantipsychotic agents, false, narcotic analgesics\nantipsychotic agents, false, meperidine\nantipsychotic agents, false, nitrates\nantipsychotic agents, false, nitrites\nantipsychotic agents, false, sympathomimetic agents\nantipsychotic agents, false, tricyclic antidepressants\nphenothiazines, false, benzodiazepines\nphenothiazines, false, mao inhibitors\nphenothiazines, false, narcotic analgesics\nphenothiazines, false, meperidine\nphenothiazines, false, nitrates\nphenothiazines, false, nitrites\nphenothiazines, false, sympathomimetic agents\nphenothiazines, false, tricyclic antidepressants\nbenzodiazepines, false, mao inhibitors\nbenzodiazepines, false, narcotic analgesics\nbenzodiazepines, false, meperidine\nbenzodiazepines, false, nitrates\nbenzodiazepines, false, nitrites\nbenzodiazepines, false, sympathomimetic agents\nbenzodiazepines, false, tricyclic antidepressants\nmao inhibitors, false, narcotic analgesics\nmao inhibitors, false, meperidine\nmao inhibitors, false, nitrates\nmao inhibitors, false, nitrites\nmao inhibitors, false, sympathomimetic agents\nmao inhibitors, false, tricyclic antidepressants\nnarcotic analgesics, false, meperidine\nnarcotic analgesics, false, nitrates\nnarcotic analgesics, false, nitrites\nnarcotic analgesics, false, sympathomimetic agents\nnarcotic analgesics, false, tricyclic antidepressants\nmeperidine, false, nitrates\nmeperidine, false, nitrites\nmeperidine, false, sympathomimetic agents\nmeperidine, false, tricyclic antidepressants\nnitrates, false, nitrites\nnitrates, false, sympathomimetic agents\nnitrates, false, tricyclic antidepressants\nnitrites, false, sympathomimetic agents\nnitrites, false, tricyclic antidepressants\nsympathomimetic agents, false, tricyclic antidepressants END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "anticholinergics antagonize the effects of antiglaucoma agents.", "output": "Let's think step by step.\nThe drug entities in this text are:\nanticholinergics, antiglaucoma agents\nSo the corresponding drug entities and relations triplets are:\nanticholinergics, effect, antiglaucoma agents END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "anticholinergic drugs in the presence of increased intraocular pressure may be hazardous when taken concurrently with agents such as corticosteroids.", "output": "Let's think step by step.\nThe drug entities in this text are:\nanticholinergic drugs, corticosteroids\nSo the corresponding drug entities and relations triplets are:\nanticholinergic drugs, effect, corticosteroids END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "anticholinergic agents may affect gastrointestinal absorption of various drugs, such as slowly dissolving dosage forms of digoxin;", "output": "Let's think step by step.\nThe drug entities in this text are:\nanticholinergic agents, digoxin\nSo the corresponding drug entities and relations triplets are:\nanticholinergic agents, mechanism, digoxin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "anticholinergic drugs may antagonize the effects of drugs that alter gastrointestinal motility, such as metoclopramide.", "output": "Let's think step by step.\nThe drug entities in this text are:\nanticholinergic drugs, metoclopramide\nSo the corresponding drug entities and relations triplets are:\nanticholinergic drugs, effect, metoclopramide END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "because antacids may interfere with the absorption of anticholinergic agents, simultaneous use of these drugs should be avoided.", "output": "Let's think step by step.\nThe drug entities in this text are:\nantacids, anticholinergic agents\nSo the corresponding drug entities and relations triplets are:\nantacids, mechanism, anticholinergic agents END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "ropivacaine should be used with caution in patients receiving other local anesthetics or agents structurally related to amide-type local anesthetics, since the toxic effects of these drugs are additive.", "output": "Let's think step by step.\nThe drug entities in this text are:\nropivacaine, anesthetics, amide-type local anesthetics\nSo the corresponding drug entities and relations triplets are:\nropivacaine, advise, anesthetics\nropivacaine, false, amide-type local anesthetics\nanesthetics, false, amide-type local anesthetics END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in vivo, the plasma clearance of ropivacaine was reduced by 70% during coadministration of fluvoxamine (25 mg bid for 2 days), a selective and potent cyp1a2 inhibitor.", "output": "Let's think step by step.\nThe drug entities in this text are:\nropivacaine, fluvoxamine\nSo the corresponding drug entities and relations triplets are:\nropivacaine, mechanism, fluvoxamine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "thus strong inhibitors of cytochrome p4501a2, such as fluvoxamine, given concomitantly during administration of ropivacaine, can interact with ropivacaine leading to increased ropivacaine plasma levels.", "output": "Let's think step by step.\nThe drug entities in this text are:\nfluvoxamine, ropivacaine, ropivacaine, ropivacaine\nSo the corresponding drug entities and relations triplets are:\nfluvoxamine, int, ropivacaine\nfluvoxamine, false, ropivacaine\nfluvoxamine, false, ropivacaine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "possible interactions with drugs known to be metabolized by cyp1a2 via competitive inhibition such as theophylline and imipramine may also occur.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntheophylline, imipramine\nSo the corresponding drug entities and relations triplets are:\ntheophylline, false, imipramine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "coadministration of a selective and potent inhibitor of cyp3a4, ketoconazole (100 mg bid for 2 days with ropivacaine infusion administered 1 hour after ketoconazole) caused a 15% reduction in in-vivo plasma clearance of ropivacaine.", "output": "Let's think step by step.\nThe drug entities in this text are:\nketoconazole, ropivacaine, ketoconazole, ropivacaine\nSo the corresponding drug entities and relations triplets are:\nketoconazole, false, ropivacaine\nketoconazole, mechanism, ropivacaine\nropivacaine, false, ketoconazole\nketoconazole, false, ropivacaine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in elderly patients concurrently receiving certain diuretics, primarily thiazides, an increased incidence of thrombopenia with purpura has been reported.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndiuretics, thiazides\nSo the corresponding drug entities and relations triplets are:\ndiuretics, false, thiazides END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "it has been reported that sulfamethoxazole may prolong the prothrombin time in patients who are receiving the anticoagulant warfarin.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsulfamethoxazole, anticoagulant, warfarin\nSo the corresponding drug entities and relations triplets are:\nsulfamethoxazole, false, anticoagulant\nsulfamethoxazole, effect, warfarin\nanticoagulant, false, warfarin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "sulfamethoxazole may inhibit the hepatic metabolism of phenytoin.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsulfamethoxazole, phenytoin\nSo the corresponding drug entities and relations triplets are:\nsulfamethoxazole, mechanism, phenytoin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "at a 1.6-g dose, sulfamethoxazole produced a slight but significant increase in the half-life of phenytoin but did not produce a corresponding decrease in the metabolic clearance rate.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsulfamethoxazole, phenytoin\nSo the corresponding drug entities and relations triplets are:\nsulfamethoxazole, mechanism, phenytoin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "sulfonamides can also displace methotrexate from plasma protein-binding sites, thus increasing free methotrexate concentrations.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsulfonamides, methotrexate, methotrexate\nSo the corresponding drug entities and relations triplets are:\nsulfonamides, mechanism, methotrexate\nsulfonamides, false, methotrexate END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "there is usually complete cross-resistance between purinethol (mercaptopurine) and tabloid brand thioguanine.", "output": "Let's think step by step.\nThe drug entities in this text are:\npurinethol, mercaptopurine, tabloid, thioguanine\nSo the corresponding drug entities and relations triplets are:\npurinethol, false, mercaptopurine\npurinethol, effect, tabloid\npurinethol, effect, thioguanine\nmercaptopurine, effect, tabloid\nmercaptopurine, effect, thioguanine\ntabloid, false, thioguanine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "as there is in vitro evidence that aminosalicylate derivatives (e.g., olsalazine, mesalazine, or sulphasalazine) inhibit the tpmt enzyme, they should be administered with caution to patients receiving concurrent thioguanine therapy.", "output": "Let's think step by step.\nThe drug entities in this text are:\naminosalicylate derivatives, olsalazine, mesalazine, sulphasalazine, thioguanine\nSo the corresponding drug entities and relations triplets are:\naminosalicylate derivatives, false, olsalazine\naminosalicylate derivatives, false, mesalazine\naminosalicylate derivatives, false, sulphasalazine\naminosalicylate derivatives, mechanism, thioguanine\nolsalazine, false, mesalazine\nolsalazine, false, sulphasalazine\nolsalazine, mechanism, thioguanine\nmesalazine, false, sulphasalazine\nmesalazine, mechanism, thioguanine\nsulphasalazine, mechanism, thioguanine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "thalidomide has been reported to enhance the sedative activity of barbiturates, alcohol, chlorpromazine, and reserpine.", "output": "Let's think step by step.\nThe drug entities in this text are:\nthalidomide, barbiturates, alcohol, chlorpromazine, reserpine\nSo the corresponding drug entities and relations triplets are:\nthalidomide, effect, barbiturates\nthalidomide, false, alcohol\nthalidomide, false, chlorpromazine\nthalidomide, false, reserpine\nbarbiturates, false, alcohol\nbarbiturates, false, chlorpromazine\nbarbiturates, false, reserpine\nalcohol, false, chlorpromazine\nalcohol, false, reserpine\nchlorpromazine, false, reserpine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "oral contraceptives: in 10 healthy women, the pharmacokinetic profiles of norethindrone and ethinyl estradiol following administration of a single dose containing 1.0 mg of norethindrone acetate and 75    g of ethinyl estradiol were studied.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncontraceptives, norethindrone, ethinyl estradiol, norethindrone acetate, ethinyl estradiol\nSo the corresponding drug entities and relations triplets are:\ncontraceptives, false, norethindrone\ncontraceptives, false, ethinyl estradiol\ncontraceptives, false, norethindrone acetate\ncontraceptives, false, ethinyl estradiol\nnorethindrone, false, ethinyl estradiol\nnorethindrone, false, norethindrone acetate\nnorethindrone, false, ethinyl estradiol\nethinyl estradiol, false, norethindrone acetate\nnorethindrone acetate, false, ethinyl estradiol END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "important non-thalidomide drug interactions drugs that interfere with hormonal contraceptives: concomitant use of hiv-protease inhibitors, griseofulvin, modafinil, penicillins, rifampin, rifabutin, phenytoin, carbamazepine, or certain herbal supplements such as st.", "output": "Let's think step by step.\nThe drug entities in this text are:\nthalidomide, hormonal contraceptives, hiv-protease inhibitors, griseofulvin, modafinil, penicillins, rifampin, rifabutin, phenytoin, carbamazepine\nSo the corresponding drug entities and relations triplets are:\nthalidomide, false, hormonal contraceptives\nthalidomide, false, hiv-protease inhibitors\nthalidomide, false, griseofulvin\nthalidomide, false, modafinil\nthalidomide, false, penicillins\nthalidomide, false, rifampin\nthalidomide, false, rifabutin\nthalidomide, false, phenytoin\nthalidomide, false, carbamazepine\nhormonal contraceptives, false, hiv-protease inhibitors\nhormonal contraceptives, false, griseofulvin\nhormonal contraceptives, false, modafinil\nhormonal contraceptives, false, penicillins\nhormonal contraceptives, false, rifampin\nhormonal contraceptives, false, rifabutin\nhormonal contraceptives, false, phenytoin\nhormonal contraceptives, false, carbamazepine\nhiv-protease inhibitors, false, griseofulvin\nhiv-protease inhibitors, false, modafinil\nhiv-protease inhibitors, false, penicillins\nhiv-protease inhibitors, false, rifampin\nhiv-protease inhibitors, false, rifabutin\nhiv-protease inhibitors, false, phenytoin\nhiv-protease inhibitors, false, carbamazepine\ngriseofulvin, false, modafinil\ngriseofulvin, false, penicillins\ngriseofulvin, false, rifampin\ngriseofulvin, false, rifabutin\ngriseofulvin, false, phenytoin\ngriseofulvin, false, carbamazepine\nmodafinil, false, penicillins\nmodafinil, false, rifampin\nmodafinil, false, rifabutin\nmodafinil, false, phenytoin\nmodafinil, false, carbamazepine\npenicillins, false, rifampin\npenicillins, false, rifabutin\npenicillins, false, phenytoin\npenicillins, false, carbamazepine\nrifampin, false, rifabutin\nrifampin, false, phenytoin\nrifampin, false, carbamazepine\nrifabutin, false, phenytoin\nrifabutin, false, carbamazepine\nphenytoin, false, carbamazepine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "john's wort with hormonal contraceptive agents may reduce the effectiveness of the contraception and up to one month after discontinuation of these concomitant therapies.", "output": "Let's think step by step.\nThe drug entities in this text are:\njohn's wort, hormonal contraceptive agents\nSo the corresponding drug entities and relations triplets are:\njohn's wort, effect, hormonal contraceptive agents END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "catecholamine-depleting drugs (e.g., reserpine) may have an additive effect when given with beta-blocking agents.", "output": "Let's think step by step.\nThe drug entities in this text are:\nreserpine, beta-blocking agents\nSo the corresponding drug entities and relations triplets are:\nreserpine, effect, beta-blocking agents END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the cns-depressant effect of propoxyphene is additive with that of other cns depressants, including alcohol.", "output": "Let's think step by step.\nThe drug entities in this text are:\npropoxyphene, cns depressants, alcohol\nSo the corresponding drug entities and relations triplets are:\npropoxyphene, effect, cns depressants\npropoxyphene, effect, alcohol\ncns depressants, false, alcohol END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "such occurrences have been reported when propoxyphene was administered to patients on antidepressants, anticonvulsants, or warfarin-like drugs.", "output": "Let's think step by step.\nThe drug entities in this text are:\npropoxyphene, antidepressants, anticonvulsants, warfarin\nSo the corresponding drug entities and relations triplets are:\npropoxyphene, false, antidepressants\npropoxyphene, false, anticonvulsants\npropoxyphene, false, warfarin\nantidepressants, false, anticonvulsants\nantidepressants, false, warfarin\nanticonvulsants, false, warfarin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "montelukast at a dose of 10 mg once daily dosed to pharmacokinetic steady state  - did not cause clinically significant changes in the kinetics of a single intravenous dose of theophylline (predominantly a cytochrome p450 1a2 substrate).", "output": "Let's think step by step.\nThe drug entities in this text are:\nmontelukast, theophylline\nSo the corresponding drug entities and relations triplets are:\nmontelukast, false, theophylline END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "- did not change the plasma concentration profile of terfenadine (a substrate of cytochrome p450 3a4) or fexofenadine, its carboxylated metabolite, and did not prolong the qtc interval following co-administration with terfenadine 60 mg twice daily.", "output": "Let's think step by step.\nThe drug entities in this text are:\nterfenadine, fexofenadine, terfenadine\nSo the corresponding drug entities and relations triplets are:\nterfenadine, false, fexofenadine\nfexofenadine, false, terfenadine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "montelukast at doses of    100 mg daily dosed to pharmacokinetic steady state:  - did not significantly alter the plasma concentrations of either component of an oral contraceptive containing norethindrone 1 mg/ethinyl estradiol 35 mcg.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmontelukast, contraceptive, norethindrone, estradiol\nSo the corresponding drug entities and relations triplets are:\nmontelukast, false, contraceptive\nmontelukast, false, norethindrone\nmontelukast, false, estradiol\ncontraceptive, false, norethindrone\ncontraceptive, false, estradiol\nnorethindrone, false, estradiol END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "- did not cause any clinically significant change in plasma profiles of prednisone or prednisolone following administration of either oral prednisone or intravenous prednisolone.", "output": "Let's think step by step.\nThe drug entities in this text are:\nprednisone, prednisolone, prednisone, prednisolone\nSo the corresponding drug entities and relations triplets are:\nprednisone, false, prednisolone\nprednisone, false, prednisolone\nprednisolone, false, prednisone\nprednisone, false, prednisolone END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "phenobarbital, which induces hepatic metabolism, decreased the auc of montelukast approximately 40% following a single 10-mg dose of montelukast.", "output": "Let's think step by step.\nThe drug entities in this text are:\nphenobarbital, montelukast, montelukast\nSo the corresponding drug entities and relations triplets are:\nphenobarbital, false, montelukast\nphenobarbital, false, montelukast END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "it is reasonable to employ appropriate clinical monitoring when potent cytochrome p450 enzyme inducers, such as phenobarbital or rifampin, are co-administered with montelukast.", "output": "Let's think step by step.\nThe drug entities in this text are:\nphenobarbital, rifampin, montelukast\nSo the corresponding drug entities and relations triplets are:\nphenobarbital, false, rifampin\nphenobarbital, advise, montelukast\nrifampin, advise, montelukast END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in drug-interaction studies, the recommended clinical dose of montelukast did not have clinically important effects on the pharmacokinetics of the following drugs: theophylline, prednisone, prednisolone, oral contraceptives (norethindrone 1 mg/ethinyl estradiol 35 mcg), terfenadine, digoxin, and warfarin.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmontelukast, theophylline, prednisone, prednisolone, contraceptives, norethindrone, ethinyl estradiol, terfenadine, digoxin, warfarin\nSo the corresponding drug entities and relations triplets are:\nmontelukast, false, theophylline\nmontelukast, false, prednisone\nmontelukast, false, prednisolone\nmontelukast, false, contraceptives\nmontelukast, false, norethindrone\nmontelukast, false, ethinyl estradiol\nmontelukast, false, terfenadine\nmontelukast, false, digoxin\nmontelukast, false, warfarin\ntheophylline, false, prednisone\ntheophylline, false, prednisolone\ntheophylline, false, contraceptives\ntheophylline, false, norethindrone\ntheophylline, false, ethinyl estradiol\ntheophylline, false, terfenadine\ntheophylline, false, digoxin\ntheophylline, false, warfarin\nprednisone, false, prednisolone\nprednisone, false, contraceptives\nprednisone, false, norethindrone\nprednisone, false, ethinyl estradiol\nprednisone, false, terfenadine\nprednisone, false, digoxin\nprednisone, false, warfarin\nprednisolone, false, contraceptives\nprednisolone, false, norethindrone\nprednisolone, false, ethinyl estradiol\nprednisolone, false, terfenadine\nprednisolone, false, digoxin\nprednisolone, false, warfarin\ncontraceptives, false, norethindrone\ncontraceptives, false, ethinyl estradiol\ncontraceptives, false, terfenadine\ncontraceptives, false, digoxin\ncontraceptives, false, warfarin\nnorethindrone, false, ethinyl estradiol\nnorethindrone, false, terfenadine\nnorethindrone, false, digoxin\nnorethindrone, false, warfarin\nethinyl estradiol, false, terfenadine\nethinyl estradiol, false, digoxin\nethinyl estradiol, false, warfarin\nterfenadine, false, digoxin\nterfenadine, false, warfarin\ndigoxin, false, warfarin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "these medications included thyroid hormones, sedative hypnotics, non-steroidal anti-inflammatory agents, benzodiazepines, and decongestants.", "output": "Let's think step by step.\nThe drug entities in this text are:\nthyroid hormones, sedative hypnotics, non-steroidal anti-inflammatory agents, benzodiazepines, decongestants\nSo the corresponding drug entities and relations triplets are:\nthyroid hormones, false, sedative hypnotics\nthyroid hormones, false, non-steroidal anti-inflammatory agents\nthyroid hormones, false, benzodiazepines\nthyroid hormones, false, decongestants\nsedative hypnotics, false, non-steroidal anti-inflammatory agents\nsedative hypnotics, false, benzodiazepines\nsedative hypnotics, false, decongestants\nnon-steroidal anti-inflammatory agents, false, benzodiazepines\nnon-steroidal anti-inflammatory agents, false, decongestants\nbenzodiazepines, false, decongestants END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "phenobarbital, which induces hepatic metabolism, decreased the auc of montelukast approximately 40% following a single 10-mg dose of montelukast.", "output": "Let's think step by step.\nThe drug entities in this text are:\nphenobarbital, montelukast, montelukast\nSo the corresponding drug entities and relations triplets are:\nphenobarbital, false, montelukast\nphenobarbital, false, montelukast END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "it is reasonable to employ appropriate clinical monitoring when potent cytochrome p450 enzyme inducers, such as phenobarbital or rifampin, are co-administered with montelukast.", "output": "Let's think step by step.\nThe drug entities in this text are:\nphenobarbital, rifampin, montelukast\nSo the corresponding drug entities and relations triplets are:\nphenobarbital, false, rifampin\nphenobarbital, advise, montelukast\nrifampin, advise, montelukast END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "carbidopa/levodopa: carbidopa/levodopa does not influence the pharmacokinetics of pramipexole in healthy volunteers (n= 10).", "output": "Let's think step by step.\nThe drug entities in this text are:\ncarbidopa, levodopa, carbidopa, levodopa, pramipexole\nSo the corresponding drug entities and relations triplets are:\ncarbidopa, false, levodopa\ncarbidopa, false, levodopa\ncarbidopa, false, pramipexole\nlevodopa, false, carbidopa\nlevodopa, false, pramipexole\ncarbidopa, false, levodopa\ncarbidopa, false, pramipexole\nlevodopa, false, pramipexole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "selegiline: in healthy volunteers (n= 11), selegiline did not influence the pharmacokinetics of pramipexole.", "output": "Let's think step by step.\nThe drug entities in this text are:\nselegiline, selegiline, pramipexole\nSo the corresponding drug entities and relations triplets are:\nselegiline, false, pramipexole\nselegiline, false, pramipexole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "amantadine: population pharmacokinetic analysis suggests that amantadine is unlikely to alter the oral clearance of pramipexole (n= 54).", "output": "Let's think step by step.\nThe drug entities in this text are:\namantadine, amantadine, pramipexole\nSo the corresponding drug entities and relations triplets are:\namantadine, false, pramipexole\namantadine, false, pramipexole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "cimetidine: cimetidine, a known inhibitor of renal tubular secretion of organic bases via the cationic transport system, caused a 50% increase in pramipexole auc and a 40% increase in half-life (n= 12).", "output": "Let's think step by step.\nThe drug entities in this text are:\ncimetidine, cimetidine, pramipexole\nSo the corresponding drug entities and relations triplets are:\ncimetidine, false, pramipexole\ncimetidine, mechanism, pramipexole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "probenecid: probenecid, a known inhibitor of renal tubular secretion of organic acids via the aruonic transporter, did not noticeably influence pramipexole pharmacokinetics (n= 12).", "output": "Let's think step by step.\nThe drug entities in this text are:\nprobenecid, probenecid, pramipexole\nSo the corresponding drug entities and relations triplets are:\nprobenecid, false, pramipexole\nprobenecid, false, pramipexole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "other drugs eliminated via renal secretion: population pharmacokinetic analysis suggests that coadministration of drugs that are secreted by the cationic transport system (e.g., cimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, and quinine) decreases the oral clearance of pramipexole by about 20%, while those secreted by the anionic transport system (e.g., cephalosporins, penicillins, indomethacin, hydrochlorothiazide, and chlorpropamide) are likely to have little effect on the oral clearance of pramipexole.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncimetidine, ranitidine, diltiazem, triamterene, verapamil, quinidine, quinine, pramipexole, cephalosporins, penicillins, indomethacin, hydrochlorothiazide, chlorpropamide, pramipexole\nSo the corresponding drug entities and relations triplets are:\ncimetidine, false, ranitidine\ncimetidine, false, diltiazem\ncimetidine, false, triamterene\ncimetidine, false, verapamil\ncimetidine, false, quinidine\ncimetidine, false, quinine\ncimetidine, mechanism, pramipexole\ncimetidine, false, cephalosporins\ncimetidine, false, penicillins\ncimetidine, false, indomethacin\ncimetidine, false, hydrochlorothiazide\ncimetidine, false, chlorpropamide\ncimetidine, false, pramipexole\nranitidine, false, diltiazem\nranitidine, false, triamterene\nranitidine, false, verapamil\nranitidine, false, quinidine\nranitidine, false, quinine\nranitidine, mechanism, pramipexole\nranitidine, false, cephalosporins\nranitidine, false, penicillins\nranitidine, false, indomethacin\nranitidine, false, hydrochlorothiazide\nranitidine, false, chlorpropamide\nranitidine, false, pramipexole\ndiltiazem, false, triamterene\ndiltiazem, false, verapamil\ndiltiazem, false, quinidine\ndiltiazem, false, quinine\ndiltiazem, mechanism, pramipexole\ndiltiazem, false, cephalosporins\ndiltiazem, false, penicillins\ndiltiazem, false, indomethacin\ndiltiazem, false, hydrochlorothiazide\ndiltiazem, false, chlorpropamide\ndiltiazem, false, pramipexole\ntriamterene, false, verapamil\ntriamterene, false, quinidine\ntriamterene, false, quinine\ntriamterene, mechanism, pramipexole\ntriamterene, false, cephalosporins\ntriamterene, false, penicillins\ntriamterene, false, indomethacin\ntriamterene, false, hydrochlorothiazide\ntriamterene, false, chlorpropamide\ntriamterene, false, pramipexole\nverapamil, false, quinidine\nverapamil, false, quinine\nverapamil, mechanism, pramipexole\nverapamil, false, cephalosporins\nverapamil, false, penicillins\nverapamil, false, indomethacin\nverapamil, false, hydrochlorothiazide\nverapamil, false, chlorpropamide\nverapamil, false, pramipexole\nquinidine, false, quinine\nquinidine, mechanism, pramipexole\nquinidine, false, cephalosporins\nquinidine, false, penicillins\nquinidine, false, indomethacin\nquinidine, false, hydrochlorothiazide\nquinidine, false, chlorpropamide\nquinidine, false, pramipexole\nquinine, mechanism, pramipexole\nquinine, false, cephalosporins\nquinine, false, penicillins\nquinine, false, indomethacin\nquinine, false, hydrochlorothiazide\nquinine, false, chlorpropamide\nquinine, false, pramipexole\npramipexole, false, cephalosporins\npramipexole, false, penicillins\npramipexole, false, indomethacin\npramipexole, false, hydrochlorothiazide\npramipexole, false, chlorpropamide\ncephalosporins, false, penicillins\ncephalosporins, false, indomethacin\ncephalosporins, false, hydrochlorothiazide\ncephalosporins, false, chlorpropamide\ncephalosporins, mechanism, pramipexole\npenicillins, false, indomethacin\npenicillins, false, hydrochlorothiazide\npenicillins, false, chlorpropamide\npenicillins, mechanism, pramipexole\nindomethacin, false, hydrochlorothiazide\nindomethacin, false, chlorpropamide\nindomethacin, mechanism, pramipexole\nhydrochlorothiazide, false, chlorpropamide\nhydrochlorothiazide, mechanism, pramipexole\nchlorpropamide, mechanism, pramipexole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "dopamine antagonists: since pramipexole is a dopamine agonist, it is possible that dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthenes) or metoclopramide, may diminish the effectiveness of mirapex.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndopamine antagonists, pramipexole, dopamine agonist, dopamine antagonists, neuroleptics, phenothiazines, butyrophenones, thioxanthenes, metoclopramide, mirapex\nSo the corresponding drug entities and relations triplets are:\ndopamine antagonists, false, pramipexole\ndopamine antagonists, false, dopamine agonist\ndopamine antagonists, false, neuroleptics\ndopamine antagonists, false, phenothiazines\ndopamine antagonists, false, butyrophenones\ndopamine antagonists, false, thioxanthenes\ndopamine antagonists, false, metoclopramide\ndopamine antagonists, false, mirapex\npramipexole, false, dopamine agonist\npramipexole, false, dopamine antagonists\npramipexole, false, neuroleptics\npramipexole, false, phenothiazines\npramipexole, false, butyrophenones\npramipexole, false, thioxanthenes\npramipexole, false, metoclopramide\npramipexole, false, mirapex\ndopamine agonist, false, dopamine antagonists\ndopamine agonist, false, neuroleptics\ndopamine agonist, false, phenothiazines\ndopamine agonist, false, butyrophenones\ndopamine agonist, false, thioxanthenes\ndopamine agonist, false, metoclopramide\ndopamine agonist, false, mirapex\ndopamine antagonists, false, neuroleptics\ndopamine antagonists, false, phenothiazines\ndopamine antagonists, false, butyrophenones\ndopamine antagonists, false, thioxanthenes\ndopamine antagonists, false, metoclopramide\ndopamine antagonists, effect, mirapex\nneuroleptics, false, phenothiazines\nneuroleptics, false, butyrophenones\nneuroleptics, false, thioxanthenes\nneuroleptics, false, metoclopramide\nneuroleptics, effect, mirapex\nphenothiazines, false, butyrophenones\nphenothiazines, false, thioxanthenes\nphenothiazines, false, metoclopramide\nphenothiazines, effect, mirapex\nbutyrophenones, false, thioxanthenes\nbutyrophenones, false, metoclopramide\nbutyrophenones, effect, mirapex\nthioxanthenes, false, metoclopramide\nthioxanthenes, effect, mirapex\nmetoclopramide, effect, mirapex END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "based on studies evaluating possible interactions of pantoprazole with other drugs, no dosage adjustment is needed with concomitant use of the following: theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam (and its active metabolite, desmethyldiazepam), diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, an oral contraceptive (levonorgestrel/ethinyl estradiol), metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, or amoxicillin.", "output": "Let's think step by step.\nThe drug entities in this text are:\npantoprazole, theophylline, cisapride, antipyrine, caffeine, carbamazepine, diazepam, desmethyldiazepam, diclofenac, naproxen, piroxicam, digoxin, ethanol, glyburide, contraceptive, levonorgestrel, ethinyl estradiol, metoprolol, nifedipine, phenytoin, warfarin, midazolam, clarithromycin, metronidazole, amoxicillin\nSo the corresponding drug entities and relations triplets are:\npantoprazole, false, theophylline\npantoprazole, false, cisapride\npantoprazole, false, antipyrine\npantoprazole, false, caffeine\npantoprazole, false, carbamazepine\npantoprazole, false, diazepam\npantoprazole, false, desmethyldiazepam\npantoprazole, false, diclofenac\npantoprazole, false, naproxen\npantoprazole, false, piroxicam\npantoprazole, false, digoxin\npantoprazole, false, ethanol\npantoprazole, false, glyburide\npantoprazole, false, contraceptive\npantoprazole, false, levonorgestrel\npantoprazole, false, ethinyl estradiol\npantoprazole, false, metoprolol\npantoprazole, false, nifedipine\npantoprazole, false, phenytoin\npantoprazole, false, warfarin\npantoprazole, false, midazolam\npantoprazole, false, clarithromycin\npantoprazole, false, metronidazole\npantoprazole, false, amoxicillin\ntheophylline, false, cisapride\ntheophylline, false, antipyrine\ntheophylline, false, caffeine\ntheophylline, false, carbamazepine\ntheophylline, false, diazepam\ntheophylline, false, desmethyldiazepam\ntheophylline, false, diclofenac\ntheophylline, false, naproxen\ntheophylline, false, piroxicam\ntheophylline, false, digoxin\ntheophylline, false, ethanol\ntheophylline, false, glyburide\ntheophylline, false, contraceptive\ntheophylline, false, levonorgestrel\ntheophylline, false, ethinyl estradiol\ntheophylline, false, metoprolol\ntheophylline, false, nifedipine\ntheophylline, false, phenytoin\ntheophylline, false, warfarin\ntheophylline, false, midazolam\ntheophylline, false, clarithromycin\ntheophylline, false, metronidazole\ntheophylline, false, amoxicillin\ncisapride, false, antipyrine\ncisapride, false, caffeine\ncisapride, false, carbamazepine\ncisapride, false, diazepam\ncisapride, false, desmethyldiazepam\ncisapride, false, diclofenac\ncisapride, false, naproxen\ncisapride, false, piroxicam\ncisapride, false, digoxin\ncisapride, false, ethanol\ncisapride, false, glyburide\ncisapride, false, contraceptive\ncisapride, false, levonorgestrel\ncisapride, false, ethinyl estradiol\ncisapride, false, metoprolol\ncisapride, false, nifedipine\ncisapride, false, phenytoin\ncisapride, false, warfarin\ncisapride, false, midazolam\ncisapride, false, clarithromycin\ncisapride, false, metronidazole\ncisapride, false, amoxicillin\nantipyrine, false, caffeine\nantipyrine, false, carbamazepine\nantipyrine, false, diazepam\nantipyrine, false, desmethyldiazepam\nantipyrine, false, diclofenac\nantipyrine, false, naproxen\nantipyrine, false, piroxicam\nantipyrine, false, digoxin\nantipyrine, false, ethanol\nantipyrine, false, glyburide\nantipyrine, false, contraceptive\nantipyrine, false, levonorgestrel\nantipyrine, false, ethinyl estradiol\nantipyrine, false, metoprolol\nantipyrine, false, nifedipine\nantipyrine, false, phenytoin\nantipyrine, false, warfarin\nantipyrine, false, midazolam\nantipyrine, false, clarithromycin\nantipyrine, false, metronidazole\nantipyrine, false, amoxicillin\ncaffeine, false, carbamazepine\ncaffeine, false, diazepam\ncaffeine, false, desmethyldiazepam\ncaffeine, false, diclofenac\ncaffeine, false, naproxen\ncaffeine, false, piroxicam\ncaffeine, false, digoxin\ncaffeine, false, ethanol\ncaffeine, false, glyburide\ncaffeine, false, contraceptive\ncaffeine, false, levonorgestrel\ncaffeine, false, ethinyl estradiol\ncaffeine, false, metoprolol\ncaffeine, false, nifedipine\ncaffeine, false, phenytoin\ncaffeine, false, warfarin\ncaffeine, false, midazolam\ncaffeine, false, clarithromycin\ncaffeine, false, metronidazole\ncaffeine, false, amoxicillin\ncarbamazepine, false, diazepam\ncarbamazepine, false, desmethyldiazepam\ncarbamazepine, false, diclofenac\ncarbamazepine, false, naproxen\ncarbamazepine, false, piroxicam\ncarbamazepine, false, digoxin\ncarbamazepine, false, ethanol\ncarbamazepine, false, glyburide\ncarbamazepine, false, contraceptive\ncarbamazepine, false, levonorgestrel\ncarbamazepine, false, ethinyl estradiol\ncarbamazepine, false, metoprolol\ncarbamazepine, false, nifedipine\ncarbamazepine, false, phenytoin\ncarbamazepine, false, warfarin\ncarbamazepine, false, midazolam\ncarbamazepine, false, clarithromycin\ncarbamazepine, false, metronidazole\ncarbamazepine, false, amoxicillin\ndiazepam, false, desmethyldiazepam\ndiazepam, false, diclofenac\ndiazepam, false, naproxen\ndiazepam, false, piroxicam\ndiazepam, false, digoxin\ndiazepam, false, ethanol\ndiazepam, false, glyburide\ndiazepam, false, contraceptive\ndiazepam, false, levonorgestrel\ndiazepam, false, ethinyl estradiol\ndiazepam, false, metoprolol\ndiazepam, false, nifedipine\ndiazepam, false, phenytoin\ndiazepam, false, warfarin\ndiazepam, false, midazolam\ndiazepam, false, clarithromycin\ndiazepam, false, metronidazole\ndiazepam, false, amoxicillin\ndesmethyldiazepam, false, diclofenac\ndesmethyldiazepam, false, naproxen\ndesmethyldiazepam, false, piroxicam\ndesmethyldiazepam, false, digoxin\ndesmethyldiazepam, false, ethanol\ndesmethyldiazepam, false, glyburide\ndesmethyldiazepam, false, contraceptive\ndesmethyldiazepam, false, levonorgestrel\ndesmethyldiazepam, false, ethinyl estradiol\ndesmethyldiazepam, false, metoprolol\ndesmethyldiazepam, false, nifedipine\ndesmethyldiazepam, false, phenytoin\ndesmethyldiazepam, false, warfarin\ndesmethyldiazepam, false, midazolam\ndesmethyldiazepam, false, clarithromycin\ndesmethyldiazepam, false, metronidazole\ndesmethyldiazepam, false, amoxicillin\ndiclofenac, false, naproxen\ndiclofenac, false, piroxicam\ndiclofenac, false, digoxin\ndiclofenac, false, ethanol\ndiclofenac, false, glyburide\ndiclofenac, false, contraceptive\ndiclofenac, false, levonorgestrel\ndiclofenac, false, ethinyl estradiol\ndiclofenac, false, metoprolol\ndiclofenac, false, nifedipine\ndiclofenac, false, phenytoin\ndiclofenac, false, warfarin\ndiclofenac, false, midazolam\ndiclofenac, false, clarithromycin\ndiclofenac, false, metronidazole\ndiclofenac, false, amoxicillin\nnaproxen, false, piroxicam\nnaproxen, false, digoxin\nnaproxen, false, ethanol\nnaproxen, false, glyburide\nnaproxen, false, contraceptive\nnaproxen, false, levonorgestrel\nnaproxen, false, ethinyl estradiol\nnaproxen, false, metoprolol\nnaproxen, false, nifedipine\nnaproxen, false, phenytoin\nnaproxen, false, warfarin\nnaproxen, false, midazolam\nnaproxen, false, clarithromycin\nnaproxen, false, metronidazole\nnaproxen, false, amoxicillin\npiroxicam, false, digoxin\npiroxicam, false, ethanol\npiroxicam, false, glyburide\npiroxicam, false, contraceptive\npiroxicam, false, levonorgestrel\npiroxicam, false, ethinyl estradiol\npiroxicam, false, metoprolol\npiroxicam, false, nifedipine\npiroxicam, false, phenytoin\npiroxicam, false, warfarin\npiroxicam, false, midazolam\npiroxicam, false, clarithromycin\npiroxicam, false, metronidazole\npiroxicam, false, amoxicillin\ndigoxin, false, ethanol\ndigoxin, false, glyburide\ndigoxin, false, contraceptive\ndigoxin, false, levonorgestrel\ndigoxin, false, ethinyl estradiol\ndigoxin, false, metoprolol\ndigoxin, false, nifedipine\ndigoxin, false, phenytoin\ndigoxin, false, warfarin\ndigoxin, false, midazolam\ndigoxin, false, clarithromycin\ndigoxin, false, metronidazole\ndigoxin, false, amoxicillin\nethanol, false, glyburide\nethanol, false, contraceptive\nethanol, false, levonorgestrel\nethanol, false, ethinyl estradiol\nethanol, false, metoprolol\nethanol, false, nifedipine\nethanol, false, phenytoin\nethanol, false, warfarin\nethanol, false, midazolam\nethanol, false, clarithromycin\nethanol, false, metronidazole\nethanol, false, amoxicillin\nglyburide, false, contraceptive\nglyburide, false, levonorgestrel\nglyburide, false, ethinyl estradiol\nglyburide, false, metoprolol\nglyburide, false, nifedipine\nglyburide, false, phenytoin\nglyburide, false, warfarin\nglyburide, false, midazolam\nglyburide, false, clarithromycin\nglyburide, false, metronidazole\nglyburide, false, amoxicillin\ncontraceptive, false, levonorgestrel\ncontraceptive, false, ethinyl estradiol\ncontraceptive, false, metoprolol\ncontraceptive, false, nifedipine\ncontraceptive, false, phenytoin\ncontraceptive, false, warfarin\ncontraceptive, false, midazolam\ncontraceptive, false, clarithromycin\ncontraceptive, false, metronidazole\ncontraceptive, false, amoxicillin\nlevonorgestrel, false, ethinyl estradiol\nlevonorgestrel, false, metoprolol\nlevonorgestrel, false, nifedipine\nlevonorgestrel, false, phenytoin\nlevonorgestrel, false, warfarin\nlevonorgestrel, false, midazolam\nlevonorgestrel, false, clarithromycin\nlevonorgestrel, false, metronidazole\nlevonorgestrel, false, amoxicillin\nethinyl estradiol, false, metoprolol\nethinyl estradiol, false, nifedipine\nethinyl estradiol, false, phenytoin\nethinyl estradiol, false, warfarin\nethinyl estradiol, false, midazolam\nethinyl estradiol, false, clarithromycin\nethinyl estradiol, false, metronidazole\nethinyl estradiol, false, amoxicillin\nmetoprolol, false, nifedipine\nmetoprolol, false, phenytoin\nmetoprolol, false, warfarin\nmetoprolol, false, midazolam\nmetoprolol, false, clarithromycin\nmetoprolol, false, metronidazole\nmetoprolol, false, amoxicillin\nnifedipine, false, phenytoin\nnifedipine, false, warfarin\nnifedipine, false, midazolam\nnifedipine, false, clarithromycin\nnifedipine, false, metronidazole\nnifedipine, false, amoxicillin\nphenytoin, false, warfarin\nphenytoin, false, midazolam\nphenytoin, false, clarithromycin\nphenytoin, false, metronidazole\nphenytoin, false, amoxicillin\nwarfarin, false, midazolam\nwarfarin, false, clarithromycin\nwarfarin, false, metronidazole\nwarfarin, false, amoxicillin\nmidazolam, false, clarithromycin\nmidazolam, false, metronidazole\nmidazolam, false, amoxicillin\nclarithromycin, false, metronidazole\nclarithromycin, false, amoxicillin\nmetronidazole, false, amoxicillin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "there have been postmarketing reports of increased inr and prothrombin time in patients receiving proton pump inhibitors, including pantoprazole, and warfarin concomitantly.", "output": "Let's think step by step.\nThe drug entities in this text are:\nproton pump inhibitors, pantoprazole, warfarin\nSo the corresponding drug entities and relations triplets are:\nproton pump inhibitors, false, pantoprazole\nproton pump inhibitors, effect, warfarin\npantoprazole, effect, warfarin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "patients treated with proton pump inhibitors and warfarin concomitantly should be monitored for increases in inr and prothrombin time.", "output": "Let's think step by step.\nThe drug entities in this text are:\nproton pump inhibitors, warfarin\nSo the corresponding drug entities and relations triplets are:\nproton pump inhibitors, advise, warfarin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "because of profound and long lasting inhibition of gastric acid secretion, pantoprazole may interfere with absorption of drugs where gastric ph is an important determinant of their bioavailability (eg, ketoconazole, ampicillin esters, and iron salts).", "output": "Let's think step by step.\nThe drug entities in this text are:\npantoprazole, ketoconazole, ampicillin, iron\nSo the corresponding drug entities and relations triplets are:\npantoprazole, mechanism, ketoconazole\npantoprazole, mechanism, ampicillin\npantoprazole, mechanism, iron\nketoconazole, false, ampicillin\nketoconazole, false, iron\nampicillin, false, iron END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "laboratory tests there have been reports of false-positive urine screening tests for tetrahydrocannabinol (thc) in patients receiving most proton pump inhibitors, including pantoprazole.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntetrahydrocannabinol, thc, proton pump inhibitors, pantoprazole\nSo the corresponding drug entities and relations triplets are:\ntetrahydrocannabinol, false, thc\ntetrahydrocannabinol, false, proton pump inhibitors\ntetrahydrocannabinol, false, pantoprazole\nthc, false, proton pump inhibitors\nthc, false, pantoprazole\nproton pump inhibitors, false, pantoprazole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "other eye drops or medications such as acetylcholine chloride (miochol) and carbachol (carboptic, isopto carbachol) may decrease the effects of suprofen ophthalmic.", "output": "Let's think step by step.\nThe drug entities in this text are:\nacetylcholine chloride, miochol, carbachol, carboptic, isopto carbachol, suprofen\nSo the corresponding drug entities and relations triplets are:\nacetylcholine chloride, false, miochol\nacetylcholine chloride, false, carbachol\nacetylcholine chloride, false, carboptic\nacetylcholine chloride, false, isopto carbachol\nacetylcholine chloride, effect, suprofen\nmiochol, false, carbachol\nmiochol, false, carboptic\nmiochol, false, isopto carbachol\nmiochol, effect, suprofen\ncarbachol, false, carboptic\ncarbachol, false, isopto carbachol\ncarbachol, effect, suprofen\ncarboptic, false, isopto carbachol\ncarboptic, effect, suprofen\nisopto carbachol, effect, suprofen END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "you cannot take mazindol if you have taken a monoamine oxidase inhibitor (maoi) such as isocarboxazid (marplan), tranylcypromine (parnate), or phenelzine (nardil) in the last 14 days.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmazindol, monoamine oxidase inhibitor, maoi, isocarboxazid, marplan, tranylcypromine, parnate, phenelzine, nardil\nSo the corresponding drug entities and relations triplets are:\nmazindol, advise, monoamine oxidase inhibitor\nmazindol, advise, maoi\nmazindol, advise, isocarboxazid\nmazindol, advise, marplan\nmazindol, advise, tranylcypromine\nmazindol, advise, parnate\nmazindol, advise, phenelzine\nmazindol, advise, nardil\nmonoamine oxidase inhibitor, false, maoi\nmonoamine oxidase inhibitor, false, isocarboxazid\nmonoamine oxidase inhibitor, false, marplan\nmonoamine oxidase inhibitor, false, tranylcypromine\nmonoamine oxidase inhibitor, false, parnate\nmonoamine oxidase inhibitor, false, phenelzine\nmonoamine oxidase inhibitor, false, nardil\nmaoi, false, isocarboxazid\nmaoi, false, marplan\nmaoi, false, tranylcypromine\nmaoi, false, parnate\nmaoi, false, phenelzine\nmaoi, false, nardil\nisocarboxazid, false, marplan\nisocarboxazid, false, tranylcypromine\nisocarboxazid, false, parnate\nisocarboxazid, false, phenelzine\nisocarboxazid, false, nardil\nmarplan, false, tranylcypromine\nmarplan, false, parnate\nmarplan, false, phenelzine\nmarplan, false, nardil\ntranylcypromine, false, parnate\ntranylcypromine, false, phenelzine\ntranylcypromine, false, nardil\nparnate, false, phenelzine\nparnate, false, nardil\nphenelzine, false, nardil END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "changes in insulin and other diabetes drug therapies may be necessary during treatment with mazindol.", "output": "Let's think step by step.\nThe drug entities in this text are:\ninsulin, mazindol\nSo the corresponding drug entities and relations triplets are:\ninsulin, advise, mazindol END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "mazindol may reduce the effects of guanethidine (ismelin).", "output": "Let's think step by step.\nThe drug entities in this text are:\nmazindol, guanethidine, ismelin\nSo the corresponding drug entities and relations triplets are:\nmazindol, effect, guanethidine\nmazindol, effect, ismelin\nguanethidine, false, ismelin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "before taking this medication, tell your doctor if you are taking a tricyclic antidepressant such as amitriptyline (elavil), amoxapine (asendin), doxepin (sinequan), nortriptyline (pamelor), imipramine (tofranil), clomipramine (anafranil), protriptyline (vivactil), or desipramine (norpramin).", "output": "Let's think step by step.\nThe drug entities in this text are:\ntricyclic antidepressant, amitriptyline, elavil, amoxapine, asendin, doxepin, sinequan, nortriptyline, pamelor, imipramine, tofranil, clomipramine, anafranil, protriptyline, vivactil, desipramine, norpramin\nSo the corresponding drug entities and relations triplets are:\ntricyclic antidepressant, false, amitriptyline\ntricyclic antidepressant, false, elavil\ntricyclic antidepressant, false, amoxapine\ntricyclic antidepressant, false, asendin\ntricyclic antidepressant, false, doxepin\ntricyclic antidepressant, false, sinequan\ntricyclic antidepressant, false, nortriptyline\ntricyclic antidepressant, false, pamelor\ntricyclic antidepressant, false, imipramine\ntricyclic antidepressant, false, tofranil\ntricyclic antidepressant, false, clomipramine\ntricyclic antidepressant, false, anafranil\ntricyclic antidepressant, false, protriptyline\ntricyclic antidepressant, false, vivactil\ntricyclic antidepressant, false, desipramine\ntricyclic antidepressant, false, norpramin\namitriptyline, false, elavil\namitriptyline, false, amoxapine\namitriptyline, false, asendin\namitriptyline, false, doxepin\namitriptyline, false, sinequan\namitriptyline, false, nortriptyline\namitriptyline, false, pamelor\namitriptyline, false, imipramine\namitriptyline, false, tofranil\namitriptyline, false, clomipramine\namitriptyline, false, anafranil\namitriptyline, false, protriptyline\namitriptyline, false, vivactil\namitriptyline, false, desipramine\namitriptyline, false, norpramin\nelavil, false, amoxapine\nelavil, false, asendin\nelavil, false, doxepin\nelavil, false, sinequan\nelavil, false, nortriptyline\nelavil, false, pamelor\nelavil, false, imipramine\nelavil, false, tofranil\nelavil, false, clomipramine\nelavil, false, anafranil\nelavil, false, protriptyline\nelavil, false, vivactil\nelavil, false, desipramine\nelavil, false, norpramin\namoxapine, false, asendin\namoxapine, false, doxepin\namoxapine, false, sinequan\namoxapine, false, nortriptyline\namoxapine, false, pamelor\namoxapine, false, imipramine\namoxapine, false, tofranil\namoxapine, false, clomipramine\namoxapine, false, anafranil\namoxapine, false, protriptyline\namoxapine, false, vivactil\namoxapine, false, desipramine\namoxapine, false, norpramin\nasendin, false, doxepin\nasendin, false, sinequan\nasendin, false, nortriptyline\nasendin, false, pamelor\nasendin, false, imipramine\nasendin, false, tofranil\nasendin, false, clomipramine\nasendin, false, anafranil\nasendin, false, protriptyline\nasendin, false, vivactil\nasendin, false, desipramine\nasendin, false, norpramin\ndoxepin, false, sinequan\ndoxepin, false, nortriptyline\ndoxepin, false, pamelor\ndoxepin, false, imipramine\ndoxepin, false, tofranil\ndoxepin, false, clomipramine\ndoxepin, false, anafranil\ndoxepin, false, protriptyline\ndoxepin, false, vivactil\ndoxepin, false, desipramine\ndoxepin, false, norpramin\nsinequan, false, nortriptyline\nsinequan, false, pamelor\nsinequan, false, imipramine\nsinequan, false, tofranil\nsinequan, false, clomipramine\nsinequan, false, anafranil\nsinequan, false, protriptyline\nsinequan, false, vivactil\nsinequan, false, desipramine\nsinequan, false, norpramin\nnortriptyline, false, pamelor\nnortriptyline, false, imipramine\nnortriptyline, false, tofranil\nnortriptyline, false, clomipramine\nnortriptyline, false, anafranil\nnortriptyline, false, protriptyline\nnortriptyline, false, vivactil\nnortriptyline, false, desipramine\nnortriptyline, false, norpramin\npamelor, false, imipramine\npamelor, false, tofranil\npamelor, false, clomipramine\npamelor, false, anafranil\npamelor, false, protriptyline\npamelor, false, vivactil\npamelor, false, desipramine\npamelor, false, norpramin\nimipramine, false, tofranil\nimipramine, false, clomipramine\nimipramine, false, anafranil\nimipramine, false, protriptyline\nimipramine, false, vivactil\nimipramine, false, desipramine\nimipramine, false, norpramin\ntofranil, false, clomipramine\ntofranil, false, anafranil\ntofranil, false, protriptyline\ntofranil, false, vivactil\ntofranil, false, desipramine\ntofranil, false, norpramin\nclomipramine, false, anafranil\nclomipramine, false, protriptyline\nclomipramine, false, vivactil\nclomipramine, false, desipramine\nclomipramine, false, norpramin\nanafranil, false, protriptyline\nanafranil, false, vivactil\nanafranil, false, desipramine\nanafranil, false, norpramin\nprotriptyline, false, vivactil\nprotriptyline, false, desipramine\nprotriptyline, false, norpramin\nvivactil, false, desipramine\nvivactil, false, norpramin\ndesipramine, false, norpramin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "pharmacokinetic properties of abacavir were not altered by the addition of either lamivudine or zidovudine or the combination of lamivudine and zidovudine.", "output": "Let's think step by step.\nThe drug entities in this text are:\nabacavir, lamivudine, zidovudine, lamivudine, zidovudine\nSo the corresponding drug entities and relations triplets are:\nabacavir, false, lamivudine\nabacavir, false, zidovudine\nabacavir, false, lamivudine\nabacavir, false, zidovudine\nlamivudine, false, zidovudine\nlamivudine, false, zidovudine\nzidovudine, false, lamivudine\nlamivudine, false, zidovudine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "no clinically significant changes to lamivudine or zidovudine pharmacokinetics were observed following concomitant administration of abacavir.", "output": "Let's think step by step.\nThe drug entities in this text are:\nlamivudine, zidovudine, abacavir\nSo the corresponding drug entities and relations triplets are:\nlamivudine, false, zidovudine\nlamivudine, false, abacavir\nzidovudine, false, abacavir END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "abacavir has no effect on the pharmacokinetic properties of ethanol.", "output": "Let's think step by step.\nThe drug entities in this text are:\nabacavir, ethanol\nSo the corresponding drug entities and relations triplets are:\nabacavir, false, ethanol END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "ethanol decreases the elimination of abacavir causing an increase in overall exposure . the addition of methadone has no clinically significant effect on the pharmacokinetic properties of abacavir.", "output": "Let's think step by step.\nThe drug entities in this text are:\nethanol, abacavir, methadone, abacavir\nSo the corresponding drug entities and relations triplets are:\nethanol, mechanism, abacavir\nethanol, false, methadone\nethanol, false, abacavir\nabacavir, false, methadone\nmethadone, false, abacavir END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in a study of 11 hiv-infected patients receiving methadone-maintenance therapy (40 mg and 90 mg daily) with 600 mg of ziagen twice daily (twice the currently recommended dose), oral methadone clearance increased 22% (90% ci 6% to 42%).", "output": "Let's think step by step.\nThe drug entities in this text are:\nmethadone, ziagen, methadone\nSo the corresponding drug entities and relations triplets are:\nmethadone, mechanism, ziagen\nziagen, false, methadone END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "sulfoxone may increase the effects of barbiturates, tolbutamide, and uricosurics.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsulfoxone, barbiturates, tolbutamide, uricosurics\nSo the corresponding drug entities and relations triplets are:\nsulfoxone, effect, barbiturates\nsulfoxone, effect, tolbutamide\nsulfoxone, effect, uricosurics\nbarbiturates, false, tolbutamide\nbarbiturates, false, uricosurics\ntolbutamide, false, uricosurics END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "it may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "output": "Let's think step by step.\nThe drug entities in this text are:\nthiazides, cyclosporine, sulfonylurea agents, warfarin, methotrexate, methotrexate, phenytoin, phenytoin\nSo the corresponding drug entities and relations triplets are:\nthiazides, false, cyclosporine\nthiazides, false, sulfonylurea agents\nthiazides, false, warfarin\nthiazides, false, methotrexate\nthiazides, false, methotrexate\nthiazides, false, phenytoin\nthiazides, false, phenytoin\ncyclosporine, false, sulfonylurea agents\ncyclosporine, false, warfarin\ncyclosporine, false, methotrexate\ncyclosporine, false, methotrexate\ncyclosporine, false, phenytoin\ncyclosporine, false, phenytoin\nsulfonylurea agents, false, warfarin\nsulfonylurea agents, false, methotrexate\nsulfonylurea agents, false, methotrexate\nsulfonylurea agents, false, phenytoin\nsulfonylurea agents, false, phenytoin\nwarfarin, false, methotrexate\nwarfarin, false, methotrexate\nwarfarin, false, phenytoin\nwarfarin, false, phenytoin\nmethotrexate, false, phenytoin\nmethotrexate, false, phenytoin\nmethotrexate, false, phenytoin\nmethotrexate, false, phenytoin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "phenothiazines are capable of potentiating cns depressants (e.g., barbiturates, anesthetics, opiates, alcohol, etc.)", "output": "Let's think step by step.\nThe drug entities in this text are:\nphenothiazines, cns depressants, barbiturates, anesthetics, opiates, alcohol\nSo the corresponding drug entities and relations triplets are:\nphenothiazines, effect, cns depressants\nphenothiazines, effect, barbiturates\nphenothiazines, effect, anesthetics\nphenothiazines, effect, opiates\nphenothiazines, effect, alcohol\ncns depressants, false, barbiturates\ncns depressants, false, anesthetics\ncns depressants, false, opiates\ncns depressants, false, alcohol\nbarbiturates, false, anesthetics\nbarbiturates, false, opiates\nbarbiturates, false, alcohol\nanesthetics, false, opiates\nanesthetics, false, alcohol\nopiates, false, alcohol END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "as well as atropine and phosphorous insecticides.", "output": "Let's think step by step.\nThe drug entities in this text are:\natropine, phosphorous insecticides\nSo the corresponding drug entities and relations triplets are:\natropine, false, phosphorous insecticides END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "pharmacokinetic studies show that there are no significant alterations in pharmacokinetic parameters of zidovudine or rifabutin to warrant dosage adjustment when megestrol acetate is administered with these drugs.", "output": "Let's think step by step.\nThe drug entities in this text are:\nzidovudine, rifabutin, megestrol acetate\nSo the corresponding drug entities and relations triplets are:\nzidovudine, false, rifabutin\nzidovudine, false, megestrol acetate\nrifabutin, false, megestrol acetate END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "a pharmacokinetic study demonstrated that coadministration of megestrol acetate and indinavir results in a significant decrease in the pharmacokinetic parameters (~36% for cmax and ~28% for auc) of indinavir.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmegestrol acetate, indinavir, indinavir\nSo the corresponding drug entities and relations triplets are:\nmegestrol acetate, mechanism, indinavir\nmegestrol acetate, false, indinavir END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "administration of a higher dose of indinavir should be considered when coadministering with megestrol acetate.", "output": "Let's think step by step.\nThe drug entities in this text are:\nindinavir, megestrol acetate\nSo the corresponding drug entities and relations triplets are:\nindinavir, advise, megestrol acetate END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the effects of indinavir, zidovudine or rifabutin on the pharmacokinetics of megestrol acetate were not studied.", "output": "Let's think step by step.\nThe drug entities in this text are:\nindinavir, zidovudine, rifabutin, megestrol acetate\nSo the corresponding drug entities and relations triplets are:\nindinavir, false, zidovudine\nindinavir, false, rifabutin\nindinavir, false, megestrol acetate\nzidovudine, false, rifabutin\nzidovudine, false, megestrol acetate\nrifabutin, false, megestrol acetate END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "streptozocin has been reported to prolong the elimination half-life of doxorubicin and may lead to severe bone marrow suppression;", "output": "Let's think step by step.\nThe drug entities in this text are:\nstreptozocin, doxorubicin\nSo the corresponding drug entities and relations triplets are:\nstreptozocin, mechanism, doxorubicin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "a reduction of the doxorubicin dosage should be considered in patients receiving zanosar concurrently.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndoxorubicin, zanosar\nSo the corresponding drug entities and relations triplets are:\ndoxorubicin, advise, zanosar END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the concurrent use of streptozocin and phenytoin has been reported in one case to result in reduced streptozocin cytotoxicity.", "output": "Let's think step by step.\nThe drug entities in this text are:\nstreptozocin, phenytoin, streptozocin\nSo the corresponding drug entities and relations triplets are:\nstreptozocin, effect, phenytoin\nphenytoin, false, streptozocin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "aramine should be used with caution in digitalized patients, since the combination of digitalis and sympathomimetic amines may cause ectopic arrhythmias.", "output": "Let's think step by step.\nThe drug entities in this text are:\naramine, digitalis, sympathomimetic amines\nSo the corresponding drug entities and relations triplets are:\naramine, false, digitalis\naramine, false, sympathomimetic amines\ndigitalis, effect, sympathomimetic amines END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "monoamine oxidase inhibitors or tricyclic antidepressants may potentiate the action of sympathomimetic amines.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmonoamine oxidase inhibitors, tricyclic antidepressants, sympathomimetic amines\nSo the corresponding drug entities and relations triplets are:\nmonoamine oxidase inhibitors, false, tricyclic antidepressants\nmonoamine oxidase inhibitors, effect, sympathomimetic amines\ntricyclic antidepressants, effect, sympathomimetic amines END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "mequitazine can interact with cns depressant, antichlolinergic, tca, maois, and alcohol.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmequitazine, cns depressant, antichlolinergic, tca, maois, alcohol\nSo the corresponding drug entities and relations triplets are:\nmequitazine, int, cns depressant\nmequitazine, int, antichlolinergic\nmequitazine, int, tca\nmequitazine, int, maois\nmequitazine, int, alcohol\ncns depressant, false, antichlolinergic\ncns depressant, false, tca\ncns depressant, false, maois\ncns depressant, false, alcohol\nantichlolinergic, false, tca\nantichlolinergic, false, maois\nantichlolinergic, false, alcohol\ntca, false, maois\ntca, false, alcohol\nmaois, false, alcohol END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "barbiturates may decrease the effectiveness of oral contraceptives, certain antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, and beta blockers.", "output": "Let's think step by step.\nThe drug entities in this text are:\nbarbiturates, contraceptives, antibiotics, quinidine, theophylline, corticosteroids, anticoagulants, beta blockers\nSo the corresponding drug entities and relations triplets are:\nbarbiturates, int, contraceptives\nbarbiturates, int, antibiotics\nbarbiturates, int, quinidine\nbarbiturates, int, theophylline\nbarbiturates, int, corticosteroids\nbarbiturates, int, anticoagulants\nbarbiturates, int, beta blockers\ncontraceptives, false, antibiotics\ncontraceptives, false, quinidine\ncontraceptives, false, theophylline\ncontraceptives, false, corticosteroids\ncontraceptives, false, anticoagulants\ncontraceptives, false, beta blockers\nantibiotics, false, quinidine\nantibiotics, false, theophylline\nantibiotics, false, corticosteroids\nantibiotics, false, anticoagulants\nantibiotics, false, beta blockers\nquinidine, false, theophylline\nquinidine, false, corticosteroids\nquinidine, false, anticoagulants\nquinidine, false, beta blockers\ntheophylline, false, corticosteroids\ntheophylline, false, anticoagulants\ntheophylline, false, beta blockers\ncorticosteroids, false, anticoagulants\ncorticosteroids, false, beta blockers\nanticoagulants, false, beta blockers END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "sulfamethizole may increase the effects of barbiturates, tolbutamide, and uricosurics.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsulfamethizole, barbiturates, tolbutamide, uricosurics\nSo the corresponding drug entities and relations triplets are:\nsulfamethizole, effect, barbiturates\nsulfamethizole, effect, tolbutamide\nsulfamethizole, effect, uricosurics\nbarbiturates, false, tolbutamide\nbarbiturates, false, uricosurics\ntolbutamide, false, uricosurics END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "it may also interact with thiazides (increased thrombocytopenia), cyclosporine (increased nephrotoxicity), sulfonylurea agents (increased hypoglycemic response), warfarin (increased anticoagulant effect), methotrexate (decreased renal excretion of methotrexate), phenytoin (decreased hepatic clearance of phenytoin).", "output": "Let's think step by step.\nThe drug entities in this text are:\nthiazides, cyclosporine, sulfonylurea agents, warfarin, methotrexate, methotrexate, phenytoin, phenytoin\nSo the corresponding drug entities and relations triplets are:\nthiazides, false, cyclosporine\nthiazides, false, sulfonylurea agents\nthiazides, false, warfarin\nthiazides, false, methotrexate\nthiazides, false, methotrexate\nthiazides, false, phenytoin\nthiazides, false, phenytoin\ncyclosporine, false, sulfonylurea agents\ncyclosporine, false, warfarin\ncyclosporine, false, methotrexate\ncyclosporine, false, methotrexate\ncyclosporine, false, phenytoin\ncyclosporine, false, phenytoin\nsulfonylurea agents, false, warfarin\nsulfonylurea agents, false, methotrexate\nsulfonylurea agents, false, methotrexate\nsulfonylurea agents, false, phenytoin\nsulfonylurea agents, false, phenytoin\nwarfarin, false, methotrexate\nwarfarin, false, methotrexate\nwarfarin, false, phenytoin\nwarfarin, false, phenytoin\nmethotrexate, false, phenytoin\nmethotrexate, false, phenytoin\nmethotrexate, false, phenytoin\nmethotrexate, false, phenytoin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "patients studied in clinical trials of tnkase were routinely treated with heparin and aspirin.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntnkase, heparin, aspirin\nSo the corresponding drug entities and relations triplets are:\ntnkase, false, heparin\ntnkase, false, aspirin\nheparin, false, aspirin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "anticoagulants (such as heparin and vitamin k antagonists) and drugs that alter platelet function (such as acetylsalicylic acid, dipyridamole, and gp iib/iiia inhibitors) may increase the risk of bleeding if administered prior to, during, or after tnkase therapy.", "output": "Let's think step by step.\nThe drug entities in this text are:\nanticoagulants, heparin, vitamin k antagonists, acetylsalicylic acid, dipyridamole, tnkase\nSo the corresponding drug entities and relations triplets are:\nanticoagulants, false, heparin\nanticoagulants, false, vitamin k antagonists\nanticoagulants, false, acetylsalicylic acid\nanticoagulants, false, dipyridamole\nanticoagulants, effect, tnkase\nheparin, false, vitamin k antagonists\nheparin, false, acetylsalicylic acid\nheparin, false, dipyridamole\nheparin, effect, tnkase\nvitamin k antagonists, false, acetylsalicylic acid\nvitamin k antagonists, false, dipyridamole\nvitamin k antagonists, effect, tnkase\nacetylsalicylic acid, false, dipyridamole\nacetylsalicylic acid, effect, tnkase\ndipyridamole, effect, tnkase END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "cimetidine: the effects of chronic cimetidine use on the metabolism of rimantadine are not known.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncimetidine, cimetidine, rimantadine\nSo the corresponding drug entities and relations triplets are:\ncimetidine, false, rimantadine\ncimetidine, false, rimantadine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "when a single 100 mg dose of rimantadine hcl was administered one hour after the initiation of cimetidine (300 mg four times a day), the apparent total rimantadine clearance of this single dose in normal healthy adults was reduced by 18% (compared to the apparent total rimantadine clearance in the same subjects in the absence of cimetidine).", "output": "Let's think step by step.\nThe drug entities in this text are:\nrimantadine hcl, cimetidine, rimantadine, rimantadine, cimetidine\nSo the corresponding drug entities and relations triplets are:\nrimantadine hcl, mechanism, cimetidine\nrimantadine hcl, false, rimantadine\nrimantadine hcl, false, rimantadine\nrimantadine hcl, false, cimetidine\ncimetidine, false, rimantadine\ncimetidine, false, rimantadine\nrimantadine, false, cimetidine\nrimantadine, false, cimetidine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "acetaminophen: rimantadine hcl, 100 mg, was given twice daily for 13 days to 12 healthy volunteers.", "output": "Let's think step by step.\nThe drug entities in this text are:\nacetaminophen, rimantadine hcl\nSo the corresponding drug entities and relations triplets are:\nacetaminophen, false, rimantadine hcl END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "coadministration with acetaminophen reduced the peak concentration and auc values for rimantadine by approximately 11%.", "output": "Let's think step by step.\nThe drug entities in this text are:\nacetaminophen, rimantadine\nSo the corresponding drug entities and relations triplets are:\nacetaminophen, mechanism, rimantadine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "aspirin: rimantadine hcl, 100 mg, was given twice daily fro 13 days to 12 healthy volunteers.", "output": "Let's think step by step.\nThe drug entities in this text are:\naspirin, rimantadine hcl\nSo the corresponding drug entities and relations triplets are:\naspirin, false, rimantadine hcl END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "peak plasma concentrations and auc of rimantadine were reduced approximately 10% in the presence of aspirin.", "output": "Let's think step by step.\nThe drug entities in this text are:\nrimantadine, aspirin\nSo the corresponding drug entities and relations triplets are:\nrimantadine, mechanism, aspirin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "trimethoprim may inhibit the hepatic metabolism of phenytoin.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntrimethoprim, phenytoin\nSo the corresponding drug entities and relations triplets are:\ntrimethoprim, mechanism, phenytoin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "trimethoprim, given at a common clinical dosage, increased the phenytoin half-life by 51% and decreased the phenytoin metabolic clearance rate by 30%.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntrimethoprim, phenytoin, phenytoin\nSo the corresponding drug entities and relations triplets are:\ntrimethoprim, mechanism, phenytoin\ntrimethoprim, mechanism, phenytoin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "pilocarpine should be administered with caution to patients taking beta adrenergic antagonists because of the possibility of conduction disturbances.", "output": "Let's think step by step.\nThe drug entities in this text are:\npilocarpine, beta adrenergic antagonists\nSo the corresponding drug entities and relations triplets are:\npilocarpine, advise, beta adrenergic antagonists END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "these effects should be considered when anticholinergic properties may be contributing to the therapeutic effect of concomitant medication (e.g., atropine, inhaled ipratropium).", "output": "Let's think step by step.\nThe drug entities in this text are:\natropine, ipratropium\nSo the corresponding drug entities and relations triplets are:\natropine, false, ipratropium END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "while no formal drug interaction studies have been performed, the following concomitant drugs were used in at least 10% of patients in either or both sj   grens efficacy studies: acetylsalicylic acid, artificial tears, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, and prednisone.", "output": "Let's think step by step.\nThe drug entities in this text are:\nacetylsalicylic acid, calcium, conjugated estrogens, hydroxychloroquine sulfate, ibuprofen, levothyroxine sodium, medroxyprogesterone acetate, methotrexate, multivitamins, naproxen, omeprazole, paracetamol, prednisone\nSo the corresponding drug entities and relations triplets are:\nacetylsalicylic acid, false, calcium\nacetylsalicylic acid, false, conjugated estrogens\nacetylsalicylic acid, false, hydroxychloroquine sulfate\nacetylsalicylic acid, false, ibuprofen\nacetylsalicylic acid, false, levothyroxine sodium\nacetylsalicylic acid, false, medroxyprogesterone acetate\nacetylsalicylic acid, false, methotrexate\nacetylsalicylic acid, false, multivitamins\nacetylsalicylic acid, false, naproxen\nacetylsalicylic acid, false, omeprazole\nacetylsalicylic acid, false, paracetamol\nacetylsalicylic acid, false, prednisone\ncalcium, false, conjugated estrogens\ncalcium, false, hydroxychloroquine sulfate\ncalcium, false, ibuprofen\ncalcium, false, levothyroxine sodium\ncalcium, false, medroxyprogesterone acetate\ncalcium, false, methotrexate\ncalcium, false, multivitamins\ncalcium, false, naproxen\ncalcium, false, omeprazole\ncalcium, false, paracetamol\ncalcium, false, prednisone\nconjugated estrogens, false, hydroxychloroquine sulfate\nconjugated estrogens, false, ibuprofen\nconjugated estrogens, false, levothyroxine sodium\nconjugated estrogens, false, medroxyprogesterone acetate\nconjugated estrogens, false, methotrexate\nconjugated estrogens, false, multivitamins\nconjugated estrogens, false, naproxen\nconjugated estrogens, false, omeprazole\nconjugated estrogens, false, paracetamol\nconjugated estrogens, false, prednisone\nhydroxychloroquine sulfate, false, ibuprofen\nhydroxychloroquine sulfate, false, levothyroxine sodium\nhydroxychloroquine sulfate, false, medroxyprogesterone acetate\nhydroxychloroquine sulfate, false, methotrexate\nhydroxychloroquine sulfate, false, multivitamins\nhydroxychloroquine sulfate, false, naproxen\nhydroxychloroquine sulfate, false, omeprazole\nhydroxychloroquine sulfate, false, paracetamol\nhydroxychloroquine sulfate, false, prednisone\nibuprofen, false, levothyroxine sodium\nibuprofen, false, medroxyprogesterone acetate\nibuprofen, false, methotrexate\nibuprofen, false, multivitamins\nibuprofen, false, naproxen\nibuprofen, false, omeprazole\nibuprofen, false, paracetamol\nibuprofen, false, prednisone\nlevothyroxine sodium, false, medroxyprogesterone acetate\nlevothyroxine sodium, false, methotrexate\nlevothyroxine sodium, false, multivitamins\nlevothyroxine sodium, false, naproxen\nlevothyroxine sodium, false, omeprazole\nlevothyroxine sodium, false, paracetamol\nlevothyroxine sodium, false, prednisone\nmedroxyprogesterone acetate, false, methotrexate\nmedroxyprogesterone acetate, false, multivitamins\nmedroxyprogesterone acetate, false, naproxen\nmedroxyprogesterone acetate, false, omeprazole\nmedroxyprogesterone acetate, false, paracetamol\nmedroxyprogesterone acetate, false, prednisone\nmethotrexate, false, multivitamins\nmethotrexate, false, naproxen\nmethotrexate, false, omeprazole\nmethotrexate, false, paracetamol\nmethotrexate, false, prednisone\nmultivitamins, false, naproxen\nmultivitamins, false, omeprazole\nmultivitamins, false, paracetamol\nmultivitamins, false, prednisone\nnaproxen, false, omeprazole\nnaproxen, false, paracetamol\nnaproxen, false, prednisone\nomeprazole, false, paracetamol\nomeprazole, false, prednisone\nparacetamol, false, prednisone END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "mutual inhibition of metabolism occurs with concurrent use of cyclosporin and methylprednisolone;", "output": "Let's think step by step.\nThe drug entities in this text are:\ncyclosporin, methylprednisolone\nSo the corresponding drug entities and relations triplets are:\ncyclosporin, mechanism, methylprednisolone END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "convulsions have been reported with concurrent use of methylprednisolone and cyclosporin.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmethylprednisolone, cyclosporin\nSo the corresponding drug entities and relations triplets are:\nmethylprednisolone, effect, cyclosporin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "drugs that induce hepatic enzymes such as phenobarbital, phenytoin, and rifampin may increase the clearance of methylprednisolone and may require increased in methylprednisolone dose to achieve the desired response.", "output": "Let's think step by step.\nThe drug entities in this text are:\nphenobarbital, phenytoin, rifampin, methylprednisolone, methylprednisolone\nSo the corresponding drug entities and relations triplets are:\nphenobarbital, false, phenytoin\nphenobarbital, false, rifampin\nphenobarbital, mechanism, methylprednisolone\nphenobarbital, advise, methylprednisolone\nphenytoin, false, rifampin\nphenytoin, mechanism, methylprednisolone\nphenytoin, advise, methylprednisolone\nrifampin, mechanism, methylprednisolone\nrifampin, advise, methylprednisolone END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "drugs such as troleandomycin and ketoconazole may inhibit the metabolism of methylprednisolone and thus decrease its clearance.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntroleandomycin, ketoconazole, methylprednisolone\nSo the corresponding drug entities and relations triplets are:\ntroleandomycin, false, ketoconazole\ntroleandomycin, mechanism, methylprednisolone\nketoconazole, mechanism, methylprednisolone END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "methylprednisolone may increase the clearance of chronic high dose aspirin.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmethylprednisolone, aspirin\nSo the corresponding drug entities and relations triplets are:\nmethylprednisolone, mechanism, aspirin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "this could lead to decreased salicylate serum levels or increase the risk of salicylate toxicity when methylprednisolone is withdrawn.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsalicylate, salicylate, methylprednisolone\nSo the corresponding drug entities and relations triplets are:\nsalicylate, false, methylprednisolone\nsalicylate, effect, methylprednisolone END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "aspirin should be used cautiously in conjunction with corticosteroids in patients suffering from hypoprothrombinemia.", "output": "Let's think step by step.\nThe drug entities in this text are:\naspirin, corticosteroids\nSo the corresponding drug entities and relations triplets are:\naspirin, advise, corticosteroids END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the effect of methylprednisolone on oral anticoagulants is variable.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmethylprednisolone, anticoagulants\nSo the corresponding drug entities and relations triplets are:\nmethylprednisolone, false, anticoagulants END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "there are reports of enhanced as well as diminished effects of anticoagulant when given concurrently with corticosteroids.", "output": "Let's think step by step.\nThe drug entities in this text are:\nanticoagulant, corticosteroids\nSo the corresponding drug entities and relations triplets are:\nanticoagulant, effect, corticosteroids END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the effects of metoclopramide on gastrointestinal motility are antagonized by anticholinergic drugs and narcotic analgesics.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmetoclopramide, anticholinergic drugs, narcotic analgesics\nSo the corresponding drug entities and relations triplets are:\nmetoclopramide, effect, anticholinergic drugs\nmetoclopramide, effect, narcotic analgesics\nanticholinergic drugs, false, narcotic analgesics END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "additive sedative effects can occur when metoclopramide is given with alcohol, sedatives, hypnotics, narcotics, or tranquilizers.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmetoclopramide, alcohol, sedatives, hypnotics, narcotics, tranquilizers\nSo the corresponding drug entities and relations triplets are:\nmetoclopramide, effect, alcohol\nmetoclopramide, effect, sedatives\nmetoclopramide, effect, hypnotics\nmetoclopramide, effect, narcotics\nmetoclopramide, effect, tranquilizers\nalcohol, false, sedatives\nalcohol, false, hypnotics\nalcohol, false, narcotics\nalcohol, false, tranquilizers\nsedatives, false, hypnotics\nsedatives, false, narcotics\nsedatives, false, tranquilizers\nhypnotics, false, narcotics\nhypnotics, false, tranquilizers\nnarcotics, false, tranquilizers END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the finding that metoclopramide releases catecholamines in patients with essential hypertension suggests that it should be used cautiously, if at all, in patients receiving monoamine oxi-dase inhibitors.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmetoclopramide, monoamine oxi-dase inhibitors\nSo the corresponding drug entities and relations triplets are:\nmetoclopramide, advise, monoamine oxi-dase inhibitors END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "absorption of drugs from the stomach may be diminished (e.g., digoxin) by metoclopramide, whereas the rate and/or extent of absorption of drugs from the small bowel may be increased (e.g., acetaminophen, tetracycline, levodopa, ethanol, cyclosporine).", "output": "Let's think step by step.\nThe drug entities in this text are:\ndigoxin, metoclopramide, acetaminophen, tetracycline, levodopa, ethanol, cyclosporine\nSo the corresponding drug entities and relations triplets are:\ndigoxin, mechanism, metoclopramide\ndigoxin, false, acetaminophen\ndigoxin, false, tetracycline\ndigoxin, false, levodopa\ndigoxin, false, ethanol\ndigoxin, false, cyclosporine\nmetoclopramide, mechanism, acetaminophen\nmetoclopramide, false, tetracycline\nmetoclopramide, false, levodopa\nmetoclopramide, false, ethanol\nmetoclopramide, false, cyclosporine\nacetaminophen, false, tetracycline\nacetaminophen, false, levodopa\nacetaminophen, false, ethanol\nacetaminophen, false, cyclosporine\ntetracycline, false, levodopa\ntetracycline, false, ethanol\ntetracycline, false, cyclosporine\nlevodopa, false, ethanol\nlevodopa, false, cyclosporine\nethanol, false, cyclosporine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "because the action of metoclopramide will influence the delivery of food to the intestines and thus the rate of absorption, insulin dosage or timing of dosage may require adjustment.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmetoclopramide, insulin\nSo the corresponding drug entities and relations triplets are:\nmetoclopramide, advise, insulin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "vasopressors, particularly metaraminol, may cause serious cardiac arrhythmias during halothane anesthesia and therefore should be used only with great caution or not at all.", "output": "Let's think step by step.\nThe drug entities in this text are:\nvasopressors, metaraminol, halothane\nSo the corresponding drug entities and relations triplets are:\nvasopressors, false, metaraminol\nvasopressors, effect, halothane\nmetaraminol, effect, halothane END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "mao inhibitors: the pressor effect of sympathomimetic pressor amines is markedly potentiated in patients receiving monoamine oxidase inhibitors (maoi).", "output": "Let's think step by step.\nThe drug entities in this text are:\nmao inhibitors, sympathomimetic pressor amines, monoamine oxidase inhibitors, maoi\nSo the corresponding drug entities and relations triplets are:\nmao inhibitors, false, sympathomimetic pressor amines\nmao inhibitors, false, monoamine oxidase inhibitors\nmao inhibitors, false, maoi\nsympathomimetic pressor amines, effect, monoamine oxidase inhibitors\nsympathomimetic pressor amines, effect, maoi\nmonoamine oxidase inhibitors, false, maoi END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the pressor response of adrenergic agents may also be potentiated by tricyclic antidepressants.", "output": "Let's think step by step.\nThe drug entities in this text are:\nadrenergic agents, tricyclic antidepressants\nSo the corresponding drug entities and relations triplets are:\nadrenergic agents, effect, tricyclic antidepressants END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "methscopolamine may interact with antidepressants (tricyclic type), mao inhibitors (e.g., phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone), quinidine, amantadine, antihistamines (e.g., diphenhydramine), other anticholinergics, potassium chloride supplements, antacids, absorbent-type anti-diarrhea medicines (e.g., kaolin-pectin), phenothiazines (e.g., chlorpromazine, promethazine).", "output": "Let's think step by step.\nThe drug entities in this text are:\nmethscopolamine, antidepressants, tricyclic, mao inhibitors, phenelzine, linezolid, tranylcypromine, isocarboxazid, selegiline, furazolidone, quinidine, amantadine, antihistamines, diphenhydramine, anticholinergics, potassium chloride, antacids, absorbent-type anti-diarrhea medicines, kaolin, pectin, phenothiazines, chlorpromazine, promethazine\nSo the corresponding drug entities and relations triplets are:\nmethscopolamine, false, antidepressants\nmethscopolamine, int, tricyclic\nmethscopolamine, int, mao inhibitors\nmethscopolamine, int, phenelzine\nmethscopolamine, int, linezolid\nmethscopolamine, int, tranylcypromine\nmethscopolamine, int, isocarboxazid\nmethscopolamine, int, selegiline\nmethscopolamine, int, furazolidone\nmethscopolamine, int, quinidine\nmethscopolamine, int, amantadine\nmethscopolamine, int, antihistamines\nmethscopolamine, int, diphenhydramine\nmethscopolamine, int, anticholinergics\nmethscopolamine, int, potassium chloride\nmethscopolamine, int, antacids\nmethscopolamine, int, absorbent-type anti-diarrhea medicines\nmethscopolamine, int, kaolin\nmethscopolamine, int, pectin\nmethscopolamine, int, phenothiazines\nmethscopolamine, int, chlorpromazine\nmethscopolamine, int, promethazine\nantidepressants, false, tricyclic\nantidepressants, false, mao inhibitors\nantidepressants, false, phenelzine\nantidepressants, false, linezolid\nantidepressants, false, tranylcypromine\nantidepressants, false, isocarboxazid\nantidepressants, false, selegiline\nantidepressants, false, furazolidone\nantidepressants, false, quinidine\nantidepressants, false, amantadine\nantidepressants, false, antihistamines\nantidepressants, false, diphenhydramine\nantidepressants, false, anticholinergics\nantidepressants, false, potassium chloride\nantidepressants, false, antacids\nantidepressants, false, absorbent-type anti-diarrhea medicines\nantidepressants, false, kaolin\nantidepressants, false, pectin\nantidepressants, false, phenothiazines\nantidepressants, false, chlorpromazine\nantidepressants, false, promethazine\ntricyclic, false, mao inhibitors\ntricyclic, false, phenelzine\ntricyclic, false, linezolid\ntricyclic, false, tranylcypromine\ntricyclic, false, isocarboxazid\ntricyclic, false, selegiline\ntricyclic, false, furazolidone\ntricyclic, false, quinidine\ntricyclic, false, amantadine\ntricyclic, false, antihistamines\ntricyclic, false, diphenhydramine\ntricyclic, false, anticholinergics\ntricyclic, false, potassium chloride\ntricyclic, false, antacids\ntricyclic, false, absorbent-type anti-diarrhea medicines\ntricyclic, false, kaolin\ntricyclic, false, pectin\ntricyclic, false, phenothiazines\ntricyclic, false, chlorpromazine\ntricyclic, false, promethazine\nmao inhibitors, false, phenelzine\nmao inhibitors, false, linezolid\nmao inhibitors, false, tranylcypromine\nmao inhibitors, false, isocarboxazid\nmao inhibitors, false, selegiline\nmao inhibitors, false, furazolidone\nmao inhibitors, false, quinidine\nmao inhibitors, false, amantadine\nmao inhibitors, false, antihistamines\nmao inhibitors, false, diphenhydramine\nmao inhibitors, false, anticholinergics\nmao inhibitors, false, potassium chloride\nmao inhibitors, false, antacids\nmao inhibitors, false, absorbent-type anti-diarrhea medicines\nmao inhibitors, false, kaolin\nmao inhibitors, false, pectin\nmao inhibitors, false, phenothiazines\nmao inhibitors, false, chlorpromazine\nmao inhibitors, false, promethazine\nphenelzine, false, linezolid\nphenelzine, false, tranylcypromine\nphenelzine, false, isocarboxazid\nphenelzine, false, selegiline\nphenelzine, false, furazolidone\nphenelzine, false, quinidine\nphenelzine, false, amantadine\nphenelzine, false, antihistamines\nphenelzine, false, diphenhydramine\nphenelzine, false, anticholinergics\nphenelzine, false, potassium chloride\nphenelzine, false, antacids\nphenelzine, false, absorbent-type anti-diarrhea medicines\nphenelzine, false, kaolin\nphenelzine, false, pectin\nphenelzine, false, phenothiazines\nphenelzine, false, chlorpromazine\nphenelzine, false, promethazine\nlinezolid, false, tranylcypromine\nlinezolid, false, isocarboxazid\nlinezolid, false, selegiline\nlinezolid, false, furazolidone\nlinezolid, false, quinidine\nlinezolid, false, amantadine\nlinezolid, false, antihistamines\nlinezolid, false, diphenhydramine\nlinezolid, false, anticholinergics\nlinezolid, false, potassium chloride\nlinezolid, false, antacids\nlinezolid, false, absorbent-type anti-diarrhea medicines\nlinezolid, false, kaolin\nlinezolid, false, pectin\nlinezolid, false, phenothiazines\nlinezolid, false, chlorpromazine\nlinezolid, false, promethazine\ntranylcypromine, false, isocarboxazid\ntranylcypromine, false, selegiline\ntranylcypromine, false, furazolidone\ntranylcypromine, false, quinidine\ntranylcypromine, false, amantadine\ntranylcypromine, false, antihistamines\ntranylcypromine, false, diphenhydramine\ntranylcypromine, false, anticholinergics\ntranylcypromine, false, potassium chloride\ntranylcypromine, false, antacids\ntranylcypromine, false, absorbent-type anti-diarrhea medicines\ntranylcypromine, false, kaolin\ntranylcypromine, false, pectin\ntranylcypromine, false, phenothiazines\ntranylcypromine, false, chlorpromazine\ntranylcypromine, false, promethazine\nisocarboxazid, false, selegiline\nisocarboxazid, false, furazolidone\nisocarboxazid, false, quinidine\nisocarboxazid, false, amantadine\nisocarboxazid, false, antihistamines\nisocarboxazid, false, diphenhydramine\nisocarboxazid, false, anticholinergics\nisocarboxazid, false, potassium chloride\nisocarboxazid, false, antacids\nisocarboxazid, false, absorbent-type anti-diarrhea medicines\nisocarboxazid, false, kaolin\nisocarboxazid, false, pectin\nisocarboxazid, false, phenothiazines\nisocarboxazid, false, chlorpromazine\nisocarboxazid, false, promethazine\nselegiline, false, furazolidone\nselegiline, false, quinidine\nselegiline, false, amantadine\nselegiline, false, antihistamines\nselegiline, false, diphenhydramine\nselegiline, false, anticholinergics\nselegiline, false, potassium chloride\nselegiline, false, antacids\nselegiline, false, absorbent-type anti-diarrhea medicines\nselegiline, false, kaolin\nselegiline, false, pectin\nselegiline, false, phenothiazines\nselegiline, false, chlorpromazine\nselegiline, false, promethazine\nfurazolidone, false, quinidine\nfurazolidone, false, amantadine\nfurazolidone, false, antihistamines\nfurazolidone, false, diphenhydramine\nfurazolidone, false, anticholinergics\nfurazolidone, false, potassium chloride\nfurazolidone, false, antacids\nfurazolidone, false, absorbent-type anti-diarrhea medicines\nfurazolidone, false, kaolin\nfurazolidone, false, pectin\nfurazolidone, false, phenothiazines\nfurazolidone, false, chlorpromazine\nfurazolidone, false, promethazine\nquinidine, false, amantadine\nquinidine, false, antihistamines\nquinidine, false, diphenhydramine\nquinidine, false, anticholinergics\nquinidine, false, potassium chloride\nquinidine, false, antacids\nquinidine, false, absorbent-type anti-diarrhea medicines\nquinidine, false, kaolin\nquinidine, false, pectin\nquinidine, false, phenothiazines\nquinidine, false, chlorpromazine\nquinidine, false, promethazine\namantadine, false, antihistamines\namantadine, false, diphenhydramine\namantadine, false, anticholinergics\namantadine, false, potassium chloride\namantadine, false, antacids\namantadine, false, absorbent-type anti-diarrhea medicines\namantadine, false, kaolin\namantadine, false, pectin\namantadine, false, phenothiazines\namantadine, false, chlorpromazine\namantadine, false, promethazine\nantihistamines, false, diphenhydramine\nantihistamines, false, anticholinergics\nantihistamines, false, potassium chloride\nantihistamines, false, antacids\nantihistamines, false, absorbent-type anti-diarrhea medicines\nantihistamines, false, kaolin\nantihistamines, false, pectin\nantihistamines, false, phenothiazines\nantihistamines, false, chlorpromazine\nantihistamines, false, promethazine\ndiphenhydramine, false, anticholinergics\ndiphenhydramine, false, potassium chloride\ndiphenhydramine, false, antacids\ndiphenhydramine, false, absorbent-type anti-diarrhea medicines\ndiphenhydramine, false, kaolin\ndiphenhydramine, false, pectin\ndiphenhydramine, false, phenothiazines\ndiphenhydramine, false, chlorpromazine\ndiphenhydramine, false, promethazine\nanticholinergics, false, potassium chloride\nanticholinergics, false, antacids\nanticholinergics, false, absorbent-type anti-diarrhea medicines\nanticholinergics, false, kaolin\nanticholinergics, false, pectin\nanticholinergics, false, phenothiazines\nanticholinergics, false, chlorpromazine\nanticholinergics, false, promethazine\npotassium chloride, false, antacids\npotassium chloride, false, absorbent-type anti-diarrhea medicines\npotassium chloride, false, kaolin\npotassium chloride, false, pectin\npotassium chloride, false, phenothiazines\npotassium chloride, false, chlorpromazine\npotassium chloride, false, promethazine\nantacids, false, absorbent-type anti-diarrhea medicines\nantacids, false, kaolin\nantacids, false, pectin\nantacids, false, phenothiazines\nantacids, false, chlorpromazine\nantacids, false, promethazine\nabsorbent-type anti-diarrhea medicines, false, kaolin\nabsorbent-type anti-diarrhea medicines, false, pectin\nabsorbent-type anti-diarrhea medicines, false, phenothiazines\nabsorbent-type anti-diarrhea medicines, false, chlorpromazine\nabsorbent-type anti-diarrhea medicines, false, promethazine\nkaolin, false, pectin\nkaolin, false, phenothiazines\nkaolin, false, chlorpromazine\nkaolin, false, promethazine\npectin, false, phenothiazines\npectin, false, chlorpromazine\npectin, false, promethazine\nphenothiazines, false, chlorpromazine\nphenothiazines, false, promethazine\nchlorpromazine, false, promethazine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "due to its effects on gastric emptying, symlin therapy should not be considered for patients taking drugs that alter gastrointestinal motility (e.g., anticholinergic agents such as atropine) and agents that slow the intestinal absorption of nutrients (e.g., alpha glucosidase inhibitors).", "output": "Let's think step by step.\nThe drug entities in this text are:\nsymlin, anticholinergic agents, atropine, alpha glucosidase inhibitors\nSo the corresponding drug entities and relations triplets are:\nsymlin, advise, anticholinergic agents\nsymlin, advise, atropine\nsymlin, advise, alpha glucosidase inhibitors\nanticholinergic agents, false, atropine\nanticholinergic agents, false, alpha glucosidase inhibitors\natropine, false, alpha glucosidase inhibitors END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "when the rapid onset of a concomitant orally administered agent is a critical determinant of effectiveness (such as analgesics), the agent should be administered at least 1 hour prior to or 2 hours after symlin injection.", "output": "Let's think step by step.\nThe drug entities in this text are:\nanalgesics, symlin\nSo the corresponding drug entities and relations triplets are:\nanalgesics, advise, symlin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in clinical trials, the concomitant use of sulfonylureas or biguanides did not alter the adverse event profile of symlin.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsulfonylureas, biguanides, symlin\nSo the corresponding drug entities and relations triplets are:\nsulfonylureas, false, biguanides\nsulfonylureas, false, symlin\nbiguanides, false, symlin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "no formal interaction studies have been performed to assess the effect of symlin on the kinetics of oral antidiabetic agents.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsymlin, antidiabetic agents\nSo the corresponding drug entities and relations triplets are:\nsymlin, false, antidiabetic agents END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "mixing symlin and insulin the pharmacokinetic parameters of symlin were altered when mixed with regular, nph, and 70/30 premixed formulations of recombinant human insulin immediately prior to injection.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsymlin, insulin, symlin, human insulin\nSo the corresponding drug entities and relations triplets are:\nsymlin, false, insulin\nsymlin, false, human insulin\ninsulin, false, symlin\ninsulin, false, human insulin\nsymlin, mechanism, human insulin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "thus, symlin and insulin should not be mixed and must be administered separately.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsymlin, insulin\nSo the corresponding drug entities and relations triplets are:\nsymlin, false, insulin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "patients receiving antibiotics and sulfonamides generally should not be treated with ganglion blockers.", "output": "Let's think step by step.\nThe drug entities in this text are:\nantibiotics, sulfonamides, ganglion blockers\nSo the corresponding drug entities and relations triplets are:\nantibiotics, false, sulfonamides\nantibiotics, advise, ganglion blockers\nsulfonamides, advise, ganglion blockers END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the action of mecamylamine may be potentiated by anesthesia, other antihypertensive drugs and alcohol.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmecamylamine, antihypertensive drugs, alcohol\nSo the corresponding drug entities and relations triplets are:\nmecamylamine, effect, antihypertensive drugs\nmecamylamine, effect, alcohol\nantihypertensive drugs, false, alcohol END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "oral metronidazole has been reported to potentiate the anticoagulant effect of coumarin and warfarin, resulting in a prolongation of prothrombin time.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmetronidazole, coumarin, warfarin\nSo the corresponding drug entities and relations triplets are:\nmetronidazole, effect, coumarin\nmetronidazole, effect, warfarin\ncoumarin, false, warfarin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "drug interactions should be kept in mind when metrogel (metronidazole gel), 1% is prescribed for patients who are receiving anticoagulant treatment, although they are less likely to occur with topical metronidazole administration because of low absorption.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmetrogel, metronidazole, metronidazole\nSo the corresponding drug entities and relations triplets are:\nmetrogel, false, metronidazole\nmetrogel, false, metronidazole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "concomitant use of alcohol with phentermine hydrochloride may result in an adverse drug interaction.", "output": "Let's think step by step.\nThe drug entities in this text are:\nalcohol, phentermine hydrochloride\nSo the corresponding drug entities and relations triplets are:\nalcohol, int, phentermine hydrochloride END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "other short-acting beta adrenergic aerosol bronchodilators should not be used concomitantly with maxair autohaler because they may have additive effects.", "output": "Let's think step by step.\nThe drug entities in this text are:\nshort-acting beta adrenergic aerosol bronchodilators, maxair autohaler\nSo the corresponding drug entities and relations triplets are:\nshort-acting beta adrenergic aerosol bronchodilators, advise, maxair autohaler END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "a study published in 2002 found that vigabatrin causes a statistically significant increase in plasma clearance of carbamazepine.", "output": "Let's think step by step.\nThe drug entities in this text are:\nvigabatrin, carbamazepine\nSo the corresponding drug entities and relations triplets are:\nvigabatrin, mechanism, carbamazepine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in 1984, drs rimmer and richens at the university of wales reported that administering vigabatrin with phenytoin lowered the serum phenytoin concentration in patients with treatment-resistant epilepsy.", "output": "Let's think step by step.\nThe drug entities in this text are:\nvigabatrin, phenytoin, phenytoin\nSo the corresponding drug entities and relations triplets are:\nvigabatrin, mechanism, phenytoin\nvigabatrin, false, phenytoin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "anticholinesterases: concurrent use of procaine hydrochloride and anticholinesterase agents may result in increased systemic toxicity since anticholinesterases inhibit the breakdown of procaine hydrochloride.", "output": "Let's think step by step.\nThe drug entities in this text are:\nanticholinesterases, procaine hydrochloride, anticholinesterase agents, anticholinesterases, procaine hydrochloride\nSo the corresponding drug entities and relations triplets are:\nanticholinesterases, false, procaine hydrochloride\nanticholinesterases, false, anticholinesterase agents\nanticholinesterases, false, procaine hydrochloride\nprocaine hydrochloride, effect, anticholinesterase agents\nprocaine hydrochloride, false, anticholinesterases\nanticholinesterase agents, false, anticholinesterases\nanticholinesterase agents, false, procaine hydrochloride\nanticholinesterases, mechanism, procaine hydrochloride END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "cns depressant medications: concurrent use of procaine hydrochloride and cns depressant medications may result in additive depressant effects.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncns depressant, procaine hydrochloride, cns depressant medications\nSo the corresponding drug entities and relations triplets are:\ncns depressant, false, procaine hydrochloride\ncns depressant, false, cns depressant medications\nprocaine hydrochloride, effect, cns depressant medications END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "hyaluronidase: hyaluronidase may increase the diffusion rate of procaine hydrochloride, resulting in a decreased time of onset, but an increase in systemic toxicity.", "output": "Let's think step by step.\nThe drug entities in this text are:\nhyaluronidase, hyaluronidase, procaine hydrochloride\nSo the corresponding drug entities and relations triplets are:\nhyaluronidase, false, procaine hydrochloride\nhyaluronidase, mechanism, procaine hydrochloride END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "neuromuscular blocking agents (such as suxamethonium chloride): concurrent use of procaine hydrochloride and neuromuscular blocking agents may result in prolongation or enhancement of the neuromuscular blockade.", "output": "Let's think step by step.\nThe drug entities in this text are:\nneuromuscular blocking agents, suxamethonium chloride, procaine hydrochloride, neuromuscular blocking agents\nSo the corresponding drug entities and relations triplets are:\nneuromuscular blocking agents, false, suxamethonium chloride\nneuromuscular blocking agents, false, procaine hydrochloride\nsuxamethonium chloride, false, procaine hydrochloride\nsuxamethonium chloride, false, neuromuscular blocking agents\nprocaine hydrochloride, effect, neuromuscular blocking agents END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "sulfonamides: concurrent use of procaine hydrochloride and sulfonamides may result in a reduction of the antibacterial action of the sulfonamide.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsulfonamides, procaine hydrochloride, sulfonamides, sulfonamide\nSo the corresponding drug entities and relations triplets are:\nsulfonamides, false, procaine hydrochloride\nsulfonamides, false, sulfonamide\nprocaine hydrochloride, effect, sulfonamides\nprocaine hydrochloride, false, sulfonamide\nsulfonamides, false, sulfonamide END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "acetazolamide: concurrent use of acetazolamide and procaine hydrochloride may extend the plasma half-life of procaine.", "output": "Let's think step by step.\nThe drug entities in this text are:\nacetazolamide, acetazolamide, procaine hydrochloride, procaine\nSo the corresponding drug entities and relations triplets are:\nacetazolamide, false, procaine hydrochloride\nacetazolamide, false, procaine\nacetazolamide, mechanism, procaine hydrochloride\nacetazolamide, false, procaine\nprocaine hydrochloride, false, procaine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "co-administration of sutent with strong inhibitors of the cyp3a4 family (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole) may increases sunitinib concentrations.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsutent, ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconizole, sunitinib\nSo the corresponding drug entities and relations triplets are:\nsutent, mechanism, ketoconazole\nsutent, mechanism, itraconazole\nsutent, mechanism, clarithromycin\nsutent, mechanism, atazanavir\nsutent, mechanism, indinavir\nsutent, mechanism, nefazodone\nsutent, mechanism, nelfinavir\nsutent, mechanism, ritonavir\nsutent, mechanism, saquinavir\nsutent, mechanism, telithromycin\nsutent, mechanism, voriconizole\nsutent, false, sunitinib\nketoconazole, false, itraconazole\nketoconazole, false, clarithromycin\nketoconazole, false, atazanavir\nketoconazole, false, indinavir\nketoconazole, false, nefazodone\nketoconazole, false, nelfinavir\nketoconazole, false, ritonavir\nketoconazole, false, saquinavir\nketoconazole, false, telithromycin\nketoconazole, false, voriconizole\nketoconazole, false, sunitinib\nitraconazole, false, clarithromycin\nitraconazole, false, atazanavir\nitraconazole, false, indinavir\nitraconazole, false, nefazodone\nitraconazole, false, nelfinavir\nitraconazole, false, ritonavir\nitraconazole, false, saquinavir\nitraconazole, false, telithromycin\nitraconazole, false, voriconizole\nitraconazole, false, sunitinib\nclarithromycin, false, atazanavir\nclarithromycin, false, indinavir\nclarithromycin, false, nefazodone\nclarithromycin, false, nelfinavir\nclarithromycin, false, ritonavir\nclarithromycin, false, saquinavir\nclarithromycin, false, telithromycin\nclarithromycin, false, voriconizole\nclarithromycin, false, sunitinib\natazanavir, false, indinavir\natazanavir, false, nefazodone\natazanavir, false, nelfinavir\natazanavir, false, ritonavir\natazanavir, false, saquinavir\natazanavir, false, telithromycin\natazanavir, false, voriconizole\natazanavir, false, sunitinib\nindinavir, false, nefazodone\nindinavir, false, nelfinavir\nindinavir, false, ritonavir\nindinavir, false, saquinavir\nindinavir, false, telithromycin\nindinavir, false, voriconizole\nindinavir, false, sunitinib\nnefazodone, false, nelfinavir\nnefazodone, false, ritonavir\nnefazodone, false, saquinavir\nnefazodone, false, telithromycin\nnefazodone, false, voriconizole\nnefazodone, false, sunitinib\nnelfinavir, false, ritonavir\nnelfinavir, false, saquinavir\nnelfinavir, false, telithromycin\nnelfinavir, false, voriconizole\nnelfinavir, false, sunitinib\nritonavir, false, saquinavir\nritonavir, false, telithromycin\nritonavir, false, voriconizole\nritonavir, false, sunitinib\nsaquinavir, false, telithromycin\nsaquinavir, false, voriconizole\nsaquinavir, false, sunitinib\ntelithromycin, false, voriconizole\ntelithromycin, false, sunitinib\nvoriconizole, false, sunitinib END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "co-administration of sutent with inducers of the cyp3a4 family (e.g., dexamethasone, phenytoin, carbamazepine, rifampin, rifabutin, rifapentin, phenobarbital, st. johns wort) may decrease sunitinib concentrations.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsutent, dexamethasone, phenytoin, carbamazepine, rifampin, rifabutin, rifapentin, phenobarbital, sunitinib\nSo the corresponding drug entities and relations triplets are:\nsutent, mechanism, dexamethasone\nsutent, mechanism, phenytoin\nsutent, mechanism, carbamazepine\nsutent, mechanism, rifampin\nsutent, mechanism, rifabutin\nsutent, mechanism, rifapentin\nsutent, mechanism, phenobarbital\nsutent, false, sunitinib\ndexamethasone, false, phenytoin\ndexamethasone, false, carbamazepine\ndexamethasone, false, rifampin\ndexamethasone, false, rifabutin\ndexamethasone, false, rifapentin\ndexamethasone, false, phenobarbital\ndexamethasone, false, sunitinib\nphenytoin, false, carbamazepine\nphenytoin, false, rifampin\nphenytoin, false, rifabutin\nphenytoin, false, rifapentin\nphenytoin, false, phenobarbital\nphenytoin, false, sunitinib\ncarbamazepine, false, rifampin\ncarbamazepine, false, rifabutin\ncarbamazepine, false, rifapentin\ncarbamazepine, false, phenobarbital\ncarbamazepine, false, sunitinib\nrifampin, false, rifabutin\nrifampin, false, rifapentin\nrifampin, false, phenobarbital\nrifampin, false, sunitinib\nrifabutin, false, rifapentin\nrifabutin, false, phenobarbital\nrifabutin, false, sunitinib\nrifapentin, false, phenobarbital\nrifapentin, false, sunitinib\nphenobarbital, false, sunitinib END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "drugs that induce hepatic enzymes such as phenobarbital, phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response.", "output": "Let's think step by step.\nThe drug entities in this text are:\nphenobarbital, phenytoin, rifampin, corticosteroids, corticosteroid\nSo the corresponding drug entities and relations triplets are:\nphenobarbital, false, phenytoin\nphenobarbital, false, rifampin\nphenobarbital, mechanism, corticosteroids\nphenobarbital, mechanism, corticosteroid\nphenytoin, false, rifampin\nphenytoin, mechanism, corticosteroids\nphenytoin, mechanism, corticosteroid\nrifampin, mechanism, corticosteroids\nrifampin, mechanism, corticosteroid\ncorticosteroids, false, corticosteroid END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "drugs such as troleandomycin and ketoconazole may inhibit the metabolism of corticosteroids and thus decrease their clearance.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntroleandomycin, ketoconazole, corticosteroids\nSo the corresponding drug entities and relations triplets are:\ntroleandomycin, false, ketoconazole\ntroleandomycin, mechanism, corticosteroids\nketoconazole, mechanism, corticosteroids END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "corticosteroids may increase the clearance of chronic high dose aspirin.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncorticosteroids, aspirin\nSo the corresponding drug entities and relations triplets are:\ncorticosteroids, mechanism, aspirin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "this could lead to decreased salicylate serum levels or increase the risk of salicylate toxicity when corticosteroid is withdrawn.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsalicylate, salicylate, corticosteroid\nSo the corresponding drug entities and relations triplets are:\nsalicylate, false, corticosteroid\nsalicylate, effect, corticosteroid END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "aspirin should be used cautiously in conjunction with corticosteroids in patients suffering from hypoprothrombinemia.", "output": "Let's think step by step.\nThe drug entities in this text are:\naspirin, corticosteroids\nSo the corresponding drug entities and relations triplets are:\naspirin, advise, corticosteroids END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the effect of corticosteroids on oral anticoagulants is variable.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncorticosteroids, anticoagulants\nSo the corresponding drug entities and relations triplets are:\ncorticosteroids, effect, anticoagulants END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "there are reports of enhanced as well as diminished effects of anticoagulants when given concurrently with corticosteroids.", "output": "Let's think step by step.\nThe drug entities in this text are:\nanticoagulants, corticosteroids\nSo the corresponding drug entities and relations triplets are:\nanticoagulants, effect, corticosteroids END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "interactions for vitamin b1 (thiamine):  loop diuretics, oral contraceptives, stavudine, tricyclic antidepressants", "output": "Let's think step by step.\nThe drug entities in this text are:\nvitamin b1, thiamine, loop diuretics, contraceptives, stavudine, tricyclic antidepressants\nSo the corresponding drug entities and relations triplets are:\nvitamin b1, false, thiamine\nvitamin b1, int, loop diuretics\nvitamin b1, int, contraceptives\nvitamin b1, int, stavudine\nvitamin b1, int, tricyclic antidepressants\nthiamine, int, loop diuretics\nthiamine, int, contraceptives\nthiamine, int, stavudine\nthiamine, int, tricyclic antidepressants\nloop diuretics, false, contraceptives\nloop diuretics, false, stavudine\nloop diuretics, false, tricyclic antidepressants\ncontraceptives, false, stavudine\ncontraceptives, false, tricyclic antidepressants\nstavudine, false, tricyclic antidepressants END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "drug-drug interactions effect of exelon    (rivastigmine tartrate) on the metabolism of other drugs: rivastigmine is primarily metabolized through hydrolysis by esterases.", "output": "Let's think step by step.\nThe drug entities in this text are:\nexelon, rivastigmine tartrate, rivastigmine\nSo the corresponding drug entities and relations triplets are:\nexelon, false, rivastigmine tartrate\nexelon, false, rivastigmine\nrivastigmine tartrate, false, rivastigmine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "no pharmacokinetic interaction was observed between rivastigmine and digoxin, warfarin, diazepam, or fluoxetine in studies in healthy volunteers.", "output": "Let's think step by step.\nThe drug entities in this text are:\nrivastigmine, digoxin, warfarin, diazepam, fluoxetine\nSo the corresponding drug entities and relations triplets are:\nrivastigmine, false, digoxin\nrivastigmine, false, warfarin\nrivastigmine, false, diazepam\nrivastigmine, false, fluoxetine\ndigoxin, false, warfarin\ndigoxin, false, diazepam\ndigoxin, false, fluoxetine\nwarfarin, false, diazepam\nwarfarin, false, fluoxetine\ndiazepam, false, fluoxetine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the elevation of prothrombin time induced by warfarin is not affected by administration of exelon.", "output": "Let's think step by step.\nThe drug entities in this text are:\nwarfarin, exelon\nSo the corresponding drug entities and relations triplets are:\nwarfarin, false, exelon END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "effect of other drugs on the metabolism of exelon: drugs that induce or inhibit cyp450 metabolism are not expected to alter the metabolism of rivastigmine.", "output": "Let's think step by step.\nThe drug entities in this text are:\nexelon, rivastigmine\nSo the corresponding drug entities and relations triplets are:\nexelon, false, rivastigmine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "single dose pharmacokinetic studies demonstrated that the metabolism of rivastigmine is not significantly affected by concurrent administration of digoxin, warfarin, diazepam, or fluoxetine.", "output": "Let's think step by step.\nThe drug entities in this text are:\nrivastigmine, digoxin, warfarin, diazepam, fluoxetine\nSo the corresponding drug entities and relations triplets are:\nrivastigmine, false, digoxin\nrivastigmine, false, warfarin\nrivastigmine, false, diazepam\nrivastigmine, false, fluoxetine\ndigoxin, false, warfarin\ndigoxin, false, diazepam\ndigoxin, false, fluoxetine\nwarfarin, false, diazepam\nwarfarin, false, fluoxetine\ndiazepam, false, fluoxetine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "population pk analysis with a database of 625 patients showed that the pharmacokinetics of rivastigmine were not influenced by commonly prescribed medications such as antacids (n=77), antihypertensives (n=72), calcium channel blockers (n=75), antidiabetics (n=21), nonsteroidal anti-inflammatory drugs (n=79), estrogens (n=70), salicylate analgesics (n=177), antianginals (n=35), and antihistamines (n=15).", "output": "Let's think step by step.\nThe drug entities in this text are:\nrivastigmine, antacids, antihypertensives, calcium channel blockers, antidiabetics, nonsteroidal anti-inflammatory drugs, estrogens, salicylate analgesics, antianginals, antihistamines\nSo the corresponding drug entities and relations triplets are:\nrivastigmine, false, antacids\nrivastigmine, false, antihypertensives\nrivastigmine, false, calcium channel blockers\nrivastigmine, false, antidiabetics\nrivastigmine, false, nonsteroidal anti-inflammatory drugs\nrivastigmine, false, estrogens\nrivastigmine, false, salicylate analgesics\nrivastigmine, false, antianginals\nrivastigmine, false, antihistamines\nantacids, false, antihypertensives\nantacids, false, calcium channel blockers\nantacids, false, antidiabetics\nantacids, false, nonsteroidal anti-inflammatory drugs\nantacids, false, estrogens\nantacids, false, salicylate analgesics\nantacids, false, antianginals\nantacids, false, antihistamines\nantihypertensives, false, calcium channel blockers\nantihypertensives, false, antidiabetics\nantihypertensives, false, nonsteroidal anti-inflammatory drugs\nantihypertensives, false, estrogens\nantihypertensives, false, salicylate analgesics\nantihypertensives, false, antianginals\nantihypertensives, false, antihistamines\ncalcium channel blockers, false, antidiabetics\ncalcium channel blockers, false, nonsteroidal anti-inflammatory drugs\ncalcium channel blockers, false, estrogens\ncalcium channel blockers, false, salicylate analgesics\ncalcium channel blockers, false, antianginals\ncalcium channel blockers, false, antihistamines\nantidiabetics, false, nonsteroidal anti-inflammatory drugs\nantidiabetics, false, estrogens\nantidiabetics, false, salicylate analgesics\nantidiabetics, false, antianginals\nantidiabetics, false, antihistamines\nnonsteroidal anti-inflammatory drugs, false, estrogens\nnonsteroidal anti-inflammatory drugs, false, salicylate analgesics\nnonsteroidal anti-inflammatory drugs, false, antianginals\nnonsteroidal anti-inflammatory drugs, false, antihistamines\nestrogens, false, salicylate analgesics\nestrogens, false, antianginals\nestrogens, false, antihistamines\nsalicylate analgesics, false, antianginals\nsalicylate analgesics, false, antihistamines\nantianginals, false, antihistamines END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "use with anticholinergics: because of their mechanism of action, cholinesterase inhibitors have the potential to interfere with the activity of anticholinergic medications.", "output": "Let's think step by step.\nThe drug entities in this text are:\nanticholinergics, cholinesterase inhibitors, anticholinergic medications\nSo the corresponding drug entities and relations triplets are:\nanticholinergics, false, cholinesterase inhibitors\nanticholinergics, false, anticholinergic medications\ncholinesterase inhibitors, int, anticholinergic medications END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "use with cholinomimetics and other cholinesterase inhibitors: a synergistic effect may be expected when cholinesterase inhibitors are given concurrently with succinylcholine, similar neuromuscular blocking agents or cholinergic agonists such as bethanechol.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncholinomimetics, cholinesterase inhibitors, cholinesterase inhibitors, succinylcholine, neuromuscular blocking agents, cholinergic agonists, bethanechol\nSo the corresponding drug entities and relations triplets are:\ncholinomimetics, false, cholinesterase inhibitors\ncholinomimetics, false, cholinesterase inhibitors\ncholinomimetics, false, succinylcholine\ncholinomimetics, false, neuromuscular blocking agents\ncholinomimetics, false, cholinergic agonists\ncholinomimetics, false, bethanechol\ncholinesterase inhibitors, false, succinylcholine\ncholinesterase inhibitors, false, neuromuscular blocking agents\ncholinesterase inhibitors, false, cholinergic agonists\ncholinesterase inhibitors, false, bethanechol\ncholinesterase inhibitors, effect, succinylcholine\ncholinesterase inhibitors, effect, neuromuscular blocking agents\ncholinesterase inhibitors, effect, cholinergic agonists\ncholinesterase inhibitors, effect, bethanechol\nsuccinylcholine, false, neuromuscular blocking agents\nsuccinylcholine, false, cholinergic agonists\nsuccinylcholine, false, bethanechol\nneuromuscular blocking agents, false, cholinergic agonists\nneuromuscular blocking agents, false, bethanechol\ncholinergic agonists, false, bethanechol END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "ketoconazole: spontaneous adverse reaction reports of patients taking concomitant ketoconazole with recommended doses of terfenadine demonstrate qt interval prolongation and rare serious cardiac events, e.g.", "output": "Let's think step by step.\nThe drug entities in this text are:\nketoconazole, ketoconazole, terfenadine\nSo the corresponding drug entities and relations triplets are:\nketoconazole, false, terfenadine\nketoconazole, effect, terfenadine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "pharmacokinetic data indicate that ketoconazole markedly inhibits the metabolism of terfenadine, resulting in elevated plasma terfenadine levels.", "output": "Let's think step by step.\nThe drug entities in this text are:\nketoconazole, terfenadine, terfenadine\nSo the corresponding drug entities and relations triplets are:\nketoconazole, mechanism, terfenadine\nketoconazole, false, terfenadine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "concomitant administration of ketoconazole and terfenadine is contraindicated.", "output": "Let's think step by step.\nThe drug entities in this text are:\nketoconazole, terfenadine\nSo the corresponding drug entities and relations triplets are:\nketoconazole, advise, terfenadine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "itraconazole: torsades de pointes and elevated parent terfenadine levels have been reported during concomitant use of terfenadine and itraconazole in clinical trials of itraconazole and from foreign post-marketing sources.", "output": "Let's think step by step.\nThe drug entities in this text are:\nitraconazole, terfenadine, terfenadine, itraconazole, itraconazole\nSo the corresponding drug entities and relations triplets are:\nitraconazole, false, terfenadine\nitraconazole, false, terfenadine\nterfenadine, false, itraconazole\nterfenadine, false, itraconazole\nterfenadine, mechanism, itraconazole\nterfenadine, false, itraconazole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "concomitant administration of itraconazole and terfenadine is contraindicated.", "output": "Let's think step by step.\nThe drug entities in this text are:\nitraconazole, terfenadine\nSo the corresponding drug entities and relations triplets are:\nitraconazole, advise, terfenadine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "due to the chemical similarity of other azole-type antifungal agents (including fluconazole, metronidazole, and miconazole) to ketoconazole, and itraconazole, concomitant use of these products with terfenadine is not recommended pending full examination of potential interactions.", "output": "Let's think step by step.\nThe drug entities in this text are:\nazole-type antifungal agents, fluconazole, metronidazole, miconazole, ketoconazole, itraconazole, terfenadine\nSo the corresponding drug entities and relations triplets are:\nazole-type antifungal agents, false, fluconazole\nazole-type antifungal agents, false, metronidazole\nazole-type antifungal agents, false, miconazole\nazole-type antifungal agents, false, ketoconazole\nazole-type antifungal agents, false, itraconazole\nazole-type antifungal agents, advise, terfenadine\nfluconazole, false, metronidazole\nfluconazole, false, miconazole\nfluconazole, false, ketoconazole\nfluconazole, false, itraconazole\nfluconazole, advise, terfenadine\nmetronidazole, false, miconazole\nmetronidazole, false, ketoconazole\nmetronidazole, false, itraconazole\nmetronidazole, advise, terfenadine\nmiconazole, false, ketoconazole\nmiconazole, false, itraconazole\nmiconazole, advise, terfenadine\nketoconazole, false, itraconazole\nketoconazole, false, terfenadine\nitraconazole, false, terfenadine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "macrolides: clinical drug interaction studies indicate that erythromycin and clarithromycin can exert an effect on terfenadine metabolism by a mechanism which may be similar to that of ketoconazole, but to a lesser extent.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmacrolides, erythromycin, clarithromycin, terfenadine, ketoconazole\nSo the corresponding drug entities and relations triplets are:\nmacrolides, false, erythromycin\nmacrolides, false, clarithromycin\nmacrolides, false, terfenadine\nmacrolides, false, ketoconazole\nerythromycin, false, clarithromycin\nerythromycin, mechanism, terfenadine\nerythromycin, false, ketoconazole\nclarithromycin, mechanism, terfenadine\nclarithromycin, false, ketoconazole\nterfenadine, false, ketoconazole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "a few spontaneous accounts of qt interval prolongation with ventricular arrhythmia including torsades de pointes, have been reported in patients receiving erythromycin or troleandomycin.", "output": "Let's think step by step.\nThe drug entities in this text are:\nerythromycin, troleandomycin\nSo the corresponding drug entities and relations triplets are:\nerythromycin, false, troleandomycin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "concomitant administration of terfenadine with clarithromycin, erythromycin, or troleandomycin is contraindicated: pending full characterization of potential interactions, concomitant administration of terfenadine with other macrolide antibiotics, including azithromycin, is not recommended.", "output": "Let's think step by step.\nThe drug entities in this text are:\nterfenadine, clarithromycin, erythromycin, troleandomycin, terfenadine, macrolide antibiotics, azithromycin\nSo the corresponding drug entities and relations triplets are:\nterfenadine, advise, clarithromycin\nterfenadine, advise, erythromycin\nterfenadine, advise, troleandomycin\nterfenadine, false, macrolide antibiotics\nterfenadine, false, azithromycin\nclarithromycin, false, erythromycin\nclarithromycin, false, troleandomycin\nclarithromycin, false, terfenadine\nclarithromycin, false, macrolide antibiotics\nclarithromycin, false, azithromycin\nerythromycin, false, troleandomycin\nerythromycin, false, terfenadine\nerythromycin, false, macrolide antibiotics\nerythromycin, false, azithromycin\ntroleandomycin, false, terfenadine\ntroleandomycin, false, macrolide antibiotics\ntroleandomycin, false, azithromycin\nterfenadine, advise, macrolide antibiotics\nterfenadine, advise, azithromycin\nmacrolide antibiotics, false, azithromycin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "studies to evaluate potential interactions of terfenadine with azithromycin are in progress.", "output": "Let's think step by step.\nThe drug entities in this text are:\nterfenadine, azithromycin\nSo the corresponding drug entities and relations triplets are:\nterfenadine, false, azithromycin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "caution is recommended when administering nexavar with compounds that are metabolized/eliminated predominantly by the ugt1a1 pathway (e.g. irinotecan).", "output": "Let's think step by step.\nThe drug entities in this text are:\nnexavar, irinotecan\nSo the corresponding drug entities and relations triplets are:\nnexavar, advise, irinotecan END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "concomitant treatment with nexavar resulted in a 21% increase in the auc of doxorubicin.", "output": "Let's think step by step.\nThe drug entities in this text are:\nnexavar, doxorubicin\nSo the corresponding drug entities and relations triplets are:\nnexavar, mechanism, doxorubicin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "caution is recommended when administering doxorubicin with nexavar.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndoxorubicin, nexavar\nSo the corresponding drug entities and relations triplets are:\ndoxorubicin, advise, nexavar END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in a pharmacokinetic study of 18 chronic hepatitis c patients concomitantly receiving methadone, treatment with peg-intron once weekly for 4 weeks was associated with a mean increase of 16% in methadone auc;", "output": "Let's think step by step.\nThe drug entities in this text are:\nmethadone, peg-intron, methadone\nSo the corresponding drug entities and relations triplets are:\nmethadone, mechanism, peg-intron\npeg-intron, false, methadone END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "since mexitil is a substrate for the metabolic pathways involving cyp2d6 and cyp1a2 enzymes, inhibition or induction of either of these enzymes would be expected to alter mexiletine plasma concentrations.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmexitil, mexiletine\nSo the corresponding drug entities and relations triplets are:\nmexitil, false, mexiletine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in a formal, single-dose interaction study (n = 6 males) the clearance of mexiletine was decreased by 38% following the coadministration of fluvoxamine, an inhibitor of cyp1a2.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmexiletine, fluvoxamine\nSo the corresponding drug entities and relations triplets are:\nmexiletine, mechanism, fluvoxamine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in another formal study (n = 8 extensive and n = 7 poor metabolizers of cyp2d6), coadministration of propafenone did not alter the kinetics of mexiletine in the poor cyp2d6 metabolizer group.", "output": "Let's think step by step.\nThe drug entities in this text are:\npropafenone, mexiletine\nSo the corresponding drug entities and relations triplets are:\npropafenone, false, mexiletine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in this crossover steady state study, the pharmacokinetics of propafenone were unaffected in either phenotype by the coadministration of mexiletine.", "output": "Let's think step by step.\nThe drug entities in this text are:\npropafenone, mexiletine\nSo the corresponding drug entities and relations triplets are:\npropafenone, false, mexiletine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "addition of mexiletine to propafenone did not lead to further electrocardiographic parameters changes of qrs, qtc, rr, and pr intervals than propafenone alone.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmexiletine, propafenone, propafenone\nSo the corresponding drug entities and relations triplets are:\nmexiletine, false, propafenone\nmexiletine, false, propafenone END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in a large compassionate use program mexitil    has been used concurrently with commonly employed antianginal, antihypertensive, and anticoagulant drugs without observed interactions.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmexitil, antihypertensive, anticoagulant drugs\nSo the corresponding drug entities and relations triplets are:\nmexitil, false, antihypertensive\nmexitil, false, anticoagulant drugs\nantihypertensive, false, anticoagulant drugs END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "a variety of antiarrhythmics such as quinidine or propranolol were also added, sometimes with improved control of ventricular ectopy.", "output": "Let's think step by step.\nThe drug entities in this text are:\nantiarrhythmics, quinidine, propranolol\nSo the corresponding drug entities and relations triplets are:\nantiarrhythmics, false, quinidine\nantiarrhythmics, false, propranolol\nquinidine, false, propranolol END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "when phenytoin or other hepatic enzyme inducers such as rifampin and phenobarbital have been taken concurrently with mexitil   , lowered mexitil    plasma levels have been reported.", "output": "Let's think step by step.\nThe drug entities in this text are:\nphenytoin, rifampin, phenobarbital, mexitil, mexitil\nSo the corresponding drug entities and relations triplets are:\nphenytoin, false, rifampin\nphenytoin, false, phenobarbital\nphenytoin, mechanism, mexitil\nphenytoin, false, mexitil\nrifampin, false, phenobarbital\nrifampin, mechanism, mexitil\nrifampin, false, mexitil\nphenobarbital, mechanism, mexitil\nphenobarbital, false, mexitil END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in a formal study, benzodiazepines were shown not to affect mexitil    plasma concentrations.", "output": "Let's think step by step.\nThe drug entities in this text are:\nbenzodiazepines, mexitil\nSo the corresponding drug entities and relations triplets are:\nbenzodiazepines, false, mexitil END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "ecg intervals (pr, qrs, and qt) were not affected by concurrent mexitil    and digoxin, diuretics, or propranolol.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmexitil, digoxin, diuretics, propranolol\nSo the corresponding drug entities and relations triplets are:\nmexitil, false, digoxin\nmexitil, false, diuretics\nmexitil, false, propranolol\ndigoxin, false, diuretics\ndigoxin, false, propranolol\ndiuretics, false, propranolol END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "concurrent administration of cimetidine and mexitil    has been reported to increase, decrease, or leave unchanged mexitil    plasma levels;", "output": "Let's think step by step.\nThe drug entities in this text are:\ncimetidine, mexitil, mexitil\nSo the corresponding drug entities and relations triplets are:\ncimetidine, mechanism, mexitil\ncimetidine, false, mexitil END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "mexitil    does not alter serum digoxin levels but magnesium-aluminum hydroxide, when used to treat gastrointestinal symptoms due to mexitil   , has been reported to lower serum digoxin levels.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmexitil, digoxin, magnesium-aluminum hydroxide, mexitil, digoxin\nSo the corresponding drug entities and relations triplets are:\nmexitil, false, digoxin\nmexitil, false, magnesium-aluminum hydroxide\nmexitil, false, digoxin\ndigoxin, false, magnesium-aluminum hydroxide\ndigoxin, false, mexitil\nmagnesium-aluminum hydroxide, false, mexitil\nmagnesium-aluminum hydroxide, mechanism, digoxin\nmexitil, false, digoxin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "concurrent use of mexitil    and theophylline may lead to increased plasma theophylline levels.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmexitil, theophylline, theophylline\nSo the corresponding drug entities and relations triplets are:\nmexitil, mechanism, theophylline\nmexitil, false, theophylline END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "this increase was observed at the first test point which was the second day after starting mexitil   . theophylline plasma levels returned to pre-mexitil    values within 48 hours after discontinuing mexitil   . if mexitil and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the mexitil    dose is changed.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmexitil, theophylline, mexitil, mexitil, mexitil, theophylline, theophylline, mexitil\nSo the corresponding drug entities and relations triplets are:\nmexitil, false, theophylline\nmexitil, false, theophylline\nmexitil, false, theophylline\ntheophylline, false, mexitil\ntheophylline, mechanism, mexitil\ntheophylline, false, mexitil\ntheophylline, false, mexitil\nmexitil, false, theophylline\nmexitil, false, theophylline\nmexitil, false, theophylline\nmexitil, false, theophylline\nmexitil, advise, theophylline\nmexitil, false, theophylline\ntheophylline, false, mexitil\ntheophylline, false, mexitil END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexitil   .", "output": "Let's think step by step.\nThe drug entities in this text are:\ncaffeine, mexitil\nSo the corresponding drug entities and relations triplets are:\ncaffeine, mechanism, mexitil END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "usage with alcohol: due to the potential for increased cns depressants effects, alcohol should be used with caution in patients who are currently receiving pentazocine.", "output": "Let's think step by step.\nThe drug entities in this text are:\nalcohol, alcohol, pentazocine\nSo the corresponding drug entities and relations triplets are:\nalcohol, false, pentazocine\nalcohol, advise, pentazocine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "thiabendazole may compete with other drugs, such as theophylline, for sites of metabolism in the liver, thus elevating the serum levels of such compounds to potentially toxic levels.", "output": "Let's think step by step.\nThe drug entities in this text are:\nthiabendazole, theophylline\nSo the corresponding drug entities and relations triplets are:\nthiabendazole, mechanism, theophylline END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "therefore, when concomitant use of thiabendazole and xanthine derivatives is anticipated, it may be necessary to monitor blood levels and/or reduce the dosage of such compounds.", "output": "Let's think step by step.\nThe drug entities in this text are:\nthiabendazole, xanthine derivatives\nSo the corresponding drug entities and relations triplets are:\nthiabendazole, advise, xanthine derivatives END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "pyrimethamine may be used with sulfonamides, quinine and other antimalarials, and with other antibiotics.", "output": "Let's think step by step.\nThe drug entities in this text are:\npyrimethamine, sulfonamides, quinine, antimalarials, antibiotics\nSo the corresponding drug entities and relations triplets are:\npyrimethamine, false, sulfonamides\npyrimethamine, false, quinine\npyrimethamine, false, antimalarials\npyrimethamine, false, antibiotics\nsulfonamides, false, quinine\nsulfonamides, false, antimalarials\nsulfonamides, false, antibiotics\nquinine, false, antimalarials\nquinine, false, antibiotics\nantimalarials, false, antibiotics END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "folinic acid (leucovorin) should be administered until normal hematopoiesis is restored.", "output": "Let's think step by step.\nThe drug entities in this text are:\nfolinic acid, leucovorin\nSo the corresponding drug entities and relations triplets are:\nfolinic acid, false, leucovorin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "mild hepatotoxicity has been reported in some patients when lorazepam and pyrimethamine were administered concomitantly.", "output": "Let's think step by step.\nThe drug entities in this text are:\nlorazepam, pyrimethamine\nSo the corresponding drug entities and relations triplets are:\nlorazepam, effect, pyrimethamine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "posicor inhibits some of the liver's ability to metabolize some other drugs - terfenadine, astemizole, cisapride, cyclosporine, and tricyclic antidepressants.", "output": "Let's think step by step.\nThe drug entities in this text are:\nposicor, terfenadine, astemizole, cisapride, cyclosporine, tricyclic antidepressants\nSo the corresponding drug entities and relations triplets are:\nposicor, mechanism, terfenadine\nposicor, mechanism, astemizole\nposicor, mechanism, cisapride\nposicor, mechanism, cyclosporine\nposicor, mechanism, tricyclic antidepressants\nterfenadine, false, astemizole\nterfenadine, false, cisapride\nterfenadine, false, cyclosporine\nterfenadine, false, tricyclic antidepressants\nastemizole, false, cisapride\nastemizole, false, cyclosporine\nastemizole, false, tricyclic antidepressants\ncisapride, false, cyclosporine\ncisapride, false, tricyclic antidepressants\ncyclosporine, false, tricyclic antidepressants END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "trilostane may interact with aminoglutethimide or mitotane (causing too great a decrease in adrenal function).", "output": "Let's think step by step.\nThe drug entities in this text are:\ntrilostane, aminoglutethimide, mitotane\nSo the corresponding drug entities and relations triplets are:\ntrilostane, int, aminoglutethimide\ntrilostane, int, mitotane\naminoglutethimide, false, mitotane END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "concomitant administration of substances that are also tubularly secreted (e.g., probenecid) could potentially result in delayed clearance of alimta.", "output": "Let's think step by step.\nThe drug entities in this text are:\nprobenecid, alimta\nSo the corresponding drug entities and relations triplets are:\nprobenecid, mechanism, alimta END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "although ibuprofen (400 mg qid) can be administered with alimta in patients with normal renal function (creatinine clearance    80 ml/min), caution should be used when administering ibuprofen concurrently with alimta to patients with mild to moderate renal insufficiency (creatinine clearance from 45 to 79 ml/min).", "output": "Let's think step by step.\nThe drug entities in this text are:\nibuprofen, alimta, ibuprofen, alimta\nSo the corresponding drug entities and relations triplets are:\nibuprofen, false, alimta\nibuprofen, false, alimta\nalimta, false, ibuprofen\nibuprofen, advise, alimta END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "patients with mild to moderate renal insufficiency should avoid taking nsaids with short elimination half-lives for a period of 2 days before, the day of, and 2 days following administration of alimta.", "output": "Let's think step by step.\nThe drug entities in this text are:\nnsaids, alimta\nSo the corresponding drug entities and relations triplets are:\nnsaids, advise, alimta END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in the absence of data regarding potential interaction between alimta and nsaids with longer half-lives, all patients taking these nsaids should interrupt dosing for at least 5 days before, the day of, and 2 days following alimta administration.", "output": "Let's think step by step.\nThe drug entities in this text are:\nalimta, nsaids, nsaids, alimta\nSo the corresponding drug entities and relations triplets are:\nalimta, false, nsaids\nalimta, false, nsaids\nnsaids, false, alimta\nnsaids, advise, alimta END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "ritalin may decrease the hypotensive effect of guanethidine.", "output": "Let's think step by step.\nThe drug entities in this text are:\nritalin, guanethidine\nSo the corresponding drug entities and relations triplets are:\nritalin, effect, guanethidine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "human pharmacologic studies have shown that ritalin may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (phenobarbital, diphenylhydantoin, primidone), phenylbutazone, and tricyclic drugs (imipramine, clomipramine, desipramine).", "output": "Let's think step by step.\nThe drug entities in this text are:\nritalin, coumarin anticoagulants, anticonvulsants, phenobarbital, diphenylhydantoin, primidone, phenylbutazone, tricyclic drugs, imipramine, clomipramine, desipramine\nSo the corresponding drug entities and relations triplets are:\nritalin, mechanism, coumarin anticoagulants\nritalin, mechanism, anticonvulsants\nritalin, mechanism, phenobarbital\nritalin, mechanism, diphenylhydantoin\nritalin, mechanism, primidone\nritalin, mechanism, phenylbutazone\nritalin, mechanism, tricyclic drugs\nritalin, mechanism, imipramine\nritalin, mechanism, clomipramine\nritalin, mechanism, desipramine\ncoumarin anticoagulants, false, anticonvulsants\ncoumarin anticoagulants, false, phenobarbital\ncoumarin anticoagulants, false, diphenylhydantoin\ncoumarin anticoagulants, false, primidone\ncoumarin anticoagulants, false, phenylbutazone\ncoumarin anticoagulants, false, tricyclic drugs\ncoumarin anticoagulants, false, imipramine\ncoumarin anticoagulants, false, clomipramine\ncoumarin anticoagulants, false, desipramine\nanticonvulsants, false, phenobarbital\nanticonvulsants, false, diphenylhydantoin\nanticonvulsants, false, primidone\nanticonvulsants, false, phenylbutazone\nanticonvulsants, false, tricyclic drugs\nanticonvulsants, false, imipramine\nanticonvulsants, false, clomipramine\nanticonvulsants, false, desipramine\nphenobarbital, false, diphenylhydantoin\nphenobarbital, false, primidone\nphenobarbital, false, phenylbutazone\nphenobarbital, false, tricyclic drugs\nphenobarbital, false, imipramine\nphenobarbital, false, clomipramine\nphenobarbital, false, desipramine\ndiphenylhydantoin, false, primidone\ndiphenylhydantoin, false, phenylbutazone\ndiphenylhydantoin, false, tricyclic drugs\ndiphenylhydantoin, false, imipramine\ndiphenylhydantoin, false, clomipramine\ndiphenylhydantoin, false, desipramine\nprimidone, false, phenylbutazone\nprimidone, false, tricyclic drugs\nprimidone, false, imipramine\nprimidone, false, clomipramine\nprimidone, false, desipramine\nphenylbutazone, false, tricyclic drugs\nphenylbutazone, false, imipramine\nphenylbutazone, false, clomipramine\nphenylbutazone, false, desipramine\ntricyclic drugs, false, imipramine\ntricyclic drugs, false, clomipramine\ntricyclic drugs, false, desipramine\nimipramine, false, clomipramine\nimipramine, false, desipramine\nclomipramine, false, desipramine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the safety of using methylphenidate in combination with clonidine or other centrally acting alpha-2 agonists has not been systemically evaluated.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmethylphenidate, clonidine, alpha-2 agonists\nSo the corresponding drug entities and relations triplets are:\nmethylphenidate, false, clonidine\nmethylphenidate, false, alpha-2 agonists\nclonidine, false, alpha-2 agonists END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "coumarin-derivative anticoagulants: prolongation of prothrombin time (pt) and international normalized ratio (inr) were observed in patients receiving zolinza concomitantly with coumarin-derivative anticoagulants.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncoumarin-derivative anticoagulants, zolinza, coumarin-derivative anticoagulants\nSo the corresponding drug entities and relations triplets are:\ncoumarin-derivative anticoagulants, false, zolinza\nzolinza, effect, coumarin-derivative anticoagulants END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "physicians should carefully monitor pt and inr in patients concurrently administered zolinza and coumarin derivatives.", "output": "Let's think step by step.\nThe drug entities in this text are:\nzolinza, coumarin derivatives\nSo the corresponding drug entities and relations triplets are:\nzolinza, advise, coumarin derivatives END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "other hdac inhibitors severe thrombocytopenia and gastrointestinal bleeding have been reported with concomitant use of zolinza and other hdac inhibitors (e.g., valproic acid).", "output": "Let's think step by step.\nThe drug entities in this text are:\nhdac inhibitors, zolinza, hdac inhibitors, valproic acid\nSo the corresponding drug entities and relations triplets are:\nhdac inhibitors, false, zolinza\nhdac inhibitors, false, valproic acid\nzolinza, effect, hdac inhibitors\nzolinza, effect, valproic acid\nhdac inhibitors, false, valproic acid END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "no pharmacokinetic interaction between 85 mg/m2 eloxatin and infusional 5-fu has been observed in patients treated every 2 weeks.", "output": "Let's think step by step.\nThe drug entities in this text are:\neloxatin, 5-fu\nSo the corresponding drug entities and relations triplets are:\neloxatin, false, 5-fu END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "increases of 5-fu plasma concentrations by approximately 20% have been observed with doses of 130 mg/m2 eloxatin dosed every 3 weeks.", "output": "Let's think step by step.\nThe drug entities in this text are:\n5-fu, eloxatin\nSo the corresponding drug entities and relations triplets are:\n5-fu, mechanism, eloxatin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "alcohol: in a multiple-dose study in 30 normal weight subjects, coadministration of xenical and 40 grams of alcohol (e.g., approximately 3 glasses of wine) did not result in alteration of alcohol pharmacokinetics, orlistat pharmacodynamics (fecal fat excretion), or systemic exposure to orlistat.", "output": "Let's think step by step.\nThe drug entities in this text are:\nalcohol, xenical, alcohol, alcohol, orlistat, orlistat\nSo the corresponding drug entities and relations triplets are:\nalcohol, false, xenical\nalcohol, false, orlistat\nalcohol, false, orlistat\nxenical, false, alcohol\nxenical, false, alcohol\nxenical, false, orlistat\nxenical, false, orlistat\nalcohol, false, orlistat\nalcohol, false, orlistat\nalcohol, false, orlistat\nalcohol, false, orlistat END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "cyclosporine: preliminary data from a xenical and cyclosporine drug interaction study indicate a reduction in cyclosporine plasma levels when xenical was coadministered with cyclosporine.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncyclosporine, xenical, cyclosporine, cyclosporine, xenical, cyclosporine\nSo the corresponding drug entities and relations triplets are:\ncyclosporine, false, xenical\ncyclosporine, false, xenical\nxenical, false, cyclosporine\nxenical, false, cyclosporine\nxenical, false, cyclosporine\ncyclosporine, false, xenical\ncyclosporine, false, xenical\nxenical, mechanism, cyclosporine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "digoxin: in 12 normal-weight subjects receiving xenical 120 mg three times a day for 6 days, xenical did not alter the pharmacokinetics of a single dose of digoxin.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndigoxin, xenical, xenical, digoxin\nSo the corresponding drug entities and relations triplets are:\ndigoxin, false, xenical\ndigoxin, false, xenical\nxenical, false, digoxin\nxenical, false, digoxin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "fat-soluble vitamin supplements and analogues: a pharmacokinetic interaction study showed a 30% reduction in beta-carotene supplement absorption when concomitantly administered with xenical.", "output": "Let's think step by step.\nThe drug entities in this text are:\nfat-soluble vitamin supplements, beta-carotene, xenical\nSo the corresponding drug entities and relations triplets are:\nfat-soluble vitamin supplements, false, beta-carotene\nfat-soluble vitamin supplements, false, xenical\nbeta-carotene, mechanism, xenical END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "xenical inhibited absorption of a vitamin e acetate supplement by approximately 60%.", "output": "Let's think step by step.\nThe drug entities in this text are:\nxenical, vitamin e acetate\nSo the corresponding drug entities and relations triplets are:\nxenical, mechanism, vitamin e acetate END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the effect of orlistat on the absorption of supplemental vitamin d, vitamin a, and nutritionally-derived vitamin k is not known at this time.", "output": "Let's think step by step.\nThe drug entities in this text are:\norlistat, vitamin d, vitamin a, vitamin k\nSo the corresponding drug entities and relations triplets are:\norlistat, false, vitamin d\norlistat, false, vitamin a\norlistat, false, vitamin k\nvitamin d, false, vitamin a\nvitamin d, false, vitamin k\nvitamin a, false, vitamin k END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "glyburide: in 12 normal-weight subjects receiving orlistat 80 mg three times a day for 5 days, orlistat did not alter the pharmacokinetics or pharmacodynamics (blood glucose-lowering) of glyburide.", "output": "Let's think step by step.\nThe drug entities in this text are:\nglyburide, orlistat, orlistat, glyburide\nSo the corresponding drug entities and relations triplets are:\nglyburide, false, orlistat\nglyburide, false, orlistat\norlistat, false, glyburide\norlistat, false, glyburide END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "nifedipine (extended-release tablets): in 17 normal-weight subjects receiving xenical 120 mg three times a day for 6 days, xenical did not alter the bioavailability of nifedipine (extended-release tablets).", "output": "Let's think step by step.\nThe drug entities in this text are:\nnifedipine, xenical, xenical, nifedipine\nSo the corresponding drug entities and relations triplets are:\nnifedipine, false, xenical\nnifedipine, false, xenical\nxenical, false, nifedipine\nxenical, false, nifedipine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "oral contraceptives: in 20 normal-weight female subjects, the treatment of xenical 120 mg three times a day for 23 days resulted in no changes in the ovulation-suppressing action of oral contraceptives.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncontraceptives, xenical, contraceptives\nSo the corresponding drug entities and relations triplets are:\ncontraceptives, false, xenical\nxenical, false, contraceptives END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "phenytoin: in 12 normal-weight subjects receiving xenical 120 mg three times a day for 7 days, xenical did not alter the pharmacokinetics of a single 300-mg dose of phenytoin.", "output": "Let's think step by step.\nThe drug entities in this text are:\nphenytoin, xenical, xenical, phenytoin\nSo the corresponding drug entities and relations triplets are:\nphenytoin, false, xenical\nphenytoin, false, xenical\nxenical, false, phenytoin\nxenical, false, phenytoin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "pravastatin: in a 2-way crossover study of 24 normal-weight, mildly hypercholesterolemic patients receiving xenical 120 mg three times a day for 6 days, xenical did not affect the pharmacokinetics of pravastatin.", "output": "Let's think step by step.\nThe drug entities in this text are:\npravastatin, xenical, xenical, pravastatin\nSo the corresponding drug entities and relations triplets are:\npravastatin, false, xenical\npravastatin, false, xenical\nxenical, false, pravastatin\nxenical, false, pravastatin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "warfarin: in 12 normal-weight subjects, administration of xenical 120 mg three times a day for 16 days did not result in any change in either warfarin pharmacokinetics (both r- and s-enantiomers) or pharmacodynamics (prothrombin time and serum factor vii).", "output": "Let's think step by step.\nThe drug entities in this text are:\nwarfarin, xenical, warfarin\nSo the corresponding drug entities and relations triplets are:\nwarfarin, false, xenical\nxenical, false, warfarin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "therefore, as vitamin k absorption may be decreased with xenical, patients on chronic stable doses of warfarin who are prescribed xenical should be monitored closely for changes in coagulation parameters.", "output": "Let's think step by step.\nThe drug entities in this text are:\nvitamin k, xenical, warfarin, xenical\nSo the corresponding drug entities and relations triplets are:\nvitamin k, mechanism, xenical\nvitamin k, false, warfarin\nvitamin k, false, xenical\nxenical, false, warfarin\nwarfarin, advise, xenical END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in vitro studies with human liver microsomes showed that terbinafine does not inhibit the metabolism of tolbutamide, ethinylestradiol, ethoxycoumarin, and cyclosporine.", "output": "Let's think step by step.\nThe drug entities in this text are:\nterbinafine, tolbutamide, ethinylestradiol, ethoxycoumarin, cyclosporine\nSo the corresponding drug entities and relations triplets are:\nterbinafine, false, tolbutamide\nterbinafine, false, ethinylestradiol\nterbinafine, false, ethoxycoumarin\nterbinafine, false, cyclosporine\ntolbutamide, false, ethinylestradiol\ntolbutamide, false, ethoxycoumarin\ntolbutamide, false, cyclosporine\nethinylestradiol, false, ethoxycoumarin\nethinylestradiol, false, cyclosporine\nethoxycoumarin, false, cyclosporine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "this may be of clinical relevance for compounds predominantly metabolized by this enzyme, such as tricyclic antidepressants,    -blockers, selective serotonin reuptake inhibitors (ssris), and monoamine oxidase inhibitors (mao-is) type b, if they have a narrow therapeutic window.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntricyclic antidepressants, selective serotonin reuptake inhibitors, ssris, monoamine oxidase inhibitors (mao-is) type b\nSo the corresponding drug entities and relations triplets are:\ntricyclic antidepressants, false, selective serotonin reuptake inhibitors\ntricyclic antidepressants, false, ssris\ntricyclic antidepressants, false, monoamine oxidase inhibitors (mao-is) type b\nselective serotonin reuptake inhibitors, false, ssris\nselective serotonin reuptake inhibitors, false, monoamine oxidase inhibitors (mao-is) type b\nssris, false, monoamine oxidase inhibitors (mao-is) type b END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in vivo drug-drug interaction studies conducted in normal volunteer subjects showed that terbinafine does not affect the clearance of antipyrine or digoxin.", "output": "Let's think step by step.\nThe drug entities in this text are:\nterbinafine, antipyrine, digoxin\nSo the corresponding drug entities and relations triplets are:\nterbinafine, false, antipyrine\nterbinafine, false, digoxin\nantipyrine, false, digoxin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "terbinafine decreases the clearance of caffeine by 19%.", "output": "Let's think step by step.\nThe drug entities in this text are:\nterbinafine, caffeine\nSo the corresponding drug entities and relations triplets are:\nterbinafine, mechanism, caffeine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "terbinafine increases the clearance of cyclosporine by 15%.", "output": "Let's think step by step.\nThe drug entities in this text are:\nterbinafine, cyclosporine\nSo the corresponding drug entities and relations triplets are:\nterbinafine, mechanism, cyclosporine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "there have been spontaneous reports of increase or decrease in prothrombin times in patients concomitantly taking oral terbinafine and warfarin, however, a causal relationship between lamisil    tablets and these changes has not been established.", "output": "Let's think step by step.\nThe drug entities in this text are:\nterbinafine, warfarin, lamisil\nSo the corresponding drug entities and relations triplets are:\nterbinafine, effect, warfarin\nterbinafine, false, lamisil\nwarfarin, false, lamisil END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "terbinafine clearance is increased 100% by rifampin, a cyp450 enzyme inducer, and decreased 33% by cimetidine, a cyp450 enzyme inhibitor.", "output": "Let's think step by step.\nThe drug entities in this text are:\nterbinafine, rifampin, cimetidine\nSo the corresponding drug entities and relations triplets are:\nterbinafine, mechanism, rifampin\nterbinafine, mechanism, cimetidine\nrifampin, false, cimetidine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "terbinafine clearance is unaffected by cyclosporine.", "output": "Let's think step by step.\nThe drug entities in this text are:\nterbinafine, cyclosporine\nSo the corresponding drug entities and relations triplets are:\nterbinafine, false, cyclosporine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "there is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, hypoglycemics, theophyllines, phenytoins, thiazide diuretics, beta blockers, and calcium channel blockers.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncontraceptives, hypoglycemics, theophyllines, phenytoins, thiazide diuretics, beta blockers, calcium channel blockers\nSo the corresponding drug entities and relations triplets are:\ncontraceptives, false, hypoglycemics\ncontraceptives, false, theophyllines\ncontraceptives, false, phenytoins\ncontraceptives, false, thiazide diuretics\ncontraceptives, false, beta blockers\ncontraceptives, false, calcium channel blockers\nhypoglycemics, false, theophyllines\nhypoglycemics, false, phenytoins\nhypoglycemics, false, thiazide diuretics\nhypoglycemics, false, beta blockers\nhypoglycemics, false, calcium channel blockers\ntheophyllines, false, phenytoins\ntheophyllines, false, thiazide diuretics\ntheophyllines, false, beta blockers\ntheophyllines, false, calcium channel blockers\nphenytoins, false, thiazide diuretics\nphenytoins, false, beta blockers\nphenytoins, false, calcium channel blockers\nthiazide diuretics, false, beta blockers\nthiazide diuretics, false, calcium channel blockers\nbeta blockers, false, calcium channel blockers END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "aspirin and other salicylate drugs will be additive to disalcid and may increase plasma concentrations of salicylic acid to toxic levels.", "output": "Let's think step by step.\nThe drug entities in this text are:\naspirin, salicylate drugs, disalcid, salicylic acid\nSo the corresponding drug entities and relations triplets are:\naspirin, false, salicylate drugs\naspirin, effect, disalcid\naspirin, false, salicylic acid\nsalicylate drugs, effect, disalcid\nsalicylate drugs, false, salicylic acid\ndisalcid, false, salicylic acid END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "salicylates given concomitantly with anticoagulant drugs may predispose to systemic bleeding.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsalicylates, anticoagulant drugs\nSo the corresponding drug entities and relations triplets are:\nsalicylates, effect, anticoagulant drugs END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "salicylates may enhance the hypoglycemic effect of oral antidiabetic drugs of the sulfonylurea class.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsalicylates, antidiabetic drugs\nSo the corresponding drug entities and relations triplets are:\nsalicylates, effect, antidiabetic drugs END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "salicylate competes with a number of drugs for protein binding sites, notably penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, and possibly corticosteroids.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsalicylate, penicillin, thiopental, thyroxine, triiodothyronine, phenytoin, sulfinpyrazone, naproxen, warfarin, methotrexate, corticosteroids\nSo the corresponding drug entities and relations triplets are:\nsalicylate, mechanism, penicillin\nsalicylate, mechanism, thiopental\nsalicylate, mechanism, thyroxine\nsalicylate, mechanism, triiodothyronine\nsalicylate, mechanism, phenytoin\nsalicylate, mechanism, sulfinpyrazone\nsalicylate, mechanism, naproxen\nsalicylate, mechanism, warfarin\nsalicylate, mechanism, methotrexate\nsalicylate, mechanism, corticosteroids\npenicillin, false, thiopental\npenicillin, false, thyroxine\npenicillin, false, triiodothyronine\npenicillin, false, phenytoin\npenicillin, false, sulfinpyrazone\npenicillin, false, naproxen\npenicillin, false, warfarin\npenicillin, false, methotrexate\npenicillin, false, corticosteroids\nthiopental, false, thyroxine\nthiopental, false, triiodothyronine\nthiopental, false, phenytoin\nthiopental, false, sulfinpyrazone\nthiopental, false, naproxen\nthiopental, false, warfarin\nthiopental, false, methotrexate\nthiopental, false, corticosteroids\nthyroxine, false, triiodothyronine\nthyroxine, false, phenytoin\nthyroxine, false, sulfinpyrazone\nthyroxine, false, naproxen\nthyroxine, false, warfarin\nthyroxine, false, methotrexate\nthyroxine, false, corticosteroids\ntriiodothyronine, false, phenytoin\ntriiodothyronine, false, sulfinpyrazone\ntriiodothyronine, false, naproxen\ntriiodothyronine, false, warfarin\ntriiodothyronine, false, methotrexate\ntriiodothyronine, false, corticosteroids\nphenytoin, false, sulfinpyrazone\nphenytoin, false, naproxen\nphenytoin, false, warfarin\nphenytoin, false, methotrexate\nphenytoin, false, corticosteroids\nsulfinpyrazone, false, naproxen\nsulfinpyrazone, false, warfarin\nsulfinpyrazone, false, methotrexate\nsulfinpyrazone, false, corticosteroids\nnaproxen, false, warfarin\nnaproxen, false, methotrexate\nnaproxen, false, corticosteroids\nwarfarin, false, methotrexate\nwarfarin, false, corticosteroids\nmethotrexate, false, corticosteroids END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "catecholamine-depleting drugs (e.g., reserpine) may have an additive effect when given with beta-blocking agents.", "output": "Let's think step by step.\nThe drug entities in this text are:\nreserpine, beta-blocking agents\nSo the corresponding drug entities and relations triplets are:\nreserpine, effect, beta-blocking agents END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "pindolol has been used with a variety of antihypertensive agents, including hydrochlorothiazide, hydralazine, and guanethidine without unexpected adverse interactions.", "output": "Let's think step by step.\nThe drug entities in this text are:\npindolol, antihypertensive agents, hydrochlorothiazide, hydralazine, guanethidine\nSo the corresponding drug entities and relations triplets are:\npindolol, false, antihypertensive agents\npindolol, false, hydrochlorothiazide\npindolol, false, hydralazine\npindolol, false, guanethidine\nantihypertensive agents, false, hydrochlorothiazide\nantihypertensive agents, false, hydralazine\nantihypertensive agents, false, guanethidine\nhydrochlorothiazide, false, hydralazine\nhydrochlorothiazide, false, guanethidine\nhydralazine, false, guanethidine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "pindolol has been shown to increase serum thioridazine levels when both drugs are co-administered.", "output": "Let's think step by step.\nThe drug entities in this text are:\npindolol, thioridazine\nSo the corresponding drug entities and relations triplets are:\npindolol, mechanism, thioridazine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "although specific drug or food interactions with mifepristone have not been studied, on the basis of this drug   s metabolism by cyp 3a4, it is possible that ketoconazole, itraconazole, erythromycin, and grapefruit juice may inhibit its metabolism (increasing serum levels of mifepristone).", "output": "Let's think step by step.\nThe drug entities in this text are:\nmifepristone, ketoconazole, itraconazole, erythromycin, mifepristone\nSo the corresponding drug entities and relations triplets are:\nmifepristone, false, ketoconazole\nmifepristone, false, itraconazole\nmifepristone, false, erythromycin\nketoconazole, false, itraconazole\nketoconazole, false, erythromycin\nketoconazole, mechanism, mifepristone\nitraconazole, false, erythromycin\nitraconazole, mechanism, mifepristone\nerythromycin, mechanism, mifepristone END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "furthermore, rifampin, dexamethasone, st.", "output": "Let's think step by step.\nThe drug entities in this text are:\nrifampin, dexamethasone\nSo the corresponding drug entities and relations triplets are:\nrifampin, false, dexamethasone END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "john   s wort, and certain anticonvulsants (phenytoin, phenobarbital, carbamazepine) may induce mifepristone metabolism (lowering serum levels of mifepristone).", "output": "Let's think step by step.\nThe drug entities in this text are:\nanticonvulsants, phenytoin, phenobarbital, carbamazepine, mifepristone, mifepristone\nSo the corresponding drug entities and relations triplets are:\nanticonvulsants, false, phenytoin\nanticonvulsants, false, phenobarbital\nanticonvulsants, false, carbamazepine\nanticonvulsants, mechanism, mifepristone\nanticonvulsants, false, mifepristone\nphenytoin, false, phenobarbital\nphenytoin, false, carbamazepine\nphenytoin, mechanism, mifepristone\nphenytoin, false, mifepristone\nphenobarbital, false, carbamazepine\nphenobarbital, mechanism, mifepristone\nphenobarbital, false, mifepristone\ncarbamazepine, mechanism, mifepristone\ncarbamazepine, false, mifepristone END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in addition to bleeding associated with heparin and vitamin k antagonists, drugs that alter platelet function (such as aspirin, dipyridamole, and abciximab) may increase the risk of bleeding if administered prior to or after retavase    therapy.", "output": "Let's think step by step.\nThe drug entities in this text are:\nheparin, vitamin k antagonists, aspirin, dipyridamole, abciximab, retavase\nSo the corresponding drug entities and relations triplets are:\nheparin, false, vitamin k antagonists\nheparin, false, aspirin\nheparin, false, dipyridamole\nheparin, false, abciximab\nheparin, effect, retavase\nvitamin k antagonists, false, aspirin\nvitamin k antagonists, false, dipyridamole\nvitamin k antagonists, false, abciximab\nvitamin k antagonists, effect, retavase\naspirin, false, dipyridamole\naspirin, false, abciximab\naspirin, effect, retavase\ndipyridamole, false, abciximab\ndipyridamole, effect, retavase\nabciximab, effect, retavase END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the occurrence of stupor, muscular rigidity, severe agitation, and elevated temperature has been reported in some patients receiving the combination of selegiline and meperidine.", "output": "Let's think step by step.\nThe drug entities in this text are:\nselegiline, meperidine\nSo the corresponding drug entities and relations triplets are:\nselegiline, effect, meperidine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "this is typical of the interaction of meperidine and maois.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmeperidine, maois\nSo the corresponding drug entities and relations triplets are:\nmeperidine, int, maois END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "severe toxicity has also been reported in patients receiving the combination of tricyclic antidepressants and eldepryl and selective serotonin reuptake inhibitors and eldepryl.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntricyclic antidepressants, eldepryl, selective serotonin reuptake inhibitors, eldepryl\nSo the corresponding drug entities and relations triplets are:\ntricyclic antidepressants, effect, eldepryl\ntricyclic antidepressants, false, selective serotonin reuptake inhibitors\ntricyclic antidepressants, false, eldepryl\neldepryl, false, selective serotonin reuptake inhibitors\nselective serotonin reuptake inhibitors, effect, eldepryl END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "one case of hypertensive crisis has been reported in a patient taking the recommended doses of selegiline and a sympathomimetic medication (ephedrine).", "output": "Let's think step by step.\nThe drug entities in this text are:\nselegiline, sympathomimetic medication, ephedrine\nSo the corresponding drug entities and relations triplets are:\nselegiline, effect, sympathomimetic medication\nselegiline, effect, ephedrine\nsympathomimetic medication, false, ephedrine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "caution should be exercised when administering zadaxin therapy in combination with other immunomodulating drugs.", "output": "Let's think step by step.\nThe drug entities in this text are:\nzadaxin, immunomodulating drugs\nSo the corresponding drug entities and relations triplets are:\nzadaxin, advise, immunomodulating drugs END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "caution should be observed in administering demser to patients receiving phenothiazines or haloperidol because the extrapyramidal effects of these drugs can be expected to be potentiated by inhibition of catecholamine synthesis.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndemser, phenothiazines, haloperidol\nSo the corresponding drug entities and relations triplets are:\ndemser, advise, phenothiazines\ndemser, advise, haloperidol\nphenothiazines, false, haloperidol END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "concurrent use of demser with alcohol or other cns depressants can increase their sedative effects.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndemser, alcohol, cns depressants\nSo the corresponding drug entities and relations triplets are:\ndemser, effect, alcohol\ndemser, effect, cns depressants\nalcohol, false, cns depressants END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the metabolism of metopirone is accelerated by phenytoin;", "output": "Let's think step by step.\nThe drug entities in this text are:\nmetopirone, phenytoin\nSo the corresponding drug entities and relations triplets are:\nmetopirone, mechanism, phenytoin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "metopirone inhibits the glucuronidation of acetaminophen and could possibly potentiate acetaminophen toxicity.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmetopirone, acetaminophen, acetaminophen\nSo the corresponding drug entities and relations triplets are:\nmetopirone, mechanism, acetaminophen\nmetopirone, effect, acetaminophen END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "dopamine antagonists, such as the neuroleptics (phenothiazines, butyrophenones, thioxanthines ) or metoclopramide, ordinarily should not be administered concurrently with permax (a dopamine agonist);", "output": "Let's think step by step.\nThe drug entities in this text are:\ndopamine antagonists, neuroleptics, phenothiazines, butyrophenones, thioxanthines, metoclopramide, permax, dopamine agonist\nSo the corresponding drug entities and relations triplets are:\ndopamine antagonists, false, neuroleptics\ndopamine antagonists, false, phenothiazines\ndopamine antagonists, false, butyrophenones\ndopamine antagonists, false, thioxanthines\ndopamine antagonists, false, metoclopramide\ndopamine antagonists, advise, permax\ndopamine antagonists, false, dopamine agonist\nneuroleptics, false, phenothiazines\nneuroleptics, false, butyrophenones\nneuroleptics, false, thioxanthines\nneuroleptics, false, metoclopramide\nneuroleptics, advise, permax\nneuroleptics, false, dopamine agonist\nphenothiazines, false, butyrophenones\nphenothiazines, false, thioxanthines\nphenothiazines, false, metoclopramide\nphenothiazines, advise, permax\nphenothiazines, false, dopamine agonist\nbutyrophenones, false, thioxanthines\nbutyrophenones, false, metoclopramide\nbutyrophenones, advise, permax\nbutyrophenones, false, dopamine agonist\nthioxanthines, false, metoclopramide\nthioxanthines, advise, permax\nthioxanthines, false, dopamine agonist\nmetoclopramide, advise, permax\nmetoclopramide, false, dopamine agonist\npermax, false, dopamine agonist END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "co-administration of oral ketoconazole 200 mg twice daily increased retapamulin geometric mean auc(0-24) and cmax by 81% after topical application of retapamulin ointment, 1% on the abraded skin of healthy adult males.", "output": "Let's think step by step.\nThe drug entities in this text are:\nketoconazole, retapamulin, retapamulin\nSo the corresponding drug entities and relations triplets are:\nketoconazole, false, retapamulin\nketoconazole, mechanism, retapamulin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "due to low systemic exposure to retapamulin following topical application in patients, dosage adjustments for retapamulin are unnecessary when co-administered with cyp3a4 inhibitors, such as ketoconazole.", "output": "Let's think step by step.\nThe drug entities in this text are:\nretapamulin, retapamulin, ketoconazole\nSo the corresponding drug entities and relations triplets are:\nretapamulin, false, ketoconazole\nretapamulin, false, ketoconazole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "based on in vitro p450 inhibition studies and the low systemic exposure observed following topical application of altabax, retapamulin is unlikely to affect the metabolism of other p450 substrates.", "output": "Let's think step by step.\nThe drug entities in this text are:\naltabax, retapamulin\nSo the corresponding drug entities and relations triplets are:\naltabax, false, retapamulin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "a multiple dose drug-drug interaction study demonstrated that ketoconazole approximately doubled paricalcitol auc0-   . since paricalcitol is partially metabolized by cyp3a and ketoconazole le is known to be a strong inhibitor of cytochrome p450 3a enzyme, care should be taken while dosing paricalcitol with ketoconazole and other strong p450 3a inhibitors including atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin or voriconazole.", "output": "Let's think step by step.\nThe drug entities in this text are:\nketoconazole, paricalcitol, paricalcitol, ketoconazole, paricalcitol, ketoconazole, atazanavir, clarithromycin, indinavir, itraconazole, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconazole\nSo the corresponding drug entities and relations triplets are:\nketoconazole, mechanism, paricalcitol\nketoconazole, false, paricalcitol\nketoconazole, false, paricalcitol\nketoconazole, false, atazanavir\nketoconazole, false, clarithromycin\nketoconazole, false, indinavir\nketoconazole, false, itraconazole\nketoconazole, false, nefazodone\nketoconazole, false, nelfinavir\nketoconazole, false, ritonavir\nketoconazole, false, saquinavir\nketoconazole, false, telithromycin\nketoconazole, false, voriconazole\nparicalcitol, false, ketoconazole\nparicalcitol, false, ketoconazole\nparicalcitol, false, atazanavir\nparicalcitol, false, clarithromycin\nparicalcitol, false, indinavir\nparicalcitol, false, itraconazole\nparicalcitol, false, nefazodone\nparicalcitol, false, nelfinavir\nparicalcitol, false, ritonavir\nparicalcitol, false, saquinavir\nparicalcitol, false, telithromycin\nparicalcitol, false, voriconazole\nparicalcitol, false, ketoconazole\nparicalcitol, false, ketoconazole\nparicalcitol, false, atazanavir\nparicalcitol, false, clarithromycin\nparicalcitol, false, indinavir\nparicalcitol, false, itraconazole\nparicalcitol, false, nefazodone\nparicalcitol, false, nelfinavir\nparicalcitol, false, ritonavir\nparicalcitol, false, saquinavir\nparicalcitol, false, telithromycin\nparicalcitol, false, voriconazole\nketoconazole, false, paricalcitol\nketoconazole, false, atazanavir\nketoconazole, false, clarithromycin\nketoconazole, false, indinavir\nketoconazole, false, itraconazole\nketoconazole, false, nefazodone\nketoconazole, false, nelfinavir\nketoconazole, false, ritonavir\nketoconazole, false, saquinavir\nketoconazole, false, telithromycin\nketoconazole, false, voriconazole\nparicalcitol, advise, ketoconazole\nparicalcitol, advise, atazanavir\nparicalcitol, advise, clarithromycin\nparicalcitol, advise, indinavir\nparicalcitol, advise, itraconazole\nparicalcitol, advise, nefazodone\nparicalcitol, advise, nelfinavir\nparicalcitol, advise, ritonavir\nparicalcitol, advise, saquinavir\nparicalcitol, advise, telithromycin\nparicalcitol, advise, voriconazole\nketoconazole, false, atazanavir\nketoconazole, false, clarithromycin\nketoconazole, false, indinavir\nketoconazole, false, itraconazole\nketoconazole, false, nefazodone\nketoconazole, false, nelfinavir\nketoconazole, false, ritonavir\nketoconazole, false, saquinavir\nketoconazole, false, telithromycin\nketoconazole, false, voriconazole\natazanavir, false, clarithromycin\natazanavir, false, indinavir\natazanavir, false, itraconazole\natazanavir, false, nefazodone\natazanavir, false, nelfinavir\natazanavir, false, ritonavir\natazanavir, false, saquinavir\natazanavir, false, telithromycin\natazanavir, false, voriconazole\nclarithromycin, false, indinavir\nclarithromycin, false, itraconazole\nclarithromycin, false, nefazodone\nclarithromycin, false, nelfinavir\nclarithromycin, false, ritonavir\nclarithromycin, false, saquinavir\nclarithromycin, false, telithromycin\nclarithromycin, false, voriconazole\nindinavir, false, itraconazole\nindinavir, false, nefazodone\nindinavir, false, nelfinavir\nindinavir, false, ritonavir\nindinavir, false, saquinavir\nindinavir, false, telithromycin\nindinavir, false, voriconazole\nitraconazole, false, nefazodone\nitraconazole, false, nelfinavir\nitraconazole, false, ritonavir\nitraconazole, false, saquinavir\nitraconazole, false, telithromycin\nitraconazole, false, voriconazole\nnefazodone, false, nelfinavir\nnefazodone, false, ritonavir\nnefazodone, false, saquinavir\nnefazodone, false, telithromycin\nnefazodone, false, voriconazole\nnelfinavir, false, ritonavir\nnelfinavir, false, saquinavir\nnelfinavir, false, telithromycin\nnelfinavir, false, voriconazole\nritonavir, false, saquinavir\nritonavir, false, telithromycin\nritonavir, false, voriconazole\nsaquinavir, false, telithromycin\nsaquinavir, false, voriconazole\ntelithromycin, false, voriconazole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "dose adjustment of zemplar capsules may be required, and ipth and serum calcium concentrations should be closely monitored if a patient initiates or discontinues therapy with a strong cyp3a4 inhibitor such as ketoconazole.", "output": "Let's think step by step.\nThe drug entities in this text are:\nzemplar, ketoconazole\nSo the corresponding drug entities and relations triplets are:\nzemplar, advise, ketoconazole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "drugs that impair intestinal absorption of fat-soluble vitamins, such as cholestyramine, may interfere with the absorption of zemplar capsules.", "output": "Let's think step by step.\nThe drug entities in this text are:\nfat-soluble vitamins, cholestyramine, zemplar\nSo the corresponding drug entities and relations triplets are:\nfat-soluble vitamins, mechanism, cholestyramine\nfat-soluble vitamins, false, zemplar\ncholestyramine, mechanism, zemplar END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "caution is advised for patients receiving high-dose aspirin and methazolamide concomitantly, as anorexia, tachypnea, lethargy, coma and death have been reported with concomitant use of high-dose aspirin and carbonic anhydrase inhibitors.", "output": "Let's think step by step.\nThe drug entities in this text are:\naspirin, methazolamide, aspirin, carbonic anhydrase inhibitors\nSo the corresponding drug entities and relations triplets are:\naspirin, advise, methazolamide\naspirin, false, carbonic anhydrase inhibitors\nmethazolamide, false, aspirin\nmethazolamide, false, carbonic anhydrase inhibitors\naspirin, effect, carbonic anhydrase inhibitors END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "drug-drug interactions: the pharmacokinetic and pharmacodynamic interactions between flomax capsules and other alpha-adrenergic blocking agents have not been determined.", "output": "Let's think step by step.\nThe drug entities in this text are:\nflomax, alpha-adrenergic blocking agents\nSo the corresponding drug entities and relations triplets are:\nflomax, false, alpha-adrenergic blocking agents END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "however, interactions may be expected and flomax capsules should not be used in combination with other alpha-adrenergic blocking agents.", "output": "Let's think step by step.\nThe drug entities in this text are:\nflomax, alpha-adrenergic blocking agents\nSo the corresponding drug entities and relations triplets are:\nflomax, advise, alpha-adrenergic blocking agents END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the pharmacokinetic interaction between cimetidine and flomax capsules was investigated.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncimetidine, flomax\nSo the corresponding drug entities and relations triplets are:\ncimetidine, false, flomax END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "therefore, flomax capsules should be used with caution in combination with cimetidine, particularly at doses higher than 0.4 mg.", "output": "Let's think step by step.\nThe drug entities in this text are:\nflomax, cimetidine\nSo the corresponding drug entities and relations triplets are:\nflomax, advise, cimetidine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "results from limited in vitro and in vivo drug-drug interaction studies between tamsulosin hci and warfarin are inconclusive.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntamsulosin hci, warfarin\nSo the corresponding drug entities and relations triplets are:\ntamsulosin hci, false, warfarin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "therefore, caution should be exercised with concomitant administration of warfarin and flomax capsules.", "output": "Let's think step by step.\nThe drug entities in this text are:\nwarfarin, flomax\nSo the corresponding drug entities and relations triplets are:\nwarfarin, advise, flomax END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "limited published data indicate that gh treatment increases cytochrome p450 (cp450) mediated antipyrine clearance in man.", "output": "Let's think step by step.\nThe drug entities in this text are:\ngh, antipyrine\nSo the corresponding drug entities and relations triplets are:\ngh, mechanism, antipyrine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "these data suggest that gh administration may alter the clearance of compounds known to be metabolized by cp450 liver enzymes (e.g., corticosteroids, sex steroids, anticonvulsants, cyclosporin).", "output": "Let's think step by step.\nThe drug entities in this text are:\ngh, corticosteroids, sex steroids, anticonvulsants, cyclosporin\nSo the corresponding drug entities and relations triplets are:\ngh, mechanism, corticosteroids\ngh, mechanism, sex steroids\ngh, mechanism, anticonvulsants\ngh, mechanism, cyclosporin\ncorticosteroids, false, sex steroids\ncorticosteroids, false, anticonvulsants\ncorticosteroids, false, cyclosporin\nsex steroids, false, anticonvulsants\nsex steroids, false, cyclosporin\nanticonvulsants, false, cyclosporin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the cns depressant effects of oxycodone hydrochloride may be additive with that of other cns depressants..", "output": "Let's think step by step.\nThe drug entities in this text are:\noxycodone hydrochloride, cns depressants\nSo the corresponding drug entities and relations triplets are:\noxycodone hydrochloride, effect, cns depressants END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "use with other central nervous system depressants: the depressant effects of morphine are potentiated by the presence of other cns depressants such as alcohol, sedatives, antihistaminics, or psychotropic drugs.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncentral nervous system depressants, morphine, cns depressants, alcohol, sedatives, antihistaminics, psychotropic drugs\nSo the corresponding drug entities and relations triplets are:\ncentral nervous system depressants, false, morphine\ncentral nervous system depressants, false, cns depressants\ncentral nervous system depressants, false, alcohol\ncentral nervous system depressants, false, sedatives\ncentral nervous system depressants, false, antihistaminics\ncentral nervous system depressants, false, psychotropic drugs\nmorphine, effect, cns depressants\nmorphine, effect, alcohol\nmorphine, effect, sedatives\nmorphine, effect, antihistaminics\nmorphine, effect, psychotropic drugs\ncns depressants, false, alcohol\ncns depressants, false, sedatives\ncns depressants, false, antihistaminics\ncns depressants, false, psychotropic drugs\nalcohol, false, sedatives\nalcohol, false, antihistaminics\nalcohol, false, psychotropic drugs\nsedatives, false, antihistaminics\nsedatives, false, psychotropic drugs\nantihistaminics, false, psychotropic drugs END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "use of neuroleptics in conjunction with oral morphine may increase the risk of respiratory depression, hypotension and profound sedation or coma.", "output": "Let's think step by step.\nThe drug entities in this text are:\nneuroleptics, morphine\nSo the corresponding drug entities and relations triplets are:\nneuroleptics, effect, morphine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "interaction with mixed agonist/antagonist opioid analgesics: agonist/antagonist analgesics (i.e., pentazocine, nalbuphine, butorphanol, or buprenorphine) should not be administered to patients who have received or are receiving a course of therapy with a proof opioid agonist analgesic.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmixed agonist/antagonist opioid analgesics, agonist/antagonist analgesics, pentazocine, nalbuphine, butorphanol, buprenorphine, opioid agonist analgesic\nSo the corresponding drug entities and relations triplets are:\nmixed agonist/antagonist opioid analgesics, false, agonist/antagonist analgesics\nmixed agonist/antagonist opioid analgesics, false, pentazocine\nmixed agonist/antagonist opioid analgesics, false, nalbuphine\nmixed agonist/antagonist opioid analgesics, false, butorphanol\nmixed agonist/antagonist opioid analgesics, false, buprenorphine\nmixed agonist/antagonist opioid analgesics, false, opioid agonist analgesic\nagonist/antagonist analgesics, false, pentazocine\nagonist/antagonist analgesics, false, nalbuphine\nagonist/antagonist analgesics, false, butorphanol\nagonist/antagonist analgesics, false, buprenorphine\nagonist/antagonist analgesics, advise, opioid agonist analgesic\npentazocine, false, nalbuphine\npentazocine, false, butorphanol\npentazocine, false, buprenorphine\npentazocine, advise, opioid agonist analgesic\nnalbuphine, false, butorphanol\nnalbuphine, false, buprenorphine\nnalbuphine, advise, opioid agonist analgesic\nbutorphanol, false, buprenorphine\nbutorphanol, advise, opioid agonist analgesic\nbuprenorphine, advise, opioid agonist analgesic END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "because there is a theoretical basis that these effects may be additive, use of ergotamine-containing or ergot-type medications (like dihydroergotamine or methysergide) and sumatriptan within 24 hours of each other should be avoided.", "output": "Let's think step by step.\nThe drug entities in this text are:\nergotamine, ergot-type medications, dihydroergotamine, methysergide, sumatriptan\nSo the corresponding drug entities and relations triplets are:\nergotamine, false, ergot-type medications\nergotamine, false, dihydroergotamine\nergotamine, false, methysergide\nergotamine, advise, sumatriptan\nergot-type medications, false, dihydroergotamine\nergot-type medications, false, methysergide\nergot-type medications, advise, sumatriptan\ndihydroergotamine, false, methysergide\ndihydroergotamine, advise, sumatriptan\nmethysergide, advise, sumatriptan END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "mao-a inhibitors reduce sumatriptan clearance, significantly increasing systemic exposure.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmao-a inhibitors, sumatriptan\nSo the corresponding drug entities and relations triplets are:\nmao-a inhibitors, mechanism, sumatriptan END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "therefore, the use of sumatriptan succinate tablets in patients receiving mao-a inhibitors is contraindicated . selective serotonin reuptake inhibitors (ssris) (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) have been reported, rarely, to cause weakness, hyperreflexia, and incoordination when coadministered with sumatriptan.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsumatriptan succinate, mao-a inhibitors, selective serotonin reuptake inhibitors, ssris, fluoxetine, fluvoxamine, paroxetine, sertraline, sumatriptan\nSo the corresponding drug entities and relations triplets are:\nsumatriptan succinate, advise, mao-a inhibitors\nsumatriptan succinate, false, selective serotonin reuptake inhibitors\nsumatriptan succinate, false, ssris\nsumatriptan succinate, false, fluoxetine\nsumatriptan succinate, false, fluvoxamine\nsumatriptan succinate, false, paroxetine\nsumatriptan succinate, false, sertraline\nsumatriptan succinate, false, sumatriptan\nmao-a inhibitors, false, selective serotonin reuptake inhibitors\nmao-a inhibitors, false, ssris\nmao-a inhibitors, false, fluoxetine\nmao-a inhibitors, false, fluvoxamine\nmao-a inhibitors, false, paroxetine\nmao-a inhibitors, false, sertraline\nmao-a inhibitors, false, sumatriptan\nselective serotonin reuptake inhibitors, false, ssris\nselective serotonin reuptake inhibitors, false, fluoxetine\nselective serotonin reuptake inhibitors, false, fluvoxamine\nselective serotonin reuptake inhibitors, false, paroxetine\nselective serotonin reuptake inhibitors, false, sertraline\nselective serotonin reuptake inhibitors, effect, sumatriptan\nssris, false, fluoxetine\nssris, false, fluvoxamine\nssris, false, paroxetine\nssris, false, sertraline\nssris, effect, sumatriptan\nfluoxetine, false, fluvoxamine\nfluoxetine, false, paroxetine\nfluoxetine, false, sertraline\nfluoxetine, effect, sumatriptan\nfluvoxamine, false, paroxetine\nfluvoxamine, false, sertraline\nfluvoxamine, effect, sumatriptan\nparoxetine, false, sertraline\nparoxetine, effect, sumatriptan\nsertraline, effect, sumatriptan END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "if concomitant treatment with sumatriptan and an ssri is clinically warranted, appropriate observation of the patient is advised.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsumatriptan, ssri\nSo the corresponding drug entities and relations triplets are:\nsumatriptan, advise, ssri END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "antacids: absorption of a single dose of myfortic was decreased when administered to 12 stable renal transplant patients also taking magnesium-aluminum containing antacids (30 ml): the mean cmax and auc(0-t) values for mpa were 25% and 37% lower, respectively, than when myfortic was administered alone under fasting conditions.", "output": "Let's think step by step.\nThe drug entities in this text are:\nantacids, myfortic, magnesium, aluminum, antacids, myfortic\nSo the corresponding drug entities and relations triplets are:\nantacids, false, myfortic\nantacids, false, magnesium\nantacids, false, aluminum\nantacids, false, myfortic\nmyfortic, mechanism, magnesium\nmyfortic, mechanism, aluminum\nmyfortic, false, antacids\nmagnesium, false, aluminum\nmagnesium, false, antacids\nmagnesium, false, myfortic\naluminum, false, antacids\naluminum, false, myfortic\nantacids, false, myfortic END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "it is recommended that myfortic and antacids not be administered simultaneously.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmyfortic, antacids\nSo the corresponding drug entities and relations triplets are:\nmyfortic, advise, antacids END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "cyclosporine: when studied in stable renal transplant patients, cyclosporine, usp (modified) pharmacokinetics were unaffected by steady state dosing of myfortic.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncyclosporine, cyclosporine, myfortic\nSo the corresponding drug entities and relations triplets are:\ncyclosporine, false, myfortic\ncyclosporine, false, myfortic END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "acyclovir/ganciclovir: may be taken with myfortic;", "output": "Let's think step by step.\nThe drug entities in this text are:\nacyclovir, ganciclovir, myfortic\nSo the corresponding drug entities and relations triplets are:\nacyclovir, false, ganciclovir\nacyclovir, false, myfortic\nganciclovir, false, myfortic END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "both acyclovir/ganciclovir and mpag concentrations are increased in the presence of renal impairment, their coexistence may compete for tubular secretion and further increase in the concentrations of the two.", "output": "Let's think step by step.\nThe drug entities in this text are:\nacyclovir, ganciclovir, mpag\nSo the corresponding drug entities and relations triplets are:\nacyclovir, false, ganciclovir\nacyclovir, false, mpag\nganciclovir, false, mpag END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "azathioprine/mycophenolate mofetil: given that azathioprine and mycophenolate mofetil inhibit purine metabolism, it is recommended that myfortic not be administered concomitantly with azathioprine or mycophenolate mofetil.", "output": "Let's think step by step.\nThe drug entities in this text are:\nazathioprine, mycophenolate mofetil, azathioprine, mycophenolate mofetil, myfortic, azathioprine, mycophenolate mofetil\nSo the corresponding drug entities and relations triplets are:\nazathioprine, false, mycophenolate mofetil\nazathioprine, false, mycophenolate mofetil\nazathioprine, false, myfortic\nazathioprine, false, mycophenolate mofetil\nmycophenolate mofetil, false, azathioprine\nmycophenolate mofetil, false, myfortic\nmycophenolate mofetil, false, azathioprine\nazathioprine, false, mycophenolate mofetil\nazathioprine, false, myfortic\nazathioprine, false, mycophenolate mofetil\nmycophenolate mofetil, false, myfortic\nmycophenolate mofetil, false, azathioprine\nmyfortic, advise, azathioprine\nmyfortic, advise, mycophenolate mofetil\nazathioprine, false, mycophenolate mofetil END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "cholestyramine and drugs that bind bile acids: these drugs interrupt enterohepatic recirculation and reduce mpa exposure when coadministered with mycophenolate mofetil.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncholestyramine, mpa, mycophenolate mofetil\nSo the corresponding drug entities and relations triplets are:\ncholestyramine, false, mpa\ncholestyramine, false, mycophenolate mofetil\nmpa, false, mycophenolate mofetil END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "therefore, do not administer myfortic with cholestyramine or other agents that may interfere with enterohepatic recirculation or drugs that may bind bile acids, for example bile acid sequestrates or oral activated charcoal, because of the potential to reduce the efficacy of myfortic.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmyfortic, cholestyramine, activated charcoal, myfortic\nSo the corresponding drug entities and relations triplets are:\nmyfortic, advise, cholestyramine\nmyfortic, advise, activated charcoal\ncholestyramine, false, activated charcoal\ncholestyramine, false, myfortic\nactivated charcoal, false, myfortic END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "oral contraceptives: given the different metabolism of myfortic and oral contraceptives, no drug interaction between these two classes of drug is expected.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncontraceptives, myfortic, contraceptives\nSo the corresponding drug entities and relations triplets are:\ncontraceptives, false, myfortic\nmyfortic, false, contraceptives END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "however, in a drug-drug interaction study, mean levonorgesterol auc was decreased by 15% when coadministered with mycophenolate mofetil.", "output": "Let's think step by step.\nThe drug entities in this text are:\nlevonorgesterol, mycophenolate mofetil\nSo the corresponding drug entities and relations triplets are:\nlevonorgesterol, mechanism, mycophenolate mofetil END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "therefore, it is recommended that oral contraceptives are co- administered with myfortic with caution and additional birth control methods be considered.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncontraceptives, myfortic\nSo the corresponding drug entities and relations triplets are:\ncontraceptives, advise, myfortic END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "live vaccines: during treatment with myfortic, the use of live attenuated vaccines should be avoided and patients should be advised that vaccinations may be less effective.", "output": "Let's think step by step.\nThe drug entities in this text are:\nlive vaccines, myfortic, live attenuated vaccines\nSo the corresponding drug entities and relations triplets are:\nlive vaccines, false, myfortic\nlive vaccines, false, live attenuated vaccines\nmyfortic, advise, live attenuated vaccines END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "interference of mpag hydrolysis may lead to less mpa available for absorption.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmpag, mpa\nSo the corresponding drug entities and relations triplets are:\nmpag, false, mpa END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "although this has not occurred in in vitro studies with coumarin-type anticoagulants, interactions with coumarin-type anticoagulants have been reported with feldene since marketing, therefore, physicians should closely monitor patients for a change in dosage requirements when administering feldene to patients on coumarin-type anticoagulants and other highly protein-bound drugs.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncoumarin-type anticoagulants, coumarin-type anticoagulants, feldene, feldene, coumarin-type anticoagulants\nSo the corresponding drug entities and relations triplets are:\ncoumarin-type anticoagulants, false, feldene\ncoumarin-type anticoagulants, false, feldene\ncoumarin-type anticoagulants, int, feldene\ncoumarin-type anticoagulants, false, feldene\nfeldene, false, coumarin-type anticoagulants\nfeldene, advise, coumarin-type anticoagulants END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "plasma levels of piroxicam are depressed to approximately 80% of their normal values when feldene is administered in conjunction with aspirin (3900 mg/day), but concomitant administration of antacids has no effect on piroxicam plasma levels . nonsteroidal anti-inflammatory agents, including feldene, have been reported to increase steady state plasma lithium levels.", "output": "Let's think step by step.\nThe drug entities in this text are:\npiroxicam, feldene, aspirin, antacids, piroxicam, nonsteroidal anti-inflammatory agents, feldene, lithium\nSo the corresponding drug entities and relations triplets are:\npiroxicam, false, feldene\npiroxicam, false, aspirin\npiroxicam, false, antacids\npiroxicam, false, nonsteroidal anti-inflammatory agents\npiroxicam, false, feldene\npiroxicam, false, lithium\nfeldene, mechanism, aspirin\nfeldene, false, antacids\nfeldene, false, piroxicam\nfeldene, false, nonsteroidal anti-inflammatory agents\nfeldene, false, lithium\naspirin, false, antacids\naspirin, false, piroxicam\naspirin, false, nonsteroidal anti-inflammatory agents\naspirin, false, feldene\naspirin, false, lithium\nantacids, false, piroxicam\nantacids, false, nonsteroidal anti-inflammatory agents\nantacids, false, feldene\nantacids, false, lithium\npiroxicam, false, nonsteroidal anti-inflammatory agents\npiroxicam, false, feldene\npiroxicam, false, lithium\nnonsteroidal anti-inflammatory agents, false, feldene\nnonsteroidal anti-inflammatory agents, mechanism, lithium\nfeldene, mechanism, lithium END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "it is recommended that plasma lithium levels be monitored when initiating, adjusting and discontinuing feldene.", "output": "Let's think step by step.\nThe drug entities in this text are:\nlithium, feldene\nSo the corresponding drug entities and relations triplets are:\nlithium, advise, feldene END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "vasopressors, particularly metaraminol, may cause serious cardiac arrhythmias during halothane anesthesia and therefore should be used only with great caution or not at all.", "output": "Let's think step by step.\nThe drug entities in this text are:\nvasopressors, metaraminol, halothane\nSo the corresponding drug entities and relations triplets are:\nvasopressors, false, metaraminol\nvasopressors, effect, halothane\nmetaraminol, effect, halothane END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "mao inhibitors - the pressor effect of sympathomimetic pressor amines is markedly potentiated in patients receiving monoamine oxidase inhibitors (maoi).", "output": "Let's think step by step.\nThe drug entities in this text are:\nmao inhibitors, sympathomimetic pressor amines, monoamine oxidase inhibitors, maoi\nSo the corresponding drug entities and relations triplets are:\nmao inhibitors, false, sympathomimetic pressor amines\nmao inhibitors, false, monoamine oxidase inhibitors\nmao inhibitors, false, maoi\nsympathomimetic pressor amines, effect, monoamine oxidase inhibitors\nsympathomimetic pressor amines, effect, maoi\nmonoamine oxidase inhibitors, false, maoi END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the pressor response of adrenergic agents may also be potentiated by tricyclic antidepressants.", "output": "Let's think step by step.\nThe drug entities in this text are:\nadrenergic agents, tricyclic antidepressants\nSo the corresponding drug entities and relations triplets are:\nadrenergic agents, effect, tricyclic antidepressants END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "acromegalic patients with diabetes mellitus being treated with insulin and/or oral hypoglycemic agents may require dose reductions of these therapeutic agents after the initiation of therapy with somavert.", "output": "Let's think step by step.\nThe drug entities in this text are:\ninsulin, hypoglycemic, somavert\nSo the corresponding drug entities and relations triplets are:\ninsulin, false, hypoglycemic\ninsulin, advise, somavert\nhypoglycemic, advise, somavert END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in clinical studies, patients on opioids often needed higher serum pegvisomant concentrations to achieve appropriate igf-i suppression compared with patients not receiving opioids.", "output": "Let's think step by step.\nThe drug entities in this text are:\nopioids, pegvisomant, opioids\nSo the corresponding drug entities and relations triplets are:\nopioids, mechanism, pegvisomant\npegvisomant, false, opioids END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "digoxin: there was a slight increase in the area under the curve (auc, 11%) and mean peak drug concentration (cmax, 18%) of digoxin with the co-administration of 100 mg sitagliptin for 10 days.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndigoxin, digoxin, sitagliptin\nSo the corresponding drug entities and relations triplets are:\ndigoxin, false, sitagliptin\ndigoxin, mechanism, sitagliptin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "no dosage adjustment of digoxin or januvia is recommended.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndigoxin, januvia\nSo the corresponding drug entities and relations triplets are:\ndigoxin, false, januvia END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "limited evidence suggests that ascorbic acid may influence the intensity and duration of action of bishydroxycoumarin.", "output": "Let's think step by step.\nThe drug entities in this text are:\nascorbic acid, bishydroxycoumarin\nSo the corresponding drug entities and relations triplets are:\nascorbic acid, mechanism, bishydroxycoumarin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "vindesine can interact with the drugs of the following categories:  - blood dyscrasia: can cause unpredictable myelotoxicity - bone marrow depressants: can cause a predictable dose-related myelotoxicity - radiation therapy: may cause marrow depression - neurotoxic medications: can cause neurologic toxicity - phenytoin: can increase seizure activity - live virus vaccines: may potentiate the replication of the vaccine virus, may increase the side effects of the vaccination, and decrease patient's response to the vaccine - mitomycin-c: may cause shortness of breath and bronchospasm - killed virus vaccines: may decrease patient's response to the vaccine", "output": "Let's think step by step.\nThe drug entities in this text are:\nvindesine, phenytoin, live virus vaccines, vaccine, mitomycin-c, killed virus vaccines, vaccine\nSo the corresponding drug entities and relations triplets are:\nvindesine, int, phenytoin\nvindesine, int, live virus vaccines\nvindesine, false, vaccine\nvindesine, int, mitomycin-c\nvindesine, int, killed virus vaccines\nvindesine, false, vaccine\nphenytoin, false, live virus vaccines\nphenytoin, false, vaccine\nphenytoin, false, mitomycin-c\nphenytoin, false, killed virus vaccines\nphenytoin, false, vaccine\nlive virus vaccines, false, vaccine\nlive virus vaccines, false, mitomycin-c\nlive virus vaccines, false, killed virus vaccines\nlive virus vaccines, false, vaccine\nvaccine, false, mitomycin-c\nvaccine, false, killed virus vaccines\nmitomycin-c, false, killed virus vaccines\nmitomycin-c, false, vaccine\nkilled virus vaccines, false, vaccine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "diuretics: excessive reductions in blood pressure may occur in patients on diuretic therapy when ace inhibitors are started.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndiuretics, ace inhibitors\nSo the corresponding drug entities and relations triplets are:\ndiuretics, false, ace inhibitors END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the possibility of hypotensive effects with univasc    can be minimized by discontinuing diuretic therapy for several days or cautiously increasing salt intake before initiation of treatment with univasc   . if this is not possible, the starting dose of moexpril should be reduced..", "output": "Let's think step by step.\nThe drug entities in this text are:\nunivasc, univasc, moexpril\nSo the corresponding drug entities and relations triplets are:\nunivasc, false, moexpril\nunivasc, false, moexpril END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "potassium supplements and potassium-sparing diuretics: univasc    can increase serum potassium because it decreases aldosterone secretion.", "output": "Let's think step by step.\nThe drug entities in this text are:\npotassium, potassium-sparing diuretics, univasc\nSo the corresponding drug entities and relations triplets are:\npotassium, false, potassium-sparing diuretics\npotassium, false, univasc\npotassium-sparing diuretics, false, univasc END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "use of potassium-sparing diuretics (spironolactone, triamterene, amiloride) or potassium supplements concomitantly with ace inhibitors can increase the risk of hyperkalemia.", "output": "Let's think step by step.\nThe drug entities in this text are:\npotassium-sparing diuretics, spironolactone, triamterene, amiloride, potassium, ace inhibitors\nSo the corresponding drug entities and relations triplets are:\npotassium-sparing diuretics, false, spironolactone\npotassium-sparing diuretics, false, triamterene\npotassium-sparing diuretics, false, amiloride\npotassium-sparing diuretics, false, potassium\npotassium-sparing diuretics, effect, ace inhibitors\nspironolactone, false, triamterene\nspironolactone, false, amiloride\nspironolactone, false, potassium\nspironolactone, effect, ace inhibitors\ntriamterene, false, amiloride\ntriamterene, false, potassium\ntriamterene, effect, ace inhibitors\namiloride, false, potassium\namiloride, effect, ace inhibitors\npotassium, effect, ace inhibitors END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "oral anticoagulants: interaction studies with warfarin failed to identify any clinically important effect on the serum concentrations of the anticoagulant or on its anticoagulant effect.", "output": "Let's think step by step.\nThe drug entities in this text are:\nanticoagulants, warfarin, anticoagulant\nSo the corresponding drug entities and relations triplets are:\nanticoagulants, false, warfarin\nanticoagulants, false, anticoagulant\nwarfarin, false, anticoagulant END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "lithium: increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ace inhibitors during therapy with lithium.", "output": "Let's think step by step.\nThe drug entities in this text are:\nlithium, lithium, lithium, ace inhibitors, lithium\nSo the corresponding drug entities and relations triplets are:\nlithium, false, ace inhibitors\nlithium, false, ace inhibitors\nlithium, false, ace inhibitors\nace inhibitors, effect, lithium END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "if a diuretic is also used, the risk of lithium toxicity may be increased.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndiuretic, lithium\nSo the corresponding drug entities and relations triplets are:\ndiuretic, effect, lithium END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "other agents: no clinically important pharmacokinetic interactions occurred when univasc    was administered concomitantly with hydrochlorothiazide, digoxin, or cimetidine.", "output": "Let's think step by step.\nThe drug entities in this text are:\nunivasc, hydrochlorothiazide, digoxin, cimetidine\nSo the corresponding drug entities and relations triplets are:\nunivasc, false, hydrochlorothiazide\nunivasc, false, digoxin\nunivasc, false, cimetidine\nhydrochlorothiazide, false, digoxin\nhydrochlorothiazide, false, cimetidine\ndigoxin, false, cimetidine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "univasc    has been used in clinical trials concomitantly with calcium-channel-blocking agents, diuretics, h2 blockers, digoxin, oral hypoglycemic agents, and cholesterol-lowering agents.", "output": "Let's think step by step.\nThe drug entities in this text are:\nunivasc, calcium-channel-blocking agents, diuretics, h2 blockers, digoxin, hypoglycemic agents\nSo the corresponding drug entities and relations triplets are:\nunivasc, false, calcium-channel-blocking agents\nunivasc, false, diuretics\nunivasc, false, h2 blockers\nunivasc, false, digoxin\nunivasc, false, hypoglycemic agents\ncalcium-channel-blocking agents, false, diuretics\ncalcium-channel-blocking agents, false, h2 blockers\ncalcium-channel-blocking agents, false, digoxin\ncalcium-channel-blocking agents, false, hypoglycemic agents\ndiuretics, false, h2 blockers\ndiuretics, false, digoxin\ndiuretics, false, hypoglycemic agents\nh2 blockers, false, digoxin\nh2 blockers, false, hypoglycemic agents\ndigoxin, false, hypoglycemic agents END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "melatonin may interact with the following drugs: aspirin and other nsaids (may lower melatonin levels), fluvoxamine (bioavailability of oral melatonin is increased with coadministration), beta blockers (may decrease melatonin levels), fluoxetine (reports of psychotic episodes when coadministered), progestin (coadministration of melatonin with progestin can inhibit ovarian function in women), benzodiazepenes and other sedating drugs (may result in additive sedation and an increased incidence of adverse effects), and corticosteroids (coadministration of melatonin and corticosteroids may interfere with the efficacy of the corticosteroids).", "output": "Let's think step by step.\nThe drug entities in this text are:\nmelatonin, aspirin, nsaids, melatonin, fluvoxamine, melatonin, beta blockers, melatonin, fluoxetine, progestin, melatonin, progestin, benzodiazepenes, corticosteroids, melatonin, corticosteroids, corticosteroids\nSo the corresponding drug entities and relations triplets are:\nmelatonin, int, aspirin\nmelatonin, int, nsaids\nmelatonin, int, fluvoxamine\nmelatonin, int, beta blockers\nmelatonin, int, fluoxetine\nmelatonin, int, progestin\nmelatonin, false, progestin\nmelatonin, int, benzodiazepenes\nmelatonin, int, corticosteroids\nmelatonin, false, corticosteroids\nmelatonin, false, corticosteroids\naspirin, false, nsaids\naspirin, false, melatonin\naspirin, false, fluvoxamine\naspirin, false, melatonin\naspirin, false, beta blockers\naspirin, false, melatonin\naspirin, false, fluoxetine\naspirin, false, progestin\naspirin, false, melatonin\naspirin, false, progestin\naspirin, false, benzodiazepenes\naspirin, false, corticosteroids\naspirin, false, melatonin\naspirin, false, corticosteroids\naspirin, false, corticosteroids\nnsaids, false, melatonin\nnsaids, false, fluvoxamine\nnsaids, false, melatonin\nnsaids, false, beta blockers\nnsaids, false, melatonin\nnsaids, false, fluoxetine\nnsaids, false, progestin\nnsaids, false, melatonin\nnsaids, false, progestin\nnsaids, false, benzodiazepenes\nnsaids, false, corticosteroids\nnsaids, false, melatonin\nnsaids, false, corticosteroids\nnsaids, false, corticosteroids\nmelatonin, false, fluvoxamine\nmelatonin, false, beta blockers\nmelatonin, false, fluoxetine\nmelatonin, false, progestin\nmelatonin, false, progestin\nmelatonin, false, benzodiazepenes\nmelatonin, false, corticosteroids\nmelatonin, false, corticosteroids\nmelatonin, false, corticosteroids\nfluvoxamine, false, melatonin\nfluvoxamine, false, beta blockers\nfluvoxamine, false, melatonin\nfluvoxamine, false, fluoxetine\nfluvoxamine, false, progestin\nfluvoxamine, false, melatonin\nfluvoxamine, false, progestin\nfluvoxamine, false, benzodiazepenes\nfluvoxamine, false, corticosteroids\nfluvoxamine, false, melatonin\nfluvoxamine, false, corticosteroids\nfluvoxamine, false, corticosteroids\nmelatonin, false, beta blockers\nmelatonin, false, fluoxetine\nmelatonin, false, progestin\nmelatonin, false, progestin\nmelatonin, false, benzodiazepenes\nmelatonin, false, corticosteroids\nmelatonin, false, corticosteroids\nmelatonin, false, corticosteroids\nbeta blockers, false, melatonin\nbeta blockers, false, fluoxetine\nbeta blockers, false, progestin\nbeta blockers, false, melatonin\nbeta blockers, false, progestin\nbeta blockers, false, benzodiazepenes\nbeta blockers, false, corticosteroids\nbeta blockers, false, melatonin\nbeta blockers, false, corticosteroids\nbeta blockers, false, corticosteroids\nmelatonin, false, fluoxetine\nmelatonin, false, progestin\nmelatonin, false, progestin\nmelatonin, false, benzodiazepenes\nmelatonin, false, corticosteroids\nmelatonin, false, corticosteroids\nmelatonin, false, corticosteroids\nfluoxetine, false, progestin\nfluoxetine, false, melatonin\nfluoxetine, false, progestin\nfluoxetine, false, benzodiazepenes\nfluoxetine, false, corticosteroids\nfluoxetine, false, melatonin\nfluoxetine, false, corticosteroids\nfluoxetine, false, corticosteroids\nprogestin, false, melatonin\nprogestin, false, benzodiazepenes\nprogestin, false, corticosteroids\nprogestin, false, melatonin\nprogestin, false, corticosteroids\nprogestin, false, corticosteroids\nmelatonin, effect, progestin\nmelatonin, false, benzodiazepenes\nmelatonin, false, corticosteroids\nmelatonin, false, corticosteroids\nmelatonin, false, corticosteroids\nprogestin, false, benzodiazepenes\nprogestin, false, corticosteroids\nprogestin, false, melatonin\nprogestin, false, corticosteroids\nprogestin, false, corticosteroids\nbenzodiazepenes, false, corticosteroids\nbenzodiazepenes, false, melatonin\nbenzodiazepenes, false, corticosteroids\nbenzodiazepenes, false, corticosteroids\ncorticosteroids, false, melatonin\nmelatonin, effect, corticosteroids\nmelatonin, false, corticosteroids END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "drugs affecting hepatic metabolism the metabolism and pharmacokinetics of remeron soltab    (mirtazapine) orally disintegrating tablets may be affected by the induction or inhibition of drug-metab-olizing enzymes.", "output": "Let's think step by step.\nThe drug entities in this text are:\nremeron soltab, mirtazapine\nSo the corresponding drug entities and relations triplets are:\nremeron soltab, false, mirtazapine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "while in vitro studies have shown that mirtazapine is not a potent inhibitor of any of these enzymes, an indication that mirtazapine is not likely to have a clinically significant inhibitory effect on the metabolism of other drugs that are substrates for these cytochrome p450 enzymes, the concomitant use of remeron soltab with most other drugs metabolized by these enzymes has not been formally studied.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmirtazapine, mirtazapine, remeron soltab\nSo the corresponding drug entities and relations triplets are:\nmirtazapine, false, remeron soltab\nmirtazapine, false, remeron soltab END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "alcohol: concomitant administration of alcohol (equivalent to 60 g) had a minimal effect on plasma levels of mirtazapine (15 mg) in 6 healthy male subjects.", "output": "Let's think step by step.\nThe drug entities in this text are:\nalcohol, alcohol, mirtazapine\nSo the corresponding drug entities and relations triplets are:\nalcohol, false, mirtazapine\nalcohol, mechanism, mirtazapine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "however, the impairment of cognitive and motor skills produced by remeron    were shown to be additive with those produced by alcohol.", "output": "Let's think step by step.\nThe drug entities in this text are:\nremeron, alcohol\nSo the corresponding drug entities and relations triplets are:\nremeron, effect, alcohol END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "accordingly, patients should be advised to avoid alcohol while taking remeron soltab. diazepam: concomitant administration of diazepam (15 mg) had a minimal effect on plasma levels of mirtazapine (15 mg) in 12 healthy subjects.", "output": "Let's think step by step.\nThe drug entities in this text are:\nalcohol, remeron soltab, diazepam, diazepam, mirtazapine\nSo the corresponding drug entities and relations triplets are:\nalcohol, advise, remeron soltab\nalcohol, false, diazepam\nalcohol, false, diazepam\nalcohol, false, mirtazapine\nremeron soltab, false, diazepam\nremeron soltab, false, diazepam\nremeron soltab, false, mirtazapine\ndiazepam, false, mirtazapine\ndiazepam, mechanism, mirtazapine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "however, the impairment of motor skills produced by remeron has been shown to be additive with those caused by diazepam.", "output": "Let's think step by step.\nThe drug entities in this text are:\nremeron, diazepam\nSo the corresponding drug entities and relations triplets are:\nremeron, effect, diazepam END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "accordingly, patients should be advised to avoid diazepam and other similar drugs while taking remeron soltab.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndiazepam, remeron soltab\nSo the corresponding drug entities and relations triplets are:\ndiazepam, advise, remeron soltab END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "interaction with other central nervous system depressants: meperidine should be used with great caution and in reduced dosage in patients who are concurrently receiving other narcotic analgesics, general anesthetics, phenothiazines, other tranquilizers, sedative-hypnotics (including barbiturates), tricyclic antidepressants and other cns depressants (including alcohol).", "output": "Let's think step by step.\nThe drug entities in this text are:\ncentral nervous system depressants, meperidine, narcotic analgesics, anesthetics, phenothiazines, tranquilizers, sedative-hypnotics, barbiturates, tricyclic antidepressants, cns depressants, alcohol\nSo the corresponding drug entities and relations triplets are:\ncentral nervous system depressants, false, meperidine\ncentral nervous system depressants, false, narcotic analgesics\ncentral nervous system depressants, false, anesthetics\ncentral nervous system depressants, false, phenothiazines\ncentral nervous system depressants, false, tranquilizers\ncentral nervous system depressants, false, sedative-hypnotics\ncentral nervous system depressants, false, barbiturates\ncentral nervous system depressants, false, tricyclic antidepressants\ncentral nervous system depressants, false, cns depressants\ncentral nervous system depressants, false, alcohol\nmeperidine, advise, narcotic analgesics\nmeperidine, advise, anesthetics\nmeperidine, advise, phenothiazines\nmeperidine, advise, tranquilizers\nmeperidine, advise, sedative-hypnotics\nmeperidine, advise, barbiturates\nmeperidine, advise, tricyclic antidepressants\nmeperidine, advise, cns depressants\nmeperidine, advise, alcohol\nnarcotic analgesics, false, anesthetics\nnarcotic analgesics, false, phenothiazines\nnarcotic analgesics, false, tranquilizers\nnarcotic analgesics, false, sedative-hypnotics\nnarcotic analgesics, false, barbiturates\nnarcotic analgesics, false, tricyclic antidepressants\nnarcotic analgesics, false, cns depressants\nnarcotic analgesics, false, alcohol\nanesthetics, false, phenothiazines\nanesthetics, false, tranquilizers\nanesthetics, false, sedative-hypnotics\nanesthetics, false, barbiturates\nanesthetics, false, tricyclic antidepressants\nanesthetics, false, cns depressants\nanesthetics, false, alcohol\nphenothiazines, false, tranquilizers\nphenothiazines, false, sedative-hypnotics\nphenothiazines, false, barbiturates\nphenothiazines, false, tricyclic antidepressants\nphenothiazines, false, cns depressants\nphenothiazines, false, alcohol\ntranquilizers, false, sedative-hypnotics\ntranquilizers, false, barbiturates\ntranquilizers, false, tricyclic antidepressants\ntranquilizers, false, cns depressants\ntranquilizers, false, alcohol\nsedative-hypnotics, false, barbiturates\nsedative-hypnotics, false, tricyclic antidepressants\nsedative-hypnotics, false, cns depressants\nsedative-hypnotics, false, alcohol\nbarbiturates, false, tricyclic antidepressants\nbarbiturates, false, cns depressants\nbarbiturates, false, alcohol\ntricyclic antidepressants, false, cns depressants\ntricyclic antidepressants, false, alcohol\ncns depressants, false, alcohol END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "concurrent administration of bacteriostatic antibiotics (e.g., erythromycin, tetracycline) may diminish the bactericidal effects of penicillins by slowing the rate of bacterial growth.", "output": "Let's think step by step.\nThe drug entities in this text are:\nbacteriostatic antibiotics, erythromycin, tetracycline, penicillins\nSo the corresponding drug entities and relations triplets are:\nbacteriostatic antibiotics, false, erythromycin\nbacteriostatic antibiotics, false, tetracycline\nbacteriostatic antibiotics, effect, penicillins\nerythromycin, false, tetracycline\nerythromycin, effect, penicillins\ntetracycline, effect, penicillins END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "penicillin blood levels may be prolonged by concurrent administration of probenecid which blocks the renal tubular secretion of penicillins.", "output": "Let's think step by step.\nThe drug entities in this text are:\npenicillin, probenecid, penicillins\nSo the corresponding drug entities and relations triplets are:\npenicillin, mechanism, probenecid\npenicillin, false, penicillins\nprobenecid, false, penicillins END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "drug interactions: women on oral contraceptives have shown a significant increase in plasma vitamin a levels.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncontraceptives, vitamin a\nSo the corresponding drug entities and relations triplets are:\ncontraceptives, mechanism, vitamin a END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "chemet is not known to interact with other drugs including iron supplements;", "output": "Let's think step by step.\nThe drug entities in this text are:\nchemet, iron\nSo the corresponding drug entities and relations triplets are:\nchemet, false, iron END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "concomitant administration of chemet with other chelation therapy, such as cana 2 edta is not recommended.", "output": "Let's think step by step.\nThe drug entities in this text are:\nchemet, cana 2 edta\nSo the corresponding drug entities and relations triplets are:\nchemet, advise, cana 2 edta END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "when methyldopa is used with other antihypertensive drugs, potentiation of antihypertensive effect may occur.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmethyldopa, antihypertensive drugs\nSo the corresponding drug entities and relations triplets are:\nmethyldopa, effect, antihypertensive drugs END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "patients may require reduced doses of anesthetics when on methyldopa.", "output": "Let's think step by step.\nThe drug entities in this text are:\nanesthetics, methyldopa\nSo the corresponding drug entities and relations triplets are:\nanesthetics, advise, methyldopa END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "when methyldopa and lithium are given concomitantly the patient should be carefully monitored for symptoms of lithium toxicity.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmethyldopa, lithium, lithium\nSo the corresponding drug entities and relations triplets are:\nmethyldopa, advise, lithium\nmethyldopa, false, lithium END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "several studies demonstrate a decrease in the bioavailability of methyldopa when it is ingested with ferrous sulfate or ferrous gluconate.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmethyldopa, ferrous sulfate, ferrous gluconate\nSo the corresponding drug entities and relations triplets are:\nmethyldopa, mechanism, ferrous sulfate\nmethyldopa, mechanism, ferrous gluconate\nferrous sulfate, false, ferrous gluconate END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "coadministration of methyldopa with ferrous sulfate or ferrous gluconate is not recommended.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmethyldopa, ferrous sulfate, ferrous gluconate\nSo the corresponding drug entities and relations triplets are:\nmethyldopa, advise, ferrous sulfate\nmethyldopa, advise, ferrous gluconate\nferrous sulfate, false, ferrous gluconate END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "methyldopa does not interfere with measurement of vma (vanillylmandelic acid), a test for pheochromocytoma, by those methods which convert vma to vanillin.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmethyldopa, vma, vanillylmandelic acid, vma, vanillin\nSo the corresponding drug entities and relations triplets are:\nmethyldopa, false, vma\nmethyldopa, false, vanillylmandelic acid\nmethyldopa, false, vma\nmethyldopa, false, vanillin\nvma, false, vanillylmandelic acid\nvma, false, vanillin\nvanillylmandelic acid, false, vma\nvanillylmandelic acid, false, vanillin\nvma, false, vanillin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "norepinephrine and dobutamine are incompatible with sodium bicarbonate solution.", "output": "Let's think step by step.\nThe drug entities in this text are:\nnorepinephrine, dobutamine, sodium bicarbonate\nSo the corresponding drug entities and relations triplets are:\nnorepinephrine, false, dobutamine\nnorepinephrine, int, sodium bicarbonate\ndobutamine, int, sodium bicarbonate END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the addition of sodium bicarbonate to parenteral solutions containing calcium should be avoided, except where compatibility has been previously established.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsodium bicarbonate, calcium\nSo the corresponding drug entities and relations triplets are:\nsodium bicarbonate, false, calcium END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the bioavailability of skelid is decreased 80% by calcium, when calcium and skelid are administered at the same time, and 60% by some aluminum- or magnesium-containing antacids, when administered 1 hour before skelid.", "output": "Let's think step by step.\nThe drug entities in this text are:\nskelid, calcium, calcium, skelid, aluminum, magnesium, antacids, skelid\nSo the corresponding drug entities and relations triplets are:\nskelid, mechanism, calcium\nskelid, false, calcium\nskelid, false, aluminum\nskelid, false, magnesium\nskelid, false, antacids\ncalcium, false, skelid\ncalcium, false, aluminum\ncalcium, false, magnesium\ncalcium, false, antacids\ncalcium, false, skelid\ncalcium, false, skelid\ncalcium, false, aluminum\ncalcium, false, magnesium\ncalcium, false, antacids\ncalcium, false, skelid\nskelid, false, aluminum\nskelid, false, magnesium\nskelid, false, antacids\naluminum, false, magnesium\naluminum, false, antacids\naluminum, mechanism, skelid\nmagnesium, false, antacids\nmagnesium, mechanism, skelid\nantacids, false, skelid END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "aspirin may decrease bioavailability of skelid by up to 50% when taken 2 hours after skelid.", "output": "Let's think step by step.\nThe drug entities in this text are:\naspirin, skelid, skelid\nSo the corresponding drug entities and relations triplets are:\naspirin, mechanism, skelid\naspirin, false, skelid END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the bioavailability of skelid is increased 2-4 fold by indomethacin but is not significantly altered by coadministration of diclofenac.", "output": "Let's think step by step.\nThe drug entities in this text are:\nskelid, indomethacin, diclofenac\nSo the corresponding drug entities and relations triplets are:\nskelid, mechanism, indomethacin\nskelid, false, diclofenac\nindomethacin, false, diclofenac END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the pharmacokinetic parameters of digoxin are not significantly modified by skelid coadministration.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndigoxin, skelid\nSo the corresponding drug entities and relations triplets are:\ndigoxin, false, skelid END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in vitro studies show that tiludronate does not displace warfarin from its binding site on protein.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntiludronate, warfarin\nSo the corresponding drug entities and relations triplets are:\ntiludronate, false, warfarin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "tetracycline, a bacteriostatic antibiotic, may antagonize the bactericidal effect of penicillin and concurrent use of these drugs should be avoided.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntetracycline, antibiotic, penicillin\nSo the corresponding drug entities and relations triplets are:\ntetracycline, false, antibiotic\ntetracycline, effect, penicillin\nantibiotic, false, penicillin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "scopolamine should be used with care in patients taking other drugs that are capable of causing cns effects such as sedatives, tranquilizers, or alcohol.", "output": "Let's think step by step.\nThe drug entities in this text are:\nscopolamine, sedatives, tranquilizers, alcohol\nSo the corresponding drug entities and relations triplets are:\nscopolamine, advise, sedatives\nscopolamine, advise, tranquilizers\nscopolamine, advise, alcohol\nsedatives, false, tranquilizers\nsedatives, false, alcohol\ntranquilizers, false, alcohol END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "e.g., other belladonna alkaloids, antihistamines (including meclizine), tricyclic antidepressants, and muscle relaxants.", "output": "Let's think step by step.\nThe drug entities in this text are:\nbelladonna alkaloids, antihistamines, meclizine, tricyclic antidepressants, muscle relaxants\nSo the corresponding drug entities and relations triplets are:\nbelladonna alkaloids, false, antihistamines\nbelladonna alkaloids, false, meclizine\nbelladonna alkaloids, false, tricyclic antidepressants\nbelladonna alkaloids, false, muscle relaxants\nantihistamines, false, meclizine\nantihistamines, false, tricyclic antidepressants\nantihistamines, false, muscle relaxants\nmeclizine, false, tricyclic antidepressants\nmeclizine, false, muscle relaxants\ntricyclic antidepressants, false, muscle relaxants END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the induction dose requirements of diprivan injectable emulsion may be reduced in patients with intramuscular or intravenous premedication, particularly with narcotics (eg, morphine, meperidine, and fentanyl, etc.)", "output": "Let's think step by step.\nThe drug entities in this text are:\ndiprivan, narcotics, morphine, meperidine, fentanyl\nSo the corresponding drug entities and relations triplets are:\ndiprivan, effect, narcotics\ndiprivan, effect, morphine\ndiprivan, effect, meperidine\ndiprivan, effect, fentanyl\nnarcotics, false, morphine\nnarcotics, false, meperidine\nnarcotics, false, fentanyl\nmorphine, false, meperidine\nmorphine, false, fentanyl\nmeperidine, false, fentanyl END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "and combinations of opioids and sedatives (eg, benzodiazepines, barbiturates, chloral hydrate, droperidol, etc.).", "output": "Let's think step by step.\nThe drug entities in this text are:\nopioids, sedatives, benzodiazepines, barbiturates, chloral hydrate, droperidol\nSo the corresponding drug entities and relations triplets are:\nopioids, false, sedatives\nopioids, false, benzodiazepines\nopioids, false, barbiturates\nopioids, false, chloral hydrate\nopioids, false, droperidol\nsedatives, false, benzodiazepines\nsedatives, false, barbiturates\nsedatives, false, chloral hydrate\nsedatives, false, droperidol\nbenzodiazepines, false, barbiturates\nbenzodiazepines, false, chloral hydrate\nbenzodiazepines, false, droperidol\nbarbiturates, false, chloral hydrate\nbarbiturates, false, droperidol\nchloral hydrate, false, droperidol END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "during maintenance of anesthesia or sedation, the rate of diprivan injectable emulsion administration should be adjusted according to the desired level of anesthesia or sedation and may be reduced in the presence of supplemental analgesic agents (eg, nitrous oxide or opioids).", "output": "Let's think step by step.\nThe drug entities in this text are:\ndiprivan, analgesic agents, nitrous oxide, opioids\nSo the corresponding drug entities and relations triplets are:\ndiprivan, advise, analgesic agents\ndiprivan, advise, nitrous oxide\ndiprivan, advise, opioids\nanalgesic agents, false, nitrous oxide\nanalgesic agents, false, opioids\nnitrous oxide, false, opioids END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the concurrent administration of potent inhalational agents (eg, isoflurane, enflurane, and halothane) during maintenance with diprivan injectable emulsion has not been extensively evaluated.", "output": "Let's think step by step.\nThe drug entities in this text are:\nisoflurane, enflurane, halothane, diprivan\nSo the corresponding drug entities and relations triplets are:\nisoflurane, false, enflurane\nisoflurane, false, halothane\nisoflurane, false, diprivan\nenflurane, false, halothane\nenflurane, false, diprivan\nhalothane, false, diprivan END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "diprivan injectable emulsion does not cause a clinically significant change in onset, intensity, or duration of action of the commonly used neuromuscular blocking agents (eg, succinylcholine and nondepolarizing muscle relaxants).", "output": "Let's think step by step.\nThe drug entities in this text are:\ndiprivan, neuromuscular blocking agents, succinylcholine, nondepolarizing muscle relaxants\nSo the corresponding drug entities and relations triplets are:\ndiprivan, false, neuromuscular blocking agents\ndiprivan, false, succinylcholine\ndiprivan, false, nondepolarizing muscle relaxants\nneuromuscular blocking agents, false, succinylcholine\nneuromuscular blocking agents, false, nondepolarizing muscle relaxants\nsuccinylcholine, false, nondepolarizing muscle relaxants END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "no significant adverse interactions with commonly used premedications or drugs used during anesthesia or sedation (including a range of muscle relaxants, inhalational agents, analgesic agents, and local anesthetic agents) have been observed.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmuscle relaxants, analgesic agents, anesthetic agents\nSo the corresponding drug entities and relations triplets are:\nmuscle relaxants, false, analgesic agents\nmuscle relaxants, false, anesthetic agents\nanalgesic agents, false, anesthetic agents END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the in vitro binding of warfarin to human plasma proteins is unaffected by tolmetin, and tolmetin does not alter the prothrombin time of normal volunteers.", "output": "Let's think step by step.\nThe drug entities in this text are:\nwarfarin, tolmetin, tolmetin\nSo the corresponding drug entities and relations triplets are:\nwarfarin, false, tolmetin\nwarfarin, false, tolmetin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "however, increased prothrombin time and bleeding have been reported in patients on concomitant tolectin and warfarin therapy.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntolectin, warfarin\nSo the corresponding drug entities and relations triplets are:\ntolectin, effect, warfarin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "therefore, caution should be exercised when administering tolectin to patients on anticoagulants.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntolectin, anticoagulants\nSo the corresponding drug entities and relations triplets are:\ntolectin, advise, anticoagulants END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in adult diabetic patients under treatment with either sulfonylureas or insulin there is no change in the clinical effects of either tolectin or the hypoglycemic agents.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsulfonylureas, insulin, tolectin, hypoglycemic agents\nSo the corresponding drug entities and relations triplets are:\nsulfonylureas, false, insulin\nsulfonylureas, false, tolectin\nsulfonylureas, false, hypoglycemic agents\ninsulin, false, tolectin\ninsulin, false, hypoglycemic agents\ntolectin, false, hypoglycemic agents END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "caution should be used if tolectin is administered concomitantly with methotrexate.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntolectin, methotrexate\nSo the corresponding drug entities and relations triplets are:\ntolectin, advise, methotrexate END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "tolectin and other nonsteroidal anti-inflammatory drugs have been reported to reduce the tubular secretion of methotrexate in an animal model, possibly enhancing the toxicity of methotrexate.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntolectin, nonsteroidal anti-inflammatory drugs, methotrexate, methotrexate\nSo the corresponding drug entities and relations triplets are:\ntolectin, false, nonsteroidal anti-inflammatory drugs\ntolectin, mechanism, methotrexate\ntolectin, false, methotrexate\nnonsteroidal anti-inflammatory drugs, mechanism, methotrexate\nnonsteroidal anti-inflammatory drugs, false, methotrexate END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "thiazide diuretics may accentuate the orthostatic hypotension that may occur with phenothiazines.", "output": "Let's think step by step.\nThe drug entities in this text are:\nthiazide diuretics, phenothiazines\nSo the corresponding drug entities and relations triplets are:\nthiazide diuretics, effect, phenothiazines END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "antihypertensive effects of guanethidine and related compounds may be counteracted when phenothiazines are used concomitantly.", "output": "Let's think step by step.\nThe drug entities in this text are:\nguanethidine, phenothiazines\nSo the corresponding drug entities and relations triplets are:\nguanethidine, effect, phenothiazines END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "concomitant administration of propranolol with phenothiazines results in increased plasma levels of both drugs.", "output": "Let's think step by step.\nThe drug entities in this text are:\npropranolol, phenothiazines\nSo the corresponding drug entities and relations triplets are:\npropranolol, mechanism, phenothiazines END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in clinical studies of tobi, patients taking tobi concomitantly with dornase alfa (pulmozyme   , genentech), (beta)-agonists, inhaled corticosteroids, other anti-pseudomonal antibiotics, or parenteral aminoglycosides demonstrated adverse experience profiles similar to the study population as a whole.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntobi, tobi, dornase alfa, pulmozyme, (beta)-agonists, corticosteroids, anti-pseudomonal antibiotics, aminoglycosides\nSo the corresponding drug entities and relations triplets are:\ntobi, false, dornase alfa\ntobi, false, pulmozyme\ntobi, false, (beta)-agonists\ntobi, false, corticosteroids\ntobi, false, anti-pseudomonal antibiotics\ntobi, false, aminoglycosides\ntobi, effect, dornase alfa\ntobi, effect, pulmozyme\ntobi, effect, (beta)-agonists\ntobi, effect, corticosteroids\ntobi, effect, anti-pseudomonal antibiotics\ntobi, effect, aminoglycosides\ndornase alfa, false, pulmozyme\ndornase alfa, false, (beta)-agonists\ndornase alfa, false, corticosteroids\ndornase alfa, false, anti-pseudomonal antibiotics\ndornase alfa, false, aminoglycosides\npulmozyme, false, (beta)-agonists\npulmozyme, false, corticosteroids\npulmozyme, false, anti-pseudomonal antibiotics\npulmozyme, false, aminoglycosides\n(beta)-agonists, false, corticosteroids\n(beta)-agonists, false, anti-pseudomonal antibiotics\n(beta)-agonists, false, aminoglycosides\ncorticosteroids, false, anti-pseudomonal antibiotics\ncorticosteroids, false, aminoglycosides\nanti-pseudomonal antibiotics, false, aminoglycosides END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "some diuretics can enhance aminoglycoside toxicity by altering antibiotic concentrations in serum and tissue.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndiuretics, aminoglycoside, antibiotic\nSo the corresponding drug entities and relations triplets are:\ndiuretics, effect, aminoglycoside\ndiuretics, false, antibiotic\naminoglycoside, false, antibiotic END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "tobi should not be administered concomitantly with ethacrynic acid, furosemide, urea, or mannitol.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntobi, ethacrynic acid, furosemide, urea, mannitol\nSo the corresponding drug entities and relations triplets are:\ntobi, advise, ethacrynic acid\ntobi, advise, furosemide\ntobi, advise, urea\ntobi, advise, mannitol\nethacrynic acid, false, furosemide\nethacrynic acid, false, urea\nethacrynic acid, false, mannitol\nfurosemide, false, urea\nfurosemide, false, mannitol\nurea, false, mannitol END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "an inhibitor of cyp2c8 (such as gemfibrozil) may increase the auc of rosiglitazone and an inducer of cyp2c8 (such as rifampin) may decrease the auc of rosiglitazone.", "output": "Let's think step by step.\nThe drug entities in this text are:\ngemfibrozil, rosiglitazone, rifampin, rosiglitazone\nSo the corresponding drug entities and relations triplets are:\ngemfibrozil, mechanism, rosiglitazone\ngemfibrozil, false, rifampin\ngemfibrozil, false, rosiglitazone\nrosiglitazone, false, rifampin\nrifampin, mechanism, rosiglitazone END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "cholestyramine: cholestyramine causes a 60% reduction in the absorption and enterohepatic cycling of raloxifene and should not be coadministered with evista.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncholestyramine, cholestyramine, raloxifene, evista\nSo the corresponding drug entities and relations triplets are:\ncholestyramine, false, raloxifene\ncholestyramine, false, evista\ncholestyramine, mechanism, raloxifene\ncholestyramine, advise, evista\nraloxifene, false, evista END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "warfarin: the coadministration of evista and warfarin has not been assessed under chronic conditions.", "output": "Let's think step by step.\nThe drug entities in this text are:\nwarfarin, evista, warfarin\nSo the corresponding drug entities and relations triplets are:\nwarfarin, false, evista\nevista, false, warfarin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "if evista is given concurrently with warfarin, prothrombin time should be monitored.", "output": "Let's think step by step.\nThe drug entities in this text are:\nevista, warfarin\nSo the corresponding drug entities and relations triplets are:\nevista, advise, warfarin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in vitro, raloxifene did not affect the binding of warfarin, phenytoin, or tamoxifen.", "output": "Let's think step by step.\nThe drug entities in this text are:\nraloxifene, warfarin, phenytoin, tamoxifen\nSo the corresponding drug entities and relations triplets are:\nraloxifene, false, warfarin\nraloxifene, false, phenytoin\nraloxifene, false, tamoxifen\nwarfarin, false, phenytoin\nwarfarin, false, tamoxifen\nphenytoin, false, tamoxifen END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "caution should be used when evista is coadministered with other highly protein-bound drugs, such as clofibrate, indomethacin, naproxen, ibuprofen, diazepam, and diazoxide.", "output": "Let's think step by step.\nThe drug entities in this text are:\nevista, clofibrate, indomethacin, naproxen, ibuprofen, diazepam, diazoxide\nSo the corresponding drug entities and relations triplets are:\nevista, advise, clofibrate\nevista, advise, indomethacin\nevista, advise, naproxen\nevista, advise, ibuprofen\nevista, advise, diazepam\nevista, advise, diazoxide\nclofibrate, false, indomethacin\nclofibrate, false, naproxen\nclofibrate, false, ibuprofen\nclofibrate, false, diazepam\nclofibrate, false, diazoxide\nindomethacin, false, naproxen\nindomethacin, false, ibuprofen\nindomethacin, false, diazepam\nindomethacin, false, diazoxide\nnaproxen, false, ibuprofen\nnaproxen, false, diazepam\nnaproxen, false, diazoxide\nibuprofen, false, diazepam\nibuprofen, false, diazoxide\ndiazepam, false, diazoxide END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "probenecid competes with meropenem for active tubular secretion and thus inhibits the renal excretion of meropenem.", "output": "Let's think step by step.\nThe drug entities in this text are:\nprobenecid, meropenem, meropenem\nSo the corresponding drug entities and relations triplets are:\nprobenecid, mechanism, meropenem\nprobenecid, false, meropenem END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "therefore, the coadministration of probenecid with meropenem is not recommended.", "output": "Let's think step by step.\nThe drug entities in this text are:\nprobenecid, meropenem\nSo the corresponding drug entities and relations triplets are:\nprobenecid, advise, meropenem END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "there is evidence that meropenem may reduce serum levels of valproic acid to subtherapeutic levels (therapeutic range considered to be 50 to 100    g/ml total valproate).", "output": "Let's think step by step.\nThe drug entities in this text are:\nmeropenem, valproic acid, valproate\nSo the corresponding drug entities and relations triplets are:\nmeropenem, mechanism, valproic acid\nmeropenem, false, valproate\nvalproic acid, false, valproate END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "other beta adrenergic aerosol bronchodilators should not be used concomitantly with alupent    (metaproterenol sulfate usp) because they may have additive effects.", "output": "Let's think step by step.\nThe drug entities in this text are:\nbeta adrenergic aerosol bronchodilators, alupent, metaproterenol sulfate\nSo the corresponding drug entities and relations triplets are:\nbeta adrenergic aerosol bronchodilators, advise, alupent\nbeta adrenergic aerosol bronchodilators, advise, metaproterenol sulfate\nalupent, false, metaproterenol sulfate END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "beta adrenergic agonists should be administered with caution to patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants, since the action of beta adrenergic agonists on the vascular system may be potentiated.", "output": "Let's think step by step.\nThe drug entities in this text are:\nbeta adrenergic agonists, monoamine oxidase inhibitors, tricyclic antidepressants, beta adrenergic agonists\nSo the corresponding drug entities and relations triplets are:\nbeta adrenergic agonists, advise, monoamine oxidase inhibitors\nbeta adrenergic agonists, advise, tricyclic antidepressants\nmonoamine oxidase inhibitors, false, tricyclic antidepressants\nmonoamine oxidase inhibitors, false, beta adrenergic agonists\ntricyclic antidepressants, false, beta adrenergic agonists END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "drug interactions: the use of zemuron    (rocuronium bromide) injection before succinylcholine, for the purpose of attenuating some of the side effects of succinylcholine, has not been studied.", "output": "Let's think step by step.\nThe drug entities in this text are:\nzemuron, rocuronium bromide, succinylcholine, succinylcholine\nSo the corresponding drug entities and relations triplets are:\nzemuron, false, rocuronium bromide\nzemuron, false, succinylcholine\nzemuron, false, succinylcholine\nrocuronium bromide, false, succinylcholine\nrocuronium bromide, false, succinylcholine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "if zemuron    is administered following administration of succinylcholine, it should not be given until recovery from succinylcholine has been observed.", "output": "Let's think step by step.\nThe drug entities in this text are:\nzemuron, succinylcholine, succinylcholine\nSo the corresponding drug entities and relations triplets are:\nzemuron, advise, succinylcholine\nzemuron, false, succinylcholine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the median duration of action of zemuron    0.6 mg/kg administered after a 1 mg/kg dose of succinylcholine when t 1 returned to 75% of control was 36 minutes (range 14-57, n=12) vs.", "output": "Let's think step by step.\nThe drug entities in this text are:\nzemuron, succinylcholine\nSo the corresponding drug entities and relations triplets are:\nzemuron, false, succinylcholine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "there are no controlled studies documenting the use of zemuron    before or after other nondepolarizing muscle relaxants.", "output": "Let's think step by step.\nThe drug entities in this text are:\nzemuron, nondepolarizing muscle relaxants\nSo the corresponding drug entities and relations triplets are:\nzemuron, false, nondepolarizing muscle relaxants END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "phenytoin, carbamazepine, and rifampicin: in patients treated with potent inducers of cyp3a4 (i.e., phenytoin, carbamazepine, and rifampicin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased.", "output": "Let's think step by step.\nThe drug entities in this text are:\nphenytoin, carbamazepine, rifampicin, phenytoin, carbamazepine, rifampicin, ondansetron, ondansetron\nSo the corresponding drug entities and relations triplets are:\nphenytoin, false, carbamazepine\nphenytoin, false, rifampicin\nphenytoin, false, carbamazepine\nphenytoin, false, rifampicin\nphenytoin, false, ondansetron\nphenytoin, false, ondansetron\ncarbamazepine, false, rifampicin\ncarbamazepine, false, phenytoin\ncarbamazepine, false, rifampicin\ncarbamazepine, false, ondansetron\ncarbamazepine, false, ondansetron\nrifampicin, false, phenytoin\nrifampicin, false, carbamazepine\nrifampicin, false, ondansetron\nrifampicin, false, ondansetron\nphenytoin, false, carbamazepine\nphenytoin, false, rifampicin\nphenytoin, mechanism, ondansetron\nphenytoin, mechanism, ondansetron\ncarbamazepine, false, rifampicin\ncarbamazepine, mechanism, ondansetron\ncarbamazepine, mechanism, ondansetron\nrifampicin, mechanism, ondansetron\nrifampicin, mechanism, ondansetron END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "however, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs.1,3  tramadol: although no pharmacokinetic drug interaction between ondansetron and tramadol has been observed, data from 2 small studies indicate that ondansetron may be associated with an increase in patient controlled administration of tramadol.4,5  chemotherapy: tumor response to chemotherapy in the p 388 mouse leukemia model is not affected by ondansetron.", "output": "Let's think step by step.\nThe drug entities in this text are:\nondansetron, tramadol, ondansetron, tramadol, ondansetron, tramadol, ondansetron\nSo the corresponding drug entities and relations triplets are:\nondansetron, false, tramadol\nondansetron, false, tramadol\nondansetron, false, tramadol\ntramadol, false, ondansetron\ntramadol, false, ondansetron\ntramadol, false, ondansetron\nondansetron, false, tramadol\nondansetron, false, tramadol\ntramadol, false, ondansetron\ntramadol, false, ondansetron\nondansetron, effect, tramadol\ntramadol, false, ondansetron END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in humans, carmustine, etoposide, and cisplatin do not affect the pharmacokinetics of ondansetron.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncarmustine, etoposide, cisplatin, ondansetron\nSo the corresponding drug entities and relations triplets are:\ncarmustine, false, etoposide\ncarmustine, false, cisplatin\ncarmustine, false, ondansetron\netoposide, false, cisplatin\netoposide, false, ondansetron\ncisplatin, false, ondansetron END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "ondansetron did not increase blood levels of high-dose methotrexate.", "output": "Let's think step by step.\nThe drug entities in this text are:\nondansetron, methotrexate\nSo the corresponding drug entities and relations triplets are:\nondansetron, false, methotrexate END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "administration of paclitaxel in combination with herceptin resulted in a two-fold decrease in herceptin clearance in a non-human primate study and in a 1.5-fold increase in herceptin serum levels in clinical studies.", "output": "Let's think step by step.\nThe drug entities in this text are:\npaclitaxel, herceptin, herceptin, herceptin\nSo the corresponding drug entities and relations triplets are:\npaclitaxel, mechanism, herceptin\npaclitaxel, false, herceptin\npaclitaxel, false, herceptin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "concomitant administrations not recommended:  - terfenadine and astemizole: certain macrolides interact with terfenadine and astemizole leading to increased serum concentrations of the latter.", "output": "Let's think step by step.\nThe drug entities in this text are:\nterfenadine, astemizole, macrolides, terfenadine, astemizole\nSo the corresponding drug entities and relations triplets are:\nterfenadine, false, astemizole\nterfenadine, false, macrolides\nterfenadine, false, astemizole\nastemizole, false, macrolides\nastemizole, false, terfenadine\nmacrolides, int, terfenadine\nmacrolides, int, astemizole\nterfenadine, false, astemizole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "although such a reaction has not been demonstrated with roxithromycin, concomitant administration of roxithromycin with terfenadine or astemizole is not recommended.", "output": "Let's think step by step.\nThe drug entities in this text are:\nroxithromycin, roxithromycin, terfenadine, astemizole\nSo the corresponding drug entities and relations triplets are:\nroxithromycin, false, terfenadine\nroxithromycin, false, astemizole\nroxithromycin, advise, terfenadine\nroxithromycin, advise, astemizole\nterfenadine, false, astemizole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "- cisapride, pimozide: other drugs such as cisapride or pimozide, which are metabolised by hepatic cyp3a isozymes have been associated with qt interval prolongation and/or cardiac arrythmias (typically torsades de pointe) as a result of increase in their serum level subsequent to interaction with significant inhibitors of the isozyme, including some macrolide antibacterials.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncisapride, pimozide, cisapride, pimozide, macrolide antibacterials\nSo the corresponding drug entities and relations triplets are:\ncisapride, false, pimozide\ncisapride, false, pimozide\ncisapride, false, macrolide antibacterials\npimozide, false, cisapride\npimozide, mechanism, macrolide antibacterials\ncisapride, false, pimozide\ncisapride, mechanism, macrolide antibacterials\npimozide, false, macrolide antibacterials END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "some anticonvulsants may interact with mephenytoin.", "output": "Let's think step by step.\nThe drug entities in this text are:\nanticonvulsants, mephenytoin\nSo the corresponding drug entities and relations triplets are:\nanticonvulsants, int, mephenytoin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "those anticonvulsants include divalproex sodium, valproic acid, and phenobarbital.", "output": "Let's think step by step.\nThe drug entities in this text are:\nanticonvulsants, divalproex sodium, valproic acid, phenobarbital\nSo the corresponding drug entities and relations triplets are:\nanticonvulsants, false, divalproex sodium\nanticonvulsants, false, valproic acid\nanticonvulsants, false, phenobarbital\ndivalproex sodium, false, valproic acid\ndivalproex sodium, false, phenobarbital\nvalproic acid, false, phenobarbital END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "mephenytoin may also affect the effects of other drugs, which include some steroid medications, warfarin, certain heart medicines, birth control pills, anti-infective medicines, furosemide and theophylline please note that mephenytoin may interact with other drugs that are not listed here.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmephenytoin, steroid medications, warfarin, anti-infective medicines, furosemide, theophylline, mephenytoin\nSo the corresponding drug entities and relations triplets are:\nmephenytoin, effect, steroid medications\nmephenytoin, effect, warfarin\nmephenytoin, effect, anti-infective medicines\nmephenytoin, effect, furosemide\nmephenytoin, effect, theophylline\nsteroid medications, false, warfarin\nsteroid medications, false, anti-infective medicines\nsteroid medications, false, furosemide\nsteroid medications, false, theophylline\nsteroid medications, false, mephenytoin\nwarfarin, false, anti-infective medicines\nwarfarin, false, furosemide\nwarfarin, false, theophylline\nwarfarin, false, mephenytoin\nanti-infective medicines, false, furosemide\nanti-infective medicines, false, theophylline\nanti-infective medicines, false, mephenytoin\nfurosemide, false, theophylline\nfurosemide, false, mephenytoin\ntheophylline, false, mephenytoin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the interaction of streptase, streptokinase, with other drugs has not been well studied.", "output": "Let's think step by step.\nThe drug entities in this text are:\nstreptase, streptokinase\nSo the corresponding drug entities and relations triplets are:\nstreptase, false, streptokinase END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "use of anticoagulants and antiplatelet agents -- streptase, streptokinase, alone or in combination with antiplatelet agents and anticoagulants, may cause bleeding complications.", "output": "Let's think step by step.\nThe drug entities in this text are:\nanticoagulants, antiplatelet agents, streptase, streptokinase, antiplatelet agents, anticoagulants\nSo the corresponding drug entities and relations triplets are:\nanticoagulants, false, antiplatelet agents\nanticoagulants, false, streptase\nanticoagulants, false, streptokinase\nanticoagulants, false, antiplatelet agents\nantiplatelet agents, false, streptase\nantiplatelet agents, false, streptokinase\nantiplatelet agents, false, anticoagulants\nstreptase, false, streptokinase\nstreptase, effect, antiplatelet agents\nstreptase, effect, anticoagulants\nstreptokinase, effect, antiplatelet agents\nstreptokinase, effect, anticoagulants\nantiplatelet agents, false, anticoagulants END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in the treatment of acute mi, aspirin, when not otherwise contraindicated, should be administered with streptokinase ( see below ).", "output": "Let's think step by step.\nThe drug entities in this text are:\naspirin, streptokinase\nSo the corresponding drug entities and relations triplets are:\naspirin, false, streptokinase END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "anticoagulation and antiplatelets after treatment for myocardial infarction -- in the treatment of acute myocardial infarction, the use of aspirin has been shown to reduce the incidence of reinfarction and stroke.", "output": "Let's think step by step.\nThe drug entities in this text are:\nantiplatelets, aspirin\nSo the corresponding drug entities and relations triplets are:\nantiplatelets, false, aspirin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the addition of aspirin to streptokinase causes a minimal increase in the risk of minor bleeding (3.9% vs. 3.1%), but does not appear to increase the incidence of major bleeding (see", "output": "Let's think step by step.\nThe drug entities in this text are:\naspirin, streptokinase\nSo the corresponding drug entities and relations triplets are:\naspirin, effect, streptokinase END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "mao inhibitors and beta adrenergic blockers increase the effects of pseudoephedrine.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmao inhibitors, beta adrenergic blockers, pseudoephedrine\nSo the corresponding drug entities and relations triplets are:\nmao inhibitors, false, beta adrenergic blockers\nmao inhibitors, effect, pseudoephedrine\nbeta adrenergic blockers, effect, pseudoephedrine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "sympathomimetics may reduce the antihypertensive effects of methyldopa, mecamylamine, reserpine and veratrum alkaloids.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsympathomimetics, methyldopa, mecamylamine, reserpine, veratrum alkaloids\nSo the corresponding drug entities and relations triplets are:\nsympathomimetics, effect, methyldopa\nsympathomimetics, effect, mecamylamine\nsympathomimetics, effect, reserpine\nsympathomimetics, effect, veratrum alkaloids\nmethyldopa, false, mecamylamine\nmethyldopa, false, reserpine\nmethyldopa, false, veratrum alkaloids\nmecamylamine, false, reserpine\nmecamylamine, false, veratrum alkaloids\nreserpine, false, veratrum alkaloids END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "because tetracyclines have been shown to depress plasma prothrombin activity, patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntetracyclines, anticoagulant, anticoagulant\nSo the corresponding drug entities and relations triplets are:\ntetracyclines, advise, anticoagulant\ntetracyclines, false, anticoagulant END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "since bacteriostatic drugs may interfere with the bactericidal action of penicillin, it is advisable to avoid giving tetracycline class drugs in conjunction with penicillin.", "output": "Let's think step by step.\nThe drug entities in this text are:\npenicillin, tetracycline class drugs, penicillin\nSo the corresponding drug entities and relations triplets are:\npenicillin, false, tetracycline class drugs\ntetracycline class drugs, advise, penicillin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium, and iron-containing preparations.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntetracyclines, antacids, aluminum, calcium, magnesium, iron\nSo the corresponding drug entities and relations triplets are:\ntetracyclines, false, antacids\ntetracyclines, mechanism, aluminum\ntetracyclines, mechanism, calcium\ntetracyclines, mechanism, magnesium\ntetracyclines, mechanism, iron\nantacids, false, aluminum\nantacids, false, calcium\nantacids, false, magnesium\nantacids, false, iron\naluminum, false, calcium\naluminum, false, magnesium\naluminum, false, iron\ncalcium, false, magnesium\ncalcium, false, iron\nmagnesium, false, iron END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the concurrent use of tetracycline and methoxyflurane has been reported to result in fatal renal toxicity.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntetracycline, methoxyflurane\nSo the corresponding drug entities and relations triplets are:\ntetracycline, effect, methoxyflurane END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "concurrent use of tetracyclines with oral contraceptives may render oral contraceptives less effective.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntetracyclines, contraceptives, contraceptives\nSo the corresponding drug entities and relations triplets are:\ntetracyclines, effect, contraceptives\ntetracyclines, false, contraceptives END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the concomitant use of sanctura with other anticholinergic agents that produce dry mouth, constipation, and other anticholinergic pharmacological effects may increase the frequency and/or severity of such effects.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsanctura, anticholinergic agents\nSo the corresponding drug entities and relations triplets are:\nsanctura, effect, anticholinergic agents END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "drugs eliminated by active tubular secretion: although studies to assess drug-drug interactions with sanctura have not been conducted, sanctura has the potential for pharmacokinetic interactions with other drugs that are eliminated by active tubular secretion (e.g. digoxin, procainamide, pancuronium, morphine, vancomycin, metformin and tenofovir).", "output": "Let's think step by step.\nThe drug entities in this text are:\nsanctura, sanctura, digoxin, procainamide, pancuronium, morphine, vancomycin, metformin, tenofovir\nSo the corresponding drug entities and relations triplets are:\nsanctura, false, digoxin\nsanctura, false, procainamide\nsanctura, false, pancuronium\nsanctura, false, morphine\nsanctura, false, vancomycin\nsanctura, false, metformin\nsanctura, false, tenofovir\nsanctura, mechanism, digoxin\nsanctura, mechanism, procainamide\nsanctura, mechanism, pancuronium\nsanctura, mechanism, morphine\nsanctura, mechanism, vancomycin\nsanctura, mechanism, metformin\nsanctura, mechanism, tenofovir\ndigoxin, false, procainamide\ndigoxin, false, pancuronium\ndigoxin, false, morphine\ndigoxin, false, vancomycin\ndigoxin, false, metformin\ndigoxin, false, tenofovir\nprocainamide, false, pancuronium\nprocainamide, false, morphine\nprocainamide, false, vancomycin\nprocainamide, false, metformin\nprocainamide, false, tenofovir\npancuronium, false, morphine\npancuronium, false, vancomycin\npancuronium, false, metformin\npancuronium, false, tenofovir\nmorphine, false, vancomycin\nmorphine, false, metformin\nmorphine, false, tenofovir\nvancomycin, false, metformin\nvancomycin, false, tenofovir\nmetformin, false, tenofovir END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "drug interactions  there are no known drug/drug interactions with oral alkeran  vaccinations with live organism vaccines are not recommended in immunocompromised individuals  nalidixic acid together with high-dose intravenous melphalan has caused deaths in children due to haemorrhagic enterocolitis.", "output": "Let's think step by step.\nThe drug entities in this text are:\nalkeran, live organism vaccines, nalidixic acid, melphalan\nSo the corresponding drug entities and relations triplets are:\nalkeran, false, live organism vaccines\nalkeran, false, nalidixic acid\nalkeran, false, melphalan\nlive organism vaccines, false, nalidixic acid\nlive organism vaccines, false, melphalan\nnalidixic acid, effect, melphalan END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "impaired renal function has been described in bone marrow transplant patients who were conditioned with high-dose intravenous melphalan and who subsequently received cyclosporin to prevent graft-versus-host disease", "output": "Let's think step by step.\nThe drug entities in this text are:\nmelphalan, cyclosporin\nSo the corresponding drug entities and relations triplets are:\nmelphalan, effect, cyclosporin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "drug interactions: inhibitors of cyp3a4 isozymes: caution is advised when midazolam is administered concomitantly with drugs that are known to inhibit the cytochrome p450 3a4 enzyme system (ie, some drugs in the drug classes of azole antimycotics, protease inhibitors, calcium channel antagonists, and macrolide antibiotics).", "output": "Let's think step by step.\nThe drug entities in this text are:\nmidazolam, azole antimycotics, protease inhibitors, calcium channel antagonists, macrolide antibiotics\nSo the corresponding drug entities and relations triplets are:\nmidazolam, advise, azole antimycotics\nmidazolam, advise, protease inhibitors\nmidazolam, advise, calcium channel antagonists\nmidazolam, advise, macrolide antibiotics\nazole antimycotics, false, protease inhibitors\nazole antimycotics, false, calcium channel antagonists\nazole antimycotics, false, macrolide antibiotics\nprotease inhibitors, false, calcium channel antagonists\nprotease inhibitors, false, macrolide antibiotics\ncalcium channel antagonists, false, macrolide antibiotics END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "drugs such as erythromycin, diltiazem, verapamil, ketoconazole, fluconazole and itraconazole were shown to significantly increase the c max and auc of orally administered midazolam.", "output": "Let's think step by step.\nThe drug entities in this text are:\nerythromycin, diltiazem, verapamil, ketoconazole, fluconazole, itraconazole, midazolam\nSo the corresponding drug entities and relations triplets are:\nerythromycin, false, diltiazem\nerythromycin, false, verapamil\nerythromycin, false, ketoconazole\nerythromycin, false, fluconazole\nerythromycin, false, itraconazole\nerythromycin, mechanism, midazolam\ndiltiazem, false, verapamil\ndiltiazem, false, ketoconazole\ndiltiazem, false, fluconazole\ndiltiazem, false, itraconazole\ndiltiazem, mechanism, midazolam\nverapamil, false, ketoconazole\nverapamil, false, fluconazole\nverapamil, false, itraconazole\nverapamil, mechanism, midazolam\nketoconazole, false, fluconazole\nketoconazole, false, itraconazole\nketoconazole, mechanism, midazolam\nfluconazole, false, itraconazole\nfluconazole, mechanism, midazolam\nitraconazole, mechanism, midazolam END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "although not studied, the potent cytochrome p450 3a4 inhibitors ritonavir and nelfinavir may cause intense and prolonged sedation and respiratory depression due to a decrease in plasma clearance of midazolam.", "output": "Let's think step by step.\nThe drug entities in this text are:\nritonavir, nelfinavir, midazolam\nSo the corresponding drug entities and relations triplets are:\nritonavir, false, nelfinavir\nritonavir, mechanism, midazolam\nnelfinavir, mechanism, midazolam END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "inducers of cyp3a4 isozymes: cytochrome p450 inducers, such as rifampin, carbamazepine, and phenytoin, induce metabolism and caused a markedly decreased c max and auc of oral midazolam in adult studies.", "output": "Let's think step by step.\nThe drug entities in this text are:\nrifampin, carbamazepine, phenytoin, midazolam\nSo the corresponding drug entities and relations triplets are:\nrifampin, false, carbamazepine\nrifampin, false, phenytoin\nrifampin, mechanism, midazolam\ncarbamazepine, false, phenytoin\ncarbamazepine, mechanism, midazolam\nphenytoin, mechanism, midazolam END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the difficulty in achieving adequate sedation may have been the result of decreased absorption of the sedatives due to both the gastrointestinal effects and stimulant effects of methylphenidate.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsedatives, methylphenidate\nSo the corresponding drug entities and relations triplets are:\nsedatives, false, methylphenidate END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the sedative effect of versed syrup is accentuated by any concomitantly administered medication which depresses the central nervous system, particularly narcotics (eg, morphine, meperidine and fentanyl), propofol, ketamine, nitrous oxide, secobarbital and droperidol.", "output": "Let's think step by step.\nThe drug entities in this text are:\nversed syrup, narcotics, morphine, meperidine, fentanyl, propofol, ketamine, nitrous oxide, secobarbital, droperidol\nSo the corresponding drug entities and relations triplets are:\nversed syrup, effect, narcotics\nversed syrup, effect, morphine\nversed syrup, effect, meperidine\nversed syrup, effect, fentanyl\nversed syrup, effect, propofol\nversed syrup, effect, ketamine\nversed syrup, effect, nitrous oxide\nversed syrup, effect, secobarbital\nversed syrup, effect, droperidol\nnarcotics, false, morphine\nnarcotics, false, meperidine\nnarcotics, false, fentanyl\nnarcotics, false, propofol\nnarcotics, false, ketamine\nnarcotics, false, nitrous oxide\nnarcotics, false, secobarbital\nnarcotics, false, droperidol\nmorphine, false, meperidine\nmorphine, false, fentanyl\nmorphine, false, propofol\nmorphine, false, ketamine\nmorphine, false, nitrous oxide\nmorphine, false, secobarbital\nmorphine, false, droperidol\nmeperidine, false, fentanyl\nmeperidine, false, propofol\nmeperidine, false, ketamine\nmeperidine, false, nitrous oxide\nmeperidine, false, secobarbital\nmeperidine, false, droperidol\nfentanyl, false, propofol\nfentanyl, false, ketamine\nfentanyl, false, nitrous oxide\nfentanyl, false, secobarbital\nfentanyl, false, droperidol\npropofol, false, ketamine\npropofol, false, nitrous oxide\npropofol, false, secobarbital\npropofol, false, droperidol\nketamine, false, nitrous oxide\nketamine, false, secobarbital\nketamine, false, droperidol\nnitrous oxide, false, secobarbital\nnitrous oxide, false, droperidol\nsecobarbital, false, droperidol END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "no significant adverse interactions with common premedications (such as atropine, scopolamine, glycopyrrolate, diazepam, hydroxyzine, and other muscle relaxants) or local anesthetics have been observed.", "output": "Let's think step by step.\nThe drug entities in this text are:\natropine, scopolamine, glycopyrrolate, diazepam, hydroxyzine, muscle relaxants, anesthetics\nSo the corresponding drug entities and relations triplets are:\natropine, false, scopolamine\natropine, false, glycopyrrolate\natropine, false, diazepam\natropine, false, hydroxyzine\natropine, false, muscle relaxants\natropine, false, anesthetics\nscopolamine, false, glycopyrrolate\nscopolamine, false, diazepam\nscopolamine, false, hydroxyzine\nscopolamine, false, muscle relaxants\nscopolamine, false, anesthetics\nglycopyrrolate, false, diazepam\nglycopyrrolate, false, hydroxyzine\nglycopyrrolate, false, muscle relaxants\nglycopyrrolate, false, anesthetics\ndiazepam, false, hydroxyzine\ndiazepam, false, muscle relaxants\ndiazepam, false, anesthetics\nhydroxyzine, false, muscle relaxants\nhydroxyzine, false, anesthetics\nmuscle relaxants, false, anesthetics END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "drugs which may potentiate the myeloproliferative effects of leukine, such as lithium and corticosteroids, should be used with caution.", "output": "Let's think step by step.\nThe drug entities in this text are:\nleukine, lithium, corticosteroids\nSo the corresponding drug entities and relations triplets are:\nleukine, effect, lithium\nleukine, effect, corticosteroids\nlithium, false, corticosteroids END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "these are described in greater detail below:  oral hypoglycemics, coumarin-type anticoagulants, phenytoin, cyclosporine, rifampin, theophylline, terfenadine, cisapride, astemizole, rifabutin, tacrolimus, short-acting benzodiazepines,  oral hypoglycemics: clinically significant hypoglycemia may be precipitated by the use of diflucan with oral hypoglycemic agents;", "output": "Let's think step by step.\nThe drug entities in this text are:\nhypoglycemics, coumarin-type anticoagulants, phenytoin, cyclosporine, rifampin, theophylline, terfenadine, cisapride, astemizole, rifabutin, tacrolimus, short-acting benzodiazepines, hypoglycemics, diflucan, hypoglycemic agents\nSo the corresponding drug entities and relations triplets are:\nhypoglycemics, false, coumarin-type anticoagulants\nhypoglycemics, false, phenytoin\nhypoglycemics, false, cyclosporine\nhypoglycemics, false, rifampin\nhypoglycemics, false, theophylline\nhypoglycemics, false, terfenadine\nhypoglycemics, false, cisapride\nhypoglycemics, false, astemizole\nhypoglycemics, false, rifabutin\nhypoglycemics, false, tacrolimus\nhypoglycemics, false, short-acting benzodiazepines\nhypoglycemics, false, diflucan\nhypoglycemics, false, hypoglycemic agents\ncoumarin-type anticoagulants, false, phenytoin\ncoumarin-type anticoagulants, false, cyclosporine\ncoumarin-type anticoagulants, false, rifampin\ncoumarin-type anticoagulants, false, theophylline\ncoumarin-type anticoagulants, false, terfenadine\ncoumarin-type anticoagulants, false, cisapride\ncoumarin-type anticoagulants, false, astemizole\ncoumarin-type anticoagulants, false, rifabutin\ncoumarin-type anticoagulants, false, tacrolimus\ncoumarin-type anticoagulants, false, short-acting benzodiazepines\ncoumarin-type anticoagulants, false, hypoglycemics\ncoumarin-type anticoagulants, false, diflucan\ncoumarin-type anticoagulants, false, hypoglycemic agents\nphenytoin, false, cyclosporine\nphenytoin, false, rifampin\nphenytoin, false, theophylline\nphenytoin, false, terfenadine\nphenytoin, false, cisapride\nphenytoin, false, astemizole\nphenytoin, false, rifabutin\nphenytoin, false, tacrolimus\nphenytoin, false, short-acting benzodiazepines\nphenytoin, false, hypoglycemics\nphenytoin, false, diflucan\nphenytoin, false, hypoglycemic agents\ncyclosporine, false, rifampin\ncyclosporine, false, theophylline\ncyclosporine, false, terfenadine\ncyclosporine, false, cisapride\ncyclosporine, false, astemizole\ncyclosporine, false, rifabutin\ncyclosporine, false, tacrolimus\ncyclosporine, false, short-acting benzodiazepines\ncyclosporine, false, hypoglycemics\ncyclosporine, false, diflucan\ncyclosporine, false, hypoglycemic agents\nrifampin, false, theophylline\nrifampin, false, terfenadine\nrifampin, false, cisapride\nrifampin, false, astemizole\nrifampin, false, rifabutin\nrifampin, false, tacrolimus\nrifampin, false, short-acting benzodiazepines\nrifampin, false, hypoglycemics\nrifampin, false, diflucan\nrifampin, false, hypoglycemic agents\ntheophylline, false, terfenadine\ntheophylline, false, cisapride\ntheophylline, false, astemizole\ntheophylline, false, rifabutin\ntheophylline, false, tacrolimus\ntheophylline, false, short-acting benzodiazepines\ntheophylline, false, hypoglycemics\ntheophylline, false, diflucan\ntheophylline, false, hypoglycemic agents\nterfenadine, false, cisapride\nterfenadine, false, astemizole\nterfenadine, false, rifabutin\nterfenadine, false, tacrolimus\nterfenadine, false, short-acting benzodiazepines\nterfenadine, false, hypoglycemics\nterfenadine, false, diflucan\nterfenadine, false, hypoglycemic agents\ncisapride, false, astemizole\ncisapride, false, rifabutin\ncisapride, false, tacrolimus\ncisapride, false, short-acting benzodiazepines\ncisapride, false, hypoglycemics\ncisapride, false, diflucan\ncisapride, false, hypoglycemic agents\nastemizole, false, rifabutin\nastemizole, false, tacrolimus\nastemizole, false, short-acting benzodiazepines\nastemizole, false, hypoglycemics\nastemizole, false, diflucan\nastemizole, false, hypoglycemic agents\nrifabutin, false, tacrolimus\nrifabutin, false, short-acting benzodiazepines\nrifabutin, false, hypoglycemics\nrifabutin, false, diflucan\nrifabutin, false, hypoglycemic agents\ntacrolimus, false, short-acting benzodiazepines\ntacrolimus, false, hypoglycemics\ntacrolimus, false, diflucan\ntacrolimus, false, hypoglycemic agents\nshort-acting benzodiazepines, false, hypoglycemics\nshort-acting benzodiazepines, false, diflucan\nshort-acting benzodiazepines, false, hypoglycemic agents\nhypoglycemics, false, diflucan\nhypoglycemics, false, hypoglycemic agents\ndiflucan, effect, hypoglycemic agents END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "one fatality has been reported from hypoglycemia in association with combined diflucan and glyburide use.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndiflucan, glyburide\nSo the corresponding drug entities and relations triplets are:\ndiflucan, effect, glyburide END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "diflucan reduces the metabolism of tolbutamide, glyburide, and glipizide and increases the plasma concentration of these agents.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndiflucan, tolbutamide, glyburide, glipizide\nSo the corresponding drug entities and relations triplets are:\ndiflucan, mechanism, tolbutamide\ndiflucan, mechanism, glyburide\ndiflucan, mechanism, glipizide\ntolbutamide, false, glyburide\ntolbutamide, false, glipizide\nglyburide, false, glipizide END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "when diflucan is used concomitantly with these or other sulfonylurea oral hypoglycemic agents, blood glucose concentrations should be carefully monitored and the dose of the sulfonylurea should be adjusted as necessary.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndiflucan, sulfonylurea oral hypoglycemic agents, sulfonylurea\nSo the corresponding drug entities and relations triplets are:\ndiflucan, advise, sulfonylurea oral hypoglycemic agents\ndiflucan, false, sulfonylurea\nsulfonylurea oral hypoglycemic agents, false, sulfonylurea END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "coumarin-type anticoagulants: prothrombin time may be increased in patients receiving concomitant diflucan and coumarin-type anticoagulants.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncoumarin-type anticoagulants, diflucan, coumarin-type anticoagulants\nSo the corresponding drug entities and relations triplets are:\ncoumarin-type anticoagulants, false, diflucan\ndiflucan, effect, coumarin-type anticoagulants END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in post-marketing experience, as with other azole antifungals, bleeding events (bruising, epistaxis, gastrointestinal bleeding, hematuria, and melena) have been reported in association with increases in prothrombin time in patients receiving fluconazole concurrently with warfarin.", "output": "Let's think step by step.\nThe drug entities in this text are:\nazole antifungals, fluconazole, warfarin\nSo the corresponding drug entities and relations triplets are:\nazole antifungals, false, fluconazole\nazole antifungals, false, warfarin\nfluconazole, effect, warfarin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "careful monitoring of prothrombin time in patients receiving diflucan and coumarin-type anticoagulants is recommended.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndiflucan, coumarin-type anticoagulants\nSo the corresponding drug entities and relations triplets are:\ndiflucan, advise, coumarin-type anticoagulants END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "phenytoin: diflucan increases the plasma concentrations of phenytoin.", "output": "Let's think step by step.\nThe drug entities in this text are:\nphenytoin, diflucan, phenytoin\nSo the corresponding drug entities and relations triplets are:\nphenytoin, false, diflucan\ndiflucan, mechanism, phenytoin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "careful monitoring of phenytoin concentrations in patients receiving diflucan and phenytoin is recommended.", "output": "Let's think step by step.\nThe drug entities in this text are:\nphenytoin, diflucan, phenytoin\nSo the corresponding drug entities and relations triplets are:\nphenytoin, false, diflucan\ndiflucan, advise, phenytoin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "cyclosporine: diflucan may significantly increase cyclosporine levels in renal transplant patients with or without renal impairment.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncyclosporine, diflucan, cyclosporine\nSo the corresponding drug entities and relations triplets are:\ncyclosporine, false, diflucan\ndiflucan, mechanism, cyclosporine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "careful monitoring of cyclosporine concentrations and serum creatinine is recommended in patients receiving diflucan and cyclosporine.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncyclosporine, diflucan, cyclosporine\nSo the corresponding drug entities and relations triplets are:\ncyclosporine, false, diflucan\ndiflucan, advise, cyclosporine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "rifampin: rifampin enhances the metabolism of concurrently administered diflucan.", "output": "Let's think step by step.\nThe drug entities in this text are:\nrifampin, rifampin, diflucan\nSo the corresponding drug entities and relations triplets are:\nrifampin, false, diflucan\nrifampin, mechanism, diflucan END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "depending on clinical circumstances, consideration should be given to increasing the dose of diflucan when it is administered with rifampin.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndiflucan, rifampin\nSo the corresponding drug entities and relations triplets are:\ndiflucan, advise, rifampin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "theophylline: diflucan increases the serum concentrations of theophylline.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntheophylline, diflucan, theophylline\nSo the corresponding drug entities and relations triplets are:\ntheophylline, false, diflucan\ndiflucan, mechanism, theophylline END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "careful monitoring of serum theophylline concentrations in patients receiving diflucan and theophylline is recommended.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntheophylline, diflucan, theophylline\nSo the corresponding drug entities and relations triplets are:\ntheophylline, false, diflucan\ndiflucan, advise, theophylline END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "terfenadine: because of the occurrence of serious cardiac dysrhythmias secondary to prolongation of the qtc interval in patients receiving azole antifungals in conjunction with terfenadine, interaction studies have been performed.", "output": "Let's think step by step.\nThe drug entities in this text are:\nterfenadine, azole antifungals, terfenadine\nSo the corresponding drug entities and relations triplets are:\nterfenadine, false, azole antifungals\nazole antifungals, effect, terfenadine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "another study at a 400-mg and 800-mg daily dose of fluconazole demonstrated that diflucan taken in doses of 400 mg per day or greater significantly increases plasma levels of terfenadine when taken concomitantly.", "output": "Let's think step by step.\nThe drug entities in this text are:\nfluconazole, diflucan, terfenadine\nSo the corresponding drug entities and relations triplets are:\nfluconazole, false, diflucan\nfluconazole, false, terfenadine\ndiflucan, mechanism, terfenadine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the combined use of fluconazole at doses of 400 mg or greater with terfenadine is contraindicated.", "output": "Let's think step by step.\nThe drug entities in this text are:\nfluconazole, terfenadine\nSo the corresponding drug entities and relations triplets are:\nfluconazole, advise, terfenadine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the coadministration of fluconazole at doses lower than 400 mg/day with terfenadine should be carefully monitored.", "output": "Let's think step by step.\nThe drug entities in this text are:\nfluconazole, terfenadine\nSo the corresponding drug entities and relations triplets are:\nfluconazole, advise, terfenadine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "cisapride: there have been reports of cardiac events, including torsade de pointes in patients to whom fluconazole and cisapride were coadministered.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncisapride, fluconazole, cisapride\nSo the corresponding drug entities and relations triplets are:\ncisapride, false, fluconazole\nfluconazole, effect, cisapride END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "a controlled study found that concomitant fluconazole 200 mg once daily and cisapride 20 mg four times a day yielded a significant increase in cisapride plasma levels and prolongation of qtc interval.", "output": "Let's think step by step.\nThe drug entities in this text are:\nfluconazole, cisapride, cisapride\nSo the corresponding drug entities and relations triplets are:\nfluconazole, mechanism, cisapride\nfluconazole, false, cisapride END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the combined use of fluconazole with cisapride is contraindicated.", "output": "Let's think step by step.\nThe drug entities in this text are:\nfluconazole, cisapride\nSo the corresponding drug entities and relations triplets are:\nfluconazole, advise, cisapride END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "astemizole: the use of fluconazole in patients concurrently taking astemizole or other drugs metabolized by the cytochrome p450 system may be associated with elevations in serum levels of these drugs.", "output": "Let's think step by step.\nThe drug entities in this text are:\nastemizole, fluconazole, astemizole\nSo the corresponding drug entities and relations triplets are:\nastemizole, false, fluconazole\nfluconazole, mechanism, astemizole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "rifabutin: there have been reports of uveitis in patients to whom fluconazole and rifabutin were coadministered.", "output": "Let's think step by step.\nThe drug entities in this text are:\nrifabutin, fluconazole, rifabutin\nSo the corresponding drug entities and relations triplets are:\nrifabutin, false, fluconazole\nfluconazole, effect, rifabutin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "patients receiving rifabutin and fluconazole concomitantly should be carefully monitored.", "output": "Let's think step by step.\nThe drug entities in this text are:\nrifabutin, fluconazole\nSo the corresponding drug entities and relations triplets are:\nrifabutin, advise, fluconazole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "tacrolimus: there have been reports of nephrotoxicity in patients to whom fluconazole and tacrolimus were coadministered.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntacrolimus, fluconazole, tacrolimus\nSo the corresponding drug entities and relations triplets are:\ntacrolimus, false, fluconazole\nfluconazole, effect, tacrolimus END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "patients receiving tacrolimus and fluconazole concomitantly should be carefully monitored.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntacrolimus, fluconazole\nSo the corresponding drug entities and relations triplets are:\ntacrolimus, advise, fluconazole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "short-acting benzodiazepines: following oral administration of midazolam, fluconazole resulted in substantial increases in midazolam concentrations and psychomotor effects.", "output": "Let's think step by step.\nThe drug entities in this text are:\nshort-acting benzodiazepines, midazolam, fluconazole, midazolam\nSo the corresponding drug entities and relations triplets are:\nshort-acting benzodiazepines, false, midazolam\nshort-acting benzodiazepines, false, fluconazole\nshort-acting benzodiazepines, false, midazolam\nmidazolam, mechanism, fluconazole\nfluconazole, false, midazolam END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "this effect on midazolam appears to be more pronounced following oral administration of fluconazole than with fluconazole administered intravenously.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmidazolam, fluconazole, fluconazole\nSo the corresponding drug entities and relations triplets are:\nmidazolam, effect, fluconazole\nmidazolam, false, fluconazole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "if short-acting benzodiazepines, which are metabolized by the cytochrome p450 system, are concomitantly administered with fluconazole, consideration should be given to decreasing the benzodiazepine dosage, and the patients should be appropriately monitored.", "output": "Let's think step by step.\nThe drug entities in this text are:\nshort-acting benzodiazepines, fluconazole, benzodiazepine\nSo the corresponding drug entities and relations triplets are:\nshort-acting benzodiazepines, advise, fluconazole\nshort-acting benzodiazepines, false, benzodiazepine\nfluconazole, false, benzodiazepine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "fluconazole tablets coadministered with ethinyl estradiol- and levonorgestrel-containing oral contraceptives produced an overall mean increase in ethinyl estradiol and levonorgestrel levels;", "output": "Let's think step by step.\nThe drug entities in this text are:\nfluconazole, ethinyl estradiol, levonorgestrel, contraceptives, ethinyl estradiol, levonorgestrel\nSo the corresponding drug entities and relations triplets are:\nfluconazole, mechanism, ethinyl estradiol\nfluconazole, mechanism, levonorgestrel\nfluconazole, false, contraceptives\nfluconazole, false, ethinyl estradiol\nfluconazole, false, levonorgestrel\nethinyl estradiol, false, levonorgestrel\nethinyl estradiol, false, contraceptives\nethinyl estradiol, false, levonorgestrel\nlevonorgestrel, false, contraceptives\nlevonorgestrel, false, ethinyl estradiol\ncontraceptives, false, ethinyl estradiol\ncontraceptives, false, levonorgestrel\nethinyl estradiol, false, levonorgestrel END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "however, in some patients there were decreases up to 47% and 33% of ethinyl estradiol and levonorgestrel levels.", "output": "Let's think step by step.\nThe drug entities in this text are:\nethinyl estradiol, levonorgestrel\nSo the corresponding drug entities and relations triplets are:\nethinyl estradiol, false, levonorgestrel END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the data presently available indicate that the decreases in some individual ethinyl estradiol and levonorgestrel auc values with fluconazole treatment are likely the result of random variation.", "output": "Let's think step by step.\nThe drug entities in this text are:\nethinyl estradiol, levonorgestrel, fluconazole\nSo the corresponding drug entities and relations triplets are:\nethinyl estradiol, false, levonorgestrel\nethinyl estradiol, false, fluconazole\nlevonorgestrel, false, fluconazole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "while there is evidence that fluconazole can inhibit the metabolism of ethinyl estradiol and levonorgestrel, there is no evidence that fluconazole is a net inducer of ethinyl estradiol or levonorgestrel metabolism.", "output": "Let's think step by step.\nThe drug entities in this text are:\nfluconazole, ethinyl estradiol, levonorgestrel, fluconazole, ethinyl estradiol, levonorgestrel\nSo the corresponding drug entities and relations triplets are:\nfluconazole, mechanism, ethinyl estradiol\nfluconazole, mechanism, levonorgestrel\nfluconazole, false, ethinyl estradiol\nfluconazole, false, levonorgestrel\nethinyl estradiol, false, levonorgestrel\nethinyl estradiol, false, fluconazole\nethinyl estradiol, false, levonorgestrel\nlevonorgestrel, false, fluconazole\nlevonorgestrel, false, ethinyl estradiol\nfluconazole, false, ethinyl estradiol\nfluconazole, false, levonorgestrel\nethinyl estradiol, false, levonorgestrel END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "although a causal relationship has not been established, there have been reports of bleeding and/or prolonged prothrombin time in patients treated with trental with and without anticoagulants or platelet aggregation inhibitors.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntrental, anticoagulants, platelet aggregation inhibitors\nSo the corresponding drug entities and relations triplets are:\ntrental, effect, anticoagulants\ntrental, effect, platelet aggregation inhibitors\nanticoagulants, false, platelet aggregation inhibitors END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "concomitant administration of trental and theophylline-containing drugs leads to increased theophylline levels and theophylline toxicity in some individuals.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntrental, theophylline, theophylline, theophylline\nSo the corresponding drug entities and relations triplets are:\ntrental, mechanism, theophylline\ntrental, false, theophylline\ntrental, false, theophylline END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "trental has been used concurrently with antihypertensive drugs, beta blockers, digitalis, diuretics, antidiabetic agents, and antiarrhythmics, without observed problems.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntrental, antihypertensive drugs, beta blockers, digitalis, diuretics, antidiabetic agents, antiarrhythmics\nSo the corresponding drug entities and relations triplets are:\ntrental, false, antihypertensive drugs\ntrental, false, beta blockers\ntrental, false, digitalis\ntrental, false, diuretics\ntrental, false, antidiabetic agents\ntrental, false, antiarrhythmics\nantihypertensive drugs, false, beta blockers\nantihypertensive drugs, false, digitalis\nantihypertensive drugs, false, diuretics\nantihypertensive drugs, false, antidiabetic agents\nantihypertensive drugs, false, antiarrhythmics\nbeta blockers, false, digitalis\nbeta blockers, false, diuretics\nbeta blockers, false, antidiabetic agents\nbeta blockers, false, antiarrhythmics\ndigitalis, false, diuretics\ndigitalis, false, antidiabetic agents\ndigitalis, false, antiarrhythmics\ndiuretics, false, antidiabetic agents\ndiuretics, false, antiarrhythmics\nantidiabetic agents, false, antiarrhythmics END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "ace inhibitors reports suggest that nsaids may diminish the antihypertensive effect of angiotensin-converting enzyme (ace) inhibitors.", "output": "Let's think step by step.\nThe drug entities in this text are:\nace inhibitors, nsaids, angiotensin-converting enzyme (ace) inhibitors\nSo the corresponding drug entities and relations triplets are:\nace inhibitors, false, nsaids\nace inhibitors, false, angiotensin-converting enzyme (ace) inhibitors\nnsaids, effect, angiotensin-converting enzyme (ace) inhibitors END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "this interaction should be given consideration in patients taking nsaids concomitantly with ace inhibitors.", "output": "Let's think step by step.\nThe drug entities in this text are:\nnsaids, ace inhibitors\nSo the corresponding drug entities and relations triplets are:\nnsaids, advise, ace inhibitors END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "aspirin: concomitant administration of aspirin (1000 mg tid) to healthy volunteers tended to increase the auc (10%) and cmax (24%) of meloxicam.", "output": "Let's think step by step.\nThe drug entities in this text are:\naspirin, aspirin, meloxicam\nSo the corresponding drug entities and relations triplets are:\naspirin, false, meloxicam\naspirin, mechanism, meloxicam END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "however, as with other nsaids, concomitant administration of meloxicam and aspirin is not generally recommended because of the potential for increased adverse effects.", "output": "Let's think step by step.\nThe drug entities in this text are:\nnsaids, meloxicam, aspirin\nSo the corresponding drug entities and relations triplets are:\nnsaids, false, meloxicam\nnsaids, advise, aspirin\nmeloxicam, advise, aspirin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "concomitant administration of low-dose aspirin with mobic may result in an increased rate of gi ulceration or other complications, compared to use of mobic alone.", "output": "Let's think step by step.\nThe drug entities in this text are:\naspirin, mobic, mobic\nSo the corresponding drug entities and relations triplets are:\naspirin, effect, mobic\naspirin, false, mobic END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "mobic is not a substitute for aspirin for cardiovascular prophylaxis.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmobic, aspirin\nSo the corresponding drug entities and relations triplets are:\nmobic, false, aspirin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "cholestyramine: pretreatment for four days with cholestyramine significantly increased the clearance of meloxicam by 50%.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncholestyramine, cholestyramine, meloxicam\nSo the corresponding drug entities and relations triplets are:\ncholestyramine, false, meloxicam\ncholestyramine, mechanism, meloxicam END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "cimetidine: concomitant administration of 200 mg cimetidine qid did not alter the single-dose pharmacokinetics of 30 mg meloxicam.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncimetidine, cimetidine, meloxicam\nSo the corresponding drug entities and relations triplets are:\ncimetidine, false, meloxicam\ncimetidine, false, meloxicam END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "digoxin: meloxicam 15 mg once daily for 7 days did not alter the plasma concentration profile of digoxin after b-acetyldigoxin administration for 7 days at clinical doses.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndigoxin, meloxicam, digoxin\nSo the corresponding drug entities and relations triplets are:\ndigoxin, false, meloxicam\nmeloxicam, false, digoxin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in vitro testing found no protein binding drug interaction between digoxin and meloxicam.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndigoxin, meloxicam\nSo the corresponding drug entities and relations triplets are:\ndigoxin, false, meloxicam END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "furosemide: clinical studies, as well as post-marketing observations, have shown that nsaids can reduce the natriuretic effect of furosemide and thiazide diuretics in some patients.", "output": "Let's think step by step.\nThe drug entities in this text are:\nfurosemide, nsaids, furosemide, thiazide diuretics\nSo the corresponding drug entities and relations triplets are:\nfurosemide, false, nsaids\nfurosemide, false, thiazide diuretics\nnsaids, effect, furosemide\nnsaids, effect, thiazide diuretics\nfurosemide, false, thiazide diuretics END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "studies with furosemide agents and meloxicam have not demonstrated a reduction in natriuretic effect.", "output": "Let's think step by step.\nThe drug entities in this text are:\nfurosemide, meloxicam\nSo the corresponding drug entities and relations triplets are:\nfurosemide, false, meloxicam END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "furosemide: single and multiple dose pharmacodynamics and pharmacokinetics are not affected by multiple doses of meloxicam.", "output": "Let's think step by step.\nThe drug entities in this text are:\nfurosemide, meloxicam\nSo the corresponding drug entities and relations triplets are:\nfurosemide, false, meloxicam END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "nevertheless, during concomitant therapy with furosemide and mobic, patients should be observed closely for signs of declining renal function, as well as to assure diuretic efficacy.", "output": "Let's think step by step.\nThe drug entities in this text are:\nfurosemide, mobic\nSo the corresponding drug entities and relations triplets are:\nfurosemide, advise, mobic END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "lithium: in clinical trials, nsaids have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance.", "output": "Let's think step by step.\nThe drug entities in this text are:\nlithium, nsaids, lithium, lithium\nSo the corresponding drug entities and relations triplets are:\nlithium, false, nsaids\nnsaids, mechanism, lithium\nnsaids, false, lithium END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in a study conducted in healthy subjects, mean pre-dose lithium concentration and auc were increased by 21% in subjects receiving lithium doses ranging from 804 to 1072 mg bid with meloxicam 15 mg qd as compared to subjects receiving lithium alone.", "output": "Let's think step by step.\nThe drug entities in this text are:\nlithium, lithium, meloxicam, lithium\nSo the corresponding drug entities and relations triplets are:\nlithium, false, meloxicam\nlithium, mechanism, meloxicam\nmeloxicam, false, lithium END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "patients on lithium treatment should be closely monitored when mobic is introduced or withdrawn.", "output": "Let's think step by step.\nThe drug entities in this text are:\nlithium, mobic\nSo the corresponding drug entities and relations triplets are:\nlithium, advise, mobic END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "methotrexate: a study in 13 rheumatoid arthritis (ra) patients evaluated the effects of multiple doses of meloxicam on the pharmacokinetics of methotrexate taken once weekly.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmethotrexate, meloxicam, methotrexate\nSo the corresponding drug entities and relations triplets are:\nmethotrexate, false, meloxicam\nmeloxicam, false, methotrexate END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "meloxicam did not have a significant effect on the pharmacokinetics of single doses of methotrexate.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmeloxicam, methotrexate\nSo the corresponding drug entities and relations triplets are:\nmeloxicam, false, methotrexate END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in vitro, methotrexate did not displace meloxicam from its human serum binding sites.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmethotrexate, meloxicam\nSo the corresponding drug entities and relations triplets are:\nmethotrexate, false, meloxicam END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "warfarin: anticoagulant activity should be monitored, particularly in the first few days after initiating or changing mobic therapy in patients receiving warfarin or similar agents, since these patients are at an increased risk of bleeding.", "output": "Let's think step by step.\nThe drug entities in this text are:\nwarfarin, mobic, warfarin\nSo the corresponding drug entities and relations triplets are:\nwarfarin, false, mobic\nmobic, advise, warfarin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the effect of meloxicam on the anticoagulant effect of warfarin was studied in a group of healthy subjects receiving daily doses of warfarin that produced an inr (international normalized ratio) between 1.2 and 1.8.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmeloxicam, warfarin, warfarin\nSo the corresponding drug entities and relations triplets are:\nmeloxicam, false, warfarin\nmeloxicam, false, warfarin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in these subjects, meloxicam did not alter warfarin pharmacokinetics and the average anticoagulant effect of warfarin as determined by prothrombin time.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmeloxicam, warfarin, warfarin\nSo the corresponding drug entities and relations triplets are:\nmeloxicam, false, warfarin\nmeloxicam, false, warfarin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "caution should be used when administering mobic with warfarin since patients on warfarin may experience changes in inr and an increased risk of bleeding complications when a new medication is introduced.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmobic, warfarin, warfarin\nSo the corresponding drug entities and relations triplets are:\nmobic, advise, warfarin\nmobic, false, warfarin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "when administered concomitantly with proamatine   , cardiac glycosides may enhance or precipitate bradycardia, a.v.", "output": "Let's think step by step.\nThe drug entities in this text are:\nproamatine, cardiac glycosides\nSo the corresponding drug entities and relations triplets are:\nproamatine, effect, cardiac glycosides END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the use of drugs that stimulate alpha-adrenergic receptors (e.g., phenylephrine, pseudoephedrine, ephedrine, phenylpropanolamine or dihydroergotamine) may enhance or potentiate the pressor effects of proamatine   . therefore, caution should be used when proamatine    is administered concomitantly with agents that cause vasoconstriction.", "output": "Let's think step by step.\nThe drug entities in this text are:\nphenylephrine, pseudoephedrine, ephedrine, phenylpropanolamine, dihydroergotamine, proamatine, proamatine\nSo the corresponding drug entities and relations triplets are:\nphenylephrine, false, pseudoephedrine\nphenylephrine, false, ephedrine\nphenylephrine, false, phenylpropanolamine\nphenylephrine, false, dihydroergotamine\nphenylephrine, effect, proamatine\nphenylephrine, false, proamatine\npseudoephedrine, false, ephedrine\npseudoephedrine, false, phenylpropanolamine\npseudoephedrine, false, dihydroergotamine\npseudoephedrine, effect, proamatine\npseudoephedrine, false, proamatine\nephedrine, false, phenylpropanolamine\nephedrine, false, dihydroergotamine\nephedrine, effect, proamatine\nephedrine, false, proamatine\nphenylpropanolamine, false, dihydroergotamine\nphenylpropanolamine, effect, proamatine\nphenylpropanolamine, false, proamatine\ndihydroergotamine, effect, proamatine\ndihydroergotamine, false, proamatine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "proamatine    has been used in patients concomitantly treated with salt-retaining steroid therapy (i.e., fludrocortisone acetate), with or without salt supplementation.", "output": "Let's think step by step.\nThe drug entities in this text are:\nproamatine, fludrocortisone acetate\nSo the corresponding drug entities and relations triplets are:\nproamatine, false, fludrocortisone acetate END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "proamatine. alpha-adrenergic blocking agents, such as prazosin, terazosin, and doxazosin, can antagonize the effects of proamatine. potential for drug interactions: it appears possible, although there is no supporting experimental evidence, that the high renal clearance of desglymidodrine (a base) is due to active tubular secretion by the base-secreting system also responsible for the secretion of such drugs as metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, and quinidine.", "output": "Let's think step by step.\nThe drug entities in this text are:\nproamatine, alpha-adrenergic blocking agents, prazosin, terazosin, doxazosin, proamatine, desglymidodrine, metformin, cimetidine, ranitidine, procainamide, triamterene, flecainide, quinidine\nSo the corresponding drug entities and relations triplets are:\nproamatine, false, alpha-adrenergic blocking agents\nproamatine, false, prazosin\nproamatine, false, terazosin\nproamatine, false, doxazosin\nproamatine, false, desglymidodrine\nproamatine, false, metformin\nproamatine, false, cimetidine\nproamatine, false, ranitidine\nproamatine, false, procainamide\nproamatine, false, triamterene\nproamatine, false, flecainide\nproamatine, false, quinidine\nalpha-adrenergic blocking agents, false, prazosin\nalpha-adrenergic blocking agents, false, terazosin\nalpha-adrenergic blocking agents, false, doxazosin\nalpha-adrenergic blocking agents, effect, proamatine\nalpha-adrenergic blocking agents, false, desglymidodrine\nalpha-adrenergic blocking agents, false, metformin\nalpha-adrenergic blocking agents, false, cimetidine\nalpha-adrenergic blocking agents, false, ranitidine\nalpha-adrenergic blocking agents, false, procainamide\nalpha-adrenergic blocking agents, false, triamterene\nalpha-adrenergic blocking agents, false, flecainide\nalpha-adrenergic blocking agents, false, quinidine\nprazosin, false, terazosin\nprazosin, false, doxazosin\nprazosin, effect, proamatine\nprazosin, false, desglymidodrine\nprazosin, false, metformin\nprazosin, false, cimetidine\nprazosin, false, ranitidine\nprazosin, false, procainamide\nprazosin, false, triamterene\nprazosin, false, flecainide\nprazosin, false, quinidine\nterazosin, false, doxazosin\nterazosin, effect, proamatine\nterazosin, false, desglymidodrine\nterazosin, false, metformin\nterazosin, false, cimetidine\nterazosin, false, ranitidine\nterazosin, false, procainamide\nterazosin, false, triamterene\nterazosin, false, flecainide\nterazosin, false, quinidine\ndoxazosin, effect, proamatine\ndoxazosin, false, desglymidodrine\ndoxazosin, false, metformin\ndoxazosin, false, cimetidine\ndoxazosin, false, ranitidine\ndoxazosin, false, procainamide\ndoxazosin, false, triamterene\ndoxazosin, false, flecainide\ndoxazosin, false, quinidine\nproamatine, false, desglymidodrine\nproamatine, false, metformin\nproamatine, false, cimetidine\nproamatine, false, ranitidine\nproamatine, false, procainamide\nproamatine, false, triamterene\nproamatine, false, flecainide\nproamatine, false, quinidine\ndesglymidodrine, mechanism, metformin\ndesglymidodrine, mechanism, cimetidine\ndesglymidodrine, mechanism, ranitidine\ndesglymidodrine, mechanism, procainamide\ndesglymidodrine, mechanism, triamterene\ndesglymidodrine, mechanism, flecainide\ndesglymidodrine, mechanism, quinidine\nmetformin, false, cimetidine\nmetformin, false, ranitidine\nmetformin, false, procainamide\nmetformin, false, triamterene\nmetformin, false, flecainide\nmetformin, false, quinidine\ncimetidine, false, ranitidine\ncimetidine, false, procainamide\ncimetidine, false, triamterene\ncimetidine, false, flecainide\ncimetidine, false, quinidine\nranitidine, false, procainamide\nranitidine, false, triamterene\nranitidine, false, flecainide\nranitidine, false, quinidine\nprocainamide, false, triamterene\nprocainamide, false, flecainide\nprocainamide, false, quinidine\ntriamterene, false, flecainide\ntriamterene, false, quinidine\nflecainide, false, quinidine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "preliminary evidence suggests that cimetidine inhibits mebendazole metabolism and may result in an increase in plasma concentrations of mebendazole.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncimetidine, mebendazole, mebendazole\nSo the corresponding drug entities and relations triplets are:\ncimetidine, mechanism, mebendazole\ncimetidine, false, mebendazole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "interactions for vitamin b2 (riboflavin):  alcohol - impairs the intestinal absorption of riboflavin", "output": "Let's think step by step.\nThe drug entities in this text are:\nvitamin b2, riboflavin, alcohol, riboflavin\nSo the corresponding drug entities and relations triplets are:\nvitamin b2, false, riboflavin\nvitamin b2, false, alcohol\nvitamin b2, false, riboflavin\nriboflavin, false, alcohol\nalcohol, mechanism, riboflavin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "probenecid - concurrent use decreases gastrointestinal absorption of riboflavin;", "output": "Let's think step by step.\nThe drug entities in this text are:\nprobenecid, riboflavin\nSo the corresponding drug entities and relations triplets are:\nprobenecid, mechanism, riboflavin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "requirements for riboflavin may be increased in patients receiving probenecid.", "output": "Let's think step by step.\nThe drug entities in this text are:\nriboflavin, probenecid\nSo the corresponding drug entities and relations triplets are:\nriboflavin, effect, probenecid END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the concomitant use of other cns depressants including sedatives, hypnotics, tranquilizers, general anesthetics, phenothiazines, other opioids, tricyclic antidepressants, monoamine oxidase (mao) inhibitors, and alcohol may produce additive cns depressant effects.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncns depressants, sedatives, hypnotics, tranquilizers, anesthetics, phenothiazines, opioids, tricyclic antidepressants, monoamine oxidase (mao) inhibitors, alcohol\nSo the corresponding drug entities and relations triplets are:\ncns depressants, false, sedatives\ncns depressants, false, hypnotics\ncns depressants, false, tranquilizers\ncns depressants, false, anesthetics\ncns depressants, false, phenothiazines\ncns depressants, false, opioids\ncns depressants, false, tricyclic antidepressants\ncns depressants, false, monoamine oxidase (mao) inhibitors\ncns depressants, false, alcohol\nsedatives, false, hypnotics\nsedatives, false, tranquilizers\nsedatives, false, anesthetics\nsedatives, false, phenothiazines\nsedatives, false, opioids\nsedatives, false, tricyclic antidepressants\nsedatives, false, monoamine oxidase (mao) inhibitors\nsedatives, false, alcohol\nhypnotics, false, tranquilizers\nhypnotics, false, anesthetics\nhypnotics, false, phenothiazines\nhypnotics, false, opioids\nhypnotics, false, tricyclic antidepressants\nhypnotics, false, monoamine oxidase (mao) inhibitors\nhypnotics, false, alcohol\ntranquilizers, false, anesthetics\ntranquilizers, false, phenothiazines\ntranquilizers, false, opioids\ntranquilizers, false, tricyclic antidepressants\ntranquilizers, false, monoamine oxidase (mao) inhibitors\ntranquilizers, false, alcohol\nanesthetics, false, phenothiazines\nanesthetics, false, opioids\nanesthetics, false, tricyclic antidepressants\nanesthetics, false, monoamine oxidase (mao) inhibitors\nanesthetics, false, alcohol\nphenothiazines, false, opioids\nphenothiazines, false, tricyclic antidepressants\nphenothiazines, false, monoamine oxidase (mao) inhibitors\nphenothiazines, false, alcohol\nopioids, false, tricyclic antidepressants\nopioids, false, monoamine oxidase (mao) inhibitors\nopioids, false, alcohol\ntricyclic antidepressants, false, monoamine oxidase (mao) inhibitors\ntricyclic antidepressants, false, alcohol\nmonoamine oxidase (mao) inhibitors, false, alcohol END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "anticholinergics or other medications with anticholinergic activity when used concurrently with opioid analgesics may result in increased risk of urinary retention and/or severe constipation, which may lead to paralytic ileus.", "output": "Let's think step by step.\nThe drug entities in this text are:\nanticholinergics, opioid analgesics\nSo the corresponding drug entities and relations triplets are:\nanticholinergics, effect, opioid analgesics END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "it has been reported that the incidence of bradycardia was increased when oxymorphone was combined with propofol for induction of anesthesia.", "output": "Let's think step by step.\nThe drug entities in this text are:\noxymorphone, propofol\nSo the corresponding drug entities and relations triplets are:\noxymorphone, effect, propofol END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in addition, cns toxicity has been reported (confusion, disorientation, respiratory depression, apnea, seizures) following coadministration of cimetidine with opioid analgesics;", "output": "Let's think step by step.\nThe drug entities in this text are:\ncimetidine, opioid analgesics\nSo the corresponding drug entities and relations triplets are:\ncimetidine, effect, opioid analgesics END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "since celontin (methsuximide) may interact with concurrently administered antiepileptic drugs, periodic serum level determinations of these drugs may be necessary (eg methsuximide may increase the plasma concentrations of phenytoin and phenobarbital).", "output": "Let's think step by step.\nThe drug entities in this text are:\ncelontin, methsuximide, antiepileptic drugs, methsuximide, phenytoin, phenobarbital\nSo the corresponding drug entities and relations triplets are:\ncelontin, false, methsuximide\ncelontin, advise, antiepileptic drugs\ncelontin, false, methsuximide\ncelontin, false, phenytoin\ncelontin, false, phenobarbital\nmethsuximide, advise, antiepileptic drugs\nmethsuximide, false, phenytoin\nmethsuximide, false, phenobarbital\nantiepileptic drugs, false, methsuximide\nantiepileptic drugs, false, phenytoin\nantiepileptic drugs, false, phenobarbital\nmethsuximide, mechanism, phenytoin\nmethsuximide, mechanism, phenobarbital\nphenytoin, false, phenobarbital END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "when atropine and pralidoxime are used together, the signs of atropinization (flushing, mydriasis, tachycardia, dryness of the mouth and nose) may occur earlier than might be expected when atropine is used alone.", "output": "Let's think step by step.\nThe drug entities in this text are:\natropine, pralidoxime, atropine\nSo the corresponding drug entities and relations triplets are:\natropine, effect, pralidoxime\npralidoxime, false, atropine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "this is especially true if the total dose of atropine has been large and the administration of pralidoxime has been delayed.", "output": "Let's think step by step.\nThe drug entities in this text are:\natropine, pralidoxime\nSo the corresponding drug entities and relations triplets are:\natropine, false, pralidoxime END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "2 - 4 the following precautions should be kept in mind in the treatment of anticholinesterase poisoning, although they do not bear directly on the use of pralidoxime: since barbiturates are potentiated by the anticholinesterases, they should be used cautiously in the treatment of convulsions;", "output": "Let's think step by step.\nThe drug entities in this text are:\npralidoxime, barbiturates, anticholinesterases\nSo the corresponding drug entities and relations triplets are:\npralidoxime, false, barbiturates\npralidoxime, false, anticholinesterases\nbarbiturates, effect, anticholinesterases END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "morphine, theophylline, aminophylline, succinylcholine, reserpine, and phenothiazine-type tranquilizers should be avoided in patients with organophosphate poisoning.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmorphine, theophylline, aminophylline, succinylcholine, reserpine, phenothiazine-type tranquilizers\nSo the corresponding drug entities and relations triplets are:\nmorphine, false, theophylline\nmorphine, false, aminophylline\nmorphine, false, succinylcholine\nmorphine, false, reserpine\nmorphine, false, phenothiazine-type tranquilizers\ntheophylline, false, aminophylline\ntheophylline, false, succinylcholine\ntheophylline, false, reserpine\ntheophylline, false, phenothiazine-type tranquilizers\naminophylline, false, succinylcholine\naminophylline, false, reserpine\naminophylline, false, phenothiazine-type tranquilizers\nsuccinylcholine, false, reserpine\nsuccinylcholine, false, phenothiazine-type tranquilizers\nreserpine, false, phenothiazine-type tranquilizers END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "reduced absorption of folic acid and digoxin have been reported when those agents were administered concomitantly with sulfasalazine.", "output": "Let's think step by step.\nThe drug entities in this text are:\nfolic acid, digoxin, sulfasalazine\nSo the corresponding drug entities and relations triplets are:\nfolic acid, false, digoxin\nfolic acid, mechanism, sulfasalazine\ndigoxin, mechanism, sulfasalazine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "when daily doses of sulfasalazine 2 g and weekly doses of methotrexate 7.5 mg were coadministered to 15 rheumatoid arthritis patients in a drug-drug interaction study, the pharmacokinetic disposition of the drugs was not altered.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsulfasalazine, methotrexate\nSo the corresponding drug entities and relations triplets are:\nsulfasalazine, false, methotrexate END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "daily doses of sulfasalazine 2 g (maximum 3 g) and weekly doses of methotrexate 7.5 mg (maximum 15 mg) were administered alone or in combination to 310 rheumatoid arthritis patients in two controlled 52-week clinical studies.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsulfasalazine, methotrexate\nSo the corresponding drug entities and relations triplets are:\nsulfasalazine, false, methotrexate END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "anticoagulants anabolic steroids may increase sensitivity to oral anticoagulants.", "output": "Let's think step by step.\nThe drug entities in this text are:\nanticoagulants, anabolic steroids, anticoagulants\nSo the corresponding drug entities and relations triplets are:\nanticoagulants, false, anabolic steroids\nanabolic steroids, effect, anticoagulants END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "warfarin: a multidose study of oxandrolone, given as 5 or 10 mg bid in 15 healthy subjects concurrently treated with warfarin, resulted in a mean increase in s-warfarin half-life from 26 to 48 hours and auc from 4.55 to 12.08 ng*hr/ml: similar increases in r-warfarin half-life and auc were also detected.", "output": "Let's think step by step.\nThe drug entities in this text are:\nwarfarin, oxandrolone, warfarin, s-warfarin, r-warfarin\nSo the corresponding drug entities and relations triplets are:\nwarfarin, false, oxandrolone\nwarfarin, false, s-warfarin\nwarfarin, false, r-warfarin\noxandrolone, mechanism, warfarin\noxandrolone, false, s-warfarin\noxandrolone, false, r-warfarin\nwarfarin, false, s-warfarin\nwarfarin, false, r-warfarin\ns-warfarin, false, r-warfarin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "when oxandrolone therapy is initiated in a patient already receiving treatment with warfarin, the inr or prothrombin time (pt) should be monitored closely and the dose of warfarin adjusted as necessary until a stable target inr or pt has been achieved.", "output": "Let's think step by step.\nThe drug entities in this text are:\noxandrolone, warfarin, warfarin\nSo the corresponding drug entities and relations triplets are:\noxandrolone, advise, warfarin\noxandrolone, false, warfarin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "furthermore, in patients receiving both drugs, careful monitoring of the inr or pt, and adjustment of the warfarin dosage if indicated are recommended when the oxandrolone dose is changed or discontinued.", "output": "Let's think step by step.\nThe drug entities in this text are:\nwarfarin, oxandrolone\nSo the corresponding drug entities and relations triplets are:\nwarfarin, advise, oxandrolone END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "oral hypoglycemic agents oxandrolone may inhibit the metabolism of oral hypoglycemic agents.", "output": "Let's think step by step.\nThe drug entities in this text are:\nhypoglycemic agents, oxandrolone, hypoglycemic agents\nSo the corresponding drug entities and relations triplets are:\nhypoglycemic agents, false, oxandrolone\noxandrolone, mechanism, hypoglycemic agents END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "adrenal steroids or acth in patients with edema, concomitant administration with adrenal cortical steroids or acth may increase the edema.", "output": "Let's think step by step.\nThe drug entities in this text are:\nadrenal steroids, acth, adrenal cortical steroids, acth\nSo the corresponding drug entities and relations triplets are:\nadrenal steroids, false, acth\nadrenal steroids, false, adrenal cortical steroids\nadrenal steroids, false, acth\nacth, false, adrenal cortical steroids\nadrenal cortical steroids, false, acth END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "methysergide may reverse the analgesic activity of narcotic analgesics.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmethysergide, narcotic analgesics\nSo the corresponding drug entities and relations triplets are:\nmethysergide, effect, narcotic analgesics END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "concurrent use with vasoconstrictor agents including ergot alkaloids, sumatriptan, and nicotine (e.g. smoking) may result in enhanced vasoconstriction.", "output": "Let's think step by step.\nThe drug entities in this text are:\nvasoconstrictor agents, ergot alkaloids, sumatriptan, nicotine\nSo the corresponding drug entities and relations triplets are:\nvasoconstrictor agents, false, ergot alkaloids\nvasoconstrictor agents, false, sumatriptan\nvasoconstrictor agents, false, nicotine\nergot alkaloids, false, sumatriptan\nergot alkaloids, false, nicotine\nsumatriptan, false, nicotine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "zidovudine competitively inhibits the intracellular phosphorylation of stavudine.", "output": "Let's think step by step.\nThe drug entities in this text are:\nzidovudine, stavudine\nSo the corresponding drug entities and relations triplets are:\nzidovudine, effect, stavudine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "therefore, use of zidovudine in combination with zerit should be avoided.", "output": "Let's think step by step.\nThe drug entities in this text are:\nzidovudine, zerit\nSo the corresponding drug entities and relations triplets are:\nzidovudine, advise, zerit END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in vitro data indicate that the phosphorylation of stavudine is also inhibited at relevant concentrations by doxorubicin and ribavirin.", "output": "Let's think step by step.\nThe drug entities in this text are:\nstavudine, doxorubicin, ribavirin\nSo the corresponding drug entities and relations triplets are:\nstavudine, effect, doxorubicin\nstavudine, effect, ribavirin\ndoxorubicin, false, ribavirin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "when administered concurrently, testolactone may increase the effects of oral anticoagulants;", "output": "Let's think step by step.\nThe drug entities in this text are:\ntestolactone, anticoagulants\nSo the corresponding drug entities and relations triplets are:\ntestolactone, effect, anticoagulants END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "cholestyramine: concomitant cholestyramine administration decreased the mean auc of total ezetimibe approximately 55%.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncholestyramine, cholestyramine, ezetimibe\nSo the corresponding drug entities and relations triplets are:\ncholestyramine, false, ezetimibe\ncholestyramine, mechanism, ezetimibe END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the incremental ldl-c reduction due to adding ezetimibe to cholestyramine may be reduced by this interaction.", "output": "Let's think step by step.\nThe drug entities in this text are:\nezetimibe, cholestyramine\nSo the corresponding drug entities and relations triplets are:\nezetimibe, effect, cholestyramine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "fibrates: the safety and effectiveness of ezetimibe administered with fibrates have not been established.", "output": "Let's think step by step.\nThe drug entities in this text are:\nfibrates, ezetimibe, fibrates\nSo the corresponding drug entities and relations triplets are:\nfibrates, false, ezetimibe\nezetimibe, false, fibrates END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "co-administration of zetia with fibrates is not recommended until use in patients is studied.", "output": "Let's think step by step.\nThe drug entities in this text are:\nzetia, fibrates\nSo the corresponding drug entities and relations triplets are:\nzetia, advise, fibrates END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "fenofibrate: in a pharmacokinetic study, concomitant fenofibrate administration increased total ezetimibe concentrations approximately 1.5-fold.", "output": "Let's think step by step.\nThe drug entities in this text are:\nfenofibrate, fenofibrate, ezetimibe\nSo the corresponding drug entities and relations triplets are:\nfenofibrate, false, ezetimibe\nfenofibrate, mechanism, ezetimibe END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "gemfibrozil: in a pharmacokinetic study, concomitant gemfibrozil administration increased total ezetimibe concentrations approximately 1.7-fold.", "output": "Let's think step by step.\nThe drug entities in this text are:\ngemfibrozil, gemfibrozil, ezetimibe\nSo the corresponding drug entities and relations triplets are:\ngemfibrozil, false, ezetimibe\ngemfibrozil, false, ezetimibe END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "hmg-coa reductase inhibitors: no clinically significant pharmacokinetic interactions were seen when ezetimibe was co-administered with atorvastatin, simvastatin, pravastatin, lovastatin, or fluvastatin.", "output": "Let's think step by step.\nThe drug entities in this text are:\nhmg-coa reductase inhibitors, ezetimibe, atorvastatin, simvastatin, pravastatin, lovastatin, fluvastatin\nSo the corresponding drug entities and relations triplets are:\nhmg-coa reductase inhibitors, false, ezetimibe\nhmg-coa reductase inhibitors, false, atorvastatin\nhmg-coa reductase inhibitors, false, simvastatin\nhmg-coa reductase inhibitors, false, pravastatin\nhmg-coa reductase inhibitors, false, lovastatin\nhmg-coa reductase inhibitors, false, fluvastatin\nezetimibe, false, atorvastatin\nezetimibe, false, simvastatin\nezetimibe, false, pravastatin\nezetimibe, false, lovastatin\nezetimibe, false, fluvastatin\natorvastatin, false, simvastatin\natorvastatin, false, pravastatin\natorvastatin, false, lovastatin\natorvastatin, false, fluvastatin\nsimvastatin, false, pravastatin\nsimvastatin, false, lovastatin\nsimvastatin, false, fluvastatin\npravastatin, false, lovastatin\npravastatin, false, fluvastatin\nlovastatin, false, fluvastatin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "cyclosporine: the total ezetimibe level increased 12-fold in one renal transplant patient receiving multiple medications, including cyclosporine.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncyclosporine, ezetimibe, cyclosporine\nSo the corresponding drug entities and relations triplets are:\ncyclosporine, false, ezetimibe\nezetimibe, mechanism, cyclosporine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "patients who take both ezetimibe and cyclosporine should be carefully monitored.", "output": "Let's think step by step.\nThe drug entities in this text are:\nezetimibe, cyclosporine\nSo the corresponding drug entities and relations triplets are:\nezetimibe, advise, cyclosporine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "multiple dose studies of ezetimibe given in combination with hmg-coa reductase inhibitors (statins) in rats and rabbits during organogenesis result in higher ezetimibe and statin exposures.", "output": "Let's think step by step.\nThe drug entities in this text are:\nezetimibe, hmg-coa reductase inhibitors, statins, ezetimibe\nSo the corresponding drug entities and relations triplets are:\nezetimibe, false, hmg-coa reductase inhibitors\nezetimibe, false, statins\nhmg-coa reductase inhibitors, false, statins\nhmg-coa reductase inhibitors, false, ezetimibe\nstatins, false, ezetimibe END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "when zetia is administered with an hmg-coa reductase inhibitor in a woman of childbearing potential, refer to the pregnancy category and package labeling for the hmg-coa reductase inhibitor.", "output": "Let's think step by step.\nThe drug entities in this text are:\nzetia, hmg-coa reductase inhibitor, hmg-coa reductase inhibitor\nSo the corresponding drug entities and relations triplets are:\nzetia, false, hmg-coa reductase inhibitor\nzetia, false, hmg-coa reductase inhibitor END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "however, ketoconazole, a potent inhibitor of cytochrome p450 3a4, may increase plasma levels of mometasone furoate during concomitant dosing.", "output": "Let's think step by step.\nThe drug entities in this text are:\nketoconazole, mometasone furoate\nSo the corresponding drug entities and relations triplets are:\nketoconazole, mechanism, mometasone furoate END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "skelaxin may enhance the effects of alcohol, barbiturates and other cns depressants.", "output": "Let's think step by step.\nThe drug entities in this text are:\nskelaxin, alcohol, barbiturates, cns depressants\nSo the corresponding drug entities and relations triplets are:\nskelaxin, effect, alcohol\nskelaxin, effect, barbiturates\nskelaxin, effect, cns depressants\nalcohol, false, barbiturates\nalcohol, false, cns depressants\nbarbiturates, false, cns depressants END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the 3-deazaneplanocin a (dznep), one of s-adenosylhomocysteine (adohcy) hydrolase inhibitors, has shown antitumor activities in a broad range of solid tumors and acute myeloid leukemia.", "output": "Let's think step by step.\nThe drug entities in this text are:\n3-deazaneplanocin a, dznep\nSo the corresponding drug entities and relations triplets are:\n3-deazaneplanocin a, false, dznep END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "we also found that bcl-2 was overexpressed in dznep insensitive cells, and cotreatment with dznep and abt-737, a bcl-2 family inhibitor, synergistically inhibited growth and induced apoptosis of dznep insensitive mm cells.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndznep, dznep, abt-737, dznep\nSo the corresponding drug entities and relations triplets are:\ndznep, false, abt-737\ndznep, effect, abt-737\nabt-737, false, dznep END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in addition, dznep insensitivity might be associated with overexpression of bcl-2, and the combination of abt-737 and dznep could synergistically induced apoptosis.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndznep, abt-737, dznep\nSo the corresponding drug entities and relations triplets are:\ndznep, false, abt-737\nabt-737, effect, dznep END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "ephedrine enhances the antinociceptive effect of dexmedetomidine in mice.", "output": "Let's think step by step.\nThe drug entities in this text are:\nephedrine, dexmedetomidine\nSo the corresponding drug entities and relations triplets are:\nephedrine, effect, dexmedetomidine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the purpose of this study was to evaluate whether the psychostimulant drug ephedrine has any effect on dexmedetomidine-induced antinociception and locomotor inhibitor activity in mice in acute application.", "output": "Let's think step by step.\nThe drug entities in this text are:\nephedrine, dexmedetomidine\nSo the corresponding drug entities and relations triplets are:\nephedrine, false, dexmedetomidine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "saline + saline, ephedrine (10   mg/kg) + saline, saline + dexmedetomidine (15     g/kg) and ephedrine (10   mg/kg) + dexmedetomidine (15     g/kg), intraperitoneally, 30 min before hot plate or holed open field tests.", "output": "Let's think step by step.\nThe drug entities in this text are:\nephedrine, dexmedetomidine, ephedrine, dexmedetomidine\nSo the corresponding drug entities and relations triplets are:\nephedrine, false, dexmedetomidine\nephedrine, false, dexmedetomidine\ndexmedetomidine, false, ephedrine\nephedrine, false, dexmedetomidine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in the hot plate test in mice, co-administration of 15     g/kg dexmedetomidine with 10   mg/kg ephedrine intraperitoneally not only enhanced, but also prolonged the duration of antinociception induced by dexmedetomidine.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndexmedetomidine, ephedrine, dexmedetomidine\nSo the corresponding drug entities and relations triplets are:\ndexmedetomidine, effect, ephedrine\nephedrine, false, dexmedetomidine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "at the same time, the locomotor inhibitory effect of dexmedetomidine was counteracted by ephedrine.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndexmedetomidine, ephedrine\nSo the corresponding drug entities and relations triplets are:\ndexmedetomidine, effect, ephedrine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "we concluded that the combined administration of dexmedetomidine with ephedrine may have beneficial effects in the treatment of pain without causing sedation, which limits the use of dexmedetomidine as an analgesic in humans.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndexmedetomidine, ephedrine, dexmedetomidine, analgesic\nSo the corresponding drug entities and relations triplets are:\ndexmedetomidine, effect, ephedrine\ndexmedetomidine, false, analgesic\nephedrine, false, dexmedetomidine\nephedrine, false, analgesic\ndexmedetomidine, false, analgesic END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "protective effect of acetyl-l-carnitine and  alpha lipoic acid against the acute toxicity of diepoxybutane to human lymphocytes.", "output": "Let's think step by step.\nThe drug entities in this text are:\nacetyl-l-carnitine, alpha lipoic acid\nSo the corresponding drug entities and relations triplets are:\nacetyl-l-carnitine, false, alpha lipoic acid END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "(ii) acetyl-l-carnitine elicits a significant protective effect on deb induced toxicity, which was potentiated by  alpha-lipoic acid.", "output": "Let's think step by step.\nThe drug entities in this text are:\nacetyl-l-carnitine, alpha-lipoic acid\nSo the corresponding drug entities and relations triplets are:\nacetyl-l-carnitine, effect, alpha-lipoic acid END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the role of p27(kip1) in dasatinib-enhanced paclitaxel cytotoxicity in human ovarian cancer cells.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndasatinib, paclitaxel\nSo the corresponding drug entities and relations triplets are:\ndasatinib, effect, paclitaxel END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the effect of dasatinib, an inhibitor of src and abl kinases, on paclitaxel sensitivity was measured in ovarian cancer cells and hey xenografts.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndasatinib, paclitaxel\nSo the corresponding drug entities and relations triplets are:\ndasatinib, false, paclitaxel END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the roles of p27(kip1), bcl-2, and cdk1 in apoptosis induced by dasatinib and paclitaxel were assessed using a terminal deoxynucleotidyl transferase-mediated dutp nick-end labeling (tunel) assay, sirna knockdown of gene expression, transfection with bcl-2 and cdk1 expression vectors, and flow cytometry.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndasatinib, paclitaxel\nSo the corresponding drug entities and relations triplets are:\ndasatinib, false, paclitaxel END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "hey cells treated with dasatinib plus paclitaxel formed fewer colonies than did cells treated with either agent alone.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndasatinib, paclitaxel\nSo the corresponding drug entities and relations triplets are:\ndasatinib, effect, paclitaxel END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "treatment of hey xenograft-bearing mice with dasatinib plus paclitaxel inhibited tumor growth more than treatment with either agent alone (average tumor volume per mouse, dasatinib + paclitaxel vs paclitaxel: 0.28 vs. 0.81 cm3, difference = 0.53 cm3, 95% confidence interval [ci] = 0.44 to 0.62 cm3, p = .014);", "output": "Let's think step by step.\nThe drug entities in this text are:\ndasatinib, paclitaxel, dasatinib, paclitaxel, paclitaxel\nSo the corresponding drug entities and relations triplets are:\ndasatinib, effect, paclitaxel\ndasatinib, false, paclitaxel\ndasatinib, false, paclitaxel\npaclitaxel, false, dasatinib\ndasatinib, false, paclitaxel\ndasatinib, false, paclitaxel END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "dasatinib + paclitaxel vs.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndasatinib, paclitaxel\nSo the corresponding drug entities and relations triplets are:\ndasatinib, false, paclitaxel END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the sirna knockdown of p27(kip1) decreased dasatinib- and paclitaxel-induced apoptosis compared with a negative control sirna (sub-g1 fraction, control sirna vs. p27(kip1) sirna: 42.5% vs. 20.1%, difference = 22.4%, 95% ci = 20.1% to 24.7%, p = .017).", "output": "Let's think step by step.\nThe drug entities in this text are:\ndasatinib, paclitaxel\nSo the corresponding drug entities and relations triplets are:\ndasatinib, false, paclitaxel END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "studies with forced expression and sirna knockdown of bcl-2 and cdk1 suggest that dasatinib-mediated induction of p27(kip1) enhanced paclitaxel-induced apoptosis by negatively regulating bcl-2 and cdk1 expression.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndasatinib, paclitaxel\nSo the corresponding drug entities and relations triplets are:\ndasatinib, effect, paclitaxel END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "inhibition of src family and abl kinases with either sirnas or dasatinib enhances paclitaxel sensitivity of ovarian cancer cells through p27(kip1)-mediated suppression of bcl-2 and cdk1 expression.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndasatinib, paclitaxel\nSo the corresponding drug entities and relations triplets are:\ndasatinib, effect, paclitaxel END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "interaction of celecoxib with different anti-cancer drugs is antagonistic in breast but not in other cancer cells.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncelecoxib, anti-cancer drugs\nSo the corresponding drug entities and relations triplets are:\ncelecoxib, effect, anti-cancer drugs END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "this study investigates the ability of cyclooxygenase-2 inhibitors to sensitize cells from different origins to several chemotherapeutic agents.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncyclooxygenase-2 inhibitors, chemotherapeutic agents\nSo the corresponding drug entities and relations triplets are:\ncyclooxygenase-2 inhibitors, false, chemotherapeutic agents END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the sensitivity, cell cycle, apoptosis and dna damage of five different cancer cell lines (hela, hct116, hepg2, mcf7 and u251) to 5-fu, cisplatin, doxorubicin and etoposide   celecoxib following different incubation schedules were analyzed.", "output": "Let's think step by step.\nThe drug entities in this text are:\n5-fu, cisplatin, doxorubicin, etoposide, celecoxib\nSo the corresponding drug entities and relations triplets are:\n5-fu, false, cisplatin\n5-fu, false, doxorubicin\n5-fu, false, etoposide\n5-fu, false, celecoxib\ncisplatin, false, doxorubicin\ncisplatin, false, etoposide\ncisplatin, false, celecoxib\ndoxorubicin, false, etoposide\ndoxorubicin, false, celecoxib\netoposide, false, celecoxib END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "we found antagonism between celecoxib and the four drugs in the breast cancer cells mcf7 following all incubation schedules and between celecoxib and doxorubicin in all cell lines except for two combinations in hct116 cells.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncelecoxib, celecoxib, doxorubicin\nSo the corresponding drug entities and relations triplets are:\ncelecoxib, false, doxorubicin\ncelecoxib, effect, doxorubicin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "these results, if confirmed in-vivo, indicate that celecoxib is not a suitable chemosensitizer for breast cancer or with doxorubicin for other cancers.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncelecoxib, doxorubicin\nSo the corresponding drug entities and relations triplets are:\ncelecoxib, false, doxorubicin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the authors report the case of an infant with confirmed congenital hypothyroidism on levothyroxine who experienced a possible drug interaction with simeticone.", "output": "Let's think step by step.\nThe drug entities in this text are:\nlevothyroxine, simeticone\nSo the corresponding drug entities and relations triplets are:\nlevothyroxine, int, simeticone END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "questioning revealed the child was taking infacol drops before feeds while on levothyroxine.", "output": "Let's think step by step.\nThe drug entities in this text are:\ninfacol, levothyroxine\nSo the corresponding drug entities and relations triplets are:\ninfacol, false, levothyroxine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "drug interaction of thyroxine with simeticone has not been reported previously and is not listed in the british national formulary for children.", "output": "Let's think step by step.\nThe drug entities in this text are:\nthyroxine, simeticone\nSo the corresponding drug entities and relations triplets are:\nthyroxine, false, simeticone END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in vivo cyp3a activity is significantly lower in cyclosporine-treated as compared with tacrolimus-treated renal allograft recipients.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncyclosporine, tacrolimus\nSo the corresponding drug entities and relations triplets are:\ncyclosporine, false, tacrolimus END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in vitro studies have identified cyclosporine and tacrolimus as cyp3a inhibitors.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncyclosporine, tacrolimus\nSo the corresponding drug entities and relations triplets are:\ncyclosporine, false, tacrolimus END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "systemic and apparent oral midazolam clearance were 24% (269    73 vs. 354    102  ml/min, p = 0.022) and 31% (479    190 vs. 688    265  ml/min, p = 0.013), respectively, lower in cyclosporine-treated patients (n = 20) than in matched tacrolimus-treated patients (n = 20).", "output": "Let's think step by step.\nThe drug entities in this text are:\nmidazolam, cyclosporine, tacrolimus\nSo the corresponding drug entities and relations triplets are:\nmidazolam, mechanism, cyclosporine\nmidazolam, false, tacrolimus\ncyclosporine, false, tacrolimus END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the latter displayed midazolam clearances similar to those in two larger cohorts of nonmatched tacrolimus-treated patients (n = 58 and n = 80) and to those receiving a calcineurin inhibitor-free regimen (n = 6).", "output": "Let's think step by step.\nThe drug entities in this text are:\nmidazolam, tacrolimus, calcineurin inhibitor\nSo the corresponding drug entities and relations triplets are:\nmidazolam, false, tacrolimus\nmidazolam, false, calcineurin inhibitor\ntacrolimus, false, calcineurin inhibitor END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "this implies that in vivo hepatic and first-pass cyp3a activities are significantly lower in patients receiving cyclosporine than in those receiving tacrolimus, indicating that, at the doses generally used in clinical practice, cyclosporine is the stronger of the two with respect to cyp3a inhibition.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncyclosporine, tacrolimus, cyclosporine\nSo the corresponding drug entities and relations triplets are:\ncyclosporine, false, tacrolimus\ntacrolimus, false, cyclosporine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "implanon   failure in an hiv-positive woman on antiretroviral therapy resulting in two ectopic pregnancies.", "output": "Let's think step by step.\nThe drug entities in this text are:\nimplanon, antiretroviral\nSo the corresponding drug entities and relations triplets are:\nimplanon, effect, antiretroviral END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "we present an interesting case of an hiv-positive woman on antiretroviral therapy having tubal pregnancies on two separate occasions with implanon in place.", "output": "Let's think step by step.\nThe drug entities in this text are:\nantiretroviral, implanon\nSo the corresponding drug entities and relations triplets are:\nantiretroviral, effect, implanon END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "synergistic interaction between sunitinib and docetaxel is sequence dependent in human non-small lung cancer with egfr tkis-resistant mutation.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsunitinib, docetaxel\nSo the corresponding drug entities and relations triplets are:\nsunitinib, int, docetaxel END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "this study was aimed to investigate the efficacy of single use of sunitinib and that of concurrent or sequential administration of sunitinib and docetaxel in nsclc cell lines that are resistant to egfr tkis.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsunitinib, sunitinib, docetaxel\nSo the corresponding drug entities and relations triplets are:\nsunitinib, false, docetaxel\nsunitinib, false, docetaxel END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "nsclc cell lines with egfr t790m mutation and k-ras mutation were exposed to either sunitinib or docetaxel or both based on various sequential administrations.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsunitinib, docetaxel\nSo the corresponding drug entities and relations triplets are:\nsunitinib, false, docetaxel END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "sunitinib exhibited dose-dependent growth inhibition in nsclc cell lines and arrested cell cycle at g1 phase, whereas docetaxel arrested at s phase.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsunitinib, docetaxel\nSo the corresponding drug entities and relations triplets are:\nsunitinib, false, docetaxel END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "although single or concurrent use of sunitinib and docetaxel has some anti-proliferative effects, the sequential administrations of both drugs remarkably enhanced anti-tumor activity.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsunitinib, docetaxel\nSo the corresponding drug entities and relations triplets are:\nsunitinib, effect, docetaxel END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "when cells were exposed to docetaxel followed by sunitinib, synergism was observed.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndocetaxel, sunitinib\nSo the corresponding drug entities and relations triplets are:\ndocetaxel, effect, sunitinib END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the molecular basis of this synergism is that the signaling pathways that were initially activated by docetaxel exposure were efficiently suppressed by the subsequent exposure to sunitinib.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndocetaxel, sunitinib\nSo the corresponding drug entities and relations triplets are:\ndocetaxel, effect, sunitinib END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "sunitinib as a single agent exhibits anti-proliferative effects in vitro in nsclc cell lines with egfr t790m and k-ras mutations but the sequential administration of docetaxel followed by sunitinib is superior to sunitinib followed by docetaxel and concurrent administration.", "output": "Let's think step by step.\nThe drug entities in this text are:\nsunitinib, docetaxel, sunitinib, sunitinib, docetaxel\nSo the corresponding drug entities and relations triplets are:\nsunitinib, false, docetaxel\nsunitinib, false, docetaxel\ndocetaxel, effect, sunitinib\ndocetaxel, false, sunitinib\nsunitinib, false, docetaxel\nsunitinib, false, docetaxel END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in the present study, we tested whether the highly specific metabotropic glutamate receptor 5 antagonist, 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine, reduces dopaminergic and noradrenergic neuronal loss in monkeys rendered parkinsonian by chronic treatment with low doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.", "output": "Let's think step by step.\nThe drug entities in this text are:\n3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine\nSo the corresponding drug entities and relations triplets are:\n3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine, false, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "weekly intramuscular 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine injections (0.2-0.5 mg/kg body weight), in combination with daily administration of 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine or vehicle, were performed until the development of parkinsonian motor symptoms in either of the two experimental groups (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine versus 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle).", "output": "Let's think step by step.\nThe drug entities in this text are:\n1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine\nSo the corresponding drug entities and relations triplets are:\n1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, false, 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine\n1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, false, 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine\n3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine, false, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine\n3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine, false, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine\n1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, false, 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine\n3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine, false, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "after 21 weeks of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment, all 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle-treated animals displayed parkinsonian symptoms, whereas none of the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine-treated monkeys were significantly affected.", "output": "Let's think step by step.\nThe drug entities in this text are:\n1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine\nSo the corresponding drug entities and relations triplets are:\n1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, false, 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine\n1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, false, 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine\n1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, effect, 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "these behavioural observations were consistent with in vivo positron emission tomography dopamine transporter imaging data, and with post-mortem stereological counts of midbrain dopaminergic neurons, as well as striatal intensity measurements of dopamine transporter and tyrosine hydroxylase immunoreactivity, which were all significantly higher in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine-treated animals than in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle-treated monkeys.", "output": "Let's think step by step.\nThe drug entities in this text are:\n1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine\nSo the corresponding drug entities and relations triplets are:\n1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, effect, 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine\n3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine, false, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine treatment also had a significant effect on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced loss of norepinephrine neurons in the locus coeruleus and adjoining a5 and a7 noradrenaline cell groups.", "output": "Let's think step by step.\nThe drug entities in this text are:\n3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine\nSo the corresponding drug entities and relations triplets are:\n3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine, effect, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/vehicle-treated animals, almost 40% loss of tyrosine hydroxylase-positive norepinephrine neurons was found in locus coeruleus/a5/a7 noradrenaline cell groups, whereas the extent of neuronal loss was lower than 15% of control values in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine-treated monkeys.", "output": "Let's think step by step.\nThe drug entities in this text are:\n1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine\nSo the corresponding drug entities and relations triplets are:\n1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, false, 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine\n1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, effect, 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "our data demonstrate that chronic treatment with the metabotropic glutamate receptor 5 antagonist, 3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine, significantly reduces 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity towards dopaminergic and noradrenergic cell groups in non-human primates.", "output": "Let's think step by step.\nThe drug entities in this text are:\n3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine\nSo the corresponding drug entities and relations triplets are:\n3-[(2-methyl-1,3-thiazol-4-yl) ethynyl] pyridine, effect, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "[interaction between clopidogrel and proton pump inhibitors].", "output": "Let's think step by step.\nThe drug entities in this text are:\nclopidogrel, proton pump inhibitors\nSo the corresponding drug entities and relations triplets are:\nclopidogrel, false, proton pump inhibitors END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the drug interaction between proton pump inhibitors and clopidogrel has been the subject of much study in recent years.", "output": "Let's think step by step.\nThe drug entities in this text are:\nproton pump inhibitors, clopidogrel\nSo the corresponding drug entities and relations triplets are:\nproton pump inhibitors, false, clopidogrel END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "contradictory results regarding the effect of proton pump inhibitors on platelet reactivity and on clinical outcome in clopidogrel-treated patients have been reported in literature.", "output": "Let's think step by step.\nThe drug entities in this text are:\nproton pump inhibitors, clopidogrel\nSo the corresponding drug entities and relations triplets are:\nproton pump inhibitors, false, clopidogrel END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "concomitant use of omeprazole and clopidogrel was found to decrease the exposure (auc) to clopidogrel's active metabolite by 50% and to sharply increase platelet reactivity, as a result of inhibition by omeprazole of cyp2c19, a cytochrome p450 (cyp) enzyme.", "output": "Let's think step by step.\nThe drug entities in this text are:\nomeprazole, clopidogrel, omeprazole\nSo the corresponding drug entities and relations triplets are:\nomeprazole, mechanism, clopidogrel\nclopidogrel, false, omeprazole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "pantoprazole has a much weaker effect on clopidogrel's pharmacokinetics and on platelet reactivity during concomitant use.", "output": "Let's think step by step.\nThe drug entities in this text are:\npantoprazole, clopidogrel\nSo the corresponding drug entities and relations triplets are:\npantoprazole, mechanism, clopidogrel END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the influence of the other proton pump inhibitors when used simultaneously with clopidogrel has not yet been investigated in adequately randomized studies.", "output": "Let's think step by step.\nThe drug entities in this text are:\nproton pump inhibitors, clopidogrel\nSo the corresponding drug entities and relations triplets are:\nproton pump inhibitors, false, clopidogrel END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "regulatory agencies state that the combination of clopidogrel and the cyp2c19 inhibitors omeprazole and esomeprazole should be avoided.", "output": "Let's think step by step.\nThe drug entities in this text are:\nclopidogrel, omeprazole, esomeprazole\nSo the corresponding drug entities and relations triplets are:\nclopidogrel, advise, omeprazole\nclopidogrel, advise, esomeprazole\nomeprazole, false, esomeprazole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "to date, there is no conclusive evidence of a clinically-relevant interaction between any of the proton pump inhibitors and clopidogrel.", "output": "Let's think step by step.\nThe drug entities in this text are:\nproton pump inhibitors, clopidogrel\nSo the corresponding drug entities and relations triplets are:\nproton pump inhibitors, false, clopidogrel END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "effect of ketoconazole-mediated cyp3a4 inhibition on clinical pharmacokinetics of panobinostat (lbh589), an orally active histone deacetylase inhibitor.", "output": "Let's think step by step.\nThe drug entities in this text are:\nketoconazole, panobinostat, lbh589, histone deacetylase inhibitor\nSo the corresponding drug entities and relations triplets are:\nketoconazole, false, panobinostat\nketoconazole, false, lbh589\nketoconazole, false, histone deacetylase inhibitor\npanobinostat, false, lbh589\npanobinostat, false, histone deacetylase inhibitor\nlbh589, false, histone deacetylase inhibitor END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "this study evaluated the effect of a potent cyp3a inhibitor, ketoconazole, on the pharmacokinetics and safety of panobinostat.", "output": "Let's think step by step.\nThe drug entities in this text are:\nketoconazole, panobinostat\nSo the corresponding drug entities and relations triplets are:\nketoconazole, false, panobinostat END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "on day 8, a single panobinostat dose was co-administered with ketoconazole.", "output": "Let's think step by step.\nThe drug entities in this text are:\npanobinostat, ketoconazole\nSo the corresponding drug entities and relations triplets are:\npanobinostat, false, ketoconazole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in the presence of ketoconazole, there was 1.6- and 1.8-fold increase in c (max) and auc of panobinostat, respectively.", "output": "Let's think step by step.\nThe drug entities in this text are:\nketoconazole, panobinostat\nSo the corresponding drug entities and relations triplets are:\nketoconazole, mechanism, panobinostat END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "phase i trial of lenalidomide and cci-779 in patients with relapsed multiple myeloma: evidence for lenalidomide-cci-779 interaction via p-glycoprotein.", "output": "Let's think step by step.\nThe drug entities in this text are:\nlenalidomide, cci-779, lenalidomide, cci-779\nSo the corresponding drug entities and relations triplets are:\nlenalidomide, false, cci-779\nlenalidomide, false, cci-779\ncci-779, false, lenalidomide\nlenalidomide, false, cci-779 END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the preclinical combination of lenalidomide with the mtor inhibitor cci-779 has displayed synergy in vitro and represents a novel combination in mm.", "output": "Let's think step by step.\nThe drug entities in this text are:\nlenalidomide, cci-779\nSo the corresponding drug entities and relations triplets are:\nlenalidomide, effect, cci-779 END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "ticagrelor (brilinta)--better than clopidogrel (plavix)", "output": "Let's think step by step.\nThe drug entities in this text are:\nticagrelor, brilinta, clopidogrel, plavix\nSo the corresponding drug entities and relations triplets are:\nticagrelor, false, brilinta\nticagrelor, false, clopidogrel\nticagrelor, false, plavix\nbrilinta, false, clopidogrel\nbrilinta, false, plavix\nclopidogrel, false, plavix END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the fda has approved ticagrelor (brilinta-astrazeneca), an oral antiplatelet drug, for use with low-dose aspirin to reduce the rate of thrombotic cardiovascular events in patients with acute coronary syndrome (acs).", "output": "Let's think step by step.\nThe drug entities in this text are:\nticagrelor, brilinta, antiplatelet drug, aspirin\nSo the corresponding drug entities and relations triplets are:\nticagrelor, false, brilinta\nticagrelor, false, antiplatelet drug\nticagrelor, effect, aspirin\nbrilinta, false, antiplatelet drug\nbrilinta, effect, aspirin\nantiplatelet drug, false, aspirin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "it will compete with clopidogrel (plavix) and prasugrel (effient) for such use.", "output": "Let's think step by step.\nThe drug entities in this text are:\nclopidogrel, plavix, prasugrel, effient\nSo the corresponding drug entities and relations triplets are:\nclopidogrel, false, plavix\nclopidogrel, false, prasugrel\nclopidogrel, false, effient\nplavix, false, prasugrel\nplavix, false, effient\nprasugrel, false, effient END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "exposure to oral s-ketamine is unaffected by itraconazole but greatly increased by ticlopidine.", "output": "Let's think step by step.\nThe drug entities in this text are:\ns-ketamine, itraconazole, ticlopidine\nSo the corresponding drug entities and relations triplets are:\ns-ketamine, false, itraconazole\ns-ketamine, effect, ticlopidine\nitraconazole, false, ticlopidine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "this study examined drug-drug interactions of oral s-ketamine with the cytochrome p450 (cyp) 2b6 inhibitor ticlopidine and the cyp3a inhibitor itraconazole.", "output": "Let's think step by step.\nThe drug entities in this text are:\ns-ketamine, ticlopidine, itraconazole\nSo the corresponding drug entities and relations triplets are:\ns-ketamine, false, ticlopidine\ns-ketamine, false, itraconazole\nticlopidine, false, itraconazole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in this randomized, blinded, crossover study, 11 healthy volunteers ingested 0.2 mg/kg s-ketamine after pretreatments with oral ticlopidine (250 mg twice daily), itraconazole (200 mg once daily), or placebo in 6-day treatment periods at intervals of 4 weeks.", "output": "Let's think step by step.\nThe drug entities in this text are:\ns-ketamine, ticlopidine, itraconazole\nSo the corresponding drug entities and relations triplets are:\ns-ketamine, false, ticlopidine\ns-ketamine, false, itraconazole\nticlopidine, false, itraconazole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "ticlopidine treatment increased the mean area under the plasma concentration-time curve extrapolated to infinity (auc(0-   )) of oral ketamine by 2.4-fold, whereas itraconazole treatment did not increase the exposure to s-ketamine.", "output": "Let's think step by step.\nThe drug entities in this text are:\nticlopidine, ketamine, itraconazole, s-ketamine\nSo the corresponding drug entities and relations triplets are:\nticlopidine, mechanism, ketamine\nticlopidine, false, itraconazole\nticlopidine, false, s-ketamine\nketamine, false, itraconazole\nketamine, false, s-ketamine\nitraconazole, false, s-ketamine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the ratio of norketamine auc(0-   ) to ketamine auc(0-   ) was significantly decreased in the ticlopidine (p &lt; 0.001) and itraconazole phases (p = 0.006) as compared to placebo.", "output": "Let's think step by step.\nThe drug entities in this text are:\nnorketamine, ketamine, ticlopidine, itraconazole\nSo the corresponding drug entities and relations triplets are:\nnorketamine, false, ketamine\nnorketamine, false, ticlopidine\nnorketamine, false, itraconazole\nketamine, false, ticlopidine\nketamine, false, itraconazole\nticlopidine, false, itraconazole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in the ticlopidine and itraconazole phases, the areas under the effect-time curves (self-reported drowsiness and performance) were significantly higher than those in the placebo phase (p < 0.05).", "output": "Let's think step by step.\nThe drug entities in this text are:\nticlopidine, itraconazole\nSo the corresponding drug entities and relations triplets are:\nticlopidine, false, itraconazole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the findings suggest that the dosage of s-ketamine should be reduced in patients receiving ticlopidine.", "output": "Let's think step by step.\nThe drug entities in this text are:\ns-ketamine, ticlopidine\nSo the corresponding drug entities and relations triplets are:\ns-ketamine, advise, ticlopidine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "improved parathyroid hormone control by cinacalcet is associated with reduction in darbepoetin requirement in patients with end-stage renal disease.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncinacalcet, darbepoetin\nSo the corresponding drug entities and relations triplets are:\ncinacalcet, false, darbepoetin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "uncontrolled hy-per-parathyroidism causes bone marrow fibrosis, leading to erythropoietin (epo) resistance.", "output": "Let's think step by step.\nThe drug entities in this text are:\nerythropoietin, epo\nSo the corresponding drug entities and relations triplets are:\nerythropoietin, false, epo END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "medical treatment with cinacalcet is effective in reducing plasma parathyroid hormone (pth) levels, but its effect on darbepoetin dosing is unknown.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncinacalcet, darbepoetin\nSo the corresponding drug entities and relations triplets are:\ncinacalcet, false, darbepoetin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the primary objective of the study was to ascertain the difference in darbepoetin responsiveness before and after 12 months of cinacalcet therapy.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndarbepoetin, cinacalcet\nSo the corresponding drug entities and relations triplets are:\ndarbepoetin, false, cinacalcet END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "reduction of pth by cinacalcet is associated with a decrease in darbepoetin requirement.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncinacalcet, darbepoetin\nSo the corresponding drug entities and relations triplets are:\ncinacalcet, effect, darbepoetin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "antidepressant-warfarin interaction and associated gastrointestinal bleeding risk in a case-control study.", "output": "Let's think step by step.\nThe drug entities in this text are:\nantidepressant, warfarin\nSo the corresponding drug entities and relations triplets are:\nantidepressant, false, warfarin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "we sought to evaluate whether initiation of an antidepressant increases the risk of hospitalization for gastrointestinal bleeding in warfarin users.", "output": "Let's think step by step.\nThe drug entities in this text are:\nantidepressant, warfarin\nSo the corresponding drug entities and relations triplets are:\nantidepressant, false, warfarin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "warfarin users had an increased odds ratio of gastrointestinal bleeding upon initiation of citalopram (or   =   1.73 [95% ci, 1.25-2.38]), fluoxetine (or   =   1.63 [95% ci, 1.11-2.38]), paroxetine (or   =   1.64 [95% ci, 1.27-2.12]), amitriptyline (or   =   1.47 [95% ci, 1.02-2.11]).", "output": "Let's think step by step.\nThe drug entities in this text are:\nwarfarin, citalopram, fluoxetine, paroxetine, amitriptyline\nSo the corresponding drug entities and relations triplets are:\nwarfarin, effect, citalopram\nwarfarin, effect, fluoxetine\nwarfarin, effect, paroxetine\nwarfarin, effect, amitriptyline\ncitalopram, false, fluoxetine\ncitalopram, false, paroxetine\ncitalopram, false, amitriptyline\nfluoxetine, false, paroxetine\nfluoxetine, false, amitriptyline\nparoxetine, false, amitriptyline END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "also mirtazapine, which is not believed to interact with warfarin, increased the risk of gi bleeding (or   =   1.75 [95% ci, 1.30-2.35]).", "output": "Let's think step by step.\nThe drug entities in this text are:\nmirtazapine, warfarin\nSo the corresponding drug entities and relations triplets are:\nmirtazapine, effect, warfarin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "warfarin users who initiated citalopram, fluoxetine, paroxetine, amitriptyline, or mirtazapine had an increased risk of hospitalization for gastrointestinal bleeding.", "output": "Let's think step by step.\nThe drug entities in this text are:\nwarfarin, citalopram, fluoxetine, paroxetine, amitriptyline, mirtazapine\nSo the corresponding drug entities and relations triplets are:\nwarfarin, effect, citalopram\nwarfarin, effect, fluoxetine\nwarfarin, effect, paroxetine\nwarfarin, effect, amitriptyline\nwarfarin, effect, mirtazapine\ncitalopram, false, fluoxetine\ncitalopram, false, paroxetine\ncitalopram, false, amitriptyline\ncitalopram, false, mirtazapine\nfluoxetine, false, paroxetine\nfluoxetine, false, amitriptyline\nfluoxetine, false, mirtazapine\nparoxetine, false, amitriptyline\nparoxetine, false, mirtazapine\namitriptyline, false, mirtazapine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "enhancement of humoral immune responses to inactivated newcastle disease and avian influenza vaccines by oral administration of ginseng stem-and-leaf saponins in chickens.", "output": "Let's think step by step.\nThe drug entities in this text are:\navian influenza vaccines, ginseng stem-and-leaf saponins\nSo the corresponding drug entities and relations triplets are:\navian influenza vaccines, false, ginseng stem-and-leaf saponins END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the objective of this study was to evaluate the effect of oral administration of ginseng stem-and-leaf saponins (gsls) on the humoral immune responses of chickens to inactivated nd and ai vaccines.", "output": "Let's think step by step.\nThe drug entities in this text are:\nginseng stem-and-leaf saponins, gsls, inactivated nd vaccines, inactivated ai vaccines\nSo the corresponding drug entities and relations triplets are:\nginseng stem-and-leaf saponins, false, gsls\nginseng stem-and-leaf saponins, false, inactivated nd vaccines\nginseng stem-and-leaf saponins, false, inactivated ai vaccines\ngsls, false, inactivated nd vaccines\ngsls, false, inactivated ai vaccines\ninactivated nd vaccines, false, inactivated ai vaccines END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in experiment 1, oral administration of gsls at a dose of 5 mg/kg of bw for 7 d on the immune response in chickens intramuscularly injected with inactivated nd vaccine was evaluated.", "output": "Let's think step by step.\nThe drug entities in this text are:\ngsls, inactivated nd vaccine\nSo the corresponding drug entities and relations triplets are:\ngsls, false, inactivated nd vaccine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in experiment 2, the same regimen of gsls was administered to chickens inoculated with inactivated ai vaccines, and an enhanced serum antibody response to ai vaccination was also observed.", "output": "Let's think step by step.\nThe drug entities in this text are:\ngsls, inactivated ai vaccines\nSo the corresponding drug entities and relations triplets are:\ngsls, effect, inactivated ai vaccines END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "calcium does not inhibit the absorption of 5 milligrams of nonheme or heme iron at doses less than 800 milligrams in nonpregnant women.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncalcium, nonheme iron, heme iron\nSo the corresponding drug entities and relations triplets are:\ncalcium, false, nonheme iron\ncalcium, false, heme iron\nnonheme iron, false, heme iron END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "calcium is the only known component in the diet that may affect absorption of both nonheme and heme iron.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncalcium, nonheme iron, heme iron\nSo the corresponding drug entities and relations triplets are:\ncalcium, mechanism, nonheme iron\ncalcium, mechanism, heme iron\nnonheme iron, false, heme iron END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "however, the evidence for a calcium effect on iron absorption mainly comes from studies that did not isolate the effect of calcium from that of other dietary components, because it was detected in single-meal studies.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncalcium, iron, calcium\nSo the corresponding drug entities and relations triplets are:\ncalcium, mechanism, iron\niron, false, calcium END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "our objective was to establish potential effects of calcium on absorption of nonheme and heme iron and the dose response for this effect in the absence of a meal.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncalcium, nonheme iron, heme iron\nSo the corresponding drug entities and relations triplets are:\ncalcium, false, nonheme iron\ncalcium, false, heme iron\nnonheme iron, false, heme iron END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "we evaluated the effects of calcium doses between 200 and 1500 mg on absorption of 5 mg nonheme iron (as ferrous sulfate).", "output": "Let's think step by step.\nThe drug entities in this text are:\ncalcium, nonheme iron, ferrous sulfate\nSo the corresponding drug entities and relations triplets are:\ncalcium, false, nonheme iron\ncalcium, false, ferrous sulfate\nnonheme iron, false, ferrous sulfate END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "we also evaluated the effects of calcium doses between 200 and 800 mg on absorption of 5 mg heme iron [as concentrated rbc (crbc)].", "output": "Let's think step by step.\nThe drug entities in this text are:\ncalcium, heme iron\nSo the corresponding drug entities and relations triplets are:\ncalcium, false, heme iron END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "calcium was administered as calcium chloride in all studies and minerals were ingested on an empty stomach.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncalcium, calcium chloride, minerals\nSo the corresponding drug entities and relations triplets are:\ncalcium, false, calcium chloride\ncalcium, false, minerals\ncalcium chloride, false, minerals END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "calcium doses   1000 mg diminished nonheme iron absorption by an average of 49.6%.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncalcium, nonheme iron\nSo the corresponding drug entities and relations triplets are:\ncalcium, mechanism, nonheme iron END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "a calcium dose of 800 mg diminished absorption of 5 mg heme iron by 37.7%.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncalcium, heme iron\nSo the corresponding drug entities and relations triplets are:\ncalcium, mechanism, heme iron END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in conclusion, we demonstrated an isolated effect of calcium (as chloride) on absorption of 5 mg of iron provided as nonheme (as sulfate) and heme (as crbc) iron.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncalcium, nonheme iron, heme iron\nSo the corresponding drug entities and relations triplets are:\ncalcium, mechanism, nonheme iron\ncalcium, mechanism, heme iron\nnonheme iron, false, heme iron END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "amphetamine locomotor sensitization and conditioned place preference in adolescent male and female rats neonatally treated with quinpirole.", "output": "Let's think step by step.\nThe drug entities in this text are:\namphetamine, quinpirole\nSo the corresponding drug entities and relations triplets are:\namphetamine, false, quinpirole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the objective was to analyze the effects of neonatal quinpirole treatment on effects of amphetamine in adolescent rats using locomotor sensitization and conditioned place preference procedures.", "output": "Let's think step by step.\nThe drug entities in this text are:\nquinpirole, amphetamine\nSo the corresponding drug entities and relations triplets are:\nquinpirole, false, amphetamine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in female rats, neonatal quinpirole treatment enhanced amphetamine locomotor sensitization compared with quinpirole-free controls sensitized to amphetamine.", "output": "Let's think step by step.\nThe drug entities in this text are:\nquinpirole, amphetamine, quinpirole, amphetamine\nSo the corresponding drug entities and relations triplets are:\nquinpirole, effect, amphetamine\nquinpirole, false, amphetamine\namphetamine, false, quinpirole\nquinpirole, false, amphetamine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "male rats demonstrated sensitization to amphetamine, although this was muted compared with female rats, and were unaffected by neonatal quinpirole.", "output": "Let's think step by step.\nThe drug entities in this text are:\namphetamine, quinpirole\nSo the corresponding drug entities and relations triplets are:\namphetamine, false, quinpirole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "rats treated with neonatal quinpirole enhanced time spent in the amphetamine-paired context compared with quinpirole-free controls conditioned with amphetamine, but only female controls conditioned with amphetamine spent more time in the drug-paired context compared with saline-treated controls.", "output": "Let's think step by step.\nThe drug entities in this text are:\nquinpirole, amphetamine, quinpirole, amphetamine, amphetamine\nSo the corresponding drug entities and relations triplets are:\nquinpirole, false, amphetamine\nquinpirole, false, amphetamine\nquinpirole, false, amphetamine\namphetamine, false, quinpirole\nquinpirole, false, amphetamine\nquinpirole, false, amphetamine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in vitro activity of minocycline combined with fosfomycin against clinical isolates of methicillin-resistant staphylococcus aureus.", "output": "Let's think step by step.\nThe drug entities in this text are:\nminocycline, fosfomycin, methicillin\nSo the corresponding drug entities and relations triplets are:\nminocycline, false, fosfomycin\nminocycline, false, methicillin\nfosfomycin, false, methicillin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "this study aimed to evaluate the in vitro activity of minocycline combined with fosfomycin against isolates of methicillin-resistant staphylococcus aureus (mrsa).", "output": "Let's think step by step.\nThe drug entities in this text are:\nminocycline, fosfomycin, methicillin\nSo the corresponding drug entities and relations triplets are:\nminocycline, false, fosfomycin\nminocycline, false, methicillin\nfosfomycin, false, methicillin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the susceptibility results for minocycline and fosfomycin were interpreted according to the most relevant criteria.", "output": "Let's think step by step.\nThe drug entities in this text are:\nminocycline, fosfomycin\nSo the corresponding drug entities and relations triplets are:\nminocycline, false, fosfomycin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the combination of minocycline and fosfomycin can be synergistic against mrsa.", "output": "Let's think step by step.\nThe drug entities in this text are:\nminocycline, fosfomycin\nSo the corresponding drug entities and relations triplets are:\nminocycline, effect, fosfomycin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "lapatinib enhances herceptin-mediated antibody-dependent cellular cytotoxicity by up-regulation of cell surface her2 expression.", "output": "Let's think step by step.\nThe drug entities in this text are:\nlapatinib, herceptin\nSo the corresponding drug entities and relations triplets are:\nlapatinib, effect, herceptin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "although it was previously reported that lapatinib combined with herceptin improved the progression-free survival rate compared with lapatinib alone for patients with herceptin-refractory her2-positive metastatic breast cancer, the mechanism is purported to be an antiproliferative effect relating to the synergism of these two agents.", "output": "Let's think step by step.\nThe drug entities in this text are:\nlapatinib, herceptin, lapatinib, herceptin\nSo the corresponding drug entities and relations triplets are:\nlapatinib, effect, herceptin\nlapatinib, false, herceptin\nherceptin, false, lapatinib\nlapatinib, false, herceptin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "we evaluated how lapatinib interacts with herceptin in her2-positive breast cancer, with a particular focus on herceptin-mediated antibody-dependent cellular cytotoxicity (adcc).", "output": "Let's think step by step.\nThe drug entities in this text are:\nlapatinib, herceptin, herceptin\nSo the corresponding drug entities and relations triplets are:\nlapatinib, false, herceptin\nlapatinib, false, herceptin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in an in vitro assay, lapatinib induced her2 expression at the cell surface of her2-positive breast cancer cell lines, leading to the enhancement of herceptin-mediated adcc.", "output": "Let's think step by step.\nThe drug entities in this text are:\nlapatinib, herceptin\nSo the corresponding drug entities and relations triplets are:\nlapatinib, effect, herceptin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "furthermore, we present a case report in which a second herceptin treatment following lapatinib resulted in the marked shrinkage of multiple metastatic tumors in her2-positive breast cancer.", "output": "Let's think step by step.\nThe drug entities in this text are:\nherceptin, lapatinib\nSo the corresponding drug entities and relations triplets are:\nherceptin, effect, lapatinib END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "lapatinib may have the potential to convert herceptin-refractory to herceptin-sensitive tumors in her2-positive breast cancer by up-regulation of the cell surface expression of her2.", "output": "Let's think step by step.\nThe drug entities in this text are:\nlapatinib, herceptin, herceptin\nSo the corresponding drug entities and relations triplets are:\nlapatinib, false, herceptin\nlapatinib, false, herceptin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "influence of piperine on ibuprofen induced antinociception and its pharmacokinetics.", "output": "Let's think step by step.\nThe drug entities in this text are:\npiperine, ibuprofen\nSo the corresponding drug entities and relations triplets are:\npiperine, false, ibuprofen END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "in the present study piperine (10 mg/kg) significantly increased the dose-dependent antinociceptive activity of ibuprofen evaluated by both acetic acid writhing and formalin test, when it was administered with ibuprofen.", "output": "Let's think step by step.\nThe drug entities in this text are:\npiperine, ibuprofen, acetic acid, ibuprofen\nSo the corresponding drug entities and relations triplets are:\npiperine, effect, ibuprofen\npiperine, false, acetic acid\npiperine, false, ibuprofen\nibuprofen, false, acetic acid\nacetic acid, false, ibuprofen END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "ibuprofen plasma concentration was also increased when it was administered with piperine.", "output": "Let's think step by step.\nThe drug entities in this text are:\nibuprofen, piperine\nSo the corresponding drug entities and relations triplets are:\nibuprofen, mechanism, piperine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the synergistic antinociception activity of ibuprofen when administered with piperine can be attributed to increased plasma concentration of ibuprofen.", "output": "Let's think step by step.\nThe drug entities in this text are:\nibuprofen, piperine, ibuprofen\nSo the corresponding drug entities and relations triplets are:\nibuprofen, mechanism, piperine\npiperine, false, ibuprofen END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "from this study it can be concluded that piperine can be used as a bioenhancer along with ibuprofen.", "output": "Let's think step by step.\nThe drug entities in this text are:\npiperine, ibuprofen\nSo the corresponding drug entities and relations triplets are:\npiperine, effect, ibuprofen END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "to determine whether the co-injection of extracellular matrix degrading enzymes improves retinal transduction following intravitreal delivery of adeno-associated virus-2 (aav2).", "output": "Let's think step by step.\nThe drug entities in this text are:\nadeno-associated virus-2, aav2\nSo the corresponding drug entities and relations triplets are:\nadeno-associated virus-2, false, aav2 END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "aav2 containing cdna encoding enhanced green fluorescent protein (gfp), under the control of a chicken   -actin promoter, was delivered by intravitreal injection to adult mice in conjunction with enzymes including collagenase, hyaluronan lyase, heparinase iii, or chondroitin abc lyase.", "output": "Let's think step by step.\nThe drug entities in this text are:\naav2, collagenase, hyaluronan lyase, heparinase iii, chondroitin abc lyase\nSo the corresponding drug entities and relations triplets are:\naav2, false, collagenase\naav2, false, hyaluronan lyase\naav2, false, heparinase iii\naav2, false, chondroitin abc lyase\ncollagenase, false, hyaluronan lyase\ncollagenase, false, heparinase iii\ncollagenase, false, chondroitin abc lyase\nhyaluronan lyase, false, heparinase iii\nhyaluronan lyase, false, chondroitin abc lyase\nheparinase iii, false, chondroitin abc lyase END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the addition of heparinase iii or chondroitin abc lyase greatly enhanced transduction of the retinal ganglion cell layer and increased the depth of transduction into the outer retina.", "output": "Let's think step by step.\nThe drug entities in this text are:\nheparinase iii, chondroitin abc lyase\nSo the corresponding drug entities and relations triplets are:\nheparinase iii, false, chondroitin abc lyase END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "hyaluronan lyase had a limited effect and collagenase was ineffective.", "output": "Let's think step by step.\nThe drug entities in this text are:\nhyaluronan lyase, collagenase\nSo the corresponding drug entities and relations triplets are:\nhyaluronan lyase, false, collagenase END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "electroretinograms survived with higher concentrations of heparinase iii and chondroitin abc lyase than were required for optimal retinal transduction.", "output": "Let's think step by step.\nThe drug entities in this text are:\nheparinase iii, chondroitin abc lyase\nSo the corresponding drug entities and relations triplets are:\nheparinase iii, false, chondroitin abc lyase END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "aav2-mediated retinal transduction is improved by co-injection of heparinase iii or chondroitin abc lyase.", "output": "Let's think step by step.\nThe drug entities in this text are:\naav2, heparinase iii, chondroitin abc lyase\nSo the corresponding drug entities and relations triplets are:\naav2, effect, heparinase iii\naav2, effect, chondroitin abc lyase\nheparinase iii, false, chondroitin abc lyase END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the aim of the present study was to investigate whether hb-egf is a therapeutic target for t-all, and to further elucidate the antitumor effects of a specific inhibitor of hb-egf, cross-reacting material 197 (crm197).", "output": "Let's think step by step.\nThe drug entities in this text are:\ncross-reacting material 197, crm197\nSo the corresponding drug entities and relations triplets are:\ncross-reacting material 197, false, crm197 END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "we elucidated the expression of hb-egf in t-all cell lines, and evaluated the effect of crm197 on these cells alone or in combination with anticancer agent.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncrm197, anticancer agent\nSo the corresponding drug entities and relations triplets are:\ncrm197, false, anticancer agent END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "crm197 induced apoptosis, and furthermore, the combination of crm197 plus doxorubicin enhanced cytotoxicity in a t-all cell line.", "output": "Let's think step by step.\nThe drug entities in this text are:\ncrm197, crm197, doxorubicin\nSo the corresponding drug entities and relations triplets are:\ncrm197, false, doxorubicin\ncrm197, effect, doxorubicin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "prevention of emergence agitation in seven children receiving low-dose ketamine and propofol total intravenous anesthesia.", "output": "Let's think step by step.\nThe drug entities in this text are:\nketamine, propofol\nSo the corresponding drug entities and relations triplets are:\nketamine, false, propofol END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "we retrospectively reviewed the records of 7 pediatric oncology patients who received low-dose ketamine in conjunction with propofol for total intravenous anesthesia (tiva) repeatedly for radiation therapy.", "output": "Let's think step by step.\nThe drug entities in this text are:\nketamine, propofol\nSo the corresponding drug entities and relations triplets are:\nketamine, false, propofol END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "ea signs were observed in all 7 patients in association with propofol tiva but did not recur in any of 123 subsequent anesthetics sessions during which low-dose ketamine was added to propofol.", "output": "Let's think step by step.\nThe drug entities in this text are:\npropofol, ketamine, propofol\nSo the corresponding drug entities and relations triplets are:\npropofol, false, ketamine\nketamine, false, propofol END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "based on this experience, we suggest that low-dose ketamine added to propofol may be associated with prevention of ea in children with a history of ea with propofol tiva.", "output": "Let's think step by step.\nThe drug entities in this text are:\nketamine, propofol, propofol\nSo the corresponding drug entities and relations triplets are:\nketamine, effect, propofol\nketamine, false, propofol END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "distinct synergistic action of piperacillin and methylglyoxal against pseudomonas aeruginosa.", "output": "Let's think step by step.\nThe drug entities in this text are:\npiperacillin, methylglyoxal\nSo the corresponding drug entities and relations triplets are:\npiperacillin, false, methylglyoxal END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "results revealed that the strains were resistant to many drugs at high levels, only piperacillin, carbenicillin, amikacin and ciprofloxacin showed resistances at comparatively lower levels.", "output": "Let's think step by step.\nThe drug entities in this text are:\npiperacillin, carbenicillin, amikacin, ciprofloxacin\nSo the corresponding drug entities and relations triplets are:\npiperacillin, false, carbenicillin\npiperacillin, false, amikacin\npiperacillin, false, ciprofloxacin\ncarbenicillin, false, amikacin\ncarbenicillin, false, ciprofloxacin\namikacin, false, ciprofloxacin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "distinct and statistically significant synergism was observed between methylglyoxal and piperacillin by disc diffusion tests when compared with their individual effects.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmethylglyoxal, piperacillin\nSo the corresponding drug entities and relations triplets are:\nmethylglyoxal, effect, piperacillin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "synergism was also noted when methylglyoxal was combined with carbenicillin and amikacin.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmethylglyoxal, carbenicillin, amikacin\nSo the corresponding drug entities and relations triplets are:\nmethylglyoxal, effect, carbenicillin\nmethylglyoxal, effect, amikacin\ncarbenicillin, false, amikacin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "interaction study of moxifloxacin and lomefloxacin with co-administered drugs.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmoxifloxacin, lomefloxacin\nSo the corresponding drug entities and relations triplets are:\nmoxifloxacin, false, lomefloxacin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "moxifloxacin and lomefloxacin are fluoroquinolone antibiotics used in treating urinary and respiratory tract infections.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmoxifloxacin, lomefloxacin, fluoroquinolone antibiotics\nSo the corresponding drug entities and relations triplets are:\nmoxifloxacin, false, lomefloxacin\nmoxifloxacin, false, fluoroquinolone antibiotics\nlomefloxacin, false, fluoroquinolone antibiotics END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "being moxifloxacin and lomefloxacin fluoroquinolones the interaction study of was carried out with sucralfate, gelusil, erythromycin and multi minerals.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmoxifloxacin, fluoroquinolones, sucralfate, gelusil, erythromycin, multi minerals\nSo the corresponding drug entities and relations triplets are:\nmoxifloxacin, false, fluoroquinolones\nmoxifloxacin, false, sucralfate\nmoxifloxacin, false, gelusil\nmoxifloxacin, false, erythromycin\nmoxifloxacin, false, multi minerals\nfluoroquinolones, false, sucralfate\nfluoroquinolones, false, gelusil\nfluoroquinolones, false, erythromycin\nfluoroquinolones, false, multi minerals\nsucralfate, false, gelusil\nsucralfate, false, erythromycin\nsucralfate, false, multi minerals\ngelusil, false, erythromycin\ngelusil, false, multi minerals\nerythromycin, false, multi minerals END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the response of moxifloxacin and lomefloxacin after interaction with co-administered drugs at different conditions and temperature were noted using a shimadzu hplc system with pda detector.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmoxifloxacin, lomefloxacin\nSo the corresponding drug entities and relations triplets are:\nmoxifloxacin, false, lomefloxacin END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "moxifloxacin and lomefloxacin reacts faster with sucralfate and gelusil in acidic media whereas with erythromycin in basic media and multi-minerals in neutral media.", "output": "Let's think step by step.\nThe drug entities in this text are:\nmoxifloxacin, lomefloxacin, sucralfate, gelusil, erythromycin, multi-minerals\nSo the corresponding drug entities and relations triplets are:\nmoxifloxacin, false, lomefloxacin\nmoxifloxacin, mechanism, sucralfate\nmoxifloxacin, mechanism, gelusil\nmoxifloxacin, mechanism, erythromycin\nmoxifloxacin, mechanism, multi-minerals\nlomefloxacin, mechanism, sucralfate\nlomefloxacin, mechanism, gelusil\nlomefloxacin, mechanism, erythromycin\nlomefloxacin, mechanism, multi-minerals\nsucralfate, false, gelusil\nsucralfate, false, erythromycin\nsucralfate, false, multi-minerals\ngelusil, false, erythromycin\ngelusil, false, multi-minerals\nerythromycin, false, multi-minerals END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "tamoxifen, an estrogen antagonist, is the standard hormone treatment for breast cancer.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntamoxifen, estrogen antagonist\nSo the corresponding drug entities and relations triplets are:\ntamoxifen, false, estrogen antagonist END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "paroxetine and fluoxetine reduce the plasma concentration of endoxifen by about 50%.", "output": "Let's think step by step.\nThe drug entities in this text are:\nparoxetine, fluoxetine, endoxifen\nSo the corresponding drug entities and relations triplets are:\nparoxetine, false, fluoxetine\nparoxetine, mechanism, endoxifen\nfluoxetine, mechanism, endoxifen END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "it is better to avoid prescribing isoenzyme cyp 2d6 inhibitors to women treated with tamoxifen for breast cancer, especially ssri antidepressants such as paroxetine and fluoxetine.", "output": "Let's think step by step.\nThe drug entities in this text are:\ntamoxifen, ssri antidepressants, paroxetine, fluoxetine\nSo the corresponding drug entities and relations triplets are:\ntamoxifen, advise, ssri antidepressants\ntamoxifen, advise, paroxetine\ntamoxifen, advise, fluoxetine\nssri antidepressants, false, paroxetine\nssri antidepressants, false, fluoxetine\nparoxetine, false, fluoxetine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "depression does not always require antidepressant drug therapy, and antidepressants have no proven preventive impact on hot flushes linked to the menopause.", "output": "Let's think step by step.\nThe drug entities in this text are:\nantidepressant drug, antidepressants\nSo the corresponding drug entities and relations triplets are:\nantidepressant drug, false, antidepressants END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "if in certain cases, an antidepressant is considered necessary, it may be advisable to replace tamoxifen with anastrozole.", "output": "Let's think step by step.\nThe drug entities in this text are:\nantidepressant, tamoxifen, anastrozole\nSo the corresponding drug entities and relations triplets are:\nantidepressant, advise, tamoxifen\nantidepressant, false, anastrozole\ntamoxifen, false, anastrozole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "[efficacy of fixed combination amlodipine/valsartan in hospitalized patients with hypertensive disease]", "output": "Let's think step by step.\nThe drug entities in this text are:\namlodipine, valsartan\nSo the corresponding drug entities and relations triplets are:\namlodipine, false, valsartan END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "efficacy and tolerability of fixed amlodipine/valsartan combination was studied in 86 patients with hypertensive disease hospitalized in departments of general internal medicine or cardiology.", "output": "Let's think step by step.\nThe drug entities in this text are:\namlodipine, valsartan\nSo the corresponding drug entities and relations triplets are:\namlodipine, false, valsartan END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "all patients had indications for antihypertensive therapy and were randomized either to fixed combination amlodipine/valsartan (n=43) or to therapy which corresponded to the hospital formulary (n=43).", "output": "Let's think step by step.\nThe drug entities in this text are:\namlodipine, valsartan\nSo the corresponding drug entities and relations triplets are:\namlodipine, false, valsartan END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "rate of achievement of target bp with fixed combination amlodipine/valsartan (93%) was comparable with that on traditional therapy (90%).", "output": "Let's think step by step.\nThe drug entities in this text are:\namlodipine, valsartan\nSo the corresponding drug entities and relations triplets are:\namlodipine, false, valsartan END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "but the use of fixed combination amlodipine/valsartan compared with traditional therapy was associated with lower clinical and self measured bp, quicker achievement of target bp (5.8+/-2.3 and 9.2+/-1.8 days, respectively, 0.05), lesser number of antihypertensive drugs (2.5+/-0.6 and 3.0+/-0.9 days, respectively), lower rate of concealed inefficacy of treatment (12 and 31%, respectively, 0.05).", "output": "Let's think step by step.\nThe drug entities in this text are:\namlodipine, valsartan, antihypertensive drugs\nSo the corresponding drug entities and relations triplets are:\namlodipine, effect, valsartan\namlodipine, false, antihypertensive drugs\nvalsartan, false, antihypertensive drugs END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "we have demonstrated appropriateness of inhospital administration of fixed amlodipine/valsartan combination as an approach allowing to achieve target bp in shorter time, with the use of fewer antihypertensive drugs, and diminishing concealed inefficacy of treatment.", "output": "Let's think step by step.\nThe drug entities in this text are:\namlodipine, valsartan, antihypertensive drugs\nSo the corresponding drug entities and relations triplets are:\namlodipine, effect, valsartan\namlodipine, false, antihypertensive drugs\nvalsartan, false, antihypertensive drugs END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "interaction of dacarbazine and imexon, in vitro and in vivo, in human a375 melanoma cells.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndacarbazine, imexon\nSo the corresponding drug entities and relations triplets are:\ndacarbazine, false, imexon END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "we evaluated mechanisms of interaction between the alkyating agent dacarbazine (dtic) and the pro-oxidant, imexon, in the human a375 melanoma cell line.", "output": "Let's think step by step.\nThe drug entities in this text are:\ndacarbazine, dtic, imexon\nSo the corresponding drug entities and relations triplets are:\ndacarbazine, false, dtic\ndacarbazine, false, imexon\ndtic, false, imexon END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the effect of dtic and imexon, alone and in combination, was evaluated for growth inhibition (mtt), radiolabeled drug uptake, cellular thiol content (hplc), and dna strand breaks (comet assay).", "output": "Let's think step by step.\nThe drug entities in this text are:\ndtic, imexon\nSo the corresponding drug entities and relations triplets are:\ndtic, false, imexon END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "there was a >75% reduction in cellular glutathione and cysteine with imexon but not dtic.", "output": "Let's think step by step.\nThe drug entities in this text are:\nimexon, dtic\nSo the corresponding drug entities and relations triplets are:\nimexon, false, dtic END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "imexon and dacarbazine show additive effects in vitro but not in vivo in human a375 melanoma cells.", "output": "Let's think step by step.\nThe drug entities in this text are:\nimexon, dacarbazine\nSo the corresponding drug entities and relations triplets are:\nimexon, effect, dacarbazine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "[influence of hemantane and doxycycline on mptp-evoked behavior violations in c57bl/6 mice].", "output": "Let's think step by step.\nThe drug entities in this text are:\nhemantane, doxycycline\nSo the corresponding drug entities and relations triplets are:\nhemantane, false, doxycycline END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the effects of anti-parkinsonian drug hemantane [(2-adamantyl)hexamethylenimine] (10 mg/kg, p. o.)", "output": "Let's think step by step.\nThe drug entities in this text are:\nanti-parkinsonian drug, hemantane, (2-adamantyl)hexamethylenimine\nSo the corresponding drug entities and relations triplets are:\nanti-parkinsonian drug, false, hemantane\nanti-parkinsonian drug, false, (2-adamantyl)hexamethylenimine\nhemantane, false, (2-adamantyl)hexamethylenimine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "and/or antibiotic drug doxycycline (100 mg/kg, p. o.), as well as that of neurotoxin 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine (mptp) (4 x 20 mg/kg, i. p.)", "output": "Let's think step by step.\nThe drug entities in this text are:\nantibiotic drug, doxycycline, 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine, mptp\nSo the corresponding drug entities and relations triplets are:\nantibiotic drug, false, doxycycline\nantibiotic drug, false, 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine\nantibiotic drug, false, mptp\ndoxycycline, false, 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine\ndoxycycline, false, mptp\n1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine, false, mptp END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "acute administration of hemantane or doxycycline failed to influence locomotion in mice, while their combination normalized motor activity.", "output": "Let's think step by step.\nThe drug entities in this text are:\nhemantane, doxycycline\nSo the corresponding drug entities and relations triplets are:\nhemantane, effect, doxycycline END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "the incubations were performed in the absence and presence of the non-specific cyp inhibitor, 1-aminobenzotriazole (abt) and isoform-specific inhibitors.", "output": "Let's think step by step.\nThe drug entities in this text are:\n1-aminobenzotriazole, abt\nSo the corresponding drug entities and relations triplets are:\n1-aminobenzotriazole, false, abt END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "abt decreased the toxicity of precocene i, increased exposure to parent compound, and decreased metabolite levels in a dose-dependent manner.", "output": "Let's think step by step.\nThe drug entities in this text are:\nabt, precocene i\nSo the corresponding drug entities and relations triplets are:\nabt, effect, precocene i END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "of the isoform-specific cyp inhibitors tested for an effect on the precocene i metabolite profile, only tranylcypromine was noticeably effective, indicating a role of cyps 2a6, 2c9, 2cl9, and 2e1.", "output": "Let's think step by step.\nThe drug entities in this text are:\nprecocene i, tranylcypromine\nSo the corresponding drug entities and relations triplets are:\nprecocene i, false, tranylcypromine END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "with respect to toxicity, the order of cyp inhibitor effectiveness was abt>diethyldithiocarbamate~tranylcypromine>ketoconazole.", "output": "Let's think step by step.\nThe drug entities in this text are:\nabt, diethyldithiocarbamate, tranylcypromine, ketoconazole\nSo the corresponding drug entities and relations triplets are:\nabt, false, diethyldithiocarbamate\nabt, false, tranylcypromine\nabt, false, ketoconazole\ndiethyldithiocarbamate, false, tranylcypromine\ndiethyldithiocarbamate, false, ketoconazole\ntranylcypromine, false, ketoconazole END"}
{"instruction": "Extract drug entities and their relationships from the following biomedical text.", "input": "furafylline and sulfaphenazole had no effect, while quinidine appeared to augment precocene i toxicity.", "output": "Let's think step by step.\nThe drug entities in this text are:\nfurafylline, sulfaphenazole, quinidine, precocene i\nSo the corresponding drug entities and relations triplets are:\nfurafylline, false, sulfaphenazole\nfurafylline, false, quinidine\nfurafylline, false, precocene i\nsulfaphenazole, false, quinidine\nsulfaphenazole, false, precocene i\nquinidine, effect, precocene i END"}
